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 Abstract 
The natural product fijiolide A is a secondary metabolite isolated from a marine-derived 
actinomycete of the genus Nocardiopsis. It displays inhibitory activity against TNF-α-induced 
activation of NFκB, an important transcription factor and a potential target for the treatment of 
different cancers and inflammation related diseases. Structurally, fijiolide A impresses by its highly 
complex molecular architecture, featuring a polychlorinated and rotationally restricted 
[2.6]paracyclophane core. The embedded highly unsaturated cyclopenta[a]indene framework is 
glycosylated with an amino ribopyranose unit. Fijiolide A is related to the Bergman 
cycloaromatization product of the C-1027 chromophore and is proposed to stem from a similar 
biosynthetic enediyne precursor. This thesis outlines a total synthesis of fijiolide A. Our synthetic 
approach features an intermolecular ruthenium-catalyzed [2+2+2] cycloaddition of three different 
alkynes to assemble the heavily substituted central arene core. Only 10 further steps were required 
to build up the strained [2.6]paracyclophane core of the fijiolide A aglycone. For this purpose we 
engineered an unprecedented macroetherification process that proceeds with remarkably high 
regio- and atropselectivity via a templated nucleophilic substitution. A late-stage glycosylation of 
the sterically encumbered tertiary alcohol enabled, for the first time, access to fijiolide A. Overall, 
the natural product fijiolide A was synthesized in a longest linear sequence of 18 steps from 
commercially available starting material. 
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Keywords: total synthesis, natural products, fijiolide, [2+2+2] cycloaddition, Pauson-Khand 
reaction, paracyclophane formation, atropselectivity, glycosylation.   
  
  
Kurzfassung 
Der Naturstoff Fijiolid A ist ein von einem marinen Actinomyceten der Gattung Nocardiopsis 
produzierter Sekundärmetabolit. Er zeigt inhibitorische Aktivität gegen TNF-α induzierte 
Aktivierung von NFκB. NFκB ist ein bedeutender Transkriptionsfaktor und potenzielles 
Zielmolekül für die Behandlung von verschiedenen Krebsarten und Entzündungskrankheiten. 
Strukturell besticht Fijiolid A durch einen hochkomplexen molekularen Aufbau und weist ein 
polychloriniertes, rotationseingeschränktes [2.6]Paracyclophan-Gerüst auf. Das eingebundene 
Cyclopenta[a]inden-Skelett ist mit einer Aminoribopyranose-Einheit glykosyliert. Fijiolid A ist 
mit dem Bergman-Cyclisierungsprodukt des C-1027 Chromophors verwandt und stammt 
mutmaßlich von einem vergleichbaren biosynthetischem Endiin-Vorläufer ab. Diese Dissertation 
beinhaltet die Entwicklung der Totalsynthese von Fijiolid A. Die Synthesestrategie zeichnet sich 
durch eine inter-molekulare Ruthenium-katalysierte [2+2+2]-Cycloaddition dreier verschiedener 
Alkine zum Aufbau des zentralen hochsubstituierten Arenkerns aus. In zehn weiteren 
Synthesestufen wurde das gespannte [2.6]Paracyclophan aufgebaut. Hierzu wurde eine Makro-
veretherungs-reaktion entwickelt, welche durch eine templat-gesteuerte nukleophile Substitution 
bemerkenswert hohe Regio- und Atropselektivitäten ermöglicht. Die Glykosylierung des sterisch 
gehinderten tertiären Alkohols erfolgte auf einer späten Synthesestufe. Dies ermöglicht erstmals 
den Zugang zu Fijiolid A. Insegesamt wurde der Naturstoff Fijiolide A in einer länsten linearen 
Sequenz  18 Syntheseszufen ausgehend von kommerziell erhältlichem Startmaterial hergestellt.  
 
Kurzfassung  VI 
 
Schlagworte: Totalsynthese, Naturstoffe, Fijiolid, [2+2+2]-Cycloaddition, Pauson-Khand-
Reaktion, Paracyclophanbildung, Atropselektivität, Glykosylierung.   
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1.1 General Introduction 
Natural products have served as a mainstay of disease therapy throughout human history.1 Until 
recently, traditional plant-based medicines represented the primary health care for approximately 
80% of the world’s inhabitants, according to a World Health Organization estimation.2 Natural 
products also play a substantial role in modern drug discovery as lead structures for the 
development of new medicines for the treatment of human diseases. Nearly 50% of all novel drugs 
approved between 1981 and 2006 are either of natural product origin, or have been developed on 
the basis of natural product lead structures.3 These cover a broad range of clinical application, from 
treatment of infectious and neurological diseases, cardiovascular and metabolic disorders, diabetes, 
as well as numerous applications in oncology.4 The vast majority of all natural product derived 
therapeutics are of terrestrial origin.5 However, the past decades have witnessed a decline in the 
discovery of unprecedented structural motifs from terrestrial sources. In this regard, the marine 
ecosystem has long been a underexplored source of biodiversity for the discovery of new bioactive 
metabolites, despite ocean covers more than 70% of the earth’s surface. Not until the mid 1970’s 
marine organisms such as algae, sponges and soft corals were more systematically investigated as 
purveyor of potential drug candidates.6 Progress in this area culminated in eight marine derived 
pharmaceutical agents being marketed by 2014, and many more that entered different phases of 
clinical trials.6 The US National Cancer Institute estimates that 1% of marine natural products 
exhibit anti-tumor activity, whereas only 0.01-0.1% of their terrestrial counterparts do.7 This 
imposingly underlines the importance of marine secondary metabolites for the development of new 
cancer therapeutics, and their provision by the synthetic community.  
  
                                                 
1 G. M. Cragg, D. J. Newman, Pure Appl. Chem. 2005, 77, 7-24. 
2 N. R. Farnsworth, O. Akerele, A. S. Bingel, D. D. Soejarto, Z. Guo, Bull. World Health Organ. 1985, 63, 965-981. 
3 D. J. Newman, G. M. Cragg, J. Nat. Prod. 2007, 70, 461-477. 
4 D. A. Dias, S. Urban, U. Roessner, Metabolites 2012, 2, 303-336. 
5 R. Montaser, H. Luesch, Future Medicinal Chemistry 2011, 3, 1475-1489. 
6 A. Martins, H. Vieira, H. Gaspar, S. Santos, Marine Drugs 2014, 12, 1066-1101. 
7 a) M. H. G. Munro, J. W. Blunt, E. J. Dumdei, S. J. H. Hickford, R. E. Lill, S. Li, C. N. Battershill, A. R. Duckworth, 
J. Biotechnol. 1999, 70, 15-25; b) S. Vinothkumar, P. S. Parameswaran, Biotechnology Advances 2013, 31, 1826-1845. 
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1.2 Isolation and Structure Elucidation of Fijiolides A and B 
As part of their program to explore marine bacterial metabolites as inhibitors of tumor initiation 
and promotion, Fenical et al. evaluated the marine-derived actinomycete strain CNS-653, isolated 
from a marine sediment sample collected from the Bequa Lagoon, Fiji. The bacterium of the genus 
Nocardiopsis was found to be the producer of two unknown secondary metabolites, fijiolide A (1) 
and B (2) (Figure 1).8 The connectivity and relative stereochemistry of 1 and 2 were elucidated on 
the basis of 2D NMR spectroscopic data, while the advanced Mosher ester method and circular 
dichroism were used to assign the absolute configurations. 
 
Figure 1: Structures of fijiolide A (1) and fijiolide B (2). 
The fijiolides, which differ only by an additional acetyl group at 17-NH for fijiolide A (cf. 1 vs. 2), 
possess several highly intriguing structural features. Specifically, 1 and 2 feature a 
chlorocyclopenta[a]indene framework, embedded into a [2.6]paracyclophane core.9 In addition, 
the restricted rotation of the β-tyrosine around the ester and ether linkage between the two 
chlorinated aromatic portions gives rise to non-biaryl atropisomerism of macrolides 1 and 2.10 
Linkage of the tertiary cyclopentadienol hydroxyl group at C-9 to an amino ribopyranose unit 
places the fijiolides in the category of glycosidic natural products. 
 
                                                 
8 S.-J. Nam, S. P. Gaudêncio, C. A. Kauffman, P. R. Jensen, T. P. Kondratyuk, L. E. Marler, J. M. Pezzuto, W. Fenical, 
J. Nat. Prod. 2010, 73, 1080-1086. 
9 For recent reviews on cyclophanes, see: a) S. Kotha, M. E. Shirbhate, G. T. Waghule, Beilstein J. Org. Chem. 2015, 
11, 1274-1331; b) T. Gulder, P. S. Baran, Nat. Prod. Rep. 2012, 29, 899-934. 
10 For a recent review on non-biaryl and heterobiaryl atropisomers, see: E. Kumarasamy, R. Raghunathan, M. P. Sibi, 
J. Sivaguru, Chem. Rev. 2015, 115, 11239-11300. 
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Application of the advanced Mosher method,11 involving NMR analysis of the corresponding (R)- 
and (S)-MTPA ester derivatives of the fijiolides, enabled determination of the absolute 
configuration of the amino sugar unit, as well as the carbinol at C-13 and the amine at C-17. 
However, assignment of the complex three-dimensional structure of 1 and 2 required judicious 
interpretation of 2D NMR spectroscopic data. Thus, Fenical et al. deduced a trans-orientation of 
the C-9 glycoside and the C-8 ether bond by the presence of a NOESY correlation between H-8 
and the proton H-1' of the β-configured anomeric center of the amino ribopyranose. This data 
suggested two possible stereoisomers of opposite absolute configuration at C-8 and C-9, which are 
depicted in Figure 2. Dipolar coupling between 22-OH and H-12 suggested a rotationally restricted 
β-tyrosine moiety, and a catechol orientation in the represented manner. Finally, a strong NOESY 
correlation between H-5 and H13, as well as between H-17 and H-23 prompted Fenical et al. to 
assign the structures of fijiolide A and B as the corresponding (8R, 9R) isomers with the depicted 
arene orientation.8 
 
Figure 2: Possible stereoisomers of fijiolide A and B with opposite configuration at C-8 and C-9                                      
and key NOESY correlations ( ). 
 
 
                                                 
11 a) J. A. Dale, H. S. Mosher, J. Am. Chem. Soc. 1973, 95, 512-519; b) T. R. Hoye, C. S. Jeffrey, F. Shao, Nat. 
Protocols 2007, 2, 2451-2458. 
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1.3 Structural Relation to the Sporolides and Cyanosporasides 
The chlorocyclopenta[a]indene core of the fijiolides is structurally related to those of the sporolides 
A and B12 (3 and 4) and cyanosporasides A-F (5-10).13 Both natural product families have also 
recently been isolated by Fenical et al. from marine actinomycete strains of the genus Salinispora 
tropica and pacifica, respectively.14,15 
 
Figure 3: Structures of the sporolides A and B (3 and 4) and cyanosporasides A-F (5-10). 
                                                 
12 For synthetic studies towards the sporolides, see: a) K. C. Nicolaou, J. Wang, Y. Tang, Angew. Chem. Int. Ed. 2008, 
47, 1432-1435; b) K. Gademann, J.-Y. Wach, Synlett 2009, 2009, 2849-2851; c) K. C. Nicolaou, Y. Tang, J. Wang, 
Angew. Chem. Int. Ed. 2009, 48, 3449-3453; d) S. Bonazzi, M. Binaghi, C. Fellay, J.-Y. Wach, K. Gademann, Synthesis 
2010, 2010, 631-642; e) K. C. Nicolaou, J. Wang, Y. Tang, L. Botta, J. Am. Chem. Soc. 2010, 132, 11350-11363; f) J. 
A. Gladding, J. P. Bacci, S. A. Shaw, A. B. Smith III, Tetrahedron 2011, 67, 6697-6706. 
13 For synthetic studies towards the cyanosporasides, see: a) D. Aburano, F. Inagaki, S. Tomonaga, C. Mukai, J. Org. 
Chem. 2009, 74, 5590-5594; b) K. Yamada, M. J. Lear, T. Yamaguchi, S. Yamashita, I. D. Gridnev, Y. Hayashi, M. 
Hirama, Angew. Chem. Int. Ed. 2014, 53, 13902-13906. 
14 G. O. Buchanan, P. G. Williams, R. H. Feling, C. A. Kauffman, P. R. Jensen, W. Fenical, Org. Lett. 2005, 7, 2731-
2734. 
15 a) D.-C. Oh, P. G. Williams, C. A. Kauffman, P. R. Jensen, W. Fenical, Org. Lett. 2006, 8, 1021-1024; b) A. L. 
Lane, S.-J. Nam, T. Fukuda, K. Yamanaka, C. A. Kauffman, P. R. Jensen, W. Fenical, B. S. Moore, J. Am. Chem. Soc. 
2013, 135, 4171-4174. 
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This common structural motif is believed to originate from a putative 9-membered enediyne 
precursor that undergoes Bergman cycloaromatization,16 followed by trapping of the intermediate 
p-benzyne biradical species by chloride, as presented for the fijiolides (Scheme 1).17  
 
Scheme 1: Formation of 1/2 from a putative enediyne precursor (11).  
The biosynthetic incorporation of chlorine into aromatic rings has long been believed to be limited 
to enzymatic electrophilic substitution by chloroperoxidases or halogenases.18 A fundamentally 
different synthetic pathway for the chlorination of p-benzyne biradicals was proposed by O’Connor 
et al. in 2007.19 Their studies on the Bergman cycloaromatization of a model 10-membered 
enediyne (clodeca-1,5-diyn-3-ene, 13) in halide containing media suggest a direct nucleophilic 
attack by a halide anion on biradical species 14, and rapid protonation of haloaryl anion 15 as the 
most likely mechanism for p-benzyne halogenation.  
 
Scheme 2: O’Connor’s proposed mechanism for nucleophilic halogenation of p-benzyne biradicals. 
O’Connor’s mechanistic proposal is in accordance with the observed mono-chlorine substitution 
of the sporolides and cyanosporasides at either of the two aromatic positions, whereas their 
dichlorinated counterparts have not been observed.  
                                                 
16 R. G. Bergman, Acc. Chem. Res. 1973, 6, 25-31. 
17 M. Jean, S. Tomasi, P. van de Weghe, Org. Biomol. Chem. 2012, 10, 7453-7456. 
18 a) C. S. Neumann, D. G. Fujimori, C. T. Walsh, Chem. Biol. 2008, 15, 99-109; b) C. D. Murphy, Nat. Prod. Rep. 
2006, 23, 147-152. 
19 C. L. Perrin, B. L. Rodgers, J. M. O'Connor, J. Am. Chem. Soc. 2007, 129, 4795-4799. 
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Further experimental evidence has recently been provided by Lear and Hirama (Scheme 3).13b 
Within the context of biomimetic synthetic studies towards the cyanosporaside aglycones via 
enediyne precursor 17, an ionic mono-halogenation of p-benzyne 19 to form 20 was shown to be 
predominant in the presence of the seawater mimic LiCl/DMSO (conditions A). The site-selective 
chlorine incorporation was traced back to a sterically more accessible C-6 position of the p-benzyne 
biradical 19. By contrast, a radical dichlorination pathway leading to 21 was active under synthetic 
conditions using CCl4.  
 
Scheme 3: Reported ionic mono- and radical dichlorination of cyanosporaside p-benzyne mimic 19. 
Whereas both the sporolides and cyanosporasides were originally isolated as 1:1 mixtures of 
positional isomers in respect to the chlorine substitution, no C-6 chlorinated regioisomer has been 
observed in the case of the fijiolides. On the basis of energy-minimizing modeling studies, Fenical 
et al. attributed this fact to a site selective chlorination of the p-benzyne biradical as a consequence 
of the more shielded C-6 position by the β-tyrosine moiety and the amino sugar side chain.8 
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1.4 Structural Relation to Enediyne Antitumor Antibiotics 
With their prominent structural features, the fijiolides possess high resemblance to the C-1027 
chromophore 22, and in particular with the corresponding Bergman cycloaromatization product 23 
(Scheme 4).20 In fact, 23 differs from fijiolides A and B by only the absence of a chloro substituent 
on the cyclopenta[a]indene core, and an additional benzoxazine moiety at the C-13 hydroxyl group. 
C-1027 is a member of the subset of chromoprotein complexes exhibiting outstanding antitumor 
antibiotic activity, and was isolated in 1988 from the culture broth of the terrestrial bacterium 
Streptomyces globisporus, strain C-1027.21 Highly reactive chromophore 22 belongs to the 
enediyne structural family and naturally exists as a 1:1 complex with a stabilizing apoprotein, 
commonly known as the entire C-1027 natural product. The apoprotein is a single polypeptide 
composed of 110 amino acids to which enediyne 22 is bound in a non-covalent manner.22,23 The 
chromophore is readily separated from its apoprotein by extraction.24 However, once separated, 22 
undergoes spontaneous cycloaromatization, and is the only enediyne natural product known to do 
so in the absence of any external activator such as nucleophiles.23 Thus, the isolated C-1027 
chromophore represents the most labile enediyne studied to date with a solvent dependent half-life 
of t½ = 50 min (EtOH, 25 °C).25 
 
Scheme 4: Structure of the C-1027 chromophore and its Bergman cycloaromatization product. 
                                                 
20 For recent synthetic studies towards the C-1027 chromophore, see: a) M. Inoue, T. Sasaki, S. Hatano, M. Hirama, 
Angew. Chem. Int. Ed. 2004, 43, 6500-6505; b) M. Inoue, I. Ohashi, T. Kawaguchi, M. Hirama, Angew. Chem. Int. 
Ed. 2008, 47, 1777-1779. 
21 J. Hu, Y.-C. Xue, M.-Y. Xie, R. U. I. Zhang, T. Otani, Y. Minami, Y. Yamada, T. Marunaka, J. Antibiot. 1988, 41, 
1575-1579; T. Otani, Y. Minami, T. Marunaka, R. Zhang, M.-Y. Xie, J. Antibiot. 1988, 41, 1580-1585. 
22 T. Otani, T. Yasuhara, Y. Minami, T. Shimazu, R. Zhang, M.-Y. Xie, Agric. Biol. Chem. 1991, 55, 407-417. 
23 M. Inoue, T. Usuki, N. Lee, M. Hirama, T. Tanaka, F. Hosoi, S. Ohie, T. Otani, J. Am. Chem. Soc. 2006, 128, 7896-
7903. 
24 Y. Minami, K.-i. Yoshida, R. Azuma, M. Saeki, T. Otani, Tetrahedron Lett. 1993, 34, 2633-2636. 
25 K.-i. Yoshida, Y. Minami, T. Otani, Y. Tada, M. Hirama, Tetrahedron Lett. 1994, 35, 5253-5256. 
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Apart from the enediyne motif, the benzoxazine moiety of 22 and 23 – not present in the 
fijiolides - was reported to be of substantial importance for the bioactivity of antitumor antibiotic 
C-1027. Thus, Dedon et al. ascertained a ~400-fold reduced binding affinity of 23 to double-
stranded DNA upon loss of the heterocyclic entity.26 More precisely, the benzoxazine was proposed 
to function as a DNA intercalator. Once situated in the minor groove of the DNA, and following 
release from its apoprotein, the corresponding p-benzyne biradical of 22 abstracts hydrogens from 
the DNA backbone sugar, ultimately resulting in oxidative cleavage of the DNA double-strand.27 
The close structural resemblance of the fijiolides with the C-1027 chromophore and its cyclization 
product suggests a common biosynthetic origin of these natural products.28 A supporting piece of 
evidence for this assumption was recently been provided by Oh et al. who reported the isolation of 
the C-1027 Chromophore-V (24) in 2014 (Figure 4).29 With the exception of the benzoxazine 
moiety, 24 is identical to fijiolide B. Moreover, C-3 chlorinated chromophore-V was isolated along 
with fijiolides A and B, and C-1027 chromophore cyclization product 23, thus linking both natural 
product families. Interestingly, the producing bacterium is an arctic actinomycete strain (ART5), 
isolated from a sediment sample of the East Siberian continental margin (water depth = 352 m). 
Although the proposed pre-fijiolide (11) (cf. Scheme 1), or a complex of either 1 or 2 with an 
associated apoprotein could not be isolated, the fijiolides are believed to stem from the 
chromoprotein subfamily of 9-membered enediyne antitumor antibiotics.28  
 
Figure 4: Structure of the recently isolated C-1027 chromophore-V (24). 
                                                 
26 L. Yu, S. Mah, T. Otani, P. Dedon, J. Am. Chem. Soc. 1995, 117, 8877-8878. 
27 a) Y. Xu, Y. Zhen, I. H. Goldberg, Biochemistry 1994, 33, 5947-5954; b) Y.-j. Xu, Z. Xi, Y.-s. Zhen, I. H. Goldberg, 
Biochemistry 1995, 34, 12451-12460. 
28 M. Jean, S. Tomasi, P. van de Weghe, Org. Biomol. Chem. 2012, 10, 7453-7456. 
29 K. Moon, C.-H. Ahn, Y. Shin, T. Won, K. Ko, S. Lee, K.-B. Oh, J. Shin, S.-I. Nam, D.-C. Oh, Marine Drugs 2014, 
12, 2526-2538. 
1. Introduction  10 
 
Prominent congeners of this subfamily are the chromophores of neocarzinostatin (26),30 kedarcidin 
(27),31 and maduropeptin (28) (Scheme 5).32 Together with the endiyne N1999A233 (25) and 
previously discussed 22, these secondary metabolites have received considerable attention from 
the synthetic community over the past two decades.34,35  
 
Scheme 5: Naturally occurring and synthesized 9-membered enediynes.34 
                                                 
30 a) N. Ishida, K. Miyazaki, K. Kumagai, M. Rikimaru, J. Antibiot. 1965, 18, 68-76; b) K. Edo, M. Mizugaki, Y. 
Koide, H. Seto, K. Furihata, N. Ōtake, N. Ishida, Tetrahedron Lett. 1985, 26, 331-334. 
31 a) J. E. Leet, D. R. Schroeder, S. J. Hofstead, J. Golik, K. L. Colson, S. Huang, S. E. Klohr, T. W. Doyle, J. A. 
Matson, J. Am. Chem. Soc. 1992, 114, 7946-7948; b) J. E. Leet, D. R. Schroeder, D. R. Langley, K. L. Colson, S. 
Huang, S. E. Klohr, M. S. Lee, J. Golik, S. J. Hofstead, J. Am. Chem. Soc. 1993, 115, 8432-8443. 
32 a) M. Hanada, H. Ohkuma, T. Yonemoto, K. Tomita, M. Ohbayashi, H. Kamei, T. Miyaki, M. Konishi, H. 
Kawaguchi, S. Forenza, J. Antibiot. 1991, 44, 403-414; b) D. R. Schroeder, K. L. Colson, S. E. Klohr, N. Zein, D. R. 
Langley, M. S. Lee, J. A. Matson, T. W. Doyle, J. Am. Chem. Soc. 1994, 116, 9351-9352. 
33 T. Ando, M. Ishii, T. Kajiura, T. Kameyama, K. Miwa, Y. Sugiura, Tetrahedron Lett. 1998, 39, 6495-6498. 
34 For recent total syntheses of nine-membered enediyne natural products, see: N1999A2: a) S. Kobayashi, S. 
Ashizawa, Y. Takahashi, Y. Sugiura, M. Nagaoka, M. J. Lear, M. Hirama, J. Am. Chem. Soc. 2001, 123, 11294-11295; 
b) S. Kobayashi, R. S. Reddy, Y. Sugiura, D. Sasaki, N. Miyagawa, M. Hirama, J. Am. Chem. Soc. 2001, 123, 2887-
2888; c) N. Ji, H. O'Dowd, B. M. Rosen, A. G. Myers, J. Am. Chem. Soc. 2006, 128, 14825-14827. Neocarzinostatin 
chromophore: d) A. G. Myers, J. Liang, M. Hammond, P. M. Harrington, Y. Wu, E. Y. Kuo, J. Am. Chem. Soc. 1998, 
120, 5319-5320; e) A. G. Myers, R. Glatthar, M. Hammond, P. M. Harrington, E. Y. Kuo, J. Liang, S. E. Schaus, Y. 
Wu, J.-N. Xiang, J. Am. Chem. Soc. 2002, 124, 5380-5401; f) S. Kobayashi, M. Hori, G. X. Wang, M. Hirama, J. Org. 
Chem. 2006, 71, 636-644. Kedarcidin chromophore: g) F. Ren, P. C. Hogan, A. J. Anderson, A. G. Myers, J. Am. 
Chem. Soc. 2007, 129, 5381-5383. Maduropeptin chromophore: h) K. Komano, S. Shimamura, Y. Norizuki, D. Zhao, 
C. Kabuto, I. Sato, M. Hirama, J. Am. Chem. Soc. 2009, 131, 12072-12073. 
35 For recent reviews on enediyne antitumor antibiotics, see: a) A. M. Irina, A. T. Boris, Russ. Chem. Rev. 2006, 75, 
825; b) I. Sato, M. Hirama, J. Synth. Org. Chem., Jpn 2010, 68, 1123-1131. 
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However, enediynes 22 and 25–28 mostly lose their antibiotic and antitumoral activity upon 
cycloaromatization.24 In contrast, the fijiolides still possess notable bioactivity, rendering them 
interesting for further biological evaluation, as outlined in section 1.5. 
 
 
1.5 Biological Activity of Fijiolides A and B 
In order to explore the bioactivity profile of the newly isolated secondary metabolites 1 and 2, 
Fenical et al. investigated their inhibitory potential against transcription factor NFκB. Thus, 
fijiolide A was found to reduce the TNF-α induced NFκB activity by 70%. Dose-dependency 
experiments revealed an IC50 value of 0.57 μM for 1, while its non-acetylated congener fijiolide B 
showed diminished biological activity. In this case, TNF-α induced NFκB activity was reduced by 
46% without a dose-dependent response. During additional exploration of the fijiolides’ potential 
as cancer chemoprevention agents, they were screened as stimuli for the metabolic detoxification 
enzyme quinone reductase 1 (QR1). In this regard, 1 was found to enhance QR1 activity with an 
induction ratio of 3.5 at 20 μg/mL (28.4 μM). A concentration of 1.8 μM was determined to double 
the induction. In contrast, fijiolide B was not observed to induce QR1 activity, thus emphasizing 
the relevance of the acetamido moiety for biological activity. Fijiolides A and B, as well as the 
structurally related C-1027 chromophore-V (24), were subjected to further testing by Oh et al.  
Benzoxazine bearing 24 exhibited strong cytotoxic effects against colon cancer cell line HCT-116 
and breast cancer cell line MDA-MB231 with IC50 values of 0.9 and 2.7 μM, respectively.29 By 
contrast, the fijiolides are not reported to display significant activity against these cell lines.8  
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1.6 NFkB as a Therapeutic Target in Cancer Treatment   
Nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) is a well-characterized 
transcription factor protein complex, and was first discovered in 1986 by Baltimore et al.36 It 
regulates the expression of nearly 500 genes.37 More than 200 of them encode proteins involved in 
immune and inflammation responses as well as cell growth control. In addition, the expression of 
tumorigenesis relevant proteins, such as cyclooxygenase (COX-2), matrix metalloproteinase 
(MMP-9), inducible nitric oxide synthase (iNOS) or antiapoptotic proteins bcl-2 and bcl-xl, is also 
mediated by NFκB.38 Due to its pivotal role in immunological processes, it has been termed 
“central mediator of the human immune response”.39 NFκB belongs to the category of rapid-acting 
primary transcription factors and is ubiquitously expressed in nearly all animal cell types.40,41 It is 
ordinarily situated in the cytoplasm as a complex with the inhibitory protein IκB, suppressing the 
translocation of the transcription factor into the nucleus.42 Hence, activation and rapid nuclear 
appearance of NFκB does not necessitate a de-novo synthesis of the protein, but merely dissociation 
from its inhibitor IκB, which renders NFκB a fast responder to harmful cellular stimuli. More than 
150 stimuli are known to activate NFκB by phosphorylation, ubiquitination or degradation of IκB 
subunits.38,43 These stimuli are exceedingly diverse and include stress, cytokines, free radicals, 
bacteria/viruses as well  tumor promotors and carcinogens, such as cigarette smoke (Figure 5A).44 
Among them, the pro-inflammatory cytokine tumor necrosis factor α (TNF-α) is one of the most 
potent activators of NFκB. Although its activation is required for a proper immune system function 
and cell survival, a misregulation of the NFκB activity is linked to inflammatory and autoimmune 
diseases, septic shock, viral infection, arthritis and asthma.45 In addition, constitutive activation of 
NFκB is largely observed in cancer cells.46 The consequences of aberrant NFκB activation are as 
manifold as its triggering factors, and lead to increased expression of genes that are associated with 
                                                 
36 R. Sen, D. Baltimore, Cell 1986, 47, 921-928. 
37 S. C. Gupta, C. Sundaram, S. Reuter, B. B. Aggarwal, Biochim. Biophys. Acta 2010, 1799, 775-787. 
38 R. J. Anto, A. Mukhopadhyay, S. Shishodia, C. G. Gairola, B. B. Aggarwal, Carcinogenesis 2002, 23, 1511-1518. 
39 H. L. Pahl, Oncogene 1999, 18, 6853-6866. 
40 M. Karin, Nature 2006, 441, 431-436. 
41 V. Metelev, S. Zhang, D. Tabatadze, A. Bogdanov, Bioconjugate Chem. 2011, 22, 759-765. 
42 A. S. Baldwin, Annu. Rev. Immunol. 1996, 14, 649-681. 
43 A. C. Bharti, B. B. Aggarwal, Biochem. Pharmacol. 2002, 64, 883-888. 
44 B. B. Aggarwal, Cancer Cell 2004, 6, 203-208. 
45 S. Luqman, J. M. Pezzuto, Phytother. Res. 2010, 24, 949-963. 
46 T. D. Gilmore, M. Herscovitch, Oncogene 2006, 25, 6887-6899. 
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cell proliferation, tumor promotion, angiogenesis, metastasis, inflammation, and suppression of 
apoptosis (Figure 5B).  
 
Figure 5: Inducers of NFκB activation (A) and cell processes influenced by NFκB (B). 
Paradoxically, chemotherapeutic treatment of tumors or radiation - applied to induce cancer cell 
apoptosis - were observed to promote NFκB activation.47 This indicates that the transcription factor 
is involved in the autodefense mechanism of affected cells and may result in desensitization, 
chemoresistance, and radioresistance.44 Selective suppression of NFκB activation is commonly 
considered to inhibit proliferation and survival of the tumor cell, and either cause apoptosis directly, 
or render cancer cells more sensitive to the action of other antitumor agents.40,48 Against this 
background, NFκB is a promising therapeutic target for the treatment of cancer and various 
inflammatory diseases, and inhibitors are current object of research in pharmaceutical industry.44  
 
 
 
 
 
 
 
     
                                                 
47 C. Y. Wang, M. W. Mayo, A. S. Baldwin, Jr., Science 1996, 274, 784-787. 
48 S. Luqman, J. M. Pezzuto, Phytother. Res. 2010, 24, 949-963. 
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2.1 Syntheses of the β-Amino Acid Fragment by Hirama et al. 
In the context of synthetic studies towards the C-1027 chromophore, Hirama et al. disclosed a 
synthetic route to the β-amino acid fragment in 1999 (Scheme 6).49 To date, no further synthetic 
approach has been published. Hirama’s synthesis commences with a selective para-benzylation of 
commercially available 3-chloro-4,5-dihydroxybenzaldehyde 29, followed by MOM-protection of 
the remaining hydroxyl group, and HWE-olefination to afford tert-butyl cinnamate 30. 
Asymmetric introduction of the nitrogen atom was accomplished by conjugate addition of Davies’ 
chiral lithium amide to furnish β-amino ester 31 in high diastereoselectivity (20:1).50 Selective 
hydrogenolysis of the O-benzyl group was attained under Pd0 catalysis and was followed by TBS 
protection, giving rise to silyl ether 32. An additional hydrogenolysis employing Rh/C was required 
for cleavage of the N-benzyl and N-α-methylbenzyl groups. Boc-protection of the resulting free 
amine, followed by the removal of the TBS group provided β-amino ester 33, which was 
demonstrated to be a competent substrate for aryl ether formation by nucleophilic epoxide opening. 
In summary, Hirama’s synthesis of the C-1027 β-amino acid fragment features 9 steps and a 
stereoselective conjugate addition of a chiral amine for the installation of the stereogenic center. 
 
                                                 
49 I. Sato, T. Kikuchi, M. Hirama, Chem. Lett. 1999, 28, 511-512. 
50 a) S. G. Davies, O. Ichihara, Tetrahedron: Asymmetry 1991, 2, 183-186; b) J. F. Costello, S. G. Davies, O. Ichihara, 
Tetrahedron: Asymmetry 1994, 5, 1999-2008. 
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Scheme 6: Hirama’s synthesis of the C-1027/fijiolide β-amino acid fragment. 
 
 
2.2 Syntheses of the C-1027/ Fijiolide Amino Sugar 
The amino sugar moiety common to both C-1027 and the fijiolides has attracted research attention 
by different groups. This led to the development of three synthetic approaches over the past two 
decades.51,52,53 These will be briefly outlined in this section. 
 
2.2.1 Hirama’s 1st Generation Synthesis  
As key contributors to the field of enediyne natural product synthesis, Hirama et al. published the 
first synthesis of methyl glycoside 42 in 1993 (Scheme 7).51 The synthesis used prenol 35 as the 
starting material, which was converted into enantioenriched (R)-dimethylglycidol 36 via Sharpless 
asymmetric epoxidation.54 36 was subjected to benzyl protection and hydrolytic regioselective 
                                                 
51 K.-i. Iida, T. Ishii, M. Hirama, T. Otani, Y. Minami, K.-i. Yoshida, Tetrahedron Lett. 1993, 34, 4079-4082. 
52 M. F. Semmelhack, Y. Jiang, D. Ho, Org. Lett. 2001, 3, 2403-2406. 
53 K. Hirai, Y. Tamura, I. Sato, M. Hirama, Synlett 2010, 2010, 2156-2158. 
54 Y. Gao, J. M. Klunder, R. M. Hanson, H. Masamune, S. Y. Ko, K. B. Sharpless, J. Am. Chem. Soc. 1987, 109, 5765-
5780. 
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epoxide opening, followed by silyl protection and hydrogenolysis to produce diol 37 in 41% yield. 
Oxidation of the primary alcohol was followed by a (Z)-selective Still-Gennari olefination. A 
subsequent lactonization under acidic conditions provided 38. Exposure to DIBAL-H and 
ketalization in acidic methanol prepared the substrate for an OsO4 catalyzed diastereoselective 
dihydroxylation to afford diol 39. Double carbamate protection of the vicinal diol prior to silyl 
ether cleavage with TBAF provided access to 40. For the key step of the synthesis, the secondary 
alcohol was activated as the corresponding triflate, thus allowing for an intramolecular carbamate 
cyclization to install the nitrogen atom adjacent to the gem-dimethyl group in 41. Finally, reductive 
cleavage of both carbamates provided methyl glycoside ()-42. Acid mediated degradation of the 
cycloaromatized C-1027 chromophore 23 gave 42 of identical spectral data and optical rotation. In 
this way, Hirama et al. established the previously unknown absolute stereochemistry and 
demonstrated the C-1027 amino sugar moiety to be 4-deoxy-4-dimethylamino-5,5-dimethyl-D-
riboyranose. In summary, Hirama’s synthesis requires 16 steps to provide ()-42 from prenol in a 
5.1% overall yield (first step excluded). 
 
Scheme 7: Hirama’s first synthesis of the C-1027 amino sugar and determination of the absolute configuration. 
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2.2.2 Semmelhack’s Synthesis  
In 2001, a second synthesis of the C-1027 amino sugar side chain was disclosed by Semmelhack 
et al. (Scheme 8).52 Their approach takes advantage of readily available α-methyl-D-
mannopyranoside (44) as the enantiopure starting material, which was subjected to double 
acetonide protection. An aqueous workup selectively hydrolyzed the 1,3-dioxane in favor of the 
more stable 1,3-dioxolane.55 Subsequent introduction of a methyl carbamate at 6-OH delivered 45. 
The synthesis continued with an activation of the C-4 hydroxyl group as the corresponding triflate. 
In close analogy to Hirama’s synthesis, nucleophilic displacement at C-4 by intramolecular 
delivery of the carbamate nitrogen atom gives rise to cyclic carbamate 46. A subsequent 4-step 
sequence consisting of an alkaline carbamate cleavage, a Cbz protection of the resulting secondary 
amine, a Swern oxidation, and an oxidative esterification provided methyl ester 47. Alkylation at 
C-5 was realized by enolate generation and simultaneous trapping with methyl iodide to furnish an 
inconsequential 2:3 mixture of diastereomers. Further conversion into dimethylamino alcohol 48 
was achieved by a one-pot reduction of both the carbamate protecting group and the methyl ester. 
The final stages of the synthesis involved a mesylation of the epimeric alcohol 48, an additional 
reduction to generate the gem-dimethyl group and ketal hydrolysis providing methyl glycoside 
()-42. In summary, Semmelhack’s synthesis comprises 13 steps to convert commercially available 
44 into the C-1027/ fijiolide amino sugar in a 9.8% overall yield. 
 
Scheme 8: Semmelhack’s synthesis of the C-1027 amino sugar moiety.  
                                                 
55 M. E. Evans, F. W. Parrish, Carbohydr. Res. 1977, 54, 105-114. 
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2.2.3 Hirama’s 2nd Generation Synthesis  
As consequence of their lasting interest in the synthesis of the C-1027 chromophore, Hirama et al. 
recently disclosed a revised synthetic approach towards the amino ribopyranose unit of 22 in 2010 
(Scheme 9). In contrast to both syntheses discussed beforehand, this chiral pool approach elegantly 
forgoes stereoselective introduction of the amino group by employment of a proteinogenic α-amino 
acid. Thus, L-glutamic acid (50) was first converted into ethyl L-pyroglutamate.56 Twofold 
methylation of the ester carbonyl group, followed by trapping of the resulting lithium alkoxide with 
TMSCl and subsequent Boc protection provided access to 51. With the gem-dimethyl group 
installed at the beginning of the synthesis, the stereoselective introduction of the cis-diol was 
achieved via elimination of the corresponding α-selenoxide, followed by OsO4 catalyzed 
dihydroxylation. Alkaline hydrolysis of the γ-lactam 52 with concomitant removal of the TMS 
group gave rise to an intermediate δ-hydroxy acid, which was lactonized to 53 under acid 
conditions. Boc deprotection, followed by double reductive amination delivered tertiary amine 54. 
Tetraisopropyldisiloxane (TIPDS) protection of the cis-diol and subsequent DIBAL-H reduction 
of the lactone provided the synthetically useable amino sugar 55, compared to the previous methyl 
glycoside ()-42 (vide supra). In summary, Hirama’s revised synthesis of the C-1027/fijiolide 
amino sugar features a shortened 12-step procedure for preparation of TIPDS protected amino 
pyranose 55 from readily available L-glutamic acid in 13% overall yield. 
 
Scheme 9: Hirama’s revised synthesis of the C-1027 amino sugar moiety. 
                                                 
56 a) S. Saijo, M. Wada, J. Himizu, A. Ishida, Chem. Pharm. Bull. 1980, 28, 1449-1458; b) Y. Hamada, O. Hara, A. 
Kawai, Y. Kohno, T. Shioiri, Tetrahedron 1991, 47, 8635-8652. 
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2.3 Glycoside Synthesis with the C-1027 Amino Sugar Unit  
Since the first report of a glycoside synthesis by Michael in 1879,57 a vast number of glycosylation 
methods have become available.58,59 The most prominent representatives among them are the 
classical Fischer glycosylation60 and the Koenigs-Knorr method,61 generally characterized by 
either acid mediated acetalization of cyclic hemiacetals or the reaction of alcohols with glycosyl 
halides in the presence of a halophilic promotor, typically a heavy metal salt. In 1980, Schmidt et 
al. introduced the use of anomeric trichloroacetimidates as glycosyl donors. He demonstrated their 
convenient preparation and remarkable scope in glycosylation of carboxylic acids, phenols, steroid 
alcohols and carbohydrates upon promotion by catalytic pTSA or BF3•OEt2.62 Due to the superior 
stability of glycosyl trichloroacetimidates and their high reactivity under mild reaction, these now-
called Schmidt donors stand out as the most popular type of glycosyl donors for the synthesis of 
complex glycosides including natural products. Using this method, even sterically encumbered and 
sensitive alcohols have been successfully glycosylated.63,64 The trichloroacetimidate method has 
also been used by Hirama et al. for glycosylation of secondary and tertiary alcohols with the 
C-1027 amino sugar moiety after activation of hemiacetal 55 as the corresponding Schmidt donor 
56 (Scheme 10).65  
 
Scheme 10: Reported synthesis of Schmidt donor 56 from amino sugar 55.  
                                                 
57 A. Michael, Am. Chem. J. 1879, 1, 305-312. 
58 For recent reviews on available glycosylation methods, see: a) X. Zhu, R. R. Schmidt, Angew. Chem. Int. Ed. 2009, 
48, 1900-1934; b) A. V. Demchenko, Synlett 2003, 2003, 1225-1240; c) K. J. Jensen, J. Chem. Soc., Perkin Trans. 1 
2002, 2219-2233; d) B. G. Davis, J. Chem. Soc., Perkin Trans. 1 2000, 2137-2160.  
59 For reviews on synthesis of complex natural glycosides, see: Y. Yang, X. Zhang, B. Yu, Nat. Prod. Rep. 2015, 32, 
1331-1355; D. P. Galonic, D. Y. Gin, Nature 2007, 446, 1000-1007; K. Toshima, Carbohydr. Res. 2006, 341, 1282-
1297; H. Pellissier, Tetrahedron 2005, 61, 2947-2993; K. C. Nicolaou, H. J. Mitchell, Angew. Chem. Int. Ed. 2001, 
40, 1576-1624; S. J. Danishefsky, M. T. Bilodeau, Angewandte Chemie International Edition in English 1996, 35, 
1380-1419. 
60 E. Fischer, Ber. Dtsch. Chem. Ges 1893, 26, 2400-2412. 
61 W. Koenigs, E. Knorr, Ber. Dtsch. Chem. Ges 1901, 34, 957-981. 
62 a) R. R. Schmidt, J. Michel, Angew. Chem. Int. Ed. 1980, 19, 731-732; b) R. R. Schmidt, Angew. Chem. Int. Ed. 
1986, 25, 212-235. 
63 Y. Yang, X. Zhang, B. Yu, Nat. Prod. Rep. 2015, 32, 1331-1355. 
64 A. Holkenbrink, J. B. Vicente, D. B. Werz, Synthesis 2009, 2009, 2596-2604. 
65 I. Sato, Y. Akahori, T. Sasaki, T. Kikuchi, M. Hirama, Chem. Lett. 1999, 28, 867-868. 
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A test glycosylation of cyclopentanol, employing catalytic TMSOTf as the promotor, afforded 
glycoside 57 in quantitative yield (Scheme 11). The β-anomer was exclusively observed. 
Moreover, good yields and β-glycosylation selectivities were achieved for early – yet sterically 
encumbered – synthetic intermediates 58 and 60 of the C-1027 chromophore synthesis. Hirama et 
al. attributed the observed high β-selectivity to the efficient shielding of the glycosyl donor’s α-
face by the sterically demanding tetraisopropyldisiloxane protecting group.65 Despite these 
promising glycosylation results, the reported broad variation in reaction conditions and 
yields/conversions, especially with respect to the temperature, suggests the need for careful 
adjustment of this parameter for each glycosyl acceptor. 
 
Scheme 11: Reported glycosylation of secondary and tertiary alcohols with Schmidt donor 56. 
 
 
 
2. State of Research   23 
 
2.4 Aims of the Project 
The inhibitory activity of fijiolide A with respect to the TNF-α induced NFκB activity renders 1 of 
therapeutic promise and a possible candidate for cancer chemoprevention and treatment. 
Concomitant with an intriguing molecular architecture, fijiolide A represents a formidable target 
for total synthesis. A modular, highly convergent, and optimally atropselective synthesis of this 
natural product was envisaged, allowing for ensuing extensive SAR studies. At the juncture of 
target selection, several synthetic studies towards related enediyne and cycloaromatized 
cyclopenta[a]indene bearing natural products had been disclosed (cf. chapter 1.3, 1.4 and 0). 
However, no synthetic studies targeting a C-3 chlorinated cyclopenta[a]indene skeleton for 
construction of the fijiolide [2.6]paracyclophane, or any other synthetic approach towards this 
natural product family had been published. As a result of the abovementioned facts, we felt as 
encouraged as challenged to elaborate a synthetic route towards fijiolide A. Our efforts towards 
this end will be presented in this thesis. 
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Retrosynthetically, fijiolide A can be dissected into two fragments by scission of the glycosidic 
bond, yielding the fijiolide A aglycone 62, and an amino sugar side chain (Scheme 12). Late-stage 
β-glycosylation of the sterically encumbered tertiary C-9 hydroxyl group of 62 represents a key 
transformation, and was envisioned to be realized by utilization of known Schmidt donor 56. 
Regarding aglycone 62, assembly of the strained [2.6]paracyclophane structure was considered the 
most challenging synthetic obstacle as rotational restriction about the ether and ester biaryl linkage 
demands an atropselective ring closure. This macrocycle lends itself to fission of the six-atom 
paracyclophane bridge at the ester, as well as retrosynthetic cleavage of the two-atom biaryl linker 
at the benzyl ether bond. Thus, aglycone 62 was disassembled to carbocyclic epoxide 63, and 
β-amino acid fragment 64.  
 
Scheme 12: General retrosynthetic analysis of fijiolide A. 
According to our proposal, identification of building blocks 63 and 64 would allow preparative 
evaluation of two complementary synthetic pathways towards 62. Specifically, aryl ether formation 
by intermolecular nucleophilic epoxide opening, followed by macrolactonization, or reversal of 
these steps, i. e. formation of the ester linkage between 63 and 64 prior to the paracyclophane 
constructing intramolecular etherification. A strategically installed hydroxyl substituent at C-10 on 
63 was envisaged to enable diastereoselective (directed) epoxidation, and also allow installation of 
the cyclopentadiene motif at late-stage of the synthesis. More detailed retrosynthetic considerations 
of fragments 63 and 64 will be provided in the chapters detailing synthetic approaches towards 
these building blocks. 
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4.1 Studies Involving RhI Catalyzed Reductive Cyclization / Pd0 Catalyzed 
Direct Arylation 
4.1.1 Retrosynthetic Analysis 
Our initial retrosynthetic analysis of the acetonide protected key fragment 65 involved a Pd0 
catalyzed direct arylation of vinyl triflate 6666 and a metal catalyzed dehalogenation of the sterically 
less encumbered Caryl-Cl bond (Scheme 13)67. The stereogenic center of the allylic alcohol in 66 
was postulated to be introduced in a diastereoselective manner by a RhI catalyzed reductive 
cyclization of 1,5-ynal 67,68 which would be in turn accessed by nucleophilic opening of 
γ-butyrolactone with terminal alkyne 68. The latter compound could be obtained via a Sonogashira 
coupling of ipso-halogenated pinacol boronate 69 and trimethylsilyl acetylene. 
 
Scheme 13: First retrosynthetic analysis of key fragment 65. 
                                                 
66 For synthesis of related indanes via direct arylation of vinal triflates, see: a) M. C. Willis, C. K. Claverie, M. F. 
Mahon, Chem. Commun. 2002, 832-833; b) A. C. F. Cruz, N. D. Miller, M. C. Willis, Org. Lett. 2007, 9, 4391-4393; 
c) M. R. Albicker, N. Cramer, Angew. Chem. Int. Ed. 2009, 48, 9139-9142; d) X.-z. Shu, M. Zhang, Y. He, H. Frei, F. 
D. Toste, J. Am. Chem. Soc. 2014, 136, 5844-5847. 
67 M. S. Viciu, G. A. Grasa, S. P. Nolan, Organometallics 2001, 20, 3607-3612. 
68 J. U. Rhee, M. J. Krische, J. Am. Chem. Soc. 2006, 128, 10674-10675. 
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Finally, 69 could be synthesized via a Sharpless asymmetric dihydroxylation (SAD) of 
commercially available styrene 70, followed by ketalization and an iridium(I) catalyzed meta-
selective Miyaura-Hartwig borylation.69  
 
 
4.1.2 Results 
In order to assess the feasibility of this strategy, the chlorine and acetonide substituents of the arene 
core of 65 were initially ignored, allowing simplification of the tricyclic fragment to 
cyclopenta[a]indene 72, which was to be synthesized from ynal 71. (Scheme 14). With 72 in hand, 
model studies on a diastereroselective epoxidation and aryl ether formation by epoxide opening 
with phenol to synthesize 73 were envisaged. 
 
Scheme 14: Envisaged model studies for fijiolide A. 
As demonstrated by Krische et al.,68 rhodium(I) catalyzed reductive cyclization of acetylenic 
aldehydes provides rapid access to highly enantioenriched exomethylene cyclopentanols (Scheme 
15), and was therefore elected to be investigated with 1,5-ynal 71. 
 
Scheme 15: Enantioselective RhI catalyzed reductive cyclization of acetylenic aldehydes according to Krische et al.  
                                                 
69 T. Ishiyama, J. Takagi, J. F. Hartwig, N. Miyaura, Angew. Chem. Int. Ed. 2002, 41, 3056-3058; J. M. Murphy, X. 
Liao, J. F. Hartwig, J. Am. Chem. Soc. 2007, 129, 15434-15435. 
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71 was synthesized via a selective mono-addition of in situ generated lithium 
phenylalkynyltrifluoroborate to γ-butyrolactone, yielding known γ-hydroxy ynone 74, which 
provided model substrate 71 after Swern oxidation (Scheme 16).70 
 
Reagents and conditions: a) Phenylacetylene (1.1 eq), nBuLi (1.1 eq), THF, 78 °C, 1.5 h; b) (COCl)2 (3.0 eq), 
DMSO (6.0 eq), Et3N (1.0 eq), 78 °C, 3 h, 61%. 
Scheme 16: Synthesis of 1,5-ynal 71. 
Submission of 71 to Krische’s cyclization conditions failed to produce β-hydroxy cyclopentanone 
75 (Table 1, entry 1). Trans hydrogenation of the ynone moiety, giving rise to known enone 76, 
was observed as the competing process.71 Consequently, a reductant screen was conducted.  
Table 1: Attempted reductive cyclization of 1,5-ynal 71. 
 
Entry Acid Reductant T [h] Yield of 75 
1 2-naphthoic acid H2 2 0%
[a] 
2 2-naphthoic acid HCO2H 22 0%
[b] 
3 2-naphthoic acid (EtO)3SiH 4 0%
[c] 
4 2-naphthoic acid Et3SiH 7 0% 
5 Ph3CCO2H H2 18 0%
[d] 
[a] Only hydrogenation to enone 76 was observed; [b] Low conversion (< 10%);                                                   
[c] Allenol silyl ether 77 was formed; [d] 22% conversion to 76. 
 
Whereas formic acid was found to shut down reactivity (entry 2), the use of triethoxysilane led to 
formation of allenol silyl ether 77 as the predominant product (entry 3).72 Utilization of 
triethylsilane as the reductant (entry 4) or tritylformic acid in place of 2-naphthoic acid did not 
                                                 
70 J. Doubský, L. Streinz, L. Lešetický, B. Koutek, Synlett 2003, 2003, 0937-0942. 
71 O. Tsuge, S. Kanemasa, T. Otsuka, T. Suzuki, Bull. Chem. Soc. Jpn. 1988, 61, 2897-2908. 
72 Structure assignment was made on the bases of 1H NMR and HRMS data, only. 
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deliver the desired cyclopentanol 75 (entry 5).  As ynones have not been reported to undergo this 
transformation, instead only propiolic esters, amides and propargyl ethers have been employed, we 
postulated that the adjacent ketone may render the alkyne too electron-poor, and therefore 
susceptible for direct hydrogenation. Modification of the ynone moiety in 71 was concluded to 
address this shortcoming. 
Thus, primary alcohol 74 was first protected as the corresponding TMS ether (Scheme 17). 
Submission of 78 to enol triflate formation was expected to lead to a competent cyclization 
precursor (79), due to reduced reactivity of the triple bond, and the spatial proximity of the reaction 
sites owing to the double bond geometry of the enol triflate. 
 
Reagents and conditions: a) TMSCl (1.1 eq), Et3N (1.5 eq), CH2Cl2, 0 °C, 1 h; b) Tf2O (1.5 eq), DTBMP (1.3 eq), 
CH2Cl2, 0 °C or 23 °C, 2.5 h, 0%; c) Tf2NPh (1.5 eq), KHMDS (1.5 eq), THF, 78 °C, 5.5 h, 0%. 
Scheme 17: Attempted synthesis of enol triflate 79. 
Unfortunately, enol triflate 79 could not be obtained due to product degradation upon attempts at 
isolation. Consequently, we proposed ketal 82 as a more stable cyclization precursor (Scheme 18). 
In addition, we anticipated increased cyclization propensity, arising from the Thorpe-Ingold effect 
of the 1,3-dioxolane. Starting from ethyl ester 80, addition of lithium phenylacetylide provided the 
known ynone 81,73 which was subjected to ketalization and subsequent ozonolysis to furnish 
unstable 1,5-ynal 82 in 65% yield (Scheme 18). 
                                                 
73 M. Schelwies, R. Moser, A. L. Dempwolff, F. Rominger, G. Helmchen, Chem. Eur. J. 2009, 15, 10888-10900. 
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Reagents and conditions: a) Phenylacetylene (2.0 eq), nBuLi (2.0 eq), THF, 78 °C, 2 h, then 78 °C to 23 °C, 30 
min, 67%; b) ethylene glycol (10 eq), pTSA (5 mol%), C6H6, reflux, 3 h, 95%; c) O3, PPh3 (1.5 eq), CH2Cl2, 78 °C, 
30 min, 68%; d) Rh(cod)OTf (5.0 mol%), (S)-Cl,MeO-BIPHEP (5.0 mol%), 2-naphthoic acid (5.0 mol%), H2 
(1 atm.), DCE, 45 °C. 
Scheme 18: Synthesis of 1,5-ynal 82 and attempted reductive cyclization. 
Employment of 82 as the reductive cyclization substrate did not provide desired spiro alcohol 84. 
Instead, transketalization to the aldehyde under the acidic reaction conditions, followed by 
hydrogenation of the released ynone functionality was observed, giving rise to known enone 83.71  
In conclusion, reductive cyclization of 1,5-ynals 71 and 82 was not achieved as a result of 
predominant and undesired trans hydrogenation of the alkyne moiety. Moreover, envisaged 
cyclization of enol triflate 79 could not be investigated due to its inherent instability. Henceforth, 
we shifted our attention to an alternative synthetic approach, discussed in the following section. 
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4.2 Studies Involving Pd0 Catalyzed Cascade Cyclization via Carbo-
palladation / Susuki Coupling / Direct Arylation 
4.2.1 Retrosynthetic Analysis 
Our revised retrosynthetic analysis of 65 incorporated a selective dechlorination of 85,67 which 
would be accessed in a single step by a palladium(0) catalyzed cascade reaction of building blocks 
88 and previously proposed pinacol boronate 69 (Scheme 19). More precisely, 85 is assumed to 
result from a direct arylation of intermediate vinyl bromide 86, in turn being formed by Suzuki 
cross coupling of palladium(II) species 87 with boronate 69. According to Scheme 19, species 87 
arises from intramolecular carbopalladation of 1,1-dibromo-1-alkene 88, after selective oxidative 
addition of Pd0 into the (Z)-vinyl bromide.74 Enantioselective access to 88 could in turn be provided 
by asymmetric alkynylation of dibromo aldehyde 89. 
 
Scheme 19: Retrosynthetic analysis of 65, involving a Pd0 catalyzed cascade cyclization. 
  
                                                 
74 a) S. Torii, H. Okumoto, T. Tadokoro, A. Nishimura, M. A. Rashid, Tetrahedron Lett. 1993, 34, 2139-2142; b) J. 
M. Nuss, R. A. Rennels, B. H. Levine, J. Am. Chem. Soc. 1993, 115, 6991-6992. 
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4.2.2 Results 
Evaluation of this revised strategy for fragment 65 began with synthesis of racemic building block 
(±)-88. Glycol cleavage of 9075 with immobilized sodium periodate76 cleanly furnished the 
corresponding bis-aldehyde, which was subjected to a Ramirez olefination to provide 
tetrabromotriene 91 (Scheme 20).77Although initially planned to be executed in one step, oxidative 
cleavage of the disubstituted double bond was found to proceed best via a stepwise oxidation to 
diol 92, followed by glycol cleavage with NaIO4/SiO2 to afford β,γ-unsaturated aldehyde 89 as the 
only alkene isomer.76 Remarkably, in the absence of silica gel the undesired corresponding α,β-
unsaturated aldehyde was solely obtained. Alkyne addition to aldehyde 89 furnished propargylic 
alcohol (±)-93 and finally 1,1-dibromoalkene (±)-88 after desilylation with TBAF. 
 
Reagents and conditions: a) OsO4 (1 mol%), NMO (1.0 eq), acetone/H2O (v/v = 4:1), 23 °C, 13 h; 49% b) NaIO4 
(1.3 eq) on SiO2, CH2Cl2, 23 °C, 20 min; c) CBr4 (2.0 eq), PPh3 (4.0 eq), CH2Cl2, 0 °C, 15 min, 49% (2 steps); d) 
OsO4 (2.0 mol%), NMO (1.5 eq), 2,6-lutidine (4.0 eq), acetone/H2O (v/v = 4:1), 23 °C, 4.5 h, 77%; e) NaIO4 (1.5 eq) 
on SiO2, CH2Cl2, 23 °C, 1.5 h; f) trimethylsilylacetylene (1.2 eq), nBuLi (1.2 eq), THF, 78 °C to 23 °C, 2 h, 43% 
(2 steps); g) TBAF (1.1 eq), THF, 0 °C, 20 min, 86%. 
Scheme 20: Synthesis of cyclization precursor (±)-88. 
                                                 
75 T. J. Donohoe, L. Mitchell, M. J. Waring, M. Helliwell, A. Bell, N. J. Newcombe, Org. Biomol. Chem. 2003, 1, 
2173-2186. 
76 The use of silica gel immobilized NaIO4 proved superior to conventional diol cleavage conducted in aqueous media, 
in terms of reaction time, product purity and ease of product isolation. For a procedure for the immobilization of NaIO4 
on SiO2, see: Y.-L. Zhong, T. K. M. Shing, J. Org. Chem. 1997, 62, 2622-2624. 
77 a) N. B. Desai, N. McKelvie, F. Ramirez, J. Am. Chem. Soc. 1962, 84, 1745-1747; b) E. J. Corey, P. L. Fuchs, 
Tetrahedron Lett. 1972, 13, 3769-3772. 
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Generally, the (E)-C(sp2)-halide bond of 1,1-dihaloalkenes shows higher reactivity in Pd catalyzed 
cross coupling reactions, leading to (Z)-configured vinyl halides.78 However, as outlined in our 
recent retrosynthetic analysis (Scheme 19), cyclizative carbopalladation of 88 would require the 
opposite selectivity for oxidative addition. Precedence for the desired selectivity was independently 
disclosed by Nuss et al. and Torii et al. in 1993.74 Therein, intramolecular carbopalladation of 1,1-
dihaloenynes 94, followed by an in situ Stille cross coupling is described, delivering cyclic 
bromoalkenes of general structure 95. Nuss and Torii attribute this finding to a transient π-
complexation of the transition metal by the pendant alkyne of 96, which preferentially delivers the 
palladium catalyst to the proximal (Z)-bromide (Scheme 21). The resulting Pd-C σ-bonded species 
97 then undergoes rapid migratory insertion to form palladium(II) species 98, followed by cross 
coupling with the present organotin reagent.  
 
Reagents and conditions: a) Pd(PPh3)4 (10 mol%), THF, 70 °C, 13 h, 57% 95a; b) Pd(OAc)2 (5 mol%), PPh3 
(10 mol%), toluene, 60 °C, 5 h, 51% 95b. 
Scheme 21: Reported Pd catalyzed dibromoenyne cyclization.74  
As the cyclization/cross coupling process is reported to occur under Stille conditions, we first 
investigated the cascade reaction of (±)-88, which differs from Nuss’ system only in shifting the 
hydroxyl group from the homopropargylic to the propargylic position, by using 
tributylphenylstannane as the organometallic coupling partner (Table 2). However, formation of 
                                                 
78 a) X. Zeng, Q. Hu, M. Qian, E.-i. Negishi, J. Am. Chem. Soc. 2003, 125, 13636-13637; b) G. A. Molander, Y. 
Yokoyama, J. Org. Chem. 2006, 71, 2493-2498. 
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the desired vinyl bromide 99 was not observed (entries 1-3).79 Similarly, neither a cyclization nor 
any cross coupling product was detected upon employment of O-benzylated (±)-88 (entry 4).  
Table 2: Attempted intramolecular carbopalladation/Stille coupling of (±)-88. 
 
Entry Catalyst Ligand (eq) Solvent (M) T [°C] Yield 
1 Pd(OAc)2 PPh3 (0.2) THF (0.02) 65 0%
[a] 
2 Pd(OAc)2 PPh3 (0.2) PhMe (0.02) 65 0%
[a] 
3 Pd(OAc)2 PPh3 (0.4) PhMe (0.1) 65 0%
[a] 
   4[b] Pd(OAc)2 PPh3 (0.2) PhMe (0.1) 60 0%
[a] 
   5[c] Pd(OAc)2
[d] PPh3 (0.4) PhMe (0.1) 60 0%
[a] 
6 Pd(dba)2 SPhos (0.2) PhMe (0.1) 60 0%
[a] 
7 Pd(OAc)2 dppe (0.2 PhMe (0.1) 60 0%
[e] 
8 Pd(OAc)2 dppp (0.2) PhMe (0.1) 60 0%
[e] 
9 Pd(OAc)2 dppf (0.2) PhMe (0.1) 60 0%
[e] 
[a] Decomposition of (±)-88; [b] Corresponding propargylic benzyl ether was used instead of (±)-88;                                 
[c] Addition of CuI (0.2 eq) and CsF (2.0 eq); [d] 20 mol%; [e] No conversion. 
Moreover, 99 remained inaccessible by activation of the arylstannane through transmetalation to 
copper(I) (entry 5),80 or when SPhos/Pd(dba)2 was employed as the catalytic system (entry 6).81 In 
contrast to the previous experiments, no conversion was achieved by use of bidentate ligands 
(entries 7-9).  
Reflecting on these unpromising studies involving Stille cross coupling, we next resorted to the 
originally intended carbopalladation/Suzuki coupling sequence, using phenylboronic acid as the 
coupling partner (Table 3).  
 
 
                                                 
79 Degradation  of  the  starting  material  to  unidentifiable  products was observed. 
80 S. P. H. Mee, V. Lee, J. E. Baldwin, Angew. Chem. Int. Ed. 2004, 43, 1132-1136. 
81 C. S. Bryan, M. Lautens, Org. Lett. 2010, 12, 2754-2757. 
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Table 3: Attempted intramolecular carbopalladation/Suzuki coupling of (±)-88. 
 
Entry Catalyst (eq) Ligand (eq) Solvent[a] Additive (eq) T [°C] Yield 
1 Pd(OAc)2 (0.2) PPh3 (0.6) PhMe K2CO3 (3.0) 60 0%
[b] 
2 Pd(dba)2 (0.1) SPhos (0.2) PhMe K3PO4 (3.0) 60 0%
[b,c] 
3 Pd(dba)2 (0.1) - EtOH Cs2CO3 (1.2) 25 0%
[b,c] 
4 Pd(OAc)2 (0.2) PPh3 (0.8) PhMe Cs2CO3 (3.0) 25 0%
[b] 
5 Pd(dba)2 (0.1) tBu3P•HBF4 (0.2) Dioxane Cs2CO3 (4.0) 90 0%
[b,c] 
6 Pd(OAc)2 (1.0) PPh3 (3.0) PhMe
 [d] Cs2CO3 (4.0) 60 0%
[b] 
[a] 0.1 M; [b] Decomposition of (±)-88; [c] Formation of 100; [d] 0.06 M. 
However, none of the evaluated catalytic systems enabled the envisaged carbopalladation/cross 
coupling sequence. Similar to previous results, decomposition of (±)-88 was observed in each case.  
A related report of palladium catalyzed coupling of propargylic alcohols with arylboronic acids to 
produce aryl allenes under similar conditions (Scheme 22),82 caused us to move away from 
unprotected propargylic alcohol (±)-88, and instead focused on protected derivatives. 
 
Scheme 22: Reported synthesis of aryl allenes from propargylic alcohols according to Yoshida and Ihara. 
Hence, we concentrated on the cascade reaction of benzyl propargyl ether (±)-101 with 
phenylboronic acid (Table 4). However, the use of Pd(OAc)2/PPh3 did not provide the desired 
cyclic bromide 102 (entry 1). We next examined the influence of protic solvents on the reaction 
outcome (entries 2, 3 and 5-7), as EtOH has been employed by Oh et al. as the solvent of choice 
for cascade cyclization/cross coupling reactions of 2-bromo-1,6-enynes (Scheme 23).83 
                                                 
82 M. Yoshida, T. Gotou, M. Ihara, Tetrahedron Lett. 2004, 45, 5573-5575. 
83 C. H. Oh, Y. M. Lim, Tetrahedron Lett. 2003, 44, 267-270. 
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Table 4: Attempted cascade cyclization/Suzuki coupling of benzyl propargyl ether (±)-101. 
 
Entry Catalyst (eq) Ligand (eq) Solvent Eq base T [°C] Yield 
1 Pd(OAc)2
 
(0.1) PPh3
 
(0.2) PhMe 0 60 0% 
2 Pd(dba)2 (0.1) - EtOH 2.0 23 0% 
3 Pd(dba)2 (0.1) tBu3P•HBF4 (0.2) EtOH 2.2 23 0% 
4 Pd(dba)2 (0.1) tBu3P•HBF4 (0.2) Dioxane 4.0 70    0%
[a] 
5 Pd(OAc)2 (0.1) tBu3P•HBF4 (0.4) EtOH 2.4 23 0% 
6 Pd(OAc)2 (0.2) PPh3 (0.8) EtOH 2.0 23    0%
[b] 
[a] Conversion of dba to 100 was observed; b) Trace amounts of 103 and 104 were detected. 
However, neither Oh’s standard cyclization conditions using Pd(dba)2/Cs2CO3 at ambient 
temperature (entry 2), nor the use of electron-rich tri-tertbutyl phosphine resulted in formation of 
102 (entries 3-5) and substrate degradation was observed in all cases. In contrast, employment of 
Pd(OAc)2/PPh3 afforded mono- and double-Suzuki coupling products 103 and 104 (entry 6). 
However, only trace amounts were detected. Thus, no information regarding the selectivity of 
oxidative addition into the carbon-bromide bond could be obtained. 
 
Scheme 23: Cascade cyclization–coupling reaction of 2-bromo-1,6-enynes according to Oh et al. 
It became increasingly apparent that the substitution pattern of the dibromoenyne two-atom linker 
must be judiciously chosen to enable the desired cascade cyclization/cross coupling process. 
Therefore, a MOM protected congener of (±)-101 was elected to be investigated next, and its 
synthesis is presented in Scheme 24. Oxidative cleavage of diol 90, followed by addition of lithium 
trimethylsilylacetylide and MOM protection of the resulting propargylic alcohol under acidic 
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conditions afforded bis-MOM ether 105.84 Subsequent Prilezhaev oxidation led to quantitative 
formation of an intermediate epoxide,85 which was subsequently cleaved with periodic acid, thus 
breaking the C10 backbone into two identical C5 aldehydes. Conversion into 1,1-dibromoalkene 
(±)-106 using CBr4/PPh3, followed by desilylation with potassium methanolate provided MOM 
protected dibromoenyne (±)-107.  
 
Reagents and conditions: a) NaIO4 on SiO2 (1.5 eq), CH2Cl2, 23 °C, 30 min, b) trimethylsilylacetylene (2.4 eq), 
nBuLi (2.4 eq), THF, 78 °C to 23 °C, 1.5 h; c) LiBr (0.8 eq), pTSA (0.2 eq), DMM, 23 °C, 36 h; d) mCPBA 
(2.0 eq), CH2Cl2, 23 °C, 12 h; e) H5IO6 (3.0 eq), CPME, 23 °C, 7 h; f) CBr4 (2.0 eq), PPh3 (4.0 eq), CH2Cl2, 0 °C, 15 
min; g) K2CO3 (0.1 eq), MeOH, 23 °C, 1.5 h. 
Scheme 24: Synthesis of MOM protected cyclization precursor (±)-107. 
Our ensuing studies on the cascade cyclization/Suzuki coupling of (±)-107 are summarized in 
Table 5. None of the screened reaction conditions led to formation of cyclic bromoalkene 108 or 
to the targeted tricyclic indene derivative by an ensuing direct arylation. Instead, mono-Suzuki 
coupling product 109 was isolated in 31% yield (entry 2). However, its double bond geometry 
could not be unambiguously assigned due to insufficient substance quantities. 
 
 
 
 
 
 
 
 
                                                 
84 J.-L. Gras, Y.-Y. K. W. Chang, A. Guerin, Synthesis 1985, 1985, 74-75. 
85 N. Prileschajew, Ber. Dtsch. Chem. Ges 1909, 42, 4811-4815. 
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Table 5: Attempted cascade cyclization/Suzuki coupling of MOM ether (±)-107. 
 
Entry Catalyst Ligand Solvent (M) T [°C] Result 
1[a] Pd(OAc)2 PPh3
[b] EtOH (0.1) 25 Traces of 109 
2[a] Pd(dba)2 PPh3 EtOH (0.06) 60 31% 109, 5% 110 
3[b] Pd(dba)2 PPh3 Dioxane (0.05) 25 Traces of 109 
4[c] Pd(dba)2 TFP Dioxane/H2O (0.1) 60 Decomposition 
5[b] Pd(dba)2 PPh3 DMF (0.1) 25 Poor conversion 
6[c] Pd(dba)2 tBu3P•HBF4 Dioxane (0.1) 60 Complex mixture 
7[a] Pd(cin)(cp) PPh3 EtOH (0.06) 60 Complex mixture 
[a] 1.5 eq PhB(OH)2, 2.0 eq Cs2CO3; [b] 0.4 eq PPh3; [c] 1.2 eq PhB(OH)2, 4.0 eq Cs2CO3;                                                   
[d]1.0 eq PhB(OH)2, 2.0 eq Cs2CO3. 
 
Consequently we subjected TMS protected dibromoenyne (±)-106 to a Negishi cross coupling,86 
providing bromoalkene 111 of unknown double bond configuration in 84% yield (Scheme 25). 
Upon desilylation (K2CO3/MeOH), spectroscopically identical material to 109 was obtained in 
sufficiently large quantities for subsequent 1D NOE studies, revealing the depicted 
(Z)-configuration of bromoalkene 109. 
 
Reagents and conditions: a) PhLi (1.2 eq), ZnBr2 (1.2 eq), (DpePhos)PdCl2 (5 mol%) THF, 23 °C, 2 h; b) K2CO3 
(0.2 eq), MeOH, 23 °C, 1.5 h. 
Scheme 25: Determination of the double bond configuration of 109. 
                                                 
86 J.-c. Shi, E.-i. Negishi, J. Organomet. Chem. 2003, 687, 518-524. 
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In contrast to the dibromoenyne systems investigated by Nuss and Torii, oxidative addition of Pd0 
into 106 was selective for the (E)-carbon bromide bond, preventing the intended cascade 
cyclization/cross coupling sequence.  
Based on this knowledge, we revised our synthetic strategy towards the tricyclic system of fijiolide 
A to take advantage of the observed high trans-selectivity for cross coupling of (±)-106. Thus, we 
postulated that (Z)-configured bromide 109 would – after oxidative addition to produce 112  
undergo intramolecular carbopalladation to form the palladium(II) species 113 (Scheme 26). This 
would set up the stage for a subsequent concerted metalation/deprotonation (CMD) step via 
intermediate 114 in the presence of a carbonate base, such as sodium bicarbonate.66c Reductive 
elimination of palladacycle intermediate 115 would close the 5-membered indene ring, and release 
tricyclic species 116, as well as regenerate the palladium catalyst.  
 
Scheme 26: Proposed mechanism of the envisaged cascade carbopalladation/direct arylation process. 
In order to explore the proposed cascade cyclization/arylation reaction, bromide 109 and TMS 
protected 111 were subjected to various palladium based catalytic systems in polar aprotic solvents 
(Table 6).66b,c However, all evaluated conditions led to either decomposition of the employed 
bromoenyne starting material, complex product mixtures or poor conversions. Notably, the desired 
reactivity also remained elusive by use of taddol-based phosphoramidite ligands T1 and T2 (entries 
6 and 9-11), which had previously been demonstrated to induce efficient direct arylation of enol 
triflates to afford indane motifs.66c Moreover, we could not enable the cascade cyclization to 117 
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by protection of the terminal alkyne or by altering the reaction temperature (cf. entries 1-7 and 
8-12). 
Table 6: Attempted carbopalladation/direct arylation reactions of bromoalkenes 109 and 111. 
 
Entry Catalyst Ligand (eq) Solvent Base T [°C] Result 
R = H 
1[a,b] Pd(OAc)2 PPh3 (0.15) DMA K2CO3 50 Decomposition 
2[a,b] Pd(OAc)2 Cy3P•HBF4
[c] DMA K2CO3 50 Decomposition 
3 Pd(OAc)2 PPh3 (0.15) DMF K2CO3 60 Decomposition 
4 Pd(OAc)2 PPh3 (0.15) DMF NaHCO3 60 Complex mixture 
5 PdCl2 PPh3 (0.2) DMF NaHCO3 60 Mainly decomp.
[d] 
6 Pd(cin)(cp) T1 (0.15) DMF NaHCO3 60 Partial decomp.
[e] 
7 PdCl2(DpePhos) - DMF Et3N 60 Mainly decomp.
[f] 
   R = TMS    
8 Pd(OAc)2 PPh3 (0.15) DMA K2CO3 25 Decomposition 
9 Pd(OAc)2 T2 (0.15) DMA K2CO3 50 Complex mixture 
10 Pd(OAc)2 T1 (0.15) DMF K2CO3 105 Decomposition 
11 CpPd(Cinnamyl) T1 (0.15) DMF K2CO3 105 Decomposition 
12 CpPd(Cinnamyl) PPh3 (0.1) DMF Et3N 60 No conversion 
[a] Identical results were obtained for vinyl bromide 111; [b] PivOH (0.2 eq) was added; [c] 0.15 eq;                                                           
[d] 17% 109 recovered; [e] 58% 109 recovered; [f] 19% 109 recovered. 
 
As a consequence of these results, we became increasingly concerned about the previously assigned 
double bond configuration of 109/111, and aimed to obtain further proof. We proposed that a 
palladium catalyzed reduction of bromoalkene 111 to the corresponding disubstituted alkene would 
provide unequivocal evidence, as the double bond configuration could then be easily determined 
on the bases of the measured 1H coupling constant between the olefinic protons. 
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Remarkably, by performing this transformation in the presence of formic acid as the reductant, and 
triethylamine as the base, a high yielding cyclization of 111 to reduced monocycle 119 was 
observed, without any traces of the expected alkene 118 (Scheme 27). Hereby, intramolecular 
carbopalladation was unintendedly observed for the first time and the (Z)-configuration of the 
starting vinyl bromide could unequivocally be confirmed. However, species 119 does not allow 
straightforward access to the desired tricyclic fragment 117 due to a lack of suitable 
functionalization. 
 
Scheme 27: Unintended reductive cyclization of vinyl bromide 109. 
Encouraged by this result, we tried to exploit the newly discovered reactivity of 111 by omission 
of the reductant in order to allow further cyclization to carbocyclic species 117 (Table 7). However, 
no reaction occurred in the absence of formic acid (entry 2), and 16% of 119 was formed in the 
presence of sub-stoichiometric amounts of HCO2H (0.2 eq) (entry 3). Moreover, we observed 
almost no reactivity when alternative carboxylic acids were employed (entries 4-5). The use of 
triethoxysilane also resulted in reductive cyclization of 111 to afford 64% 119, but the targeted 
tricycle 116 was not detected (entry 6). Interestingly, replacement of Et3N by K2CO3 repressed the 
formation of reduced monocycle 119 to a great extent, however, formation of 117 was still not 
observed (entry 8). Finally, use of PivOH/K2CO3 led to decomposition of the starting material 
(entry 8). 
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Table 7: Cascade cyclization attempts on bromoalkene 111. 
 
Entry Base Additive (eq) Result 
1 Et3 N HCO2H 77% 119 
2 Et3 N - no conversion 
3 Et3 N HCO2H 
[a] 16% 119 
4 Et3 N AcOH no conversion 
5 Et3 N PivOH poor conversion
[b] 
6 Et3 N (EtO)3SiH 64% 119 
7 K2CO3 HCO2H 17% 119 
8 K2CO3 PivOH decomposition 
[a] 0.2 eq; [b] 85% 111 recovered. 
From the experiments summarized in Table 7 it became clear that the presence of a reducing agent 
is essential for the observed mono-cyclization of precursor 111. Omitting or replacing the reductant 
did not enable an intramolecular carbopalladation/direct arylation sequence. 
As we were unsuccessful of cyclizing various 1,1-dibromoenynes and (Z)-bromoenynes to afford 
annulated indenes, we revised out strategy towards fijiolide A, and studies in this direction are 
discussed in the following section. 
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4.3 Studies Involving RuII Catalyzed [2+2+2] Cycloaddition / AuI Catalyzed 
Bis-Alkyne Isomerization 
4.3.1 Retrosynthetic Analysis  
A revised strategy towards the cyclopenta[a]indene core of fijiolide A is presented in Scheme 28. 
Construction of carbocyclic fragment 120 is proposed to be accomplished using a gold(I) catalyzed 
cycloisomerization of bis-alkyne 121,87 which, in turn, will be accessed via Sonogashira coupling 
of aryl iodide 122 and protected propargyl alcohol 123. A chlorodeboronation traces 122 back to 
heavily substituted boraphthalide species 124. The synthesis of 124 is envisaged to be achieved in 
a single step from diynylboronate 125, propargylic alcohol 126 and internal alkyne 127 via a 
temporary boron tether enabled intermolecular [2+2+2] cyclotrimerization.88 
 
Scheme 28: Retrosynthetic analysis of tricyclic indene 120 involving a AuI catalyzed bis-alkyne cycloisomerization. 
  
                                                 
87 L. Ye, Y. Wang, D. H. Aue, L. Zhang, J. Am. Chem. Soc. 2012, 134, 31-34. 
88 Y. Yamamoto, J.-i. Ishii, H. Nishiyama, K. Itoh, J. Am. Chem. Soc. 2004, 126, 3712-3713. 
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4.3.2 Results  
Our third generation strategy towards the fijiolide cyclopenta[a]indene core is based on a gold(I) 
catalyzed cycloisomerization process recently disclosed by Zhang et al. in 2012.87 The authors 
report direct access to tricyclic indenes from readily available 1,2-alkynylbenzenes via gold 
vinylidene species.33 The proposed mechanism for this transformation, exemplified on Zhang’s 
least substituted cyclization substrate, is provided in Scheme 29. Activation of the bis-alkyne 128 
by BrettPhosAuNTf2 (134) allows for deprotonation of the terminal alkyne by the employed 
pyridine N-oxide (N1) species to afford gold acetylide 129. Another BrettPhosAuNTf2 is believed 
to activate the second triple bond (130) and facilitate a 5-endo-dig cyclization to produce gold 
vinylidene intermediate 131. This highly reactive species is proposed to undergo a C-H insertion 
leading to tricyclic species 132, which releases the tricyclic indene species 133 upon 
protodeauration. 
 
Scheme 29: Proposed mechanism for the gold(I) catalyzed bis-alkyne cycloisomerization.87 
133 completely represents the unsubstituted carbocyclic framework of the postulated synthetic 
intermediate 120. To adopt this method for our synthetic target, a heteroatom-substitution of the 
propargylic positon in 128 was required. This modification has not been reported by Zhang et al. 
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Thus, we first focused on synthesis of model substrate 135 in order to investigate the feasibility of 
this methodology to access 136.  
 
Scheme 30: Envisaged synthesis of model cyclopenta[a]indene 136. 
Synthesis of bis-alkynes 135a (R = TES) and 135b (R = Bn) was accomplished by successive 
Sonogashira coupling of 2-bromoiodobenzene with methyl propargyl alcohol and 
trimethylsilylacetylene, followed by desilylation to afford bis-alkyne 137, which was subsequently 
protected as its corresponding benzyl or TES ether (Scheme 31).  
 
Reagents and conditions: a) but-3-yn-2-ol (1.2 eq), (PPh3)2PdCl2 (1 mol%), CuI (2 mol%), Et3N, 50 °C, 54% (100% 
brsm); b) trimethylsilylacetylene (1.3 eq), (PhCN)2PdCl2 (3 mol%), (tBu)3P•HBF4 (6 mol%), CuI (3 mol%), 
HN(iPr)2 (1.3 eq), dioxane, 30 °C, 1.5 h; c) TBAF (1.2 eq), 0 °C, 20 min, 34% (2 steps); d) TESCl (4.0 eq), 1H-
imidazole (4.0 eq), DMF, 23 °C, 13 h, 86%; e) NaH (1.5 eq), BnBr (1.3 eq), TBAI (0.3 eq), THF, 23 °C, 3 h, 87%. 
Scheme 31: Syntheses of functionalized bis-alkynes 135a and 135b. 
With bis-alkynes 135, the BrettPhosAuNTf2 catalyzed cycloisomerization was attempted under the 
reported conditions (Table 8). No formation of the targeted cyclopenta[a]indenes was observed 
(entries 1 and 7). Attempts to enhance conversion of TES ether 135a by increasing the 
concentration or reaction temperature only led to desilylation (entries 2 and 3). Employment of an 
alternative N-oxide (N2) (entries 4 and 8), or omission of the base (entries 5-6) likewise did not 
provide the desired indene derivatives. Analogous experiments with the corresponding PMB 
propargylic ether resulted in similarly low conversions (10-32%), without any trace of the desired 
product (data not shown). In addition, a beneficial effect on the cycloisomerization reaction by 
addition of water, as reported by Zhang et al., was neither observed (entry 9).  
 
4. Studies towards the Chlorocyclopenta[a]indene Fragment 48 
 
Table 8: Attempts at cycloisomerization of bis-alkynes 135a and 135b. 
 
Entry R N-oxide Solvent 
T  
[°C] 
T  
[h] 
Yield / conversion 
[%][a] 
1 TES N1 DCE 23 5 0 / 18 
2 TES N1    DCE[b] 23 5 48 (137) / 87 
3 TES N1 DCE 50 18 65 (137)/ 100 
4 TES N2 DCE 23 5 0 /19 
5 TES - DCE 23 18 0 / 28 
6 TES - DCE 50 19 0 / 29 
7 Bn N1 DCE 23 21 0 / 36 
8 Bn N2 DCE 23 7 0 / 28 
9 Bn N2    CDCl3
[c] 23 21 0 / 43 
[a] Determined by 1H NMR using 1,3,5-TMB as internal standard; [b] 1.0 M in DCE;  [c] 10 eq H2O were added. 
Based on these results, we presumed that ether-substitution at the propargylic position may not be 
tolerated. To prove this assumption, and to verify the reproducibility of Zhang’s method in our 
hands, bis-alkynes substrates 138a-c were synthesized in analogy to 135.89 An excellent yield was 
attained for cyclopenta[a]indene 139a (Scheme 32), thus proving the reproducibility of this 
methodology, and confirming the activity of the prepared catalyst 134.90,91  
 
Scheme 32: Verified reproducibility of the AuI catalyzed bis-alkyne isomerization process. 
                                                 
89 For a synthesis of the employed propargyl alcohol, see: Jeong, E. J. Kang, L. T. Sung, S. K. Hong, E. Lee, J. Am. 
Chem. Soc. 2002, 124, 14655-14662. 
90 a) B. P. Fors, D. A. Watson, M. R. Biscoe, S. L. Buchwald, J. Am. Chem. Soc. 2008, 130, 13552-13554; b) L. Ye, 
W. He, L. Zhang, Angew. Chem. Int. Ed. 2011, 50, 3236-3239. 
91 In contrast to the synthesis of 139a, cycloisomerization of 128 could not be reproduced. Only low yields of 13% 
(62% reported) of 133 were obtained under various reaction conditions. 
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Active catalyst 134 was then employed in cycloisomerization attempts of bis-alkynes 138 (Table 
9). As illustrated, the propargyl ether group completely shuts down the cyclization process (entry 
1 and 2 vs. 3-5). 
Table 9: Cycloisomerization studies on bis-alkynes 138a-c. 
 
Entry R  N-oxide 
T  
[°C] 
T  
[h] 
NMR Yield / 
conversion [%] 
1 H N1 23 4 58[a] / 82 
2 H N2 23 6 85 / 88 
3 OTBS N2 23 4 0 / 18 
4 OTBS N2 50 18 0 / 33 
5 OBn N2 23 19 0 / 39 
[a] Isolated yield. 
As a consequence we shifted our attention to silyl-substituted cycloisomerization precursors, which 
we proposed to be an adequate forerunner for the desired hydroxycyclopenta[a]indenes by 
Fleming-Tamao oxidation.92 Thus, propargyl silane 140 was synthesized from propionaldehyde.93 
Subsequent transformation into 141 was realized by a reaction sequence consisting of two 
Sonogashira couplings and TMS cleavage with AgNO3/KCN, according to the procedure of 
Rajagopalan and Zweifel (Scheme 33).94 Unfortunately, 141 did not undergo the desired 
cycloisomerization reaction to provide 142, but was slowly degraded under the reaction conditions.  
 
 
                                                 
92 a) K. Tamao, N. Ishida, T. Tanaka, M. Kumada, Organometallics 1983, 2, 1694-1696; b) I. Fleming, R. Henning, 
H. Plaut, J. Chem. Soc., Chem. Commun. 1984, 29-31. 
93 M. S. Betson, I. Fleming, Org. Biomol. Chem. 2003, 1, 4005-4016. 
94 S. Rajagopalan, G. Zweifel, Synthesis 1984, 1984, 111-112. 
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Reagents and conditions: a) 2-bromoiodobenzene (0.8 eq), (PPh3)2PdCl2 (3.0 mol%), CuI (6.0 mol%), Et3N (5.0 eq), 
THF, 23 °C, 2 h; b) trimethylsilylacetylene (1.3 eq), (PhCN)2PdCl2 (5.0 mol%), (tBu)3P•HBF4 (10 mol%), CuI 
(5.0 mol%), HN(iPr)2 (1.4 eq), dioxane, 23 °C, 3 h; b) AgNO3 (1.8 eq), EtOH/H2O (3:1), 0 °C, 1 h, then KCN 
(8.9 eq), 23 °C, 2 h, 11% (3 steps); d) 134 (5.0 mol%), N2 (0.5 eq), H2O (10 eq), DCE, 23 °C, 19 h, decomposition. 
Scheme 33: Synthesis of silylated bis-alkyne 141 and attempted cycloisomerization. 
An alternative cycloisomerization precursor would be TMS-substituted alkyne 145, which was 
synthesized from dibromoalkene 143 in analogy to 141 (Scheme 34).95,96 Despite the poor yield 
for its preparation (6% over 3 steps), 145 could be shown to cycloisomerize in the presence of 
BrettPhosAuNTf2 to afford 146. Thus, although silyl substitution was generally tolerated, it could 
not be used at the desired propargylic C-10 position. 
  
Reagents and conditions: a) nBuLi (2.1 eq), THF, 78 °C to 23 °C, 2.5 h; b) (PPh3)2PdCl2 (3.0 mol%), CuI 
(6.0 mol%), Et3N (5.0 eq), THF, 23 °C, 2 h, 38%; c) (PhCN)2PdCl2 (6 mol%), (tBu)3P•HBF4 (12 mol%), CuI 
(6.0 mol%), HN(iPr)2 (1.4 eq), dioxane, 30 °C, 3 h; f) AgNO3 (1.8 eq), EtOH/H2O (3:1), 0 °C, 1 h, then KCN 
(8.9 eq), 23 °C, 2 h; g) 134 (5 mol%), N2 (0.5 eq), H2O (10 eq), CDCl3, 23 °C, 19 h. 
Scheme 34: Synthesis of silylated bis-alkyne 145 and cycloisomerization to 146. 
 
                                                 
95 E. Piers, A. V. Gavai, J. Org. Chem. 1990, 55, 2374-2379. 
96 145 and 146 were not fully characterized and tentatively assigned by means of 1H NMR spectroscopy. 
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Although 146 could be used in principle to access fijiolide A, we considered an alternative strategy 
towards a C-11 functionalized key fragment, involving an allenic Pauson-Khand reaction, as 
described by Liu et al. (Scheme 35).97 Results towards this end are discussed in the following 
section. 
 
Scheme 35: Synthesis of cyclopenta[a]inden-2-one via an allenic Pauson-Khand reaction according to Liu et al. 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
97 S. Datta, R.-S. Liu, Tetrahedron Lett. 2005, 46, 7985-7988. 
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4.4 Studies Involving RuII Catalyzed [2+2+2] Cycloaddition / Allenic Pauson-
Khand Reaction 
4.4.1 Retrosynthetic Analysis 
Our fourth retrosynthetic analysis of the key fragment targets the slightly modified tricyclic 
indenylcyclopentenone 149 (Scheme 36). 149 was identified as the product of an allenic Pauson-
Khand reaction of allene-yne 150.98 The allene handle in 150 was postulated to arise from a base-
induced isomerization of a propargyl group,99 while the chlorine atom was to be installed by a 
chlorodeboronation reaction of boraphthalide 151. According to Scheme 36, access to the highly 
substituted arene core of 151 would be provided by an intermolecular RuII catalyzed 
cyclotrimerization of alkynylboronate 125, propargylic alcohol 126, and symmetrical alkyne 152.88 
 
 
Scheme 36: Retrosynthetic analysis of the tricycle 149 via an allenic Pauson-Khand approach.  
                                                 
98 B. Alcaide, P. Almendros, Eur. J. Org. Chem. 2004, 2004, 3377-3383. 
99 a) M. E. Jung, J. A. Hagenah, J. Org. Chem. 1987, 52, 1889-1902; b) K.-S. Masters, M. Wallesch, S. Bräse, J. Org. 
Chem. 2011, 76, 9060-9067; c) B. Blanco, A. Sedes, A. Peon, H. Lamb, A. R. Hawkins, L. Castedo, C. Gonzalez-
Bello, Org. Biomol. Chem. 2012, 10, 3662-3676. 
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4.4.2 Results 
As a synthesis of unsubstituted indenylcyclopentenone 148 has already been reported (cf. chapter 
4.3.2, Scheme 35),97 our revised synthetic strategy involving an allenic Pauson-Khand reaction 
would merely require a suitable substitution of the arene core. We proposed that an intermolecular 
[2+2+2] cycloaddition would be a rapid and elegant approach, in contrast to more conventional 
and step-extensive benzene functionalization strategies. In 2004 Yamamoto and coworkers 
reported a ruthenium catalyzed intermolecular [2+2+2] cycloaddition of three unsymmetrical 
alkynes to afford boron substituted arenes (Scheme 37).88  
 
Scheme 37: Yamamoto’s intermolecular [2+2+2] cycloaddition. 
This powerful cyclotrimerization method allows a steep increase in molecular complexity, taking 
advantage of a temporary boron tether to control the regioselectivity of the [2+2+2] cycloaddition, 
and simultaneously repressing parasitic homotrimerization. The resulting boraphthalides of general 
structure 156, were shown to serve as efficient coupling partners in Suzuki-Miyaura couplings with 
aryl halides (157),88,100 or participate in Pd0 catalyzed carbonylation reactions, leading to 
substituted phthalides 158.101 Mechanistically, Yamamoto et al. propose an initial and reversible 
B-O-C linkage between the alkynylboronate species 153 and the propargylic alcohol 154 (Scheme 
38). The boron tethered 1,6-diyne 159, is a competent substrate for oxidative cyclization with the 
RuII catalyst, affording ruthenacycle 160. Reversible coordination of the third alkyne part gives rise 
to π-complexes 161 and 162. Insertion of the coordinated alkyne is then postulated to occur 
exclusively into the Ru-C bond anti to the boronate moiety as a consequence of the synergistic 
effect of both the steric influence of the substituent R1 and the electronic directing effect of the 
                                                 
100 Y. Yamamoto, J.-i. Ishii, H. Nishiyama, K. Itoh, Tetrahedron 2005, 61, 11501-11510. 
101 Y. Yamamoto, J.-i. Ishii, H. Nishiyama, K. Itoh, J. Am. Chem. Soc. 2005, 127, 9625-9631. 
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electron-deficient boron center.101 Moreover, unfavorable steric repulsion between the substituent 
R3 of the coordinated terminal alkyne and the chloro ligand of the metal center in 161 is believed 
to favor insertion via species 162. Reductive elimination from 163 then releases the 
cyclotrimerization product 156 as the only observed regioisomer. 
 
Scheme 38: Proposed mechanism of Yamamoto's boron tethered alkyne cyclotrimerization. 
Based on Yamamoto’s reports, we targeted boraphthalide 151 (Scheme 36), and aimed to utilize 
the aryl boronic acid moiety for a later incorporation of the chlorine atom via deborylative halogen. 
To realize this goal, selective formation an arylboronic acid derivative with a meta-substituent 
would be required, as opposed to the para-regioselectivity observed by Yamamoto et al. We 
hypothesized that installation of an removable blocking substituent, such as a TMS group, on the 
third alkyne component may reverse the orientation of the alkyne with respect to the metal center, 
as depicted in π-complex 164 (Scheme 39). Thus, unfavored steric repulsion between the bulky 
TMS group and the ruthenium ligands in 166 would be avoided. Consequently, preferential alkyne 
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insertion via π-complex 164 would place the bulky TMS group para to the boronic acid, and R3 at 
the meta-position, giving rise to penta-substituted benzene 165. 
 
Scheme 39: Hypothesized preferential formation of parasilyl arylbronic acids. 
In order to investigate this hypothesis, alkynylboronates 169 and 125 were synthesized from 
commercially available alkynes (Scheme 40). The preparation of known 169 from methyl 
propargyl ether 168 proceeded smoothly,102 but in low yield. In contrast, the synthesis of required 
125 following a one-pot literature procedure proved troublesome in terms of product isolation. 
According to Schwarz et al.,103 125 is obtained in up to 95% purity as the residue after distillative 
removal of all volatiles at 90 °C/12 mbar. In several attempts to reproduce this procedure, exposure 
of the crude product to heat led to severe polymerization and 125 could not be detected by 1H NMR 
analysis. Consequently, the procedure was modified so that the intermediate lithium borate salt 171 
was isolated as a solid and meticulously washed with dry Et2O to remove unreacted B(OiPr)3 and 
TMS acetylene dimer 170. In contrast to diynylboronate 125, 171 does not exhibit particular 
moisture sensitivity and does not require an inert atmosphere for handling and filtration. 
Nevertheless, 171 was kept at 30 °C under N2 for long-term storage. Subsequent reaction of 171 
with anhydrous HCl, followed by filtration under inert conditions and removal of all volatiles under 
high vacuum furnished diynylboronate 125 in high purity as an amber-colored liquid.   
                                                 
102 R. Morita, E. Shirakawa, T. Tsuchimoto, Y. Kawakami, Org. Biomol. Chem. 2005, 3, 1263-1268. 
103 A. M. McAnoy, S. Dua, D. Schröder, J. H. Bowie, H. Schwarz, J. Phys. Chem. A 2004, 108, 2426-2430. 
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Reagents and conditions: a) nBuLi (1.0 eq), Et2O, 78 °C, 1 h, then B(OiPr)3 (1.0 eq),78 °C, 4 h, then HCl 
(1.0 eq),78 °C to 23 °C, 1 h, 25%; b) MeLi•LiBr (1.1 eq), Et2O, 23 °C, 14 h, then B(OiPr)3 (1.5 eq), 78 °C to 
23 °C, 3.5 h, 79%; c) HCl (1.3 eq), Et2O,  78 °C to 23 °C, 45 min, 71%.   
Scheme 40: Synthesis of alkynylboronates 169 and 125. 
Known propargyl alcohols (±)-126 and (±)-174 were synthesized from glycerol 172 (Scheme 
41),104,105 and subsequently examined in the [2+2+2] cycloaddition reaction (Table 10). 
  
Reagents and conditions: a) TBSCl (1.0 eq), glycerin (20 eq), CH2Cl2/DMF (3:1), 18 °C, 3 h, 88%; b) NaIO4 
(1.8 eq), CH2Cl2/H2O (1:1), 2 h, 87%; c) ethynylmagnesium bromide (1.2 eq), 0 °C, 1 h, 65% (±)-126;                               
d) trimethylsilylacetylene (1.1 eq), nBuLi (1.2 eq), 78 °C to 23 °C, 45 min, 90% (±)-174. 
Scheme 41: Synthesis of propargyl alcohols (±)-126 and (±)-174. 
We began by reproducing Yamamoto’s synthesis of boraphthalide 175a, proceeding in 66% yield 
from propargyl alcohol, 1-hexyne and alkynylboronate 169 (entry 1). By consecutive substitution 
of the alkyne components, we discovered that utilization of either secondary propargylic alcohol 
(±)-126 or diynylboronate 125, efficiently provided the corresponding boraphthalides 175b and 
175c in 62% and 72%, respectively (entries 2-3). Remarkably, common employment of both 
smoothly delivered tetrasubstituted benzene 175d in 70% yield (entry 4).  
                                                 
104 a) S. Kim, C. M. Cho, Tetrahedron Lett. 1995, 36, 4845-4848; b) Q. Liu, G. Yue, N. Wu, G. Lin, Y. Li, J. Quan, 
C.-c. Li, G. Wang, Z. Yang, Angew. Chem. Int. Ed. 2012, 51, 12072-12076. 
105 I. Paterson, O. Delgado, G. J. Florence, I. Lyothier, M. O'Brien, J. P. Scott, N. Sereinig, J. Org. Chem. 2005, 70, 
150-160. 
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Table 10: [2+2+2] cycloadditions towards the fully substituted fijiolide arene core. 
 
 
[a] Modifications compared to the literature compound 175 are highlighted in color;                                                
structures were tentatively assigned on the bases of 1H NMR spectroscopy. 
We next replaced the third alkyne component (1-hexyne) by TMS substituted alkynes to test the 
desired inversion of regioselectivity. However, utilization of commercially available 
(iodoethynyl)trimethyl-silane resulted in marginal conversion and failed to furnish iodobenzene 
175e. Similarly, employment of known 1,5-bis(trimethylsilyl)penta-1,4-diyne106 led to poor 
conversion, and no trace of product 175f, bearing a TMS propargyl group as the later allene synthon 
(entry 6). Accordingly, the employment of TMS substituted alkynes as the third alkyne component 
appeared to shut down the [2+2+2] cycloaddition process. To address this shortcoming, we revised 
our working hypothesis, and wondered if we could invert the reported regioselectivity by the 
installation of a sterically demanding substituent on the terminal propargyl alcohol (Scheme 42). 
Thus, a TMS group adjacent to the metal center in ruthenacycle 176 was assumed to result in a 
preferential orientation of the coordinating alkyne with the substituent R3 pointing away from the 
guiding TMS group (177 preferred over 179), thus resulting in selective formation of meta-
                                                 
106 B. Du, M. F. Farona, D. B. McConnville, W. J. Youngs, Tetrahedron 1995, 51, 4359-4370. 
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substituted arylboronic acid derivative 178. Moreover, we expected the insertion rate for the third 
– now terminal  alkyne to be less affected by the TMS substituent, compared to our previous 
substitution strategy. 
 
Scheme 42: Hypothesized direction of the regioselectivity by use of substituted propargylic alcohols. 
Indeed, the respective experiment employing alkynylboronate 125, propargyl alcohol (±)-174 and 
1-hexyne regioselectively afforded meta-substituted arylboronic ester 181, as confirmed by 
1D NOE studies (Scheme 43). 
 
Scheme 43: Confirmation of the envisioned regioselectivity in the [2+2+2] cycloaddition. 
With this promising result, we screened functionalized terminal alkynes that would allow 
preparation of an arylallene at a later stage of the synthesis (Table 11). As observed for the 
formation 181, the reaction rates of substituted propargyl alcohols were consistently low. As a 
result, homotrimerization of the terminal alkyne component became a major side reaction, thus 
leading to consumption of the terminal alkyne before it could participate in the boraphthalide 
forming [2+2+2] cycloaddition. Nevertheless, formation of about 5% 182a was observed when 
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commercially available trimethyl(penta-1,4-diyn-1-yl)silane was employed (Table 11, entry 1). 
The use of methyl propargyl ether provided boraphthalide 182b in slightly increased yield of 11%, 
whereas no formation of 182c was observed in the reaction with propargyl bromide (entries 2-3).  
Table 11: Screening of functionalized terminal alkynes in the [2+2+2] cycloaddition. 
 
 
[a] Determined by 1H NMR using 1,3,5-TMB as internal standard; products were not isolated.                                                                             
Similarly, [2+2+2] cycloadditions utilizing methyl propiolate, or bromine substituted propargyl 
alcohol107 failed to deliver products 182d and 182e (entries 4-5). An increased yield of 31% 182f 
was achieved by using freshly prepared homopropargylaldehyde dimethyl acetal (entry 6).108  
 
 
 
                                                 
107 Y. Tang, L. Shen, B. J. Dellaria, R. P. Hsung, Tetrahedron Lett. 2008, 49, 6404-6409. 
108 S. Shang, H. Iwadare, D. E. Macks, L. M. Ambrosini, D. S. Tan, Org. Lett. 2007, 9, 1895-1898. 
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Among boraphthalides 182a-182f, bis-alkyne substituted 182a was believed to enable the most 
rapid access to an allene-yne species as the later allenic Pauson-Khand precursor, despite the low 
initial yield. Therefore, the [2+2+2] cycloaddition employing alkyne 183 was studied in greater 
detail (Table 12). Starting from an NMR yield of ~5% (entry 1), the influence of the reaction 
temperature and the stoichiometry of alkyne 183 was first investigated (entries 2-6). However, no 
increased formation of 182a at 50 – 70 °C or in the presence of either lower or higher amounts of 
terminal alkyne 183 was observed, and parasitic homotrimerization of 183 persisted as the 
predominant process. Increased catalyst loadings of 30 mol% and 100 mol% still provided desired 
182a in low yields of 5–10%, respectively (entries 7-8.) Consequently, the homotrimerization 
process of 183 was hoped be slowed down by lowering its concentration by slow addition of the 
alkyne via syringe pump. However, continuous addition of 183 over 6 hours still furnished 
boraphthalide 182a in an unsatisfactory low yield of 11% (entry 9).  
Table 12: Optimization studies towards boraphthalide 182a – Part I. 
 
Entry 
Cp*Ru(cod)Cl 
[mol%] 
183 
[eq] 
T 
[°C] 
Yield 
[%][a] 
1 10 4.0 23 ~5 
2 10 4.0 50 traces 
3 10 4.0 70 traces 
4 10 1.5 70 0 
5 10 1.5 23 traces 
6 10 15 23 0 
7 30 4.0 23 5 
8 100 1.5 23 5-10 
9 10 4.0[b] 23 11 
[a] Determined by 1H NMR using 1,3,5-trimethoxybenzene as internal standard; [b] Slow addition over 6 h. 
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We speculated that an initial transesterification, followed by removal of the released isopropanol 
prior to addition of the catalyst and the third alkyne, would shift the initial equilibrium towards 
1,6-diyne 185, thus allowing for higher reaction rates of the [2+2+2] cycloaddition (Table 12). 
Indeed, a major breakthrough was achieved by premixing 125 and (±)-174 in DCE, and subsequent 
drying under high vacuum. Ensuing slow addition of the third alkyne to a solution of 184 and 
Cp*Ru(cod)Cl in DCE considerably increased the yield of 182a to 29% (entry 1). In order to further 
improve this result prolonged reaction times were applied but were found to be detrimental as a 
result of product decomposition (entries 2-4). Slightly elevated temperature also did not improve 
the reaction outcome (entries 5-6). However, the manner of catalyst addition was found to have a 
substantial influence on the reaction yield. Slow addition of a Cp*Ru(cod)Cl solution increased the 
yield to 41% (entry 7). The yield could also be pushed to 51% by addition of all of the catalyst and 
alkyne at the start of the [2+2+2] cycloaddition reaction (entry 8). 
Table 13: Optimization towards boraphthalide 182a – Part II. 
 
Entry 
Cp*Ru(cod)Cl 
addition 
Addition of 183 
[eq] 
T 
[°C] 
t 
[h] 
yield 
[%][a] 
1 1 x 15 mol% 4.0 over 6 h 23 19 29 
2 1 x 15 mol% 4.0 over 6 h 23 60 12 
3 1 x 15 mol% 4.0 23 60 20 
4 1 x 15 mol% 1.5 23 60 22 
5 1 x 15 mol% 4.0 over 6 h 40 19 24 
6 1 x 15 mol% 4.0 40 19 25 
7 15 mol% over 10 h 4.0 23 21 41 
8 1 x 15 mol% 4.0 23 20 51 
9 2 x 7.5 mol% 4.0 23 20 60 
10 3 x 5.0 mol% 4.0 23 24 33[b,c] 
11 2 x 7.5 mol% 4.0 33 21 40[c,d] 
12 2 x 7.5 mol% 2 x 2.0 23 22 55[c,e] 
[a] Determined by 1H NMR using 1,3,5-TMB as internal standard; [b] Reaction was conducted in 0.17 mmol scale; [c] 
Isolated yield after chromatography using a Biotage Isolera Four purification system; [d] Reaction was conducted in 
12 parallel batches (67.5 μmol each); [e] 125 and (±)-174 were premixed in Et2O instead of DCE. 
4. Studies towards the Chlorocyclopenta[a]indene Fragment 62 
 
However, portionwise addition of the catalyst (2 x 7.5 mol%) was discovered to further boost the 
yield to 60% yield of 182a (entry 9). Application of this procedure to increased reaction scales 
provided 182a in acceptable preparative yields (entries 10-11). Finally, a portionwise addition of 
both catalyst and diyne 183 on preparative scale resulted in isolation of 182a in 55% yield as a 
single regioisomer. Noteworthy, the meticulous removal of LiCl from diynylboronate 125 was 
found to be essential for the attainment of high reaction yields, as it interferes with the catalyst 
activity. Uptake of 125 in pentane and re-filtration under inert conditions provided diynylboronate 
125 of highest purity. 
With boraphthalide 182a in hand, we next shifted our research focus to the installation of the 
required chlorine substituent. Chlorodeboronation of arylboronic acids has emerged as a promising 
alternative to circumvent classical arene chlorination by electrophilic aromatic substitution. The 
latter often suffers from limitations in terms of chemoselectivity and regioselectivity.109 Several 
reagents, such as dichlorodimethylhydantoin,110 trichloroisocyanuric acid,109 N-chlorosuccinimide 
(NCS),111 and copper(II) chloride112 have been employed for the conversion of arylboron 
compounds to aryl chlorides. However, ipso-chlorination of boraphthalides, affording ortho-
chlorobenzyl alcohols has not yet been reported.  
Inspired by the work of Hartwig et al.,112c we first evaluated the transformation of 182a with CuCl2 
in aqueous methanol, resulting in complete recovery of the starting material in several 
chlorodeboronation attempts (Scheme 44).  
 
Scheme 44: Attempted chlorodeboronation of 182a using CuCl2. 
 
                                                 
109 G. A. Molander, L. N. Cavalcanti, J. Org. Chem. 2011, 76, 7195-7203. 
110 R. H. Szumigala, P. N. Devine, D. R. Gauthier, R. P. Volante, J. Org. Chem. 2004, 69, 566-569. 
111 H. Wu, J. Hynes, Org. Lett. 2010, 12, 1192-1195. 
112 a)  A. D. Ainley, F. Challenger, J. Chem. Soc. 1930, 2171-2180; b) J. W. Huffman, A. L. Thompson, G. W. Kabalka, 
M. R. Akula, Synthesis 2005, 2005, 547-550; c) J. M. Murphy, X. Liao, J. F. Hartwig, J. Am. Chem. Soc. 2007, 129, 
15434-15435. 
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Employment of stoichiometric amounts of NCS and copper(I) chloride in refluxing acetonitrile as 
reported by Hynes et al. (Scheme 45),111 resulted in a complex product mixture due to unselective 
silyl cleavage. Still, undefined amounts of aryl chlorides were detected in the crude mixture 
(HRMS), showcasing the general feasibility of the intended chlorodeboronation process. 
 
Scheme 45: Reported chlorodeboronation of arylboronic acids using CuCl/NCS.111 
As boraphthalide 182a was not available in high quantities, model chlorodeboronation studies were 
conducted on trisubstituted arylboronate ester 175d. Importantly, our studies showed that addition 
of H2O to the NCS/CuCl reagent system promoted the chlorination process, and considerably 
enhanced the reaction rate. Two to five equivalents of water were found to be beneficial. Execution 
of the reaction with considerably higher loadings of water or even in MeCN/H2O (1:1) led to 
undesired side reactions and product degradation. We attribute the water-promoted 
chlorodeboronation to an in situ hydrolysis of the boraphthalide to the corresponding arylboronic 
acid. This can then undergo the desired chlorodeboronation reaction. A similar observation has 
been made by Hynes et al., who reported a much higher chlorodeboronation reaction rate for 
arylboronic acids compared to their ester congeners.111 As a consequence 182a was subjected to 
NCS/CuCl/H2O, resulting in a 22% yield of desired arylchloride 185 (Scheme 46). However, silyl 
cleavage occurred to a considerable extent, giving rise to isolation of 186, along with 33% 
unreacted starting material. Diol 186 could be converted back to the desired 185 in 84% yield by 
treatment with TBSCl, DMAP, and Et3N in dry CH2Cl2. 
 
Scheme 46: Chlorodeboronation of 182a using NCS/CuCl/H2O. 
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Having synthesized the fully substituted arene core of the fijiolides, modification of 185 for the 
intended allenic Pauson-Khand reaction was the next challenge to be tackled. Ideally, bis-alkyne 
185 would simultaneously undergo global (threefold) trimethylsilyl cleavage, as well as 
isomerization of the propargyl group, to deliver allene-yne 187 (Scheme 47). Moreover, the TBS 
protecting group on the primary alcohol would be retained in this process, necessitating a 
chemoselective Si-C bond cleavage.  
 
Scheme 47: “Ideal” and realized transformation of 185 into an allenic Pauson-Khand precursor. 
We assumed that methanolic KOH could be used to realize the intended transformation, and allene-
yne 188 was isolated in high yield after optimization of the reaction conditions.99a,113 However, 
selective cleavage of the aryl TMS group prior to TBS deprotection could not be achieved using 
methanolic KOH. 
With very limited amounts of the unstable allene-yne 188 in hand,114 we focused on realization of 
the allenic Pauson-Khand reaction. Treatment of 188 with freshly prepared Mo(CO)3(MeCN)397,115 
provided the desired indenylcyclopentenone 189 (Scheme 48). However, low yields of 22-26%, 
were obtained, although the reaction appeared to proceed cleanly, as judged by TLC and 1H NMR 
analysis. Unfortunately, we were unable to determine the fate of the missing mass balance. The 
crude NMR yields correspond to the isolated yields. 
                                                 
113 a) C. Heiss, E. Marzi, M. Schlosser, Eur. J. Org. Chem. 2003, 2003, 4625-4629; b) M. Tsukazaki, V. Snieckus, 
Can. J. Chem. 1992, 70, 1486-1491. 
114 188 (orange oil) was observed to decompose and form a poorly soluble red gum upon storage (even at 30 °C). The 
same was true for all related allene-yne species. Thus, they were immediately subjected to the Pauson-Khand reaction. 
115 a) K. M. Al-Kathumi, L. A. P. Kane-Maguire, J. Inorg. Nucl. Chem. 1972, 34, 3759-3764; b) D. P. Tate, W. R. 
Knipple, J. M. Augl, Inorg. Chem. 1962, 1, 433-434; c) F. Edelmann, P. Behrens, S. Behrens, U. Behrens, J. 
Organomet. Chem. 1986, 310, 333-355. 
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Scheme 48: Allenic Pauson-Khand reaction of allene-yne 188. 
After having successfully implemented a racemic synthesis of functionalized indenyl-
cyclopentenone 189, we next focused on a scaled-up asymmetric synthesis, which required the 
preparation of propargyl alcohol 174 in an enantioselective manner. A variety of synthetic methods 
for the synthesis of enantioenriched propargylic alcohols have become available over the past two 
decades.116 In particular, metal-mediated or catalyzed enantioselective addition of terminal alkynes 
to aldehydes or ketones has emerged as a very powerful tool to attain propargyl alcohols of high 
optical purity.117 We decided to test Carreira’s Zn(OTf)2/N-methylephedrine (NME)-mediated 
alkynylation method for an asymmetric synthesis of 174 (Table 14).118,119 Employment of TBS 
protected glycolaldehyde 173 in a catalytic process119 furnished highly enantioenriched propargyl 
alcohol (+)-174 (91% ee), albeit in very low yield (entry 1). Application of Carreira’s 
stoichiometric version118 of this reaction resulted in only slightly increased yields of 10% and 16% 
with comparable optical purity, irrespective of the aldehyde addition procedure (entries 2-3). We 
proposed that the poor yields may be due to low stability of the TBS group toward the reaction 
conditions,120 thus we tested TBDPS protected glycolaldehyde 190.121 Improved, albeit still 
moderate yields of 35–42% were obtained for propargyl alcohol (+)-191, exhibiting a higher 
enantiomeric purity of 97% ee in all cases (entries 3-6).  
 
  
                                                 
116 B. M. Trost, A. H. Weiss, Adv. Synth. Catal. 2009, 351, 963-983. 
117 M. Turlington, Y. Yue, X.-Q. Yu, L. Pu, J. Org. Chem. 2010, 75, 6941-6952. 
118 D. E. Frantz, R. Fässler, E. M. Carreira, J. Am. Chem. Soc. 2000, 122, 1806-1807. 
119 N. K. Anand, E. M. Carreira, J. Am. Chem. Soc. 2001, 123, 9687-9688. 
120 E. El-Sayed, N. K. Anand, E. M. Carreira, Org. Lett. 2001, 3, 3017-3020. 
121 L. D. Fader, E. M. Carreira, Org. Lett. 2004, 6, 2485-2488. 
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Table 14: Carreira alkynylation studies. 
 
Entry Aldehyde 
Aldehyde 
addition 
x / y/ z 
[mol%] 
t 
[h] 
Yield 
[%] 
ee 
[%] 
   1[a] 173 over 3 h 22 / 20 /50 12 4 91 
2 173 one portion 120 / 110 /120 3 10 92 
3 173 over 3 h 120 / 110 /120 3 16 93 
4 190 over 3 h 120 / 110 /120 2 38 97 
5 190 over 3 h 220 / 210 / 220 2 42 97 
6 190 one portion 220 / 210 / 220 2 35 97 
[a] Reaction was conducted at 60 °C. 
Since a synthesis of fijiolide A via 191 would not only require a highly enantioselective reaction, 
but also high yielding preparation of 191, we next pursued an alternative approach toward this 
building block. In addition to nucleophilic addition of alkynes to carbonyls, the enantioselective 
reduction of ynones has been established as a reliable synthetic route to enantioenriched propargyl 
alcohols. High enantioselectivities have been achieved by use of Noyori’s transfer hydrogenation 
catalyst (Ts-Dpen)Ru(p-cymene) in protic solvents, preferentially isopropanol.122,123 In order to 
apply this methodology, ynone 194 was synthesized from methyl glycolate 192 via TBDPS 
protection,124 followed by conversion into the corresponding commercially available Weinreb 
amide 193 (Scheme 49).124,125 Addition of lithium trimethylsilylacetylide to 193 provided the 
required ynone 194 in excellent yield and purity. Noteworthy, the work-up procedure for 194 
turned out to be of tremendous importance with respect to the subsequent reaction. Quenching the 
reaction with aqueous ammonium chloride at 78 °C or 0 °C led to up to 25% of a TMS cleavage 
product, which could not be completely removed via flash chromatography due to the instability 
of 194 on silica.126 This impurity was found to severely inhibit the Noyori transfer hydrogenation 
process.123 Its formation could be avoided by quenching the reaction with acetic acid. Thus, crude 
                                                 
122 K.-J. Haack, S. Hashiguchi, A. Fujii, T. Ikariya, R. Noyori, Angew. Chem. Int. Ed. 1997, 36, 285-288. 
123 K. Matsumura, S. Hashiguchi, T. Ikariya, R. Noyori, J. Am. Chem. Soc. 1997, 119, 8738-8739. 
124 H. Nemoto, M. Nagamochi, H. Ishibashi, K. Fukumoto, J. Org. Chem. 1994, 59, 74-79. 
125 J. M. Williams, R. B. Jobson, N. Yasuda, G. Marchesini, U.-H. Dolling, E. J. J. Grabowski, Tetrahedron Lett. 1995, 
36, 5461-5464. 
126 Thus impure material can still be converted to the enantioenriched 191, provided the catalyst loading exceeds the 
degree of contamination. 
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ynone 194 was directly used for the reduction step, giving propargyl alcohol 191 in 93% yield and 
96% ee. 
 
Reagents and conditions: a) 192 (1.1 eq), TBDPSCl (1.0 eq), DMAP (0.1 eq), 1H-imidazole (1.5 eq), DMF, 23 °C, 
5 h, 99%; b) Me(OMe)NH•HCl (1.6 eq), iPrMgCl (3.0 eq), THF, 20 °C to 0 °C, 3 h, 98%; c) 
trimethylsilylacetylene (1.6 eq), nBuLi (1.4 eq), THF, 78 °C to 5 °C, 1.5 h, then acetic acid (1.5 eq) at 78 °C, 
97%; d) (S,S)-Noyori catalyst (3.5mol%), iPrOH, 24 °C, 4 h, 93%, 96% ee. 
Scheme 49: Asymmetric synthesis of propargyl alcohol 191 via Noyori transfer hydrogenation. 
Gram-quantities of enantioenriched 191 were subjected to the [2+2+2] cycloaddition with 
diynylboronate 125 and diyne 183 (Scheme 50). Remarkably, boraphthalide 195 was isolated in 
59% yield (67% brsm), as a single regioisomer. Moreover, we encountered a high stability of 
TBDPS protected 195 in the ensuing chlorodeboronation step. Thus, unreacted starting material 
could be re-isolated and re-submitted to the reaction conditions. This allowed for the synthesis of 
the fully substituted fijiolide arene core 196 in 70% yield after 5 consecutive chlorodeboronation 
reactions. 
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Reagents and conditions: a) 125 (1.1 eq), Et2O, 23 °C, 4.5 h, then 1 mbar, 23 °C, 4.5 h, then Cp*Ru(cod)Cl (3 x 
4.4 mol%, 183 (3 x 1.3 eq), DCE, 23 °C, 36 h, 59% (67% brsm); b) NCS (1.0 eq), CuCl (1.0 eq), H2O (5.0 eq), 
MeCN, 80 °C, 22 h, 70% (after 5 consecutive reactions of re-isolated 195). 
Scheme 50: Synthesis of the fully substituted, enantioenriched fijiolide arene core. 
While the primary TBDPS ether appeared to be less prone to Si-O bond cleavage during 
chlorodeboronation, the opposite was true for the subsequent TMS cleavage/isomerization process. 
Hence, selective cleavage of all trimethylsilyl groups, while retaining the TBDPS ether was not 
achievable. Nevertheless, allene-yne 197 could be obtained in high yield, and was immediately 
subjected to the allenic Pauson-Khand reaction, affording indenylcyclopentenone 198 in 40% yield 
(Table 15, entry 1). However, we observed poor reproducibility of this transformation (entry 2), 
and therefore conducted further optimization studies. The reaction was found to proceed at 0 °C, 
and even at 78 °C, albeit the yield was not improved (entries 3-4). Changing from a stoichiometric 
molybdenum complex to catalytic [Rh(CO)2Cl]2 under a CO atmosphere led to a comparable low 
yield of 26% (entry 5).127 Reacting 197 with Mo(CO)6 in toluene, activated with DMSO, enhanced 
the yield to over 40%, while being completely reproducible (entry 6).97,128 Thus, a larger scale 
synthesis of 198 was carried out under these conditions, resulting in a comparable 41% yield 
                                                 
127 a) Y. Koga, T. Kobayashi, K. Narasaka, Chem. Lett. 1998, 27, 249-250; b) N. Jeong, S. Lee, B. K. Sung, 
Organometallics 1998, 17, 3642-3644; c) K. M. Brummond, M. M. Davis, C. Huang, J. Org. Chem. 2009, 74, 8314-
8320. 
128 a) A. K. Gupta, D. I. Park, C. H. Oh, Tetrahedron Lett. 2005, 46, 4171-4174; b) K. M. Brummond, D. Chen, Org. 
Lett. 2008, 10, 705-708. 
4. Studies towards the Chlorocyclopenta[a]indene Fragment 69 
 
(entry 7). Finally, brief exposure (13 min) of 197 to molybdenum hexacarbonyl at 90 °C furnished 
198 in an improved 50% yield (entry 8).  
Table 15: Attempted optimization of the Pauson-Khand reaction of allene-yne 197. 
 
Entry Reagent[a] Solvent 
T 
[°C] 
t 
[min] 
Yield 
1 Mo(CO)3(MeCN)3
[b] CH2Cl2 23 75 40 
2 Mo(CO)3(MeCN)3
[c] CH2Cl2 23 75 32 
3 Mo(CO)3(MeCN)3
[b] CH2Cl2 0 180    24
[d] 
4 Mo(CO)3(MeCN)3
[b] CH2Cl2 78 180     21
[d] 
5 [Rh(CO)2Cl]2
[e] PhMe 90 75 26 
6 Mo(CO)6
[f] PhMe 100 90 41 
7 Mo(CO)6
[f] PhMe 100 20    41[g] 
8 Mo(CO)6
[f] PhMe 90 13    50[h] 
[a] 1.0 – 1.1 eq were standardly employed; [b] Prepared by heating Mo(CO)6 and MeCN in a sealed vial at 80 °C for 
24 h; [c] Prepared by refluxing Mo(CO)6 in MeCN for 1 h; [d] NMR yield; [e] Reaction was conducted under a CO 
atmosphere; [f] DMSO (5.0 eq) was added as the activator; [g] 10 times larger scale; [h] 30 times larger scale. 
With this result in hand, focus was shifted to the conversion of 198 into the fijiolide A aglycone. 
As outlined in chapter 3, our synthetic strategy envisioned a nucleophilic opening of an indene 
epoxide by the β-amino acid fragment for installation of the aryl ether bond at C-8. Thus, we were 
keen on validating a selective epoxidation of the C-8/C-9 indenyl double bond, despite full 
conjugation with the enone moiety through the aromatic ring. After a brief screening of oxidation 
conditions, treatment of indenylcyclopentenone 198 with an excess of mCPBA in toluene was 
found to provide the desired epoxide 199 in 51% yield (Scheme 51). Notably, epoxidation occurred 
chemoselectively, albeit without facial selectivity, leaving the presumably less electron-rich enone 
double bond intact.  
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Moreover, the progress of this transformation can be followed by a change in coloration from a 
bright orange solution to a colorless suspension. This observation held true for most of the indenyl 
double bond oxidizing reactions and can be rationalized by the loss of the fulvene motif (from Latin 
“fulvus” for dull yellow, tawny) upon oxidation.129 
 
Scheme 51: Epoxidation of indenylcyclopentenone 198 with mCPBA. 
Having validated the required chemoselectivity in epoxidation of the tricyclic key fragment, 
synthetic access to the β-amino acid moiety and ensuing fragment coupling became the topic of 
investigation. These studies are the object of discussion in the following chapters. 
  
                                                 
129 a) J. H. Day, Chem. Rev. 1953, 53, 167-189; b) B. Halton, Eur. J. Org. Chem. 2005, 2005, 3391-3414. 
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5.1 Retrosynthetic Analysis 
Our retrosynthesis of β-amino acid fragment 64 features an acetylation and saponification of 
protected β-amino ester 200 (Scheme 52). Access to 200 was envisioned to be realized by a direct 
enantioselective reductive amination of β-keto ester 201, which may be obtained by 
decarboxylative Claisen condensation of a malonate species with 5-chlorovanillic acid 202.  
 
Scheme 52: Retrosynthetic analysis of the β-amino acid fragment. 
 
5.2 Results 
In the forward direction, commercially available 5-chlorovanillic acid 202 was considered as a 
viable starting material for the synthesis of the β-amino acid fragment. At the outset, we reasoned 
that a synthesis of 64 may not be achievable maintaining a free phenolic hydroxyl group. Therefore, 
202 was first benzyl protected via a two-step sequence involving saponification of the 
intermediately formed benzyl ester affording benzoic acid 203 (Scheme 53). Elongation of the 
carbon chain was successfully realized via a decarboxylative Claisen condensation. According to 
the procedure of Masamune et al., suspension of methyl potassium malonate and MgCl2 in THF, 
followed by addition of activated 203 (CDI) furnished β-keto ester 201 in 87% yield.130 
                                                 
130 D. W. Brooks, L. D. L. Lu, S. Masamune, Angew. Chem. Int. Ed. 1979, 18, 72-74. 
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Reagents and conditions: a) K2CO3 (2.8 eq), BnBr (2.8 eq), DMF, 27 °C, 15 h; b) aq. NaOH, EtOH, 80 °C, 1 h, 82% 
(2 steps); c) CDI (1.2 eq), MgCl2 (1.1 eq), MeO2CCH2CO2K (1.5 eq), THF, 23 °C, 17 h, 87%. 
Scheme 53: Synthesis of β-keto ester 201. 
As evident by recent reports from Cooper,131 Bunlaksananusorn,132 de Vries,133 and Matsumura,134 
direct enantioselective reductive amination of β-keto esters is a powerful tool to access highly 
enantioenriched β-amino esters. Biphep- or Segphos-derived ligands are most commonly employed 
for these ruthenium(II)-catalyzed high pressure transformations. We elected to examine 
commercially available (R)-DM-SegphosRu(OAc)2 for the reductive amination of 201. 
Experiments using ammonium acetate as the nitrogen source led to formation of anticipated 
enamine intermediate 204, however, reduction to afford 200 was not observed (Scheme 54).   
 
Scheme 54: Failed direct enantioselective reductive amination of β-keto ester 201. 
This shortcoming was overcome by realization of a two-step procedure, splitting the steps of 
enamine formation and enamine reduction. Thus, 204 was synthesized by refluxing 201 with 
ammonium acetate in methanol (Scheme 55). Submission of crude 204 to similar reduction 
conditions as before (omitting ammonia), enabled isolation of the desired β-amino ester 200 in 
good yield and an excellent enantioselectivity of 97% ee. 
                                                 
131 X. Huang, E. O’Brien, F. Thai, G. Cooper, Org. Process Res. Dev. 2010, 14, 592-599. 
132 T. Bunlaksananusorn, F. Rampf, Synlett 2005, 2005, 2682-2684. 
133 G. F. Busscher, L. Lefort, J. G. O. Cremers, M. Mottinelli, R. W. Wiertz, B. d. Lange, Y. Okamura, Y. Yusa, K. 
Matsumura, H. Shimizu, J. G. de Vries, A. H. M. de Vries, Tetrahedron: Asymmetry 2010, 21, 1709-1714. 
134 K. Matsumura, X. Zhang, K. Hori, T. Murayama, T. Ohmiya, H. Shimizu, T. Saito, N. Sayo, Org. Process Res. 
Dev. 2011, 15, 1130-1137. 
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Reagents and conditions: a) NH4OAc (5.0 eq), MeOH, 70 °C, 9 h, 97%, b) ((R)-DM-
Segphos)Ru(OAc)2 (1.0 mol%), AcOH (2.0 eq), H2 (30 atm.), MeOH, 80 °C, 5 h, 65%, 97% ee. 
Scheme 55: Synthesis of β-amino ester 200. 
Acetylation of 200 proceeded smoothly to provide β-amido ester 205 (Scheme 56). The subsequent 
hydrogenolysis of the benzyl ether was found to be exceedingly sensitive to solvent and reaction 
time. Thus, employment of 10% Pd/C in MeOH gave a mixture of the desired phenol 206 (22%) 
and dechlorinated phenol 207 (77%) after 12 h (Scheme 56).49,135 Altering the solvent to ethyl 
acetate furnished 206 in virtually quantitative yield after only 25 minutes. Further treatment of 206 
with aqueous sodium hydroxide cleanly saponified the ester moiety and allowed isolation of the β-
amino acid fragment 64 in excellent yield.  
 
Reagents and conditions: a) AcCl (1.2 eq), Et3N (1.3 eq), CH2Cl2, 23 °C, 1 h, 93%; b) 10% Pd/C (10 mol%), H2 
(1 atm.), MeOH, 23 °C, 12 h, 22% 206, 77% 207; b) 10% Pd/C (2.5 mol%), H2 (1 atm.), EtOAc, 23 °C, 25 min, 
>99% 206; d) aq. NaOH ( 4.0 eq), THF/MeOH, 25 °C, 1.5 h, 99%. 
Scheme 56: Completion of the β-amino acid synthesis. 
                                                 
135 Dechlorinated phenol 207 was not separable from phenol 206, but identified based on 1H NMR and HRMS 
analysis. 
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From the outset, two complementary strategies towards the fijiolide’s [2.6]paracyclophane were 
considered, both starting from synthesized building blocks 198 and 64 (Scheme 57). In the context 
of strategy A, diastereoselective epoxidation of indene 198 (or a related structure), followed by 
intermolecular opening with an appropriate β-amino acid would lead to seco-acid 208. 
Macrolactonization would then provide [2.6]paracyclophane 209. In contrast, strategy B would 
proceed via intermolecular esterification and indene epoxidation in either order, giving cyclization 
precursor 210. [2.6]Paracyclophane formation would then be realized by an unprecedented 
macroetherification reaction. 
 
Scheme 57: Complementary strategies towards the [2.6]paracyclophane from fragments 198 and 64. 
The atropselectivity of [2.6]paracyclophane formation in both strategies would be of paramount 
importance. Due to numerous macrolactonization methods being described,136 synthetic studies 
following strategy A were conducted first. 
                                                 
136 A. Parenty, X. Moreau, J. M. Campagne, Chem. Rev. 2006, 106, 911-939. 
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6.1 Intermolecular Etherification/ Macrolactonization Approach 
6.1.1 Attempted Fragment Coupling via Nucleophilic Epoxide Opening 
With indene epoxide 199 in hand (cf. chapter 4.4.2), we began investigating epoxide opening by 
the β-amino acid fragment to introduce the aryl ether linkage. Prior to testing the fragment coupling 
with advanced material, simple phenol was employed as a β-amino acid surrogate. As depicted in 
Scheme 58, initial trials failed under the applied reaction conditions.137,138,139 It is worth mentioning 
that epoxide 199 appeared to be poorly stable towards base. For all executed experiments, 
formation of a black reaction mixture was observed immediately upon addition of all reagents into 
the reaction vial, and unspecific degradation of the starting material was observed in each case.140  
  
Reagents and conditions: a) PhOH (2.0 eq), Et3N (2.0 eq), MeOH/H2O (v/v = 4/1), 70 °C, 1 h; b) PhOH (2.0 eq), 
CsF (5.0 eq), DMF, 70 °C, 18 h; c) PhOK (2.0 eq), DMF, 35 °C, 2 h. 
Scheme 58: Attempted opening of epoxide 199 with phenol. 
We reasoned that the presence of the ketone may be the origin of the encountered base sensitivity, 
thus interfering in the reactions described above. More precisely, α-deprotonated enone species 
212 (Scheme 59) could give rise to a fulvene exo-epoxide 213 (Scheme 59, path A), or result in 
formation of cyclopentadienone intermediate 214 via intramolecular epoxide opening (Scheme 59, 
path B). Both structural motifs are reported to be highly reactive, and rapidly undergo [4+2] 
cycloaddition reactions and polymerization.141 
                                                 
137 J. R. Luly, N. Yi, J. Soderquist, H. Stein, J. Cohen, T. J. Perun, J. J. Plattner, J. Med. Chem. 1987, 30, 1609-1616. 
138 a) S. Kawata, M. Hirama, Tetrahedron Lett. 1998, 39, 8707-8710; b) T. Sasaki, M. Inoue, M. Hirama, Tetrahedron 
Lett. 2001, 42, 5299-5303. 
139 a) J. R. Vyvyan, J. M. Oaksmith, B. W. Parks, E. M. Peterson, Tetrahedron Lett. 2005, 46, 2457-2460; b) J. Zezula, 
K. C. Rice, T. Hudlicky, Synlett 2007, 2007, 2863-2867. 
140 Similarly, complete substrate degradation was observed in all attempts to convert indenylcyclopentenones into 
fulvene triflates by deprotonation and simultaneous trapping of the enolate with PhNTf2 or Comins reagent. 
141 a) G. Bernardinelli, A. F. Thomas, C. Perret, Acta Cryst. C 1986, 42, 638-640; b) T. Jikyo, M. Eto, K. Harano, J. 
Chem. Soc., Perkin Trans. 1 1998, 3463-3470; c) Z. Xi, Q. Song, J. Org. Chem. 2000, 65, 9157-9159. 
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Scheme 59: Potential keto epoxide decomposition pathways under basic conditions.  
Subsequent fragment coupling studies were conducted on a less precious epoxide. Thus, 
indenylcyclopentenone 148 was synthesized and converted into epoxide (±)-215 using mCPBA 
(Scheme 60).97 Pleasingly, Lewis acid mediated nucleophilic opening of epoxide (±)-215 provided 
the target phenolether (±)-216 in 65% yield.142  
 
Reagents and conditions: a) mCPBA (10 eq), PhMe, 23 °C, 2.5 h, 71%; b) PhOH (10 eq), BF3•OEt2 (3.0 eq), 
CH2Cl2, 0 °C, 45 min, 65%. 
Scheme 60: Successful opening of model epoxide (±)-215 with phenol.  
Direct application of these conditions to the opening of epoxide (±)-215 with β-amino ester 206 
(cf. Scheme 57) predominantly led to decomposition of (±)-215 (Scheme 61) and only trace 
amounts of arylether 8,9-trans-217 were detected (HRMS). Conversion of fully functionalized 
epoxide 199 with 206 under the same conditions did not deliver any aryl ether 8,9-trans-218. 
Several additional coupling attempts to produce 8,9-trans-217, employing Sc(OTf)3, Al(OTf)3, 
CsF and CeCl3•7H2O under various conditions led to yields significantly below 10% in all cases.  
 
  
                                                 
142 D. Aburano, F. Inagaki, S. Tomonaga, C. Mukai, J. Org. Chem. 2009, 74, 5590-5594. 
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Reagents and conditions: a) (±)-215 (1.0 eq), 206 (10 eq), BF3•OEt2 (3.0 eq), CH2Cl2, 0 °C, 45 min;                                  
b) 199 (1.0 eq), 206 (10 eq), BF3•OEt2 (3.0 eq), CH2Cl2, 0 °C, 45 min. 
Scheme 61: Failed coupling of β-amino ester 206 with epoxides (±)-215 and 199. 
Efficient nucleophilic opening of epoxides by β-amino ester 219 and CsF has been reported by 
Hirama et al. (Scheme 62).138b,143,49 In contrast to our keto epoxide systems 199 and (±)-215, these 
epoxides do not feature enone moieties, but instead protected allylic alcohols.  
 
Scheme 62: Hirama’s CsF mediated coupling of 219 to epoxides. 
Guided by Hirama’s work (Scheme 62), we aimed to prepare a protected hydroxy epoxide and re-
examine the CsF mediated coupling with a phenolic nucleophile. In addition, a fluoride tolerating 
protecting group on the vicinal diol was envisaged. To realize this goal, acetonide 222 was to be 
synthesized from chlorobenzene 196 (Scheme 63). Remarkably, addition of TBAF to 196 at room 
temperature resulted in a four-fold silyl cleavage and isomerization of the propargyl handle in a 
very clean manner.99b Subsequent exposure of allene-yne 220 to FeCl3 in acetone afforded 
acetonide 221 in 79% yield over 2 steps.144 The ensuing Pauson-Khand reaction delivered 
acetonide 222 in 56% yield. 
                                                 
143 M. Inoue, T. Sasaki, S. Hatano, M. Hirama, Angew. Chem. Int. Ed. 2004, 43, 6500-6505. 
144 I. Karame, M. Alame, A. Kanj, G. N. Baydoun, H. Hazimeh, M. el Masri, L. Christ, C. R. Chim. 2011, 14, 525-
529. 
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Reagents and conditions: a) TBAF (5.0 eq), THF, 23 °C, 45 min; b) FeCl3 (0.1 eq), acetone, 23 °C, 40 min, 79% 
(2 steps); c) Mo(CO)6 (1.5 eq), DMSO (10 eq), PhMe, 90 °C, 15 min, 56%. 
Scheme 63: Synthesis of acetonide 222. 
We then subjected 222 to epoxidation with mCPBA, and obtained keto epoxide 223 as a 1:1 
mixture of diastereomers (Scheme 64). The enone was then reduced to the corresponding allylic 
alcohol 224. Reduction with both NaBH4 and DIBAL-H at low temperature gave rise to complex 
crude product mixtures. These could not be purified by flash chromatography due to decomposition 
upon exposure to silica gel. 
 
Reagents and conditions: a) mCPBA (10 eq), PhMe, 30 °C, 4 h, 90%; b) NaBH4 (1.2 eq), EtOH, 18 °C, 2 h;            
c) DIBAL-H (2.2 eq), THF, 78 °C, 2 h. 
Scheme 64: Attempted synthesis of hydroxyl epoxide 224. 
Similar observations have been made by Hirama and Myers during their studies of 9-membered 
cyclic epoxy enediynes (Scheme 65).145,146 These systems spontaneously undergo Bergman 
cyclization to form unstable tricyclic epoxides of close structural resemblance to 224.  
                                                 
145 K.-i. Iida, M. Hirama, J. Am. Chem. Soc. 1995, 117, 8875-8876. 
146 A. G. Myers, S. D. Goldberg, Angew. Chem. Int. Ed. 2000, 39, 2732-2735. 
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Scheme 65: Reported related unstable tricyclic epoxides. 
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6.1.2 Fragment Coupling via Nucleophilic Substitution of Activated Alcohols 
It appeared our initial strategy towards the fijiolide A [2.6]paracyclophane via nucleophilic epoxide 
opening was unfeasible due to the inherent base sensitivity of the employed keto epoxides. We 
hypothesized that a mono-activated C-8/C-9 diol would render the key fragment less susceptible 
towards base-induced decomposition, and consequently allow fragment coupling by an SN2 
reaction. Our accordingly modified fragment coupling strategy is depicted in Scheme 66.  
 
Scheme 66: Envisaged fragment coupling and [2.6]paracyclophane formation via SN2/macrolactonization. 
To explore this strategy, model substrate 148 was first subjected to dihydroxylation,147 followed 
by chemoselective activation of the benzylic hydroxyl group of cis-diol (±)-225 (Scheme 67). 
Attempted triflation using Tf2O/pyridine or Tf2O/DTBMP led to clean conversion, as judged by 
TLC, followed by product degradation upon attempts at isolation. Reaction of (±)-225 with MsCl 
and Et3N activated both hydroxyl groups, and was followed by elimination of the tertiary mesylate 
to give rise to indenylcyclopentenone 227.148 We found that selective tosylation at 8-OH proceeded 
smoothly. Therefore, model tosylate (±)-228 was used as the electrophilic coupling partner in 
subsequent experiments towards arylether 8,9-trans-217 ( Table 16), which could not be separated 
from unreacted β-amino ester 206 via flash chromatography. 
 
                                                 
147 L. Jørgensen, S. J. McKerrall, C. A. Kuttruff, F. Ungeheuer, J. Felding, P. S. Baran, Science 2013, 341, 878-882. 
148 Compound 227 was not isolated. Its structure was tentativelly assigned by 1H NMR analysis of the crude reaction 
mixture. 
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Reagents and conditions: a) OsO4 (5.0 mol%), NMO (1.2 eq), citric acid (1.2 eq), tBuOH/H2O (1:1), 23 °C, 17 h, 
77%; b) Tf2O (2.5 eq), pyridine (5.0 eq), CH2Cl2, 78 °C, 2 h; c) Tf2O (1.5 eq), DTBMP (3.0 eq), CH2Cl2, 78 °C, 
2 h; D) MsCl (1.5 eq), Et3N (1.5 eq), CH2Cl2, 0 °C to 23 °C, 20 h; b) TsCl (2.0 eq), pyridine, 23 °C, 61 h, 94%. 
Scheme 67: Investigated activation of cis-diol (±)-225. 
Utilization of K2CO3 in MeCN, or CsF in DMF, mainly led to degradation of the starting tosylate 
and only trace amounts of the desired aryl ether were observed (entry 1-2).149,150 Employing 
NaH/DMF and DBU/dioxane slightly improved the yield of 8,9-trans-217 to 8% and 19%, 
respectively (entries 3-4).151 A more promising 23% yield at 45% conversion was obtained using 
Cs2CO3 in THF under microwave irradiation (entry 5).152 The reaction yield could be further 
increased to 42% by a prolonged reaction time (entry 6). However, more than 50% of starting 
tosylate was still degraded, and therefore could not be re-isolated. Altering the reaction temperature 
did not enable higher yields, or recovery of starting material (entries 7-8). Complete degradation 
of (±)-228 was observed by conducting the reaction at higher concentration (entry 9). In order to 
enable larger reaction scales, the reaction was performed under conventional heating to provide 
8,9-trans-217 in 34% (THF) and 35% (dioxane, 90% conversion) yield, respectively (entries 10-
11). A notable solvent dependence on arylether formation was encountered: utilization of DMF 
resulted in only an 8% yield, besides degradation of (±)-228 (entry 12). As DMF is known to 
undergo degradation to CO and dimethylamine at high temperature, especially under basic 
conditions, we assume that potentially formed HNMe2 could undergo undesirable side reactions 
with the enone moiety. 
 
                                                 
149 T. Ohsumi, M. Hatakoshi, H. Kisida, N. Matsuo, I. Nakayama, N. Itaya, Agric. Biol. Chem. 1985, 49, 3197-3202. 
150 P. Ballard, R. H. Bradbury, C. S. Harris, L. F. A. Hennequin, M. Hickinson, J. G. Kettle, J. Kendrew, T. Klinowska, 
D. J. Ogilvie, S. E. Pearson, E. J. Williams, I. Wilson, Bioorg. Med. Chem. Lett. 2006, 16, 4908-4912. 
151 J. F. Bower, P. Szeto, T. Gallagher, Org. Lett. 2007, 9, 3283-3286. 
152 N. K. Jobson, A. R. Crawford, D. Dewar, S. L. Pimlott, A. Sutherland, Bioorg. Med. Chem. Lett. 2009, 19, 4996-
4998. 
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Table 16: Optimization table for the SN2 reaction of (±)-228 with β-tyrosine derivative 206. 
 
Entry Base (eq) Solvent 
T 
[°C] 
t 
[h] 
Yield / 
conversion[a] 
1 K2CO3 (7.5)
[b] MeCN 70 8 <5 / 100 
2 CsF (1.5) DMF 70 → 90 36        <5 / 84 
3 NaH (1.9)[c] DMF 45 → 80 36    8 / 100 
4 DBU (1.2) Dioxane 85 24 19 / 66 
5 Cs2CO3 (2.4) THF 100 (MW) 4 23 / 45 
6 Cs2CO3 (2.4) THF 100 (MW) 8  42 / 100 
7 Cs2CO3 (1.2) THF 150 MW) 1  21 / 100 
8 Cs2CO3 (2.4) THF 85 (MW) 6         33 / 92 
9 Cs2CO3 (2.4) THF
[d] 100 (MW) 8     0 / 100 
10 Cs2CO3 (1.2) THF 100 6  34 / 100 
11 Cs2CO3 (1.2) Dioxane 100 6 35 / 90 
12 Cs2CO3 (2.4) DMF 100 (MW) 8    8 / 100 
[a] Determined by 1H NMR using 1,3,5-TMB as internal standard;                                                                                            
[b] 5.0 eq 206 were employed; [c] 2.0 eq 206 were employed; [d] reaction concentration of 0.35 M. 
After successful realization of this model reaction, we next examined the applicability of the aryl 
ether forming SN2 reaction to the fully functionalized fijiolide A cyclopenta[a]indene core. In 
analogy to the synthesis of (±)-228, 222 was chemoselectively dihydroxylated at the indenyl double 
bond (dr = 1.2:1), and subsequently mono-activated with TsCl (Scheme 68). Submission of 8,9-
cis-229 to Cs2CO3 in dioxane furnished aryl ether 8,9-trans-230 in 41% yield, along with 18% 
unreacted starting material. 
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Reagents and conditions: a) OsO4 (5.0 mol%), NMO (2.0 eq), THF/H2O (v/v = 9/1), 23 °C, 4 h, 76%, dr = 1.2:1; b) 
TsCl (4.0 eq), DMAP (15 mol%), pyridine, 23 °C, 13 h, 96%; c) 206 (1.2 eq), Cs2CO3 (1.2 eq), dioxane, 90 °C, 
7.5 h, 41% (50% brsm). 
Scheme 68: Synthesis of aryl ether 8,9-trans-230 by nucleophilic substitution. 
With preparative quantities in hand, 8,9-trans-230 required modification for the crucial 
macrolactonization step. Pleasingly, 8,9-trans-230 proved very tolerant towards Brønsted acids, 
and removal of the acetonide in neat TFA proceeded smoothly (Scheme 69). At this stage, 
8,9-trans-231 could be easily separated from unreacted β-tyrosine 206 that had been employed in 
the fragment coupling step. Saponification of the methyl ester of 8,9-trans-231 provided seco-acid 
8,9-trans-208 in almost quantitative yield, enabling extensive studies of the subsequent 
macrolactonization step. 
  
Reagents and conditions: a) TFA (90 mM), 0 °C, 1 h, 90%;                                                                                              
b) LiOH (1.5 eq), MeCN/H2O (v/v = 1/1), 23 °C, 4 h, 94%. 
Scheme 69: Synthesis of seco-acid 8,9-trans-208. 
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6.1.3 Macrolactonization Studies 
In order to access the fully functionalized fijiolide A [2.6]paracyclophane 209 from seco-acid 8,9-
trans-208, numerous macrolactonization methods were screened (Table 17). We commenced by 
screening Corey-Nicolaou conditions153 in CH2Cl2, PhMe or THF as solvent. However, severe 
solubility issues were encountered for the highly polar seco-acid, as a result of the three unprotected 
hydroxyl groups, the acetamide, and the free carboxylic acid. Therefore, no conversion was 
achieved (entry 1). Consequently, we executed the macrolactonization in pure polar aprotic 
solvents, or as mixtures with more commonly employed solvents for macrocyclization. Re-
examining the method of Corey and Nicolaou in DMF resulted in dissolution of the starting 
material. However, no conversion into the intermediate thiopyridyl ester, or to the desired 209 and 
its 8-epi-9-epi diastereomer 232 was observed (entry 2). A similar result was obtained using 
refluxing toluene as the solvent (entry 3). Attempted activation of the seco-acid by conversion into 
a mixed Yamaguchi anhydride engendered only trace conversion, with no detectable formation of 
209/232 (entry 4).154 The same result was obtained for attempted activation of 8,9-trans-208 with 
Mukaiyama’s reagent (entries 5).155 Following this, the recently developed macrolactonization 
method reported by Shiina et al., using 2-methyl-nitrobenzoic acid anhydride (MNBA) for 
carboxylic acid activation was examined. However, low conversion, and again no detectable traces 
of the desired macrolactone resulted from these experiments (entries 6-8).156 In addition, we 
subjected 8,9-trans-208 to Mitsunobu macrolactonization conditions and achieved full conversion 
after only 90 minutes. However, no formation of any [2.6]paracyclophane product was observed 
(entry 9). Overall, in none of these cyclization attempts, intermolecular esterification affording a 
seco-acid dimer could be ascertained by 1H NMR and HRMS analysis.  
 
 
 
 
                                                 
153 E. J. Corey, K. C. Nicolaou, J. Am. Chem. Soc. 1974, 96, 5614-5616. 
154 J. Inanaga, K. Hirata, H. Saeki, T. Katsuki, M. Yamaguchi, Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993. 
155 T. Mukaiyama, M. Usui, K. Saigo, Chem. Lett. 1976, 5, 49-50. 
156 a) I. Shiina, M. Kubota, R. Ibuka, Tetrahedron Lett. 2002, 43, 7535-7539; b) I. Shiina, M. Kubota, H. Oshiumi, M. 
Hashizume, J. Org. Chem. 2004, 69, 1822-1830. 
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Table 17: Examined macrolactonization conditions. 
 
Entry  Reagents (eq) and conditions 
1 (PyS)2 (1.6), PPh3 (1.7), CH2Cl2, PhMe or THF, 23 °C 
2 (PyS)2 (2.0), PPh3 (2.0), DMF, 23 °C, 24 h 
3 (PyS)2 (1.5), PPh3 (1.5), PhMe, 110 °C, 18 h 
4 2,4,6-TCBC (10), Et3N (20), DMAP (20), THF/DMF, 23 °C to 50 °C, 17 h
[a] 
5 1-Methyl-2-chloropyridinium iodide (5.0), Et3N (10), MeCN, 85 °C, 44 h 
6 MNBA (2.4), DMAP (4.8), CH2Cl2/DMF, 40 °C, 13 h
[b] 
7 MNBA (2.4), DMAP (4.8), CH2Cl2/DMF, 23 °C, 19 h
[c] 
8 MNBA (4.0), DMAP (8.0), CH2Cl2, 23 °C, 120 h 
9 DIAD (12), PPh3 (12), THF/DMF, 0 °C to 10 °C, 90 min
[d] 
[a] Addition of 8,9-trans-208 over 4 h; [b] Addition of 8,9-trans-208 over 12 h;                                                                  
[c] Addition of 8,9-trans-208 over 15 h; [d] Addition of 8,9-trans-208 over 2 h.  
We next turned to Masamune’s macrolactonization method.157 This features activation of an 
independently prepared thioester with a thiophilic metal salt, such as mercury, silver or copper.136 
Although this requires an additional synthetic step, we speculated that a thioester would enhance 
the solubility. We were therefore interested in accessing tert-butyl thioester 8,9-trans-233 (Scheme 
70). Whereas submission of 8,9-trans-30 to Steglich esterification conditions (DCC, DMAP, 
tBuSH) did not provide the desired thioester,158 8,9-trans-233 could be isolated in 74% yield after 
activation of the seco-acid with HATU. Despite this pleasingly clean transformation, due to the 
advanced synthetic nature of 8,9-trans-233, only very limited quantities (2.5 mg) were obtained, 
still as an inseparable 1.2:1 mixture of C-8/C-9-diastereomers. Unfortunately, activation of the 
thioester with [CuOTf]2•PhMe in the presence of Hünig’s base at 50 °C did not provide macrocycle 
209, or its diastereomeric congener 232. Instead, only unreacted starting material could be detected 
                                                 
157 S. Masamune, G. S. Bates, J. W. Corcoran, Angew. Chem. Int. Ed. 1977, 16, 585-607. 
158 B. Neises, W. Steglich, Angew. Chem. 1978, 90, 556-557. 
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in the crude reaction mixture. An attempted HATU mediated macrocyclization of seco-acid 8,9-
trans-208 also failed to provide the desired paracyclophane.   
 
Reagents and conditions: a) HATU (3.0 eq), tBuSH (6.0 eq), iPr2NEt (3.0 eq), DMF, 0 °C to 23°C, 13 h, 74%; b) 
[CuOTf]2•PhMe (2.5 eq), ), iPr2NEt (10 eq), PhMe, 50 °C, 22 h. 
Scheme 70: Attempted Masamune macrocyclization of thioester 8,9-trans-233. 
Another attempt to access the fijiolide A [2.6]paracyclophane via a more soluble 8,9-trans-208 
derivative was envisaged. In this approach, silyl protection of the secondary benzylic hydroxyl 
group was anticipated to serve a dual purpose: improve solubility, and prevent undesired 
esterification. Thus, seco-acid 8,9-trans-208 was reacted with TBSCl/1H-imidazole, giving rise to 
a mixture of bis- and tris-silylated compounds, mainly consisting of 8,9-trans-234, as judged by 
1H NMR (Scheme 71). Attempts to cleave the primary TBS ether, as well as the silyl ester of crude 
8,9-trans-234 with camphorsulfonic acid (CSA) in CDCl3/MeOH-d4 were made. However, no 
conversion was observed for this transformation by 1H NMR spectroscopy, even upon heating of 
the reaction mixture at 50 °C for 24 h.  
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Reagents and conditions: a) TBSCl (5.0 eq), 1H-imidazole (10 eq), DMF, 23 °C, 18 h, 70-78%; b) CSA (1.0 eq), 
CDCl3/MeOH-d4, 23 °C to 50 °C, 48 h. 
Scheme 71: Attempted modification of seco-acid 8,9-trans-208. 
Based on the unsuccessful macrolactonization results discussed in this section, this strategy 
towards the fijiolide A [2.6]paracyclophane was abandoned in favor of a more successful synthetic 
approach, which was executed in parallel. This strategy is discussed in chapter 6.2.  
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6.2 Intermolecular Esterification / Macroetherification Approach 
6.2.1 Atropselective Synthesis of the [2.6]Paracyclophane 
As outlined at the beginning of chapter 6, our complementary strategy towards the fijiolides’ 
macrocyclic aglycone bases on the synthesis of the [2.6]paracyclophane core via an intermolecular 
esterification, followed by a macrocyclic etherification (Strategy B, Scheme 57). Following our 
difficulties observed in nucleophilic epoxide opening, we planned this strategy to proceed via an 
intramolecular SN2 reaction using a tosylate leaving group (Scheme 72). Hence, this synthetic 
approach would require preparation of cyclization precursor 236, whose synthesis was envisaged 
via ester coupling of previously synthesized tosylate 8,9-cis-229 and β-amino acid 237.   
 
Scheme 72: Revised synthetic strategy for the fijiolide A [2.6]paracyclophane involving macroetherification. 
To realize this goal, the acetonide group in 8,9-cis-229 was hydrolyzed with aqueous HCl, 
furnishing vicinal diol 8,9-cis-238 in high yield (Scheme 73). Subsequent EDCI/DMAP mediated 
esterification of β-amino acid 237 gave rise to a variety of ester products, which could be separated 
by chromatographic means. Mono-esters 8,9-cis-239 and 8-epi-9-epi-239 were isolated in 30% and 
13% yield, respectively. The absolute stereochemistry at C-8 and C-9 of both diastereomers could 
not be assigned on the bases of 1D and 2D NMR experiments, thus we were unaware which 
stereoisomer would lead to the correct paracyclophane 209. However, both compounds could be 
clearly differentiated from ester 8,9-cis-240, formed in 9% yield via esterification of the secondary 
benzylic hydroxyl group. We did not observe its 8-epi-9-epi counterpart as a reaction product. 
However, diesters 8,9-cis-241 and 8-epi-9-epi-241 were isolated in combined 37% yield. 
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Reagents and conditions: a) 2 M HCl (30 eq), MeCN, 23 °C, 1 h, 95%; b) 237 (1.4 eq), EDCI (1.4 eq), DMAP 
(0.1 eq), CH2Cl2/DMF (v/v = 7/1), 0 °C, 20 h. 
Scheme 73: Unselective fragment coupling towards cyclization precursor 236. 
At this stage we did not optimize the ester coupling step, but instead continued to explore the 
macroetherification approach with the more abundant diastereomer 8,9-cis-239. This was 
converted into cyclization precursor 8,9-cis-236 by reaction with TBAF under buffered conditions 
(Scheme 74). With phenol 8,9-cis-236 in hand, we investigated the [2.6]paracyclophane formation. 
For this purpose, we applied the previously developed conditions for intermolecular fragment 
coupling (Cs2CO3, dioxane, 90 °C). Although the possible paracyclophanes 209 and 232 could not 
be isolated, they were clearly found by mass spectroscopy. The presence of p-toluenesulfonic acid, 
as the predominant component of the crude reaction mixture suggested that an SN2 displacement 
had indeed taken place. It was concluded that the desired macrocyclization reaction did proceed 
(to an unknown extent), but was accompanied by extensive substrate degradation due to the base 
sensitive nature of the β-hydroxy ketone. 
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Reagents and conditions: a) TBAF (1.5 eq), AcOH (26 eq), THF, 0 °C, 3 h, 82%; b) Cs2CO3 (4.0 eq), dioxane, 
23 °C, 1 h, then 90 °C, 18 h. 
Scheme 74: Attempted paracyclophane formation via keto ester 8,9-cis-236.  
In order to address this shortcoming, cyclization precursor 8,9-cis-236 was reduced under Luche 
conditions (Scheme 75). Remarkably, 1,2-reduction proceeded with complete diastereoselectivity, 
providing cyclization precursor 8,9-cis-242 of unknown absolute configuration at C-8, C-9 and 
C-11.159 At this stage, we did not assign the relative configuration between C-9 and C‑11 as it was 
assumed to be irrelevant for testing its ability to undergo paracyclophane formation. In a further 
macrocyclization attempt, submission of 8,9-cis-242 to Cs2CO3/dioxane in the presence of 4Å 
molecular sieves resulted in formation of deacetylated vicinal diol 245 (40%), along with an 
unknown product in 38% yield. 1H NMR analysis of the isolated compound revealed a loss of the 
tosylate, while maintaining all other functional groups present in the targeted [2.6]paracyclophanes 
243 and 244.160 Unfortunately, the unidentified product degraded completely before a full structure 
elucidation could be achieved.  
                                                 
159 A. L. Gemal, J. L. Luche, J. Am. Chem. Soc. 1981, 103, 5454-5459. 
160 A high resolution mass for 243/atrop-243 corresponding to [M+H]+ or [M+Na]+ was not detected, but a mass 
corresponding to [M+H-H2O]+ was. 
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Reagents and conditions: a) NaBH4 (3.0 eq), CeCl3•7H2O (3.0 eq), THF/MeOH (v/v = 1/1), 78 °C to 50 °C, 3 h, 
96%; b) Cs2CO3 (12 eq), 4Å-MS, dioxane, 90 °C, 5 h. 
Scheme 75: Attempted paracyclophane formation via hydroxy ester 8,9-cis-242.  
Despite not obtaining spectroscopic proof for a macrocyclic aryl ether, the aforementioned results 
appeared promising, and prompted us to further explore the macroetherification approach. We 
aimed to prepare a more sophisticated substrate for macrocyclization, and precursor 246 was 
designed as the next target to be investigated (Scheme 76). 246 features a protected secondary 
benzylic hydroxyl group at C-13, and was planned to be synthesized from likewise protected 
primary alcohol 247. Thus, formation of undesired diester products during fragment coupling could 
be avoided. From the outset, the C-11 position would be reduced to the alcohol oxidation state and 
appropriately protected. We assumed that TBS protection of both the C-13 and C-11 hydroxyl 
group would be suitable, hence a preparation of 247 by trisilylation of tetraol 245, followed by 
selective cleavage of the presumably most labile primary silyl ether was envisioned. 
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Scheme 76: Retrosynthetic analysis for doubly protected cyclization precursor 246. 
In order to accomplish the outlined synthetic strategy towards cyclization precursor 246, acetonide 
8,9-cis-229 was converted into tris-silyl ether 9,11-trans-249 by sequential acetonide cleavage, 
Luche reduction of the enone moiety, and threefold TBS protection of the intermediate tetraol 
(Scheme 77).   
 
Reagents and conditions: a) 2 M HCl (26 eq), MeCN, 23 °C, 1 h; b) NaBH4 (1.5 eq), CeCl3•7H2O (1.5 eq), 
THF/MeOH (1/1), 50 °C, 40 min; c) TBSOTf (5.0 eq), 2,6-lutidine (17 eq), CH2Cl2/THF (10/1), 0 °C, 1 h, 86% 
(3 steps). 
Scheme 77: Synthesis of tris-silyl ether 9,11-trans-249. 
As observed earlier, enone reduction proceeded with complete diastereoselectivity. Based on NOE 
NMR experiments of a closely related model substrate, the relative configuration between C-9 and 
C-11 was tentatively assigned to be trans. We concluded that the tertiary alcohol at C-9 directs 
hydride delivery to the same face of the indenylcyclopentenone, giving rise to the trans-relationship 
between C-9/C-11. Synthesis of 247 required a selective desilylation of the primary alcohol in 
preference to both secondary alcohols. As the tert-butyldimethylsilyl group is the most commonly 
used protecting group for this type of transformation, two literature conditions for the selective 
TBS cleavage of model substrate 250 were examined first.161  
                                                 
161 R. D. Crouch, Tetrahedron 2013, 69, 2383-2417. 
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As shown in Scheme 78, both CSA in MeOH/CH2Cl2 and FeCl3 in pure MeOH provided known 
mono-silyl alcohol 251 in good yields.162,163 
 
Reagents and conditions: a) CSA (20 mol%), MeOH/CH2Cl2, 0 °C, 1.5 h, 83%;                                                                
b) FeCl3 (100 mol%), MeOH, 23 °C, 3.5 h, 75%. 
Scheme 78: Reaction conditions for selective TBS cleavage on model substrate 250. 
However, employing the higher yielding conditions to 9,11-trans-249 mainly resulted in double 
silyl ether cleavage (Table 18). Thus, allylic alcohol 9,11-trans-252 was the predominant reaction 
product, and only 14% of desired 9,11-trans-247 was obtained (entry 1). Numerous conditions for 
selective primary silyl ether cleavage were screened. PPTS, ammonium fluoride and buffered 
TBAF, all provided significant quantities of mono-silyl ether 9,11-trans-252 (entries 2-5). Using 
1% AcOH in THF did not cleave any silyl ether bond at 30 °C (entry 6), and NBS in aqueous 
DMSO led to oxidative side reactions (entry 7). Reflecting on these results, we inferred that the 
intrinsic lability of the allylic C-11 silyl ether was too high to implement a chemoselective mono-
desilylation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
162 J. A. Gladding, J. P. Bacci, S. A. Shaw, A. B. Smith III, Tetrahedron 2011, 67, 6697-6706. 
163 P. Saravanan, V. K. Singh, J. Indian Chem. Soc. 1998, 75, 565-567. 
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Table 18: Attempted selective primary TBS ether cleavage of tris-silyl ether 9,11-trans-249. 
 
Entry Reagents (eq) and conditions Result 
1 CSA (0.2), MeOH, 0 °C, 5 h 14% 247 + 74% 252 
2 PPTS (0.3), MeOH, 0 °C to 23 °C, 48 h. low conversion to 252 
3 NH4F (20), MeOH, 23 °C, 14 h mainly formation of 252 
4 NH4F (1.0), MeOH, 60 °C, 24 h low conversion to 252 
5 TBAF (1.0), AcOH (1.1) THF, 0 °C to 23 °C, 14 h low conversion to 252 
6 1% AcOH, THF, 30 °C, 92 h no conversion 
7 NBS (1.0), aq. DMSO, 30 °C, 13 h (oxidative) side reactions 
 
The bis-silyl ether protecting group strategy was abandoned and a more orthogonal approach 
involving MOM protection of the C-11 hydroxyl group was pursued. Once again starting from 
acetonide 8,9-cis-229, Luche reduction of the enone afforded the corresponding allylic alcohol in 
a diastereoselective manner (Scheme 79). Reaction with freshly prepared MOMCl164 furnished 
C-11-methoxymethyl ether 8,9-cis-253 in acceptable yield. Treatment with 2 M aqueous HCl 
cleanly hydrolyzed the acetonide, leaving the previously installed MOM ether untouched. 
Subsequent protection of the vicinal diol delivered bis-TBS ether 8,9-cis-254 in 69% yield. 
Chemoselective deprotection with CSA in MeOH/CH2Cl2 proceeded smoothly to selectively 
provide the primary alcohol. The two diastereoisomers 255a and 255b could now be separated by 
flash chromatography, and were obtained in 43% and 37% yield, respectively. 
                                                 
164 M. Berliner, K. Belecki, Org. Synth. 2007, 84, 102. 
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Reagents and conditions: a) NaBH4 (1.5 eq), CeCl3•7H2O (1.5 eq), THF/MeOH (1/1), 50 °C, 45 min, 96%; b) 
MOMCl (3.0 eq), EtN(iPr)2 (3.0 eq), CH2Cl2, 23 °C, 16 h, 56% (74% brsm); c) 2 M HCl (13 eq), MeCN, 23 °C, 3 h; 
d) TBSOTf (3.0 eq), 2,6-lutidine (6.0 eq), CH2Cl2, 0 °C, 1 h, 69% (2 steps); e) CSA (0.2 eq), CH2Cl2/MeOH (1/1), 
0 °C, 6 h, 43% 255a (undesired), 37% 255b (desired). 
Scheme 79: Synthesis of MOM protected primary alcohols 255a and 255b. 
With 255a and 255b in hand, we focused on the conversion into the desired macrocyclization 
precursor. At this point, we were still not aware of the absolute configuration at C-8/C-9 for both 
diastereomers, and elected to use 255b.  
In contrast to the preparation of cyclization precursor 236, fragment 255b was not subjected to 
esterification with TBS protected β-amino acid 237, but with its TES derived congener 256 
(Scheme 80). 
 
Scheme 80: Synthesis of β-amino acid 256 from 64. 
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We undertook this modification for two reasons: first, synthesis of 256 from 64 proceed in much 
higher yield compared to TBS protection due to the more facile hydrolytic cleavage of the 
unavoidably formed trialkylsilyl ester.165 Secondly, a higher chemoselectivity for cleavage of a 
TES aryl ether in the presence of an alkyl TBS ether was assumed. EDCI mediated coupling of 
255b and 256 gave TES protected ester 257 in 50% yield, along with 25% of the deprotected and 
targeted phenol 258 (Scheme 81). According to TLC analysis, TES cleavage occurred during 
workup with saturated aqueous sodium bicarbonate, suggesting a hydrolytically labile silyl ether 
bond. The remaining quantities of 257 were submitted to mild aryl silyl ether cleavage using DBU 
in aqueous MeCN.166  
 
Reagents and conditions: a) 255b (1.0 eq), 256 (1.4 eq), EDCI (1.3 eq), DMAP (25 mol%), CH2Cl2, 0 °C, 4 h, 50% 
257, 25% 258; b) DBU (1.0 eq), MeCN/H2O (95/5), 23 °C, 30 min, 84%. 
Scheme 81: Synthesis of MOM protected cyclization precursor 258. 
The macroetherification of 258, constructing the desired [2.6]paracyclophane ring, and introducing 
axial chirality into the molecule, was now the focus of our studies. Heating of 258 in the presence 
of two equivalents of cesium carbonate in DMF cleanly provided two products of distinctly 
different polarity on TLC. After isolation, both products were extensively analyzed by 1D and 2D 
NMR, revealing the [2.6]paracyclophane motif in both compounds. Much to our delight, and 
largely by means of 1H-1H-ROESY NMR data, the major product, isolated in 46% yield, could be 
assigned as the desired atropisomer 259 (Scheme 82). Accordingly, the minor and more polar 
isomer (31% yield) was identified as atropisomer 260, exhibiting an opposite orientation of the β-
                                                 
165 T. W. Greene, P. G. M. Wuts, Protective Groups in Organic Synthesis, 3rd ed., John Wiley & Sons, Inc., 1999. 
166 C.-E. Yeom, H. W. Kim, S. Y. Lee, B. M. Kim, Synlett 2007, 2007, 146-150. 
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tyrosine arene core. Thus, the realized [2.6]paracyclophane forming macrocyclization featured an 
atropselectivity of 1.5:1 (259:260),167 and proceeded in high overall yield of 77% (Scheme 82). 
 
Scheme 82: First realized atropselective [2.6]paracyclophane formation. 
The key 1H-1H-ROESY correlations, used for structure elucidation of species 259, and an excerpt 
of the corresponding 2D NMR spectrum are provided in Figure 6. Distinct dipolar coupling 
between H-23/H-17, and H-12/22-OMe, as well as between H-19/17-NH strongly suggest an 
orientation of the β-tyrosine aromatic core in the depicted manner. In addition, a heteronuclear 
scalar coupling between H-8/C-21 was observed by HMBC NMR spectroscopy providing evidence 
for macrocyclic ring closure by the intended nucleophilic substitution at C-8. As for structure 
assignment of fijiolide A and B (cf. chapter 1.2), the absolute configuration of 259 at C-8/C-9 could 
now be assigned by means of ROESY NMR experiments.  
 
 
 
 
 
 
 
 
                                                 
167 Determined by 1H NMR spectroscopy of the crude reaction product. 
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Figure 6: Results of the 2D NMR analysis of [2.6]paracyclophane 259. 
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b) Excerpt of the ROESY spectrum of [2.6]paracyclophane 259 (400 MHz, CDCl3). 
 
a) Key ROESY correlations for [2.6]paracyclophane 259. 
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Dipolar coupling between H-5/H-13 strongly supports a C-8/C-9 configuration as shown in Figure 
6 and allows for assignment of 259 as the targeted [2.6]paracyclophane diastereomer. By way of 
illustration, no ROESY correlation between H-5/H-13 would be anticipated for diastereomer 8-
epi-9-epi-11-epi-259 (Figure 7a). For the sake of completeness, the observed key ROESY 
correlation allowing structural assignment of atropisomer 260 are indicated in Figure 7b. 
 
 
 
Figure 7: Structures and ROESY correlation for hypothetical 8-epi-9-epi-11-epi-259 and 260. 
In contrast to 259, the ROESY spectrum of 260 does not exhibit a correlation according to dipolar 
coupling between 17-NH and the proximate arene proton (H-23). However, ROESY correlations 
between H-19/H-17 and 22-OMe/H-8 as well 22-OMe/H-6 clearly indicate the presence of the 
depicted atropisomer. In addition, a direct dipolar coupling between protons H23 and H6, being 
located on the two different benzene rings, is indicative for the shown atropisomer. Moreover, this 
illustrates the close proximity of the aromatic cores, resulting in restricted rotation of the β-tyrosine 
benzene, and giving rise to its planar chirality.   
 
 
 
 
 
b) Observed key ROESY correlations  
        for 260 ( ). 
 
 
a) Anticipated nonexistent ROESY correlation  
    for 8-epi-9-epi-11-epi -259 ( ). 
 
 
6. Studies towards the Fijiolide A Aglycone  102 
 
We attempted to interconvert 260 into the desired atropisomer 259 (Scheme 83). Heating 260 up 
to 170 °C for 5 h, did not result in any conversion. Instead, full recovery of the starting material 
was achieved, evidencing the configurational stability of cyclophane 260 and its excellent thermal 
stability.  
 
Scheme 83: Attempted interconversion of [2.6]paracyclophane 260 into 259. 
As thermal atropisomer interconversion had proven infeasible, we were interested in tuning the 
macrocyclization process to enhance the atropselectivity. The influence of the C-11 hydroxyl 
substituent on the orientation of the phenolic moiety during nucleophilic ring closure was 
investigated first. In terms of both synthesis of the cyclization precursor, and the installation of the 
cyclopentadiene motif after macrocyclization, an unprotected C-11 hydroxyl group appeared to be 
the most step-economic option. To this end, hydroxy esters 262a and its 8-epi-9-epi-11-epi 
diastereomer 262b were successfully synthesized from 8,9-cis-229, according to Scheme 84. A 
three-step sequence beginning with acetonide cleavage, followed by a double TBS protection, and 
selective mono-desilylation delivered a 1:1 diastereomeric mixture of primary alcohols 261. 
Esterification with previously described β-amino acid 256, followed by Luche reduction, provided 
a separable mixture of 262a and its 8-epi-9-epi-11-epi diastereomer 262b. The stereochemistry of 
both diastereomers was tentatively assigned by comparison with the 1H NMR spectra of 257 and 
258. The chemical shift of the acetamide methyl group was the most characteristic signal appearing 
at a lower chemical shift for the desired diastereomer. 
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Reagents and conditions: a) 2 M HCl (26 eq), MeCN, 23 °C, 1.5 h; b) TBSOTf (2.3 eq), 2,6-lutidine (4.5 eq), 
CH2Cl2, 0 °C, 75 min, 86% (2 steps); c) CSA (25 mol%), CH2Cl2/MeOH (1/1), 0 °C, 6.5 h, 87%; d) β-amino acid 45 
(1.4 eq), EDCI, (1.3 eq), DMAP (23 mol%), CH2Cl2, 0 °C, 19 h, 79%; e) NaBH4 (1.5 eq), CeCl3•7H2O (1.5 eq), 
THF/MeOH (1/1), 55 °C, 40 min, 41% 262a, 42% 262b. 
Scheme 84: Synthesis of 11-hydroxy cyclization precursors 262a and 262b. 
Inspired by the work of Sorensen et al. reporting a CsF mediated O-alkylation of a triethylsilyl 
phenol ether for the total synthesis of viridin,168,169 we hypothesized that a treatment of 262a with 
CsF would accordingly result in direct [2.6]paracyclophane formation. In this way, the additional 
TES deprotection step could be cut. Remarkably, reacting 262a with 2.0 equivalents of CsF at 
100 °C in DMF smoothly induced macrocyclization, affording desired product 263 in 61% isolated 
yield, along with 22% of atropisomer 264 (Scheme 85). This corresponds to an improved 
atropselectivity of 2.8:1.167 Notably, the secondary benzylic TBS ether is fully retained under these 
conditions. 
                                                 
168 E. A. Anderson, E. J. Alexanian, E. J. Sorensen, Angew. Chem. Int. Ed. 2004, 43, 1998-2001. 
169 T. Oriyama, K. Noda, K. Yatabe, Synlett 1997, 1997, 701-703. 
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Scheme 85: Improved [2.6]paracyclophane formation employing 11-hydroxy silyl ether 262a and CsF. 
After developing a shorter, higher yielding and more atropselective synthesis of the fijiolide A 
[2.6]paracyclophane ring, we were interested if macrocyclization also occurs when the 8-epi-9-epi-
11-epi diastereomer 262b is subjected to the reaction conditions. Indeed, the corresponding 
macrocyclic aryl ethers 265 and 266 were formed upon treatment with CsF in hot DMF (Scheme 
86). However, the isolated yields of 37% (265) and 28% (266), as well as the atropselectivity of 
1.3:1 are considerably lower than those for the cyclization of 262a.167 In agreement with the 
atropselectivities of paracyclophane formations discussed earlier, the major atropisomer 265 
displays an aromatic ring orientation that brings the 22-OMe group in close proximity to the C-12 
and the C-11 hydroxyl group. Further indication for a correctly assigned absolute configuration at 
C-8/C-9 in 259/260, and hence also in 263/264, was provided by the anticipated absence of a 1H-
1H-ROESY correlation between H-5 and H-13 for 265 and 266 (cf. Scheme 86 and Figure 7a). 
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Scheme 86: [2.6]paracyclophane formation employing 262b. 
As fijiolide A features a free phenolic hydroxyl group, tests to hydrolyze the methyl ether at 
22-OMe of 259 were conducted at this stage (Table 19). Lewis acidic conditions, for instance 
boron tribromide, were first examined as they could potentially cleave both the methyl ether and 
the MOM protecting group, directly providing 268.170 Exposure of 259 to BBr3 resulted in complex 
product mixtures, without observable demethylation (entries 1-2). Moreover, a B(C6F5)3 mediated 
one-pot arylether cleavage/silylether formation, as reported by Yamamoto et al., failed to provide 
269 (entry 4).171 Nucleophilic deprotection of 259 using nPentylSLi/DMF led to complete substrate 
degradation within 30 minutes (entry 4).  
 
 
 
 
 
 
                                                 
170 Y. Wu, O. R. Seguil, J. K. De Brabander, Org. Lett. 2000, 2, 4241-4244. 
171 V. Gevorgyan, M. Rubin, S. Benson, J.-X. Liu, Y. Yamamoto, J. Org. Chem. 2000, 65, 6179-6186. 
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Table 19: Attempted demethylation of [2.6]paracyclophane 259. 
 
Entry Conditions 
Expected 
product 
Result 
1 BBr3 (4.0 eq), CH2Cl2, 78 °C to 0 °C, 3 h 267/268 Complex mixture 
2 BBr3 (5.0 eq), CH2Cl2, 78 °C, 45 min 267/268 Complex mixture 
3 
B(C6F5)3 (2.0 eq), Et3SiH (10 eq),              
CH2Cl2, 0 °C to 23 °C, 30 min 
269 Complex mixture 
4 nPentylSLi (2.5 eq), DMF, 120 °C, 30 min 267 Degradation 
 
 
Due to its potential synthetic merits, the Yamamoto protocol was further evaluated on simpler 
model substrates, containing fewer Lewis basic sites than the advanced [2.6]paracyclophane 
(Table 20). Catalytic B(C6F5)3 (10 mol%) in the presence of triethylsilane, resulted in no 
conversion of 205 into silylether 270 (entry 1). In contrast, stoichiometric quantities of Lewis acid 
quantitatively converted phenol 206 into TES aryl ether 273, without demethylation being detected. 
Re-subjection of 273 to even higher B(C6F5)3 loadings gave rise to methyl ester cleavage, but did 
not affect methyl ether bond scission to deliver 272. 
  
6. Studies towards the Fijiolide A Aglycone  107 
 
Table 20: Attempted demethylation of β-amino methyl esters utilizing the Yamamoto protocol. 
 
Entry 
Starting 
material 
Conditions Result 
1 205 
B(C6F5)3 (0.1 eq), Et3SiH (2.2 eq), 
CH2Cl2, 55 °C to 23 °C, 24 h 
No conversion 
2 206 
B(C6F5)3 (1.0 eq), Et3SiH (2.3 eq), 
CH2Cl2, 0 °C to 23 °C, 6.5 h 
98% 273 
3 273 
B(C6F5)3 (3.0 eq), Et3SiH (5.0 eq), 
CH2Cl2, 23 °C, 7 h 
Ester cleavage 
 
In summary, demethylation at the 22-OMe position to reveal the free phenol could not be 
accomplished. In addition, direct conversion of model methyl ethers into TES protected phenols 
were met with failure. These findings prompted us to revise the structure of the macrocyclization 
precursor. Having regard to our previous observation that an unprotected C-11 hydroxyl group 
increased the atropselectivity of [2.6]paracyclophane formation, we wondered if this process would 
allow - or even benefit - from employment of an unprotected or an in situ generated 22-OH group.  
In order to investigate this proposal, β-amino-acid 64 was successfully demethylated with BBr3. 
The resulting catechol moiety was silylated to afford double TES protected β-amino-acid 274 
(Scheme 87). 
 
Reagents and conditions: a) BBr3 (5.0 eq), CH2Cl2, 23 °C, 28 h, 66%; b) TESCl (3.6 eq), DMAP (15 mol%), Et3N 
(4.5 eq), THF, 23 °C, 2h, 65% 
Scheme 87: Syntheses of bis-TES protected β-amino acid 274 from 64. 
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Synthesis of previous cyclization precursors via bis-TBS ether 8,9-cis-275 had proven expedient. 
Therefore, a more concise synthetic approach towards this intermediate was developed, omitting 
the intermediate acetonide protection of the vicinal diol (Scheme 88). In this respect, aryl chloride 
196 was first globally desilylated and isomerized with TBAF, followed by a double TBS protection 
of the diol moiety, furnishing the previously proposed allene-yne 150 (cf. Scheme 36). In turn, 150 
was immediately subjected to a Pauson-Khand reaction, affording indenylcyclopentenone 149 in 
52% overall yield. Although being extensively studied, Sharpless asymmetric dihydroxylation of 
149 at the indenyl double bond proceeded at best in 71% yield, and with low facial selectivity 
(dr = 1.1:1, vide infra),172 affording 8,9-cis-275 as a 1:1 mixture of diastereomers after tosylation 
of the secondary benzylic hydroxyl group. 
 
Reagents and conditions: a) TBAF (5.0 eq), THF, 23 °C, 45 min; b) TBSOTf (2.5 eq), 2,6-lutidine (5.0 eq), CH2Cl2, 
0 °C, 1 h; c) Mo(CO)6 (1.5 eq), DMSO (10 eq), PhMe, 90 °C, 20 min, 52% (3 steps); d) OsO4 (4.0 mol%), 
(DHQ)2PHAL (10 mol%), NMO (2.0 eq), THF/H2O (v/v = 10/1), 0 °C, 4 h, 71% (dr = 1.1:1); e) TsCl (4.0 eq), 
DMAP (15 mol%), pyridine, 23 °C, 15 h, 92%. 
Scheme 88: Shortened synthesis of bis-TBS ether 8,9-cis-275. 
 
  
                                                 
172 a) E. N. Jacobsen, I. Marko, W. S. Mungall, G. Schroeder, K. B. Sharpless, J. Am. Chem. Soc. 1988, 110, 1968-
1970; b) K. B. Sharpless, W. Amberg, Y. L. Bennani, G. A. Crispino, J. Hartung, K. S. Jeong, H. L. Kwong, K. 
Morikawa, Z. M. Wang, J. Org. Chem. 1992, 57, 2768-2771; c) H. C. Kolb, M. S. VanNieuwenhze, K. B. Sharpless, 
Chem. Rev. 1994, 94, 2483-2547. 
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In analogy to previous routes, the diastereomeric mixture of bis-TBS ether 8,9-cis-275 was 
selectively mono-desilylated with CSA, and the diastereomers were separated by flash 
chromatography. In parallel, 261a and 261b were subjected to esterification with β-amino acid 274, 
followed by Luche reduction to provide desired cyclization precursor 276a and its 8-epi-9-epi-11-
epi counterpart 276b. 
 
Reagents and conditions: a) CSA (25 mol%), CH2Cl2/MeOH (1/1), 0 °C, 7 h, 45% 261a, 43% 261b; b) 274 (1.5 eq), 
EDCI, (2.0 eq), DMAP (20 mol%), CH2Cl2, 23 °C, 5 h, 69%; c) NaBH4 (1.5 eq), CeCl3•7H2O (1.5 eq), THF/MeOH 
(1/1), 55 °C, 45 min, 98%; d) 274 (1.4 eq), EDCI, (1.4 eq), DMAP (25 mol%), CH2Cl2, 0 °C, 18 h, 64%; e) NaBH4 
(1.5 eq), CeCl3•7H2O (1.5 eq), THF/MeOH (1/1), 55 °C, 1 h, 82%. 
Scheme 89: Synthesis of cyclization precursor 276a and its 8-epi-9-epi-11-epi diastereomer 276b. 
276a was subjected to macroetherification, bearing in mind that a double silyl protection of the 
catechol moiety could lead to unintended [2.6]metacyclophane formation. CsF mediated double 
TES cleavage led to formation of the desired [2.6]paracyclophane 268 in 60% isolated yield 
(Scheme 90). Notably, the macrocyclization occurs in a highly atrop- and regioselective manner. 
While regioisomeric [2.6]metacyclophane 277 was isolated as a byproduct in 8% yield, the 
corresponding [2.6]paracyclophane atropisomer 278 was not observed.  
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Thus, the regioselectivity of the realized paracyclophane formation was determined to be 6.8:1,167 
whereas the atropselectivity was benchmarked to ≥5:1.173 
 
Scheme 90: [2.6]paracyclophane formation of cyclization precursor 276a. 
A rationale for the observed regio- and atropselectivity of [2.6]paracyclophane formation is 
presented in Scheme 91.174 Each of the investigated substrates with desired C-8/C-9 configuration 
forms an intermediate cesium phenolate of the general structure I upon treatment with CsF or 
Cs2CO3. The coordination abilities of the C-22, and in particular the C-11 substituents, are thought 
to induce a substrate preorganization, preferentially leading to intermediate III vs. II. The favorable 
templating interactions in III are believed to facilitate nucleophilic substitution of the tosylate by 
the proximate phenolate, resulting in formation of the desired atropisomer. Moreover, this 
rationalized templating effect, which should be strongest for cyclization precursor 276a, also 
controls catechol orienttion of [2.6]metacyclophane 277 by ring closure via the same preorganized 
intermediate III. Furthermore, the observed relationship between decreasing atropselectivity with 
increasing substitution at C-11 and C-22 is in agreement with the outlined rationale. 
                                                 
173 The major unidentified product by 1H NMR spectroscopy was assumed to be the undesired atropisomer 278, 
although its structure could not be ascribed reliably. 
174 C. Heinz, N. Cramer, J. Am. Chem. Soc. 2015, 137, 11278-11281. 
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Scheme 91: Rationale for the encountered atrop-and regioselectivity in [2.6]paracyclophane formation. 
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An additional piece of evidence for this template effect was obtained by macrocyclization of 8-epi-
9-epi-11-epi-diastereomer 276b (Scheme 92). [2.6]Paracyclophane 279 was isolated as the 
expected predominant regio- and atropisomer, presumably formed via preorganized intermediate 
IV. Similar to the cyclization of substrate 276a, the corresponding atropisomer was not detected. 
However, [2.6]metacyclophane 280 was isolated as the main reaction byproduct, again with a 
catechol orientation arising from templated intermediate IV. Thus, macrocyclization of 276b 
proceeded with a regioselectivity of 3.3:1,167 and an atropselectivity of ≥11:1.173 
 
Reagents and conditions: a) CsF (3.0 eq), 4Å-MS, DMF, 100 °C, 11 h, 37% 279, 20% 280. 
Scheme 92: [2.6]paracyclophane formation of cyclization precursor 276b. 
Additional optimization of the macroetherification process was then investigated (Table 21).167 
Starting from an isolated yield of 56% and 7.0:1 regioselectivity under standard conditions (entry 
1), an increased regioselectivity of 12:1 was obtained by lowering the temperature to 80 °C. 
However, a considerably longer reaction time was required to provide 268 in slightly diminished 
yield (entry 2). Executing the reaction in N-methyl-2-pyrrolidone (NMP) led to increased side 
product formation, resulting in only 38% yield, however the regioselectivity appeared to be slightly 
enhanced. Thus, CsF in DMF at 100 °C persisted as the conditions of choice for 
[2.6]paracyclophane formation. 
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Table 21: Investigation of temperature and solvent influence on [2.6]paracyclophane formation. 
 
Entry Conditions[a] 
Yield 
[%] 
Regioselectivity 
268:277 
1 DMF, 100 °C, 8.5 h 56 7.0:1 
2 DMF, 80 °C, 36 h 53 12:1 
3 NMP, 100 °C, 8.5 h    38[b] 8.9:1 
[a] Reactions were conducted in 30.0 mg (28.5 μmol) scale; [b] 83% conversion of 276a. 
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6.2.2 Dihydroxylation Studies 
Nowadays, the asymmetric dihydroxylation (AD) of olefins could be considered as a largely 
overcome synthetic obstacle. However, we found the OsO4 catalyzed facial selective 
dihydroxylation of indenyl-cyclopentenones to be an extremely challenging task. Our studies 
towards this end will be presented in this section. We commenced our studies by application of the 
“classical” Sharpless AD procedure to model system 148 (Table 22). Employment of 
(DHQ)2PHAL containing AD-mix-α under biphasic conditions (tBuOH/H2O) resulted in poor 
solubility of the dihydroxylation substrate and sluggish conversion (entry 1). Thus, moderately 
enantioenriched diol 225 (45% ee) was obtained in poor yield of 35%. While the use of MTBE as 
the organic solvent was observed to dramatically slow down the process (entry 2), employment of 
THF accelerated the conversion of 148. However, the low yields of 225 as the only identifiable 
reaction product suggested an incompatibility of the indenylcyclopentenone substrate with basic 
reaction conditions. In fact, K2CO3 mediated degradation of 148 was also observed in the absence 
of the AD-mix (entry 4).  
Table 22: Studied “classical” SAD of model system 148. 
 
Entry Additives Solvent 
T 
[°C] 
t 
[h] 
Conv. / Yield[b] / ee 
1 MeSO2NH2 (1.0 eq) tBuOH 0 72 72 / 35 / 45 
2 MeSO2NH2 (1.0 eq) MTBE 23 14 d n.d. / trace / n.d. 
3 MeSO2NH2 (1.0 eq) THF 23 12 86 / 18 / 37 
4 No AD mix, K2CO3 (3.0 eq) tBuOH 23 26 74 / 0 / - 
[a] Classical SAD conditions were applied (1.4 g AD-mix-α/mmol olefin ≙ 0.2 mol% K2OsO2(OH)4,                         
1.0 mol% (DHQ)2PHAL, 3.0 eq K2CO3, 3.0 eq K3Fe(CN)6  [b] Determined by 1H NMR spectroscopy                                             
using 1,3,5-TMB as internal standard. 
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Consequently, we aimed to improve the dihydroxylation outcome by the employment of increased 
catalyst and ligand loadings in combination with buffered conditions (Table 23). As a reference 
reaction, 148 was first dihydroxylated using K2CO3 as the sole base, providing 225 in 31% yield 
and 43% ee after 21 h (entry 1). Addition of NaHCO3 resulted in slightly improved yields 
of equally enantioenriched diol 225 (entry 2). A 5% increase in ee was gained by executing the 
reaction at 0 °C, although base induced decomposition of 148 persisted to be a severely competitive 
process (entry 3). With respect to this result, the common employment of tBuOH/THF was found 
to be beneficial in terms of product yield (45%, entry 4). The replacement of K2CO3 by Na2CO3 
resulted in an unfavorable 35% yield, however, the facial selectivity was slightly improved to 
afford 225 in 51% ee.  
Table 23: Studied asymmetric dihydroxylation of 148 under modified Sharpless conditions. 
 
Entry Additives (3.0 eq) Solvent 
T 
[°C] 
t 
[h] 
Conv. / Yield[a] / ee 
1 K2CO3 tBuOH 23 21 91 / 31 / 43 
2 K2CO3/NaHCO3 tBuOH 23 22 80 / 43 / 44 
3 K2CO3/NaHCO3 tBuOH 0 36 77 / 28 / 49 
4 K2CO3/NaHCO3 tBuOH/THF (1:1) 0 36 87 / 45 / 46 
5 Na2CO3/NaHCO3 tBuOH 0 36 83 / 35 / 51 
[a] Determined by 1H NMR spectroscopy using 1,3,5-TMB as internal standard. 
As both yield and enantiomeric excess of the dihydroxylation reaction still lagged behind 
preparatively useful levels, we refrained from employment of basic reaction conditions and 
K3Fe(CN)6 as the terminal oxidant. Instead, attention was shifted to NMO as the oxidant in virtually 
neutral reaction media (Table 24). Still using Sharpless’ (DHQ)2PHAL ligand, asymmetric 
dihydroxylation of 148 in tBuOH/H2O at ambient temperature proceeded sluggishly to afford 
poorly enantioenriched diol 225 (10% ee) in 17% yield (entry 1). Attempted process acceleration 
by addition of methanesulfonamide – generally resulting in accelerated hydrolysis of the 
intermediate osmium(VI) glycolate – had no impact on the reaction outcome (entry 2).172b 
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Application of these conditions to 148 in CH2Cl2/H2O led to an increased yield of 45% for 225, 
although almost no facial selectivity was observed (entry 3). While the use THF/acetone/H2O as 
the reaction media was even inferior in terms of yield and ee (entry 4), a significant increase in 
yield to 86% was observed by executing the reaction in THF/H2O (entry 5). As the 
enantioselectivity of this transformation was poor (14% ee), another chinchona alkaloid derived, 
but anthraquinone-based ligand class was evaluated.175 Employment of (DHQD)2AQN resulted in 
an optimized yield of 92%, concomitant with a slight increase in enantioselectivity to 22% ee (entry 
6). Unexpectedly, utilization of this dihydroquinidine (DHQD) derived ligand led to preferential 
dihydroxylation of the same face of 148 as observed for (DHQ)2PHAL, derived from 
“pseudoenantiomeric” dihydroquinine (DHQ). Further variation of the AD conditions by 
decreasing the reaction temperature to 0 °C (entry 7), or additional employment of 
methanesulfonamide (entry 8), did not lead to higher enantioselectivities. 
Table 24: Studied dihydroxylation of 148 employing NMO as the terminal oxidant. 
 
Entry x / y /z [mol%] Solvent 
T 
[°C] 
t 
[h] 
Conv. / Yield[a] / ee 
1 5 / 10 /130 tBuOH/H2O (1:1) 23 45 51 / 17 / 10 
2    5 / 10 /130[b] tBuOH/H2O (1:1) 23 45 50 / 18 / 10 
3    5 / 10 /130[b] CH2Cl2/H2O (4:1) 23 45 62 / 45 / 3 
4 3 / 10 / 200 THF/Acetone/H2O
[c] 0 70 48 / 21 / 0 
5 5 / 10 / 200 THF/H2O (10:1) 23 1.5 100 / 86 / 14 
6   5 / 10[d] / 200 THF/H2O (10:1) 23 1 100 / 92 / 22 
7   4 / 10[d] / 200 THF/H2O (10:1) 0 4 100 / 87 / 20 
8     4 / 10[d] / 200[b] THF/H2O (10:1) 0 4 100 / 80 / 18 
[a] Determined by 1H NMR spectroscopy using 1,3,5-TMB as internal standard; [b] 1.0 eq MeSO2NH2 were added;           
[c] Solvent ratio 1:1:1; [d] (DHQD)2AQN was employed instead of (DHQ)2PHAL. 
 
                                                 
175 H. Becker, K. B. Sharpless, Angew. Chem. Int. Ed. 1996, 35, 448-451. 
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Subsequently, we changed the dihydroxylation substrate, and hoped to achieve higher facial 
selectivity for bis-silyl ether 149 by the potential synergy of its inherent stereochemical bias and 
ligand control (Table 25). Application of the previously highest yielding conditions 
((DHQD)2AQN/THF/H2O) to 149 resulted in 79% yield of a 1:2.3 diastereomeric mixture of 281 
in favor of the undesired (8R,9S) diastereomer (entry 1). Employment of “pseudoenantiomeric” 
ligand (DHQ)2AQN led to a comparable yield, but to an equimolar mixture of the desired (8S,9R)-
281 with its 8-epi-9-epi counterpart (entry 2). As observed previously, AD using mixtures of 
tBuOH proceeded dramatically slower (entry 3), and even favored formation of the undesired 
diastereomer when THF was omitted (entry 4).  
Table 25: Studied asymmetric dihydroxylation of 149. 
 
Entry Ligand Solvent T [°C] t [h] Conv. / Yield[a] / dr[b] 
1 (DHQD)2AQN THF/H2O (10:1) 23 1 100 / 79 / 1:2.3 
2 (DHQ)2AQN THF/H2O (10:1) 23 1.5 100 / 77 / 1:1 
3 (DHQ)2AQN
[c] tBuOH/THF/H2O/
 (4:4:1) 23 22 81 / 64 / 1:1 
4 (DHQ)2AQN tBuOH/H2O
 (1:1) 23 43 73/ 47 / 1:1.4 
5 (DHQ)2PHAL tBuOH/THF/H2O
[d] (1:1:2) 0 24 96 / 43 / 1.8:1 
6 (DHQ)2PHAL tBuOH/H2O
 (1:1) 23 72 93 / 76 / 1:1.3 
7 (DHQ)2PHAL THF/H2O (10:1) 23 1 100 / 71 / 1:1.2 
8 (DHQ)2PHAL THF/H2O (10:1) 0 2 100 / 91 / 1:1.1 
9 (DHQ)2PHAL THF/H2O (10:1) 0 4 100 / 71 / 1:1.1
[e] 
10 (DHQ)2Pyr THF/H2O (10:1) 0 3 96 / 66 / 1:1.2 
11 (DHQ)2Pyr tBuOH/H2O
 (1:1) 23 68 100 / 42 / 1:1.5 
[a] Determined by 1H NMR spectroscopy using 1,3,5-TMB as internal standard; [b] ratio of desired/undesired 
diastereomer; [c] Addition of 149 over 11 h; [d] biphasic conditions using K3Fe(CN)6, K2CO3, NaHCO3, MeSO2NH2; 
[e]  Reaction was conducted on 1.0 mmol scale: isolated yield is reported. 
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A similar solvent-dependent behavior was encountered if the ligand was changed to phthalazine-
derived (DHQ)2PHAL (entries 5 and 6). Notably, a 1.8:1 mixture of diastereomers in favor of the 
desired one, resulted from application of the “classical”, though buffered, Sharpless conditions 
(entry 5). However, base mediated substrate degradation still occurred to an unfavorable extent. 
Again, a more promising results in terms of yield was obtained using a THF/H2O mixture as solvent 
(entry 7). Reaction execution at 0 °C finally resulted in 91% NMR yield on 0.02 mmol scale (entry 
8), which dropped to 71% isolated yield upon scale up to 1.0 mmol (entry 9 and Scheme 88). Poor 
diastereoselectivity in favor of the undesired diastereomer was observed in both cases (dr = 1:1.1). 
Last, we evaluated pyrimidine-derived ligand (DHQ)2PYR (entries 10 and 11). However, both 
reaction yield and diastereoselectivity were inferior compared to (DHQ)2PHAL. As we were 
unable to concomitantly achieve both high levels of facial selectivity and high yield for the 
dihydroxylation process, we then explored the feasibility of a cis-diboration/oxidation approach to 
access diol (8S,9R)-275. According to a procedure of Morken et al.,176 indenylcyclopentenone 149 
was reacted with bis(catecholato)diboron in the presence of chirally ligated rhodium(I), targeting 
intermediate 282. However, we could not detect formation of diboron species 282. Accordingly, 
submission of the reaction mixture to oxidative deborylation did not afford the desired diol (8R,9S)-
281. Therefore, the OsO4 catalyzed dihydroxylation of 149 employing (DHQ)2PHAL as the ligand 
(Table 25, entries 8 and 9) remained the method of choice for the synthesis of (8R,9S)-281. 
 
Scheme 93: Attempted cis-diboration/oxidation of indenylcyclopentenone 149. 
  
                                                 
176 J. B. Morgan, S. P. Miller, J. P. Morken, J. Am. Chem. Soc. 2003, 125, 8702-8703; S. Trudeau, J. B. Morgan, M. 
Shrestha, J. P. Morken, J. Org. Chem. 2005, 70, 9538-9544. 
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6.3 2nd Generation Synthesis of the β-Amino Acid from 5-Chloroveratric Acid 
As discussed in section 6.2.1, double TES protection of the catechol moiety of the β-amino acid 
proved beneficial to the atropselectivity of the macrocyclization process. As preparation of double 
TES protected β-amino acid 274 is not requiring a chemical differentiation between both phenolic 
hydroxyl groups, a shorter synthesis of this building block was envisaged. Thus, commercially 
available 5-chloroveratric acid (283) was identified as a viable starting material (Scheme 94).  
 
Scheme 94: 1st generation and planned 2nd generation synthesis of β-amino acid 274. 
In analogy, benzoic acid 283 was converted into β-keto ester 284 in quantitative yield (Scheme 
95). Similarly, transformation of 284 into enamine 285 proceeded without loss of material. 
Enantioselective enamine reduction provided β-amino ester 286 in excellent optical purity (98% 
ee) and 56% yield after the first chromatographic purification step of the synthesis. We ascribed 
the moderate yield 286 to the formation of a dimer-like side product, which was tentatively 
assigned as 287.  
 
Reagents and conditions: a) CDI (1.2 eq), MgCl2 (1.1 eq), MeO2CCH2CO2K (1.5 eq), THF, 23 °C, 18 h, >99%; b) 
NH4OAc (5.0 eq), MeOH, 70 °C, 12 h, >99%; c) ((R)-DM-Segphos)Ru(OAc)2 (1.0 mol%), AcOH (2.0 eq), H2 
(30 atm.), MeOH, 80 °C, 6.5 h, 56%, 98% ee. 
Scheme 95: Synthesis of β-amino ester 286. 
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Ensuing N-acetylation proceeded smoothly affording acetamide 287 (Scheme 96). Global 
demethylation of 287 was accomplished using Fujita’s method, employing AlBr3/EtSH in 
CH2Cl2.177 The obtained crude catechol 288 was subjected to TES protection, furnishing bis-
triethylsilyl β-amino acid 274 in good yield over two steps.  
 
Reagents and conditions: a) AcCl (1.2 eq), Et3N (1.3 eq), CH2Cl2, 23 °C, 1 h, 87%; b) AlBr3 (8.0 eq), EtSH (70 eq), 
CH2Cl2, 23 °C, 21 h, c) TESCl (6.6 eq), DMAP (15 mol%), Et3N (8.0 eq), DMF, 23 °C, 8 h, 65% (2 steps). 
Scheme 96: Synthesis of β-amino acid 274. 
Thus, the 2nd generation synthesis of 274 provided the β-amino acid fragment of fijiolide A in 6 
steps and good overall yield of 32% from commercially available 5-chloroveratric acid. As only 
three chromatographic purification steps were required, this approach allows rapid access to multi-
gram quantities of the highly enantioenriched 274. 
 
 
 
 
  
                                                 
177 M. Node, K. Nishide, K. Fuji, E. Fujita, J. Org. Chem. 1980, 45, 4275-4277. 
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6.4 Studies Targeting Dehydration of the C-11 Allylic Alcohol  
With a reliable synthetic route toward [2.6]paracyclophane 268 in hand, our focus shifted towards 
elimination of the C-11 hydroxyl group to install the cyclopentadiene moiety. According to our 
recent retrosynthetic analysis (Scheme 97), 1 was to be obtained from postulated fijiolide A 
precursor 289 via glycosylation of the tertiary C-9 hydroxyl group. 289 was envisaged to be directly 
accessed from 268 via C-11 dehydration, and would allow synthesis of the fijiolide A aglycone by 
cleavage of the C-13 silyl ether.  
 
Scheme 97: Envisioned completion of the synthesis of 1 via protected fijiolide A aglycone 289. 
In order to investigate the dehydration reaction, 22-OMe [2.6]paracyclophane 263 was selected as 
an advanced model system. Its protected phenol reduces the number of nucleophilic sites that could 
potentially interfere with dehydration strategies. Still, the desired transformation would require 
high chemoselectivity, ensuring dehydration of the secondary allylic alcohol in favor of the tertiary 
allylic hydroxyl group. We began our studies employing freshly prepared Burgess reagent (Table 
26, entries 1-2).178,179 While no conversion to 290 was achieved in toluene, execution of the reaction 
in THF resulted in formation of an unidentified product, which did not contain a cyclopentadiene 
moiety. Next, Martin’s sulfurane (Figure 8a) was screened.180 Employment of 1.2 equivalents of 
reagent on less than 2 mg scale of 263, cleanly led to formation of a new product (entry 3). The 
structure of this species was tentatively assigned as benzyl ether 291, with an inverted configuration 
                                                 
178 E. M. Burgess, H. R. Penton, E. A. Taylor, J. Am. Chem. Soc. 1970, 92, 5224-5226. 
179 S. Carret, A. Blanc, Y. Coquerel, M. Berthod, A. E. Greene, J.-P. Deprés, Angew. Chem. Int. Ed. 2005, 44, 5130-
5133. 
180 a) J. C. Martin, R. J. Arhart, J. Am. Chem. Soc. 1971, 93, 4327-4329; b) R. J. Arhart, J. C. Martin, J. Am. Chem. 
Soc. 1972, 94, 5003-5010. 
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at C-11 (Figure 8b). This result is unexpected as secondary bis(trifluoromethyl)benzyl ethers 
usually undergo elimination to the corresponding olefin, and only a few secondary 
bis(trifluoromethyl)benzyl ethers have even been isolated.181 Addition of base to the reaction 
mixture did not facilitate elimination, perhaps as result of poor orbital overlap for an E2 elimination 
to occur (entry 4). Dehydration via activation of the C-11 hydroxyl group with MsCl, followed by 
Et3N or DBU mediated elimination did not deliver the desired 290, but instead resulted in substrate 
decomposition (entries 5-6). Altering the electrophilic activation reagent to Tf2O gave rise to a new 
product, whose structure could not be assigned due to rapid decomposition of the sample after 
isolation. An attempt to dehydrate 263 under acidic conditions with pTSA showed no conversion 
after 24 h (entry 8). 
Table 26: Investigated dehydration of [2.6]paracyclophane 263. 
 
Entry Conditions 
T 
[°C] 
t 
[h] 
Result 
1 Burgess reagent (1.1 eq), PhMe 23 8 No conversion 
2 Burgess reagent (2.6 eq), THF 23 16 Undesired product 
3 Martin’s sulfurane[a] (1.2 eq), CH2Cl2 0 1 42% 291 
4 Martin’s sulfurane[a] (1.2 eq), Et3N (5.0 eq), CH2Cl2 23 1 291 (yield n.d.) 
5 MsCl (1.2 eq), Et3N (5.0 eq), CH2Cl2 0 3 Decomposition 
6 MsCl (2.4 eq), DBU (5.0 eq), CH2Cl2 23 24 Decomposition 
7 Tf2O (2.4 eq), 2,6-lut. (10 eq), CH2Cl2 78 1.5 Unidentified product
[b] 
8 pTSA (1.0 eq), PhMe 23 24 No conversion 
 [a] Martin’s sulfurane was purchased from TCI Chemicals and used as received; [b] An unidentified pure product by     
1H NMR was isolated but rapidly decomposed in CDCl3. 
                                                 
181 a) H.-S. Cho, J. Yu, J. R. Falck, J. Am. Chem. Soc. 1994, 116, 8354-8355; b) J. R. Falck, J. Yu, H.-S. Cho, 
Tetrahedron Lett. 1994, 35, 5997-6000; c) T. Sato, T. Yamazaki, Y. Nakanishi, J.-i. Uenishi, M. Ikeda, J. Chem. Soc., 
Perkin Trans. 1 2002, 1438-1443; d) K. Iwasaki, R. Kanno, T. Morimoto, T. Yamashita, S. Yokoshima, T. Fukuyama, 
Angew. Chem. Int. Ed. 2012, 51, 9160-9163. 
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Figure 8: a) Structure of Martin’s sulfurane; b) Isolated product after reacting 263 with Martin’s sulfurane. 
Although efforts to install the cyclopentadiene motif on model substrate 263 were not successful, 
direct dehydration of the more advanced paracyclophane 268 was also attempted. Utilization of 
Martin’s Sulfurane, Burgess Reagent, or dehydration conditions such as I2/PPh3/1H-imidazole and 
POCl3/pyridine likewise failed to provide desired 289, and substrate decomposition was observed 
in most cases. As a consequence, we investigated methyltriphenoxyphosphonium iodide (MTPI) 
for direct dehydration of 268. MTPI is reported to selectively dehydrate secondary alcohols in polar 
aprotic solvents, such as HMPA or DMPU, while tertiary alcohols and phenols are unaffected.182 
Pleasingly, conversion of 268 with MTPI in DMPU was found to provide desired cyclopentadiene 
289 in 25-40% yield after isolation by preparative HPLC (Scheme 98).183 Detrimentally, 289 
turned out to be quite unstable, especially toward acidic media. We attribute this finding to the 
cyclopentadieneol motif. In fact, we are only aware of a single report by Itô et al. describing an 
isolated 1,2-disubstituted cyclopentadienol and its facile elimination to fulvene derivatives.184  
 
Scheme 98: Successful dehydration of 268 with MTPI. 
                                                 
182 J.-R. Dormoy, B. Castro, in Encyclopedia of Reagents for Organic Synthesis, John Wiley & Sons, Ltd, 2001. 
183 Reaction was conducted employing 2.0 mg (3.1 μmol) of azeotropically dried 268 and purchased MTPI (Sigma 
Aldrich), purified by washing with dry Et2O. 
184 Y. Fujise, T. Morishima, K. Namiwa, T. Shiokawa, Y. Fukazawa, S. Itô, Tetrahedron Lett. 1983, 24, 4261-4264. 
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In addition, reproducing the dehydration of 268 with MTPI proved difficult. Numerous 
modifications to the reaction conditions were evaluated to improve the reproducibility, and are 
presented in Table 27. Neither altering the reaction temperature (entries 2-4), nor the solvent to 
HMPA or DMI (5-7), or addition of a basic additive aiming to prevent acid mediated substrate 
decomposition (entries 8-10), improved the reproducibility and yield. Moreover, application of 
different purification methods for MTPI (entries 11-14), or utilization of freshly prepared MTPI185 
(entries 15-17) were also unsuccessful. 
  
                                                 
185 J. P. H. Verheyden, J. G. Moffatt, J. Org. Chem. 1970, 35, 2319-2326. 
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Table 27: Attempts to reproduce the C-11 dehydration of 268 with MTPI. 
 
Entry 
MTPI 
[Eq] 
Conditions Additive Result (Crude NMR) 
1 5.0[a] DMPU, 70 °C, 2 h - 50-60% Conversion / 25-40% 289 
2 10[b] DMPU, 70 °C, 1 h - ≤5% 289 / decomposition 
3 2.0[b] DMPU, 50 °C, 1 h - Complete decomposition 
4 5.0[a] DMPU, 23 °C, 24 h - No conversion 
5 2.0[b] DMI, 50 °C, 1 h - 62% Conversion / decomposition 
6 10[b] HMPA, 70 °C, 1 h - ≤17% 289 / decomposition 
7 5.0[a] HMPA, 70 °C, 2 h - Traces of 289 / decomposition 
8 5.0[a] DMPU, 70 °C, 2 h K2CO3 (1.5 eq) Traces of 289 / decomposition 
9 3.0[b] DMPU, 70 °C, 2 h K2CO3 (6.0 eq) Complete decomposition 
10 2.0[d] DMPU, 70 °C, 1 h DBU (4.0 eq) 65% Conversion / traces of 289 
11 5.0[c] DMPU, 70 °C, 2 h - ≤7% 289 / decomposition 
12 3.2[e] DMPU, 70 °C, 2 h - 43% Conversion / decomposition 
13 5.7[e] DMPU, 70 °C, 2 h - Complete decomposition 
14 14[e] DMPU, 70 °C, 2 h - Complete decomposition 
15 2.0[f] DMPU, 70 °C, 1 h - 45% Conversion / decomposition 
16 3.0[f] DMPU, 70 °C, 75 min - 20% of a more polar product 
17 3.0[f] DMPU, 70 °C, 45 min - 26% of an unidentified product 
18 7.7[b] DMPU, 70 °C, 4 h - 7% Isolated yield / decomposition 
[a] Purchased MTPI (Sigma Aldrich) was washed with dry Et2O (6 x) to afford a pale brown solid; [b] Purchased MTPI 
(Sigma Aldrich) was precipitated from dry CH2Cl2 (5 x) to afford an off-white solid; [c] Purchased MTPI (Sigma 
Aldrich) was washed with dry Et2O (3 x) to afford a brown solid; [d] Purchased MTPI (Sigma Aldrich) was washed 
with dry Et2O (4 x) followed by dry EtOAc (3 x) to afford a yellow/orange solid; [e] Purchased MTPI (Acros 
Organics) was used as received (dark brown moist solid); [f] Freshly prepared MTPI (yellow solid) of highest purity 
by NMR, compared to all other MTPI batches. 
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Still, a single further dehydration experiment of slightly increased reaction scale provided 289 in 
7% isolated yield (Scheme 99). Treatment with TBAF on sub-milligram scale cleanly afforded the 
fijiolide A aglycone 62 in 70-80% yield.186 Similar to 289, the fijiolide A aglycone did not prove 
stable and decomposed when stored at 30 °C in a DMSO matrix. 
 
Reagents and conditions: a) MTPI (6.6 eq), DMPU, 70 °C, 4 h, 7%, b) TBAF (3.0 eq), 0 °C, 1 h, 70-80%. 
Scheme 99: Synthesis of the fijiolide A aglycone 62. 
 
 
 
 
 
 
 
The instability of cyclopentadienols 289 and 62 prompted us to revise our synthetic strategy for 
installation of the amino sugar moiety (cf. Scheme 97). In particular, Brønsted or Lewis acid 
                                                 
186 The structure of 62 was tentatively assigned by 1H, COSY and ROESY NMR spectroscopy and in comparison with 
the reported NMR data for fijiolide A. 
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assisted activation of glycosyl donor 56 in presence of protected fijiolide A aglycone 289 was 
deemed critical. This would require a stable coupling partner. Our new strategy towards 1 involved 
a Grieco elimination step after successful coupling of selenide 292 to the amino sugar                    
(Scheme 100).187 
 
Scheme 100: Revised strategy for completion of the synthesis of 1 via selenide 292. 
To realize this goal, Mitsunobu-type installation of an o-nitrophenylselenide substituent at C-11 
was necessary.188 Employment of PBu3/o-NO2PhCN proved suitable for this purpose, however, 
low and erratic yields of 24-53% were initially attained for selenide 292.189 In an effort to address 
this shortcoming, lowering the reaction temperature from ambient temperature to 78 °C turned 
out to be crucial for clean conversion. Thus, reproducible and scale-independent yields of up to 
93% were obtained (Scheme 101).  
                                                 
187 a) K. B. Sharpless, M. W. Young, R. F. Lauer, Tetrahedron Lett. 1973, 14, 1979-1982; b) P. A. Grieco, S. Gilman, 
M. Nishizawa, J. Org. Chem. 1976, 41, 1485-1486; c) H. J. Reich, S. Wollowitz, J. E. Trend, F. Chow, D. F. 
Wendelborn, J. Org. Chem. 1978, 43, 1697-1705. 
188 P. A. Grieco, S. Gilman, M. Nishizawa, J. Org. Chem. 1976, 41, 1485-1486. 
189 The C-11 stereochemistry in 293 was determined by ROESY NMR studies. 
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Reagents and conditions: a) o-NO2PhSeCN (3.0 eq), PBu3 (3.1 eq), THF, 78 °C, 1.5 h, 93%; b) H2O2 (32 eq), THF, 
23 °C, 23 h, decomposition; c) o-NO2PhSeCN (4.0 eq), PBu3 (4.2 eq), CH2Cl2, 23 °C, 75 min, 64%. 
Scheme 101: Selenylation of [2.6]paracyclophane 268 and attempted direct Grieco elimination.  
Interestingly, formation of a different reaction product was observed when the solvent was changed 
to CH2Cl2, or DMPU contaminated starting material was employed. Although we do not yet have 
unequivocal evidence for the structure of this compound, NMR studies, HRMS, IR, and the 
experimentally demonstrated absence of a free hydroxyl group,190 suggests the formation of doubly 
bridged bis-aryl ether 293. We rationalize this outcome by additional activation of the tertiary 
allylic alcohol, and subsequent nucleophilic substitution by the spatially close free phenol. 
Although uncommon, Mitsunobu reactions of tertiary alcohols with phenols, proceeding with 
inversion of configuration have been reported.191  
In order to probe the feasibility of installing the desired cyclopentadiene motif via syn-elimination 
of an intermediate selenoxide, 292 was treated with hydrogen peroxide, disappointingly resulting 
in substrate degradation. Considering the successful Grieco elimination of a related, but simpler 
substrate by Hirama et al., it was reasoned that the free tertiary alcohol in 292 may be interfering 
with intended syn-elimination.192 To probe this proposal, selenide 292 was converted into bis-TES 
ether 294, which was then subjected to selenide oxidation with H2O2 (Scheme 102). In this case, 
syn-elimination provided a mixture of compounds, including cyclopentadiene 295. Subsequent 
                                                 
190 All attempts to install a silyl group on 293 via reaction with TESOTf/2,6-lutidine were met with failure. 
191 Y.-J. Shi, D. L. Hughes, J. M. McNamara, Tetrahedron Lett. 2003, 44, 3609-3611. 
192 M. Inoue, S. Hatano, M. Kodama, T. Sasaki, T. Kikuchi, M. Hirama, Org. Lett. 2004, 6, 3833-3836. 
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addition of TBAF afforded a mixture of the previously synthesized fijiolide A aglycone 62, and its 
13-OH protected congener 289. Thus, the feasibility of the Grieco elimination procedure for the 
synthesis of fijiolide A was demonstrated. 
 
Reagents and conditions: a) TESOTf (30 eq), 2,6-lutidine (60 eq), CH2Cl2, 23 °C, 7 h, 45%; b) H2O2 (20 eq), THF, 
23 °C, 8 h, yield n.d.; c) TBAF (10 eq), THF, THF/CH2Cl2, 0 °C, 1.5 h, 62 (minor product, yield n.d.), 289 (major 
product, yield n.d.).  
Scheme 102: Synthesis of the fijiolide A aglycone 62 via Grieco elimination. 
Glycosylation of selenide 292 posed the next challenge, and studies concerning this matter are 
discussed in chapter 8.
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7.1 Synthesis of TIPDS Protected Amino Sugar 55 
A synthesis of the amino sugar moiety, found in both the C-1027 chromophore and the fijiolides, 
has been previously reported by Hirama and Semmelhack (cf. chapter 2.2).52,53 We elected to 
follow Hirama’s second generation approach towards the amino ribopyranose for several reasons: 
This synthesis provides direct access to the useful tetraisopropyldisiloxane (TIPDS) protected 
amino sugar 55, which was reported to undergo the required selective β-glycosylation of tertiary 
alcohols after trichloroacetimidate activation (cf. chapter 2.3). In addition, we presumed that 
glycosylation of a late-stage fijiolide A precursor would require extensive evaluation of reaction 
conditions, and would potentially necessitate glycosylation studies on a model substrate. As a high 
excess of glycosyl donor was expected to be essential to achieve acceptable levels of conversion, 
a synthesis of the amino sugar must ensure ample supply of this building block in a reliable and 
reproducible manner. In being explicitly described to provide large scale quantities of 55 (10.6 g, 
23.7 mmol), Hirama’s synthesis meets this criterion well. Our synthesis of 55 is summarized in 
Scheme 103 and follows closely Hirama’s route. Generally, high reproducibility was encountered 
allowing straightforward access to 55. However, minor modification to the original procedure was 
undertaken, and a brief discussion is disclosed. In deviation from Hirama’s report, ethyl 
L-pyroglutamate 297 was accessed in quantitative yield via esterification of readily available 
L-pyroglutamic acid 296.193 Transformation to tertiary TMS ether 298, Boc protection of the 
γ-lactam, and selenoxide elimination proceeded smoothly to provide 299. The reported catalyst 
loading of OsO4 was decreased from 10 mol% to 2.0 mol% in the subsequent dihydroxylation step, 
resulting in only a marginally lower yield for diol 52 compared to Hirama’s result (84% vs. 91%). 
Whereas the subsequent 2-step procedure for transformation of γ-lactam 52 into δ-lactone 53 
proceeded smoothly, practical challenges were encountered during synthesis of dimethylamino diol 
54. Due to the extremely high water solubility of 54, low yields were obtained following Hirama’s 
protocol. A modified workup procedure provided remedy. Further alkalization of the NaCl 
saturated aqueous phase (NaHCO3) from pH 8-9 to pH 10 with 2 M NaOH, followed by extraction 
with chloroform instead of EtOAc, turned out to be key for isolation of 54 in greater than 60% 
yield. Despite our yield (66%) lagging behind Hirama’s reported yield of 79% yield, we attained 
dramatically higher yields for the subsequent TIPDS protection to furnish lactone 301 (91% vs. 
                                                 
193 L. S. Nazarova, Y. B. Rozonov, A. M. Likhosherstov, T. V. Morozova, A. P. Skoldinov, N. V. Kaverina, V. A. 
Markin, Pharm. Chem. J. 1984, 18, 811-815; J. Zaminer, C. Brockmann, P. Huy, R. Opitz, C. Reuter, M. Beyermann, 
C. Freund, M. Müller, H. Oschkinat, R. Kühne, H.-G. Schmalz, Angew. Chem. Int. Ed. 2010, 49, 7111-7115. 
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56%), thus compensating for the aforementioned shortcoming. Lactone reduction provided desired 
55 as an inconsequential mixture of its cyclic hemiacetal and open-chain aldehyde form. However, 
erratic yields for this step were encountered, with an observed tendency for lower yields upon 
scale-up.194 
 
Reagents and conditions: a) SOCl2, (1.2 eq), EtOH, 23 °C, 17 h, ≥99%; b) MeLi (2.5 eq), THF, 78 °C to 23 °C, 3 h, 
then TMSCl (6.0 eq), Et3N, (6.1 eq), 4.5 h, 49%; c) Boc2O (1.9 eq), Et3N (2.0 eq), DMAP (0.2 eq), MeCN, 23 °C, 
14 h; d) LHMDS (1.5 eq), PhSeCl (1.3 eq),THF, 78 °C, 1.5 h; e) H2O2 (3.4 eq), pyridine (3.0 eq), CH2Cl2, 0 °C, 75 
min, 87% (2 steps); f) OsO4 (2.0 mol%), NMO (2.0 eq), acetone/tBuOH/H2O (v/v = 1/3.3/1.5), 23 °C, 18 h, 84%; g) 
LiOH (3.0 eq), THF/H2O, 0 °C, 2 h; h) pTSA (5.0 mol%), CH2Cl2, 23 °C, 6 h, 83% (2 steps); i) TFA (26 eq), 
CH2Cl2, 23 °C, 100 min, j) HCHO (36 eq), HCO2H (2.0 eq), NaBH3CN (2.1 eq), MeCN, 23 °C, 3.5 h, 66% (2 steps); 
k) TIPDSCl (2.0 eq), 1H-imidazol (4.0 eq), DMF, 23 °C, 14 h, 91%; l) DIBAL-H (2.0 eq), CH2Cl2, 78 °C, 80 min, 
67-97%. 
Scheme 103: Synthesis of the protected fijiolide amino sugar moiety, according to the procedure of Hirama et al. 
                                                 
194 Loss of material appears to arise from prolonged exposure to SiO2 during chromatographic purification. 
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7.2 Trichloroacetimidate Activation of Amino Sugar 55 
A glycosylation of tertiary alcohols with amino sugar 55 has already been reported by Hirama et 
al. and was initially discussed in chapter 2.3. Conversion of hemiacetal 55 into its corresponding 
trichloroacetimidate 56 was found to be the method of choice to attain both high reactivity, and 
suitable β-selectivity.65 Although utilized in glycosylation studies, neither a procedure for the DBU 
mediated trichloroacetimidate activation of hemiacetal 55, nor spectroscopic data for glycosyl 
donor 56 were provided. Additionally, no information about the stability of 56 can be gathered 
from Hirama’s report. Concerning isolation of 56, we hypothesized that a purification step would 
be required to remove DBU as it was expected to interfere with any subsequent Lewis or Brønsted 
acid glycosylation promoter.195 However, classical acid-base extraction was deemed unsuitable for 
removal due to the amino group of 56, and potential for hydrolysis of the formed 
trichloroacetimidate. Direct chromatographic purification of the reaction mixture was therefore 
anticipated to be the isolation technique of choice. However, several trials to synthesize glycosyl 
donor 56 by reaction with trichloroacetonitrile (10  40 eq) and DBU (0.2 – 2.0 eq) in 
dichloromethane led to complex mixtures and incomplete conversion even after prolonged reaction 
times, judged by TLC. Similar results were obtained using NaH or Cs2CO3 as the base (Scheme 
104). Moreover, attempted isolation of 56 by flash chromatography did not provide the desired 
glycosyl donor. Instead, glycal 302, arising from trichloroacetimidate elimination or direct 
dehydration of the free anomeric hydroxyl group of 55, was isolated in up to 69% yield after 
purification over SiO2. In contrast, use of basic Al2O3 as the stationary phase, did not allow for 
isolation of any amino sugar species, presumably due to complete substrate degradation.  
 
Scheme 104: Failed attempts for synthesis of Schmidt donor 56. 
 
                                                 
195 a) R. R. Schmidt, Angew. Chem. Int. Ed. 1986, 25, 212-235; b) S. Hanessian, Preparative carbohydrate chemistry, 
Marcel Dekker, New York, 1997. 
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The DBU mediated activation of 55 with trichloroacetonitrile (25 eq) was subsequently monitored 
by 1H NMR spectroscopy. Only trace conversion was observed in the presence of 0.2 eq DBU after 
2 h in CD2Cl2. However, further addition of DBU (0.5 eq) led to exceedingly clean formation of a 
new product, which became almost the only detectable species upon addition of further 0.2 eq DBU 
after 4.5 h. This was assigned to be the desired trichloroacetimidate by comparison with 1H NMR 
chemical shifts of related glycosyl donors.196 However, increasing formation of the elimination 
product was observed upon prolonged reaction times, resulting in 16% glycal 302 after 21 h. We 
concluded, that the DBU mediated formation of 56 is indeed a very clean process.197 However, the 
reaction time has to be carefully chosen to avoid unfavorable elimination of the newly formed 
trichloroacetimidate. Moreover, it became apparent that specific reagents and isolation conditions 
had to be carefully developed in order to allow separation of 56 from DBU. Guided by studies on 
the synthesis of highly unstable L-kedarosamine Schmidt donor 304 (Scheme 105),198 we 
contemplated the utilization of polymer-bound DBU (pDBU), which would allow isolation of 56 
by simple filtration of the reaction mixture. 
 
Scheme 105: pDBU mediated activation of unstable l-kedarosamine amino sugar 27. 
Pleasingly, a brief optimization of reaction conditions resulted in isolation of desired the Schmidt 
donor in quantitative yield after reacting 55 with trichloroacetonitrile and pDBU for 4 h, followed 
by filtration and removal of all volatiles under inert atmosphere (Scheme 106). Similar to our 
previous observation, increasing formation of glycal 302 was observed if pDBU was not filtered 
off in a timely manner. Interestingly, further elimination of 56 was ascertained even after filtration 
and storage of 56 as a solution in CD2Cl2 at ambient temperature. Complete conversion into glycal 
302 was observed within 24 h hours. By contrast, 56 was discovered to be exceedingly more stable 
in aromatic solvents. Thus, a NMR sample in C6D6 did not show formation of 302, or any other 
degradation product after storage for 4 days at ambient temperature. In addition, the stability of 56 
                                                 
196 A. G. Myers, R. Glatthar, M. Hammond, P. M. Harrington, E. Y. Kuo, J. Liang, S. E. Schaus, Y. Wu, J.-N. Xiang, 
J. Am. Chem. Soc. 2002, 124, 5380-5401. 
197 In retrospect, previously observed unclean and incomplete conversion is likely to be the result of product 
decomposition on analytical SiO2 or Al2O3 coated TLC plates.   
198 I. Ohashi, M. J. Lear, F. Yoshimura, M. Hirama, Org. Lett. 2004, 6, 719-722. 
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in benzene-d6 was not affected by contamination with residual water. Conveniently from a 
preparative point view, the Schmidt donor could even be stored for 2  3 weeks at 30 °C in a 
benzene matrix (glovebox) without detectable evidence for degradation. 
 
Scheme 106: Successful trichloroacetimidate activation of 55 using pDBU.  
With a reliable and scalable synthesis of Schmidt donor 56 in hand, we were now able to start 
subsequent glycosylation studies on selenide 292. We began by first modelling this reaction, and 
these studies are described in chapter 8.  
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8.1 Glycosylation Studies 
From the outset, late-stage coupling of the amino sugar moiety to any fijiolide A precursor was 
considered a key challenge of the synthesis. Glycosylation of the sterically encumbered tertiary 
C-9 hydroxyl group would require a highly activated glycosyl donor. At the same time, harsh 
reaction conditions to promote glycosylation had to be circumvented due to the sensitivity of the 
glycosyl acceptor. As initially outlined in chapter 2.3, Schmidt donors featuring an anomeric 
trichloroacetimidate group have emerged as powerful building blocks for glycosylation under fairly 
mild conditions. For that reason, Schmidt donor 56 has been employed by Hirama et al. for 
successful glycosylation of synthetic intermediates in the context of their synthetic studies towards 
the C-1027 chromophore.65 According to our envisioned late-stage Grieco elimination strategy (cf. 
Scheme 100, chapter 6.4), glycosylation of the intended acceptor 292 was thought to be particularly 
challenging due to the close proximity of the C-11 arylselenide substituent. Hence, glycosylation 
studies were initially conducted on model substrate 306, which was accessible by Mitsunobu-type 
arylselenylation of known diol 305.199 
 
Scheme 107: Synthesis of model glycosylation substrate (±)-306. 
With (±)-306 in hand, glycosylation was first attempted in dichloromethane using TMSOTf for 
activation of 56.64,65 The desired β-glycosylated species 1,3-cis-307 was obtained in 34% yield, 
and as a 1.1:1 mixture of diastereoisomers (Scheme 108). Following this, Grieco elimination was 
attempted with H2O2. Et3N was additionally added as a sacrificial amine to prevent N-oxide 
formation of the amino sugar moiety. Thus, glycosylated cyclopentadienol 308 was obtained in 
≥45% NMR yield, as a 1.9:1 mixture of diastereomers. This positive result prompted us to apply 
our glycosylation/elimination procedure to the synthesis of fijiolide A. 
                                                 
199 P. Bladon, S. McVey, P. L. Pauson, G. D. Broadhead, W. M. Horspool, J. Chem. Soc. C 1966, 306-312. 
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Reagents and conditions: a) Schmidt donor 56 (2.5 eq), TMSOTf (2.0 eq), 4Å-MS, CH2Cl2, 40 °C to 0 °C, 6 h, 
34% (56% conversion); b) H2O2 (40 eq), Et3N (10 eq), THF, 23 °C, 22 h, ≥45% (1H NMR).  
Scheme 108: Glycosylation and subsequent Grieco elimination of model substrate (±)-306. 
Protection of the presumably more nucleophilic free phenol in 292 prior to glycosylation was 
considered necessary for progression of the synthesis. Consequently, 292 was reacted with 
TBSOTf/2,6-lutidine. Unexpectedly, this reaction provided the C-9 TBS ether 310 instead of 309 
(Scheme 109). Even upon addition of 30 equivalents TBSOTf, we observed chemoselectivity for 
the protection of the tertiary alcohol and a reluctance of the phenol to engage in the silylation 
reaction. This prompted us to use 292 directly as the glycosylation substrate (Scheme 110). 
 
Scheme 109: Unexpected selectivity in silylation of selenide 292.  
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The glycosylation of 292 with 10 equivalents of Schmidt donor 56 yielded only trace amounts of 
the targeted species 311. Instead the C-9 TMS ether 312 was isolated as the main product. We 
attribute the formation of 312 to a direct silylation of the tertiary alcohol with TMSOTf, enabled 
by amino sugar 56 carrying a built-in base. 
 
Scheme 110: Attempted glycosylation of 292 utilizing TMSOTf as the activating Lewis acid. 
As a result, we were forced to re-examine glycosylation conditions to prevent parasitic 9-OH 
silylation. Model substrate (±)-306 was re-consulted for this purpose and our results are 
summarized in Table 28. In an attempt to shut down alcohol silylation by using BF3•OEt2 as the 
activating Lewis acid, substrate degradation was observed as the predominant process (entries 1 
and 2). As dichloromethane is the most common solvent for silylation employing trialkylsilyl 
triflates, it appeared to be an inappropiate choice for the desired glycosylation reaction. Hence, we 
aimed to limit silylether formation by utilization of solvents that would hamper this process. 
Glycosylation using TMSOTf in Et2O and PhMe provided higher yields of 1,3-cis-307 (entries 3-
4). It was observed that 20% and 35% of Schmidt donor 56, respectively, had not been consumed 
during these reactions. We interpreted this observation as a potential for further improvement in 
yield by prolonged reaction times, or increased Lewis acid loading. Activation of 56 with the less 
reactive TESOTf afforded 57% of the glycosylation product in PhMe (entries 5-6). Even sterically 
encumbered TBSOTf in Et2O or PhMe performed well, furnishing 1,3-cis-307 in 38% and 32%, 
respectively. Notably, conversion of both (±)-306 and 56 was lower in these cases, especially when 
PhMe was used (entries 7-8). Finally, a significant increase in yield to 70% was observed by 
running the glycosylation in PhMe, employing 3.0 equivalents of the activating TBSOTf. As 
previously, no TBS protection of (±)-306 occurred at 20 °C. 
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Table 28: Glycosylation optimization studies. 
 
Entry Lewis Acid Solvent 
Conversion / Yield[a] 
[%] 
Unreacted 56 
[%] 
1 BF3•OEt2
[b,c] CH2Cl2 75 / 17 0 
2 BF3•OEt2
[c] CH2Cl2 71 / 17 0 
3 TMSOTf Et2O 77 / 48 20 
4 TMSOTf PhMe 89 / 46 35 
5 TESOTf Et2O 58 / 39 18 
6 TESOTf PhMe 75 / 57 31 
7 TBSOTf Et2O 54 / 38 26 
8 TBSOTf PhMe 57/ 32 43 
9 TBSOTf[d] PhMe 85/ 70 36 
[a] Determined by 1H NMR using dimethyl terephthalate as internal standard;                                                                                                 
[b] Excess of Lewis acid resulted in predominant decomposition of (±)-306, 56 and 1,3-cis-307;                                                                                                        
[c]  Reaction was conducted at 0 °C; [d] 3.0 eq TBSOTf were used. 
Since TBSOTf was assumed to be too sterically hindered for 9-OH silylation, while still efficiently 
activating Schmidt donor 56, it became the Lewis acid of choice for the follow-up glycosylation 
studies of 292 (Scheme 111). Remarkably, the desired β-anomer 311 could be isolated in 49% 
yield after activation of 9.0 equivalents of 56 with TBSOTf. Formation of the corresponding 
α-anomer was not observed at all. The glycosylation of 292 at the tertiary alcohol in favor of the 
free phenol was confirmed by ROESY NMR spectroscopy (Scheme 111). 
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Scheme 111: Glycosylation of selenide 292 and key ROESY correlations verifying the structure of 311. 
 
 
8.2 Installation of the Cyclopentadiene and Isolation of Synthetic Fijiolide A 
Having achieved the key glycosylation step, synthesis of fijiolide A was to be completed by syn-
elimination of the aryl selenide, and finally a global deprotection. Based on the previously observed 
instability of cyclopentadiene featuring fijiolide A precursors, global desilylation of 311 was 
envisaged first. A screen of few deprotection conditions rapidly provided satisfactory results 
(Scheme 112). HF•pyridine was found to first cleave the disiloxane protecting group, followed by 
the benzylic TBS ether in very clean manner. 
 
Reagents and conditions: a) 40% HF (233 eq), MeCN, 23 °C, 4.5 h; b) HF•py (300 eq), THF/py (10/1), 23 °C, 17 h. 
Scheme 112: μg-Scale global desilylation of selenide 311. 
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Subsequent tests to perform a syn-elimination of 313 to afford fijiolide A were not fruitful. Product 
mixtures, containing trace amounts of the target molecule were obtained, as detected by HRMS. 
Use of H2O2/THF, H2O2/Et3N/THF, mCPBA/CH2Cl2 or mCPBA/TFA/CH2Cl2 for Grieco 
elimination led to preferential formation of a “hydrated” form of 1, along with an additionally 
oxidized species, which is attributed to N-oxide formation (vide infra). As a result, Grieco 
elimination prior to desilylation was investigated (Table 29). Submission of 311 to H2O2/Et3N in 
THF resulted in slow formation of a mixture of compounds (entry 1). By HRMS analysis the 
mixture was tentatively assigned to consist of the desired elimination product 314, allylic alcohol 
315, allylic alcohol N-oxide 316, and an oxidized starting material (not shown).200 We attribute the 
formation of allylic alcohols 315 and 316 to a seleno-Mislow-Evans [2,3] sigmatropic 
rearrangement, typically observed upon oxidation of allylic selenides.201 
Table 29: Studies on the selective syn-elimination of selenide 311. 
 
Entry Reagent Solvent t [h] Result[a] 
1 H2O2/Et3N
[b] THF 24 314 + 315 + 316 + oxidized 311 
2 H2O2
[b] THF 1 Exclusively 315 
3 H2O2
[b] MeOH 1.5 Nearly exclusively 316 
4 mCPBA[c] CH2Cl2 1 315 + oxidized 311 
5 H2O2/Et3N
[b] PhMe 17 314 + 315 (3:1) 
6 H2O2/Et3N
[b,d] PhMe 23 314 + oxidized 311 (1.6:1) 
[a] Evaluated by direct HRMS analysis of the reaction mixture or the crude product; [b] 10 eq of Et3N and 500-        
5000 eq of H2O2 were used; [c] 1.0 eq mCPBA was used; [d] Reaction was conducted with 500 μg 311. 
                                                 
200 Due to identical molecular formula, differentiation between presence of a selenoxide or N-oxide species could not 
be effected by means of HRMS. 
201 a) P. Bickart, F. W. Carson, J. Jacobus, E. G. Miller, K. Mislow, J. Am. Chem. Soc. 1968, 90, 4869-4876; b) K. B. 
Sharpless, R. F. Lauer, J. Am. Chem. Soc. 1972, 94, 7154-7155; c) D. A. Evans, G. C. Andrews, Acc. Chem. Res. 1974, 
7, 147-155; d) H. J. Reich, J. Org. Chem. 1975, 40, 2570-2572. 
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In order to suppress the rearrangement pathway, further reaction condition were screened. 
Omission of Et3N led to rapid oxidation of the selenide and subsequent [2,3] sigmatropic 
rearrangement to give undesired 315 exclusively (entry 2). This was an unexpected result as Et3N 
- initially added as a sacrificial amine to prevent N-Oxide formation - appears to slow the rate of 
selenium oxidation as well as impact the fate of the intermediate selenoxide. A tremendous solvent 
effect on N-oxide formation was observed when H2O2 in MeOH was used, resulting in predominant 
formation of 316 after 1.5 h (entry 3). Employment of mCPBA as the oxidant in dichloromethane 
yielded a 1:1 mixture of the undesired 315 and oxidized starting material after 1 h. No further 
conversion was observed (entry 4). A biphasic reaction mixture using toluene and aqueous H2O2 
as solvents turned out to promote the desired syn-elimination. Initially rapid and clean conversion 
to 314 (30% after 35 min) was observed. An additional 16.5 h were required to afford a 3:1 mixture 
of 314 with rearranged alcohol 315 (entry 5). A similar behavior was observed on larger scale 
(500 μg 311). A formed equimolar mixture of 314 and oxidized 311 after 5 h required an additional 
18 h for conversion into a 1.6:1 mixture of the same species (entry 6). We speculated that if 311 
gives rise to a mixture of diastereomeric selenoxides upon oxidation, then one selenoxide 
diastereomer may undergo facile syn-elimination, whereas this process may be considerably slower 
for the other diastereomer. An alternative explanation to this is that the reaction is inhibited by 
o‑nitrophenol selenenic acid, which is inevitably formed by syn-elimination of 311 (product 
inhibition). Neither reaction deceleration nor a [2,3] sigmatropic rearrangement had been observed 
in previously executed Grieco elimination of selenides 294 and 1,3-cis-307 (cf. Scheme 102 and 
Scheme 108). This suggests that the free phenol in 311 could detrimentally interact with the 
selenoxide, for instance, by hydrogen bonding to the Se→O bond or, more likely, to the more 
proximal o-nitrophenyl substituent. In order to probe this hypothesis, 311 was subjected to phenol 
protection, affording TES ether 317 in 71% yield (Scheme 113). 
 
Scheme 113: TES protection of 311.  
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A 30 μg sample of 317 was subsequently reacted with Et3N (10 eq) in toluene/aq. H2O2 (~8:1, 
1500 eq H2O2). Remarkably, exclusive formation of the desired cyclopentadiene 318 within 3.5 h 
was observed (Scheme 114). Thus, the phenol was demonstrated to wield an enormous influence 
on the reaction outcome, and selective syn-elimination occurs when protected as the corresponding 
TES ether. Grieco elimination of 317 was successively scaled up. Whereas clean and rapid 
conversion to 318 was observed for 0.5 mg of substrate, a noticeably longer reaction time, and 
increased byproduct formation was encountered on 3.9 mg scale. We ascribed this finding to a less 
efficient phase exchange between aqueous H2O2 and the organic layer upon scale-up. Constant 
sonication of the reaction mixture was found to address this problem, leading to reduced reaction 
times and reproducible results. To complete the synthesis of 1, multi-milligram quantities of 317 
were apportioned into 2.0 mg reaction batches and treated with H2O2/Et3N under constant 
sonication, in parallel. Thus, a preparatively useful 67% yield of 318 was achieved for the crucial 
elimination step (Scheme 114). Subsequent global desilylation proceeded smoothly under 
previously established conditions (HF•py, pyridine), and provided the putative target molecule 
fijiolide A in 84% isolated yield. 
 
Reagents and conditions: a) H2O2 (1500 eq), Et3N (10 eq), PhMe, 25 °C, sonication, 5 h, 67%:                                  
b) HF•py (356 eq), pyridine (566 eq), THF, 23 °C, 7.5 h, 84%. 
Scheme 114: Completion of the synthesis of fijiolide A by Grieco elimination and global deprotection. 
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In order to compare 1 with the isolated natural fijiolide A, the synthetic sample was converted into 
its trifluoroacetic acid salt by addition of 2.0 equivalents TFA in DMSO-d6. NMR spectroscopic 
analysis (600 MHz, DMSO-d6) revealed a match with the spectra of natural 1.202 The presence of 
fijiolide A as the corresponding TFA salt was not reported by Fenical and coworkers. However, 
the demonstrated match of NMR spectra only upon addition of TFA to the free base strongly 
indicates isolation of 1 as the TFA salt. Utilization of TFA as a HPLC eluent additive explains this 
fact. The purest sample of synthetic material was obtained by preparative reverse-phase HPLC, 
and was used for final comparison with natural fijiolide A. An excellent accordance of NMR 
chemical shifts was observed, with only very minor deviations for the exchangeable protons and 
the amino sugar moiety (chapter 8.3). This observation was traced back to non-identical NMR 
sample preparation. Our sample of synthetic fijiolide A • TFA in DMSO-d6 appeared to be 
considerably less concentrated, while the water content was higher, compared to Fenical’s NMR 
sample. A temperature-dependent deviation in NMR chemical shifts of the exchangeable protons 
was exclude as both spectra were acquired at 27 °C. Interestingly, the 1H chemical shifts of fijiolide 
A proved largely unaffected by the TFA concentration. 
In summary, an atropselective synthesis of fijiolide A was realized in 18 steps in the longest linear 
sequence and 37 total steps including the 12 steps for the preparation of the known Schmidt donor. 
The match of NMR spectroscopic data and optical rotations for synthetic and natural fijiolide A 
verifies a correct structure assignment by Fenical et al, including the atropisomerism.  
  
                                                 
202 Kindly provided by Fenical et al. 
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8.3 NMR Spectroscopic Comparison of Natural and Synthetic Fijiolide A 
 
Table 30: Comparison of 1H NMR (600 MHz, DMSO-d6) spectroscopic data of natural and synthetic                
fijiolide A • TFA (referenced to H8 = 5.870 ppm). 
 
No 
Natural 1 • TFA Synthetic 1 • TFA 
Deviation  
Δδ [ppm] 
δH [ppm] mult. (J [Hz]) δH [ppm] mult. (J [Hz]) 
5 6.64 d (8.0) 6.64 d (8.1) 0.00 
6 7.09 d (7.7) 7.08 d (8.0) -0.01 
8 5.87 s 5.87 s 0.00 
10 6.62 d (5.5) 6.62 d (5.5) 0.00 
11 6.65 dd (5.5, 2.2) 6.65 dd (5.5, 1.9) 0.00 
12 6.76 d (2.0) 6.76 s 0.00 
13 4.66 dd (11.1, 4.1) 4.66 dt (11.2, 4.3) 0.00 
14 4.24; 3.65 t (10.5); dd (9.8, 3.9) 4.24; 3.64 t (10.5); dd (9.8, 3.7) 0.00; -0.01 
16 2.58; 2.07 dd (13.5, 3.6); t (13.2) 2.58; 2.06 dd (13.3, 3.9); t (13.0) 0.00; -0.01 
17 4.62 ddd (12.1, 8.3, 3.6) 4.61 ddd (11.9, 8.2, 3.4) -0.01 
19 6.53 d (2.0) 6.52 d (1.9) -0.01 
23 5.98 d (2.1) 5.98 d (1.9) 0.00 
25 1.74 s 1.74 s 0.00 
1’ 4.46 d (8.0) 4.46 d (7.9) 0.00 
2’ 2.92 dd (8.5, 3.7) 2.95-2.89 m 0.00 
3’ 4.08-4.03 m 4.06-4.01 m -0.02 
4’ 3.12–3.06 m 3.12-3.06 m 0.00 
4’-Me2 2.80 br. s 2.80 d (3.3) 0.00 
4’-Me2 2.80 br. s 2.79 d (3.3) -0.01 
6’-Meα 1.37 s 1.37 s 0.00 
6’-Meβ 1.42 s 1.42 s 0.00 
13-OH 5.84 br. s 5.74 d (4.4) -0.10 
17-NH 8.41 d (8.2) 8.32 d (7.7) -0.09 
22-OH 8.36 s 8.32 s -0.04 
2’-OH 4.95 br. s 4.96 d (5.5) 0.01 
3’-OH 5.70 br. s 5.64 br. s -0.06 
4’-NH+ 9.12 br. s 8.88 br. s -0.24 
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Table 31: Comparison of 13C{1H} NMR (600 MHz, DMSO-d6) spectroscopic data of natural and synthetic                
fijiolide A • TFA (referenced to H9 = 99.80 ppm). 
 
No 
Natural 1 • TFA 
       δC [ppm] 
Synthetic 1 • TFA 
       δC [ppm] 
Deviation 
ΔδC [ppm] 
1 148.79 148.78  0.01            
2 135.82 135.82  0.00 
3 126.75 126.76 -0.01 
4 139.35 13931  0.04 
5 129.15 129.14  0.01 
6 125.37 125.36  0.01 
7 147.82 147.81  0.01 
8 83.36 83.37 -0.01 
9 99.80 99.80  0.00 
10 135.54 135.52  0.02 
11 138.11 138.13 -0.02 
12 129.46 129.48 -0.02 
13 72.48 72.50 -0.02 
14 65.58 65.57  0.01 
15 169.01 168.97  0.04 
16 42.89 43.03 -0.14 
17 49.69 49.70 -0.01 
18 138.94 138.91  0.03 
19 114.3 114.30  0.00 
20 129.33 129.30  0.03 
21 138.35 138.36 -0.01 
22 151.83 151.83  0.00 
23 114.01 114.05 -0.04 
24 168.42 168.36  0.06 
25 22.63 22.65 -0.02 
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Continued Table 31 
1' 93.21 93.15  0.06 
2' 69.49 69.6 -0.11 
3' 67.47 67.53 -0.06 
4' 69.68 69.61  0.07 
5' 74.89 74.86  0.03 
4'-Me2 42.89 43.03 -0.14 
4'-Me2 44.59 44.58  0.01 
6'-Meα 31.64 31.83 -0.19 
6'-Meβ 21.02 20.95  0.07 
 
  
8. Completion of the Synthesis  150 
 
      
Figure 9: Comparison of 1H NMR spectra (600 MHz, DMSO-d6) of natural fijiolide A • TFA (top)                         
and synthetic material (bottom).                                       
         
Figure 10: Comparison of 13C{1H} NMR spectra (600 MHz, DMSO-d6) of natural fijiolide A • TFA (top)                         
and synthetic material (bottom).
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This thesis discusses our conducted synthetic studies towards fijiolide A and presents the first total 
synthesis of this highly bioactive natural product. Fijiolide A (1) is a secondary metabolite of a 
marine-derived actinomycete strain of the genus Nocardiopsis. Its isolation and structure 
elucidation was reported by Fenical et al. in 2010. Concomitantly, 1 was described to reduce the 
TNF-α-induced NFκB activation by 70% with an IC50 value of 0.57 µM. As an inducible, rapid-
acting transcription factor, NFκB is involved in cellular responses to harmful stimuli, and has been 
linked to numerous inflammatory and autoimmune diseases, as well as to cancer. The constitutive 
NFκB activation in tumor cells, results in anti-apoptosis, cell survival, tumor promotion, metastasis 
and proliferation, rendering the selective NFκB inhibition a promising therapeutic tool for cancer 
therapy and chemoprevention. Apart from its biological profile, fijiolide A impresses by its 
intriguing structural assembly featuring a rotationally restricted chlorinated β-tyrosine moiety 
within a [2.6]paracyclophane structure. Moreover, 1 possesses a C-3 chlorinated 
cyclopenta[a]indene skeleton, which is embedded into the macrocyclic aglycone of an amino 
ribopyranose unit. Thus, fijiolide A represents an equally attractive as well as challenging target 
for total synthesis. Retrosynthetically, 1 was disassembled into aglycone 62 and the known Schmidt 
donor 5649 by glycosidic bond scission (Scheme 115). Paracyclophane 62 was further dissected 
into cyclopenta[a]indene 319 and β-amino acid 64 by strategic cleavage of the aryl ether and ester 
functionality. 
 
Scheme 115: Disconnection strategy for fijiolide A. 
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Our studies initially focused on the C-10 functionalized key fragment 319, which we aimed to 
further functionalize by a directed epoxidation of the indenyl double bond. However, already the 
simplified model system 136 remained synthetically inaccessible (Scheme 116). Rhodium 
catalyzed reductive cyclization of ynal 71 and related substrates failed to provide hydroxy 
cyclopentanone 75 due to predominant reduction of the ynone moiety (strategy I).68 An investigated 
cascade cyclization/cross coupling approach, employing dibromoenyne 320 also did not prove 
expedient (strategy II). The unanticipated selective oxidative addition of Pd0 into the (E)-vinyl 
bromide bond prevented the envisaged cyclization/cross coupling to produce 321,74 but instead 
enabled synthesis of (Z)-vinyl bromide 322. However, the envisioned cyclization cascade to form 
tricycle 136 via palladium(II) species 323 could also not be realized. In the context of strategy III, 
a gold(I) catalyzed cycloisomerization of bis-alkynes 135 was investigated. However, hetero and 
silyl substitution at the propargylic position was demonstrated to be incompatible with the 
cyclization procedure reported by Zhang et al.87 
 
Scheme 116: Unsuccessful approaches towards C-10 functionalized model system 136.  
Consequently, an allenic Pauson-Khand strategy targeting the C-11 functionalized 
indenylcyclopentenone 319 was envisaged (Scheme 117). For the synthesis of the required highly 
substituted allene-yne precursor 325, an intermolecular [2+2+2] cycloaddition approach was 
pursued that inverted the regioselectivity reported by Yamamoto et al.88 
9. Summary and Conclusion  154 
 
 
Scheme 117: Revised strategy for the fijiolide A key fragment 324.  
For this purpose, Weinreb amide 193 was converted into propargyl alcohol 191 via enantioselective 
transfer hydrogenation of the corresponding ynone (Scheme 118). The strategically installed, 
removable TMS group of 191 allowed a regioselective [2+2+2] cycloaddition with diynylboronate 
125 and terminal alkyne 183 via a boron-tethered 1,6-diyne species. This enabled the isolation of 
boraphthalide 195 in 59% yield as a single regioisomer. 
 
Scheme 118: Regioselective intermolecular [2+2+2] cycloaddition for the fijiolide arene core. 
Exploitation of the boronic acid handle allowed oxidative conversion of 195 into aryl chloride 196 
(Scheme 119). Indenylcyclopentenone 222 could be rapidly accessed in three steps by desilylation 
with excess TBAF, which concomitantly triggered an isomerization of the propargyl group. 
Subsequent glycol protection, and the key allenic Pauson-Khand reaction provided tricycle 222. 
Although chemoselective epoxidation of 222 at the indenyl double bond was feasible, the inherent 
base sensitivity of the corresponding keto-epoxide prevented aryl ether linkage at C-8 via 
nucleophilic epoxide opening. The C-8 position was therefore activated via chemoselective Upjohn 
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dihydroxylation, followed by tosylation of the secondary benzylic hydroxyl group to obtain 8,9-
cis-229. 
 
Scheme 119: Synthesis of key fragment 8,9-cis-229 via chlorodeboronation/allenic Pauson-Khand reaction. 
An elaborated concise synthesis of the β-amino acid fragment of fijiolide A is presented in Scheme 
120. Conversion of 5-chlorovanillic acid (202) into the corresponding benzyl ether was followed 
by a decarboxylative Claisen condensation to furnish β-keto ester 201. Ensuing enantioselective 
reduction of the corresponding enamine provided access to highly enantioenriched β-amino ester 
200. Acetylation of the primary amine, and hydrogenolysis completed the synthesis of the β-amino 
acid fragment 206 in only 7 steps and 42% overall yield. 
 
Scheme 120: 1st generation synthesis of the fijiolide β-amino acid fragment 206. 
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With building blocks 8,9-cis-229 and 206 in hand, a macrolactonization strategy towards the 
fijiolide paracyclophane was evaluated (Scheme 121). Fragment coupling via nucleophilic 
displacement at C-8 performed best in the presence of Cs2CO3. Subsequent acetonide hydrolysis, 
and ester saponification provided seco-acid 8,9-trans-208 as a mixture of two C-8 and C-9 epimeric 
diastereomers. Despite an extensive screen of macrolactonization conditions, including the 
procedures of Corey and Nicolaou, Yamaguchi, Mukaiyama, Shiina, Mitsunobu, and Masamune, 
both possible [2.6]paracyclophanes 209 and 232 remained inaccessible.  
 
Scheme 121: Synthesis of seco-acid 8,9-trans-208 and attempted macrolactonization. 
Consequently, an alternative strategy towards macrocyclic ring closure via aryl ether linkage at 
C-8 was pursued. For this purpose, various cyclization precursors were investigated. For the 
realization of a step-economic route to the most elaborated congener, the syntheses of both building 
blocks were modified. Desilylation/isomerization of aryl chloride 196 was followed by double TBS 
protection of the resulting glycol, and a subsequent allenic Pauson-Khand reaction to afford 
indenylcyclopentenone 149 (Scheme 122). Although being subjected to extensive optimization 
studies, asymmetric dihydroxylation of the indenyl double bond proceeded with low facial 
selectivity (dr = 1.1:1) in favor of the undesired diastereomer. Classical SAD conditions (AD-mix-
α) were not applicable due to the high base sensitivity of 149, resulting in substrate decomposition. 
nevertheless, employment of (DHQ)2PHAL allowed reproducible yields of the corresponding C-
8/C-9 diol, which was subsequently tosylated at 8-OH. Selective acidic cleavage of the primary 
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silyl ether enabled facile separation of the desired alcohol 261a from its 8-epi-9-epi diastereomer 
261b. 
 
Scheme 122: 6-Step synthesis of primary alcohol 261a from aryl chloride 196. 
The synthesis of double TES protected β-amino acid fragment 274 could be realized in only 6 steps 
from 5-chloroveratric acid (283). In analogy to the 1st generation synthesis, 283 was first converted 
into β-amino ester 286 in an enantioselective manner. An ensuing three-step procedure comprising 
acetylation, followed by global demethylation, and TES protection of the catechol moiety gave rise 
to β-amino acid 274 in 32% overall yield. 
 
Scheme 123: 2nd generation synthesis of the fijiolide β-amino acid fragment. 
 
9. Summary and Conclusion  158 
 
EDCI mediated ester coupling of 261a with 274, and subsequent diastereoselective 1,2-reduction 
provided access to cyclization precursor 276a (Scheme 124). Treatment with CsF in hot DMF 
cleaved at first both phenolic TES groups and induced then an intramolecular cyclization to give 
the desired cyclophane 268 in 60% isolated yield. The remarkably high regio- and atropselectivity 
of this [2.6]paracyclophane formation was rationalized by a template effect, leading to 
preorganized intermediate III.  Facile nucleophilic substitution of the tosylate by the proximate 
phenolate closes the macrocycle in atropselective manner. The observed relationship between 
decreasing atropselectivity with increasing substitution at C-11 and C-22 is in full agreement with 
this template-effect rational. While we could not isolate the atropisomer of 268, the regioisomeric 
[2.6]metacyclophane was formed in 8% yield by nucleophilic substitution at C-8 by the distal C-22 
phenolate in III. 
 
Scheme 124: Regio-and atropselective synthesis of the fijiolide [2.6]paracyclophane core. 
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Retention of the C-13 TBS ether in 268, allowed selective Mitsunobu-type selenylation at C-11, 
and prepared the substrate for a later Grieco elimination (Scheme 125). β-Selective glycosylation 
of the tertiary C-9 hydroxyl group with Schmidt donor 56 under TBSOTf promotion allowed 
isolation of selenyl glycoside 311 in notable 46% yield over two steps. Lewis or Brønsted acid 
mediated glycosylation of cyclopentadienol substrates was avoided due to the observed instability 
of the fijiolide A aglycon 62. The completion of the synthesis required silyl protection of the free 
phenol to enable smooth selenoxide elimination to install the cyclopentadiene moiety. Mild global 
desilylation with HF•pyridine afforded fijiolide A in 40% yield over the final three steps.  
 
Scheme 125: Selenylation and glycosylation of paracyclophane 268 and completion of the synthesis. 
In brief, this thesis describes the first total synthesis of fijiolide A. The natural product was accessed 
in 18 steps in the longest linear sequence, and 0.4% overall yield from commercially available 
starting material. The total step count adds up to 37 steps including 12 steps for the synthesis of the 
glycosyl donor. The synthesis showcases the power of ruthenium catalyzed intermolecular [2+2+2] 
cycloaddition to selectively assemble the heavily substituted fijiolide arene core. A further key step 
is an unprecedented regio- and atropselective macroetherification reaction for the construction of 
the rotationally restricted [2.6]paracyclophane.  
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10.1 General Methods 
All reactions were carried out under an atmosphere of nitrogen in oven-dried glassware with 
magnetic stirring, unless otherwise indicated. Toluene, THF, Et2O, acetonitrile and 
dichloromethane were purified by an Innovative Technology Solvent Delivery System. Chemicals 
were used as obtained from the suppliers, unless otherwise indicated. If needed, reagents and 
solvents were distilled from CaH2 except for DMF (CaSO4). Reaction progress was generally 
monitored by analytical thinlayer chromatography (TLC) on commercial glass plates coated with 
0.25 mm silica gel (E. Merck, Kieselgel 60 F254). Compounds were either visualized under UV-
light at 254 nm or by dipping the plates in either an ethanolic vanillin solution or an aqueous 
potassium permanganate solution followed by heating. Flash chromatography was performed with 
Silicycle silica gel 60 (0.040-0.063 μm grade) using the indicated eluent mixtures. Selenium 
containing compounds were chromatographically purified using N2 overpressure instead of 
compressed air. Proton nuclear magnetic resonance (1H NMR) data were generally acquired at 
400 MHz on a Bruker AV400 spectrometer. Chemical shifts (δ) are reported in parts per million 
(ppm) relative to incompletely deuterated CDCl3 (s, 7.27 ppm), C6D6 (s, 7.16 ppm), CD2Cl2 (t, 
5.32 ppm), acetone-d6 (quin, 2.05 ppm) or DMSO-d6 (quin, 2.50 ppm). Splitting patterns are 
designated as s, singlet; d, doublet; t, triplet; q, quartet; quin, quintet; sept, septet; m, multiplet; br., 
broad. Proton decoupled Carbon-13 nuclear magnetic resonance (13C{1H} NMR) data 
were generally acquired at 101 MHz on a Bruker AV400 spectrometer. Chemical shifts are 
reported in ppm relative to CDCl3 (77.00 ppm), C6D6 (128.39 ppm), CD2Cl2 (54.00 ppm), 
acetone-d6 (29.92 ppm) or DMSO (39.51 ppm). All NMR data were recorded at 298 K. Infrared 
(IR) data were recorded on an Alpha-P Bruker FT-IR Spectrometer. Absorbance frequencies are 
reported in reciprocal centimeters (cm-1). HRMS measurements were performed by an Agilent LC-
MS TOF. High resolution mass are given in m/z. Optical rotations were measured on a Polartronic 
M polarimeter using a 0.5 cm cell with a Na 589 nm filter.  
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10.2  Studies towards the Chlorocyclopenta[a]indene Fragment 
10.2.1 Studies Involving RhI Catalyzed Reductive Cyclization / Pd0 Catalyzed Direct 
Arylation 
1,5-Ynal 71  
 
To a solution of (COCl)2 (1.80 mL, 20.9 mmol, 3.0 eq) in dry CH2Cl2 (15 mL) was added DMSO 
(2.97 mL, 41.8 mmol, 6.0 eq) dropwise at 78 °C. The resulting mixture was stirred for 20 min 
before a solution of keto alcohol 7470 (1.31 g, 6.96 mmol, 1.0 eq) in dry CH2Cl2 (10 mL) was 
added at 78 °C. After stirring at 78 °C for 2 h, Et3N (7.76 mL, 55.7 mmol, 8.0 eq) was added 
dropwise and the resulting mixture was stirred for an additional hour at 78 °C. The reaction 
was then quenched by addition of sat. aqueous sodium bicarbonate (50 mL) and allowed to warm 
to 23 °C. The aqueous phase was extracted with CH2Cl2 (3 x 50 mL), the combined organic 
layers were washed with brine (50 mL), dried over MgSO4, filtered, and the solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane/EtOAc 10/1) to afford 1,5-ynal 71 (791 mg, 4.25 mmol, 61%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 9.85 (t, J = 0.6 Hz, 1H), 7.60 – 7.56 (m, 2H), 7.50 – 7.44 (m, 
1H), 7.42 – 7.37 (m, 2H), 3.05 (t, J = 6.3 Hz, 2H), 2.88 (t, J = 6.4 Hz, 2H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 199.6, 185.1, 133.0 (2C), 130.8, 128.6 (2C), 119.7, 91.5, 87.3, 37.6, 37.3 
ppm; Rf = 0.22 (n-pentane/EtOAc 10/1). 
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TMS ether 78 
 
To an ice-cooled solution of keto alcohol 74 (200 mg, 1.06 mmol, 1.0 eq) in dry CH2Cl2 (8.0 mL) 
was added Et3N (221 μL, 1.59 mmol, 1.5 eq) and TMSCl (148 μL, 1.17 mmol, 1.1 eq). The 
resulting mixture was stirred at 0 °C for 1 h before being quenched by addition of additional 
Et3N (1 mL) and water (4 mL). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), the 
combined organic layers were washed with brine (8 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 60/1 to 30/1) to afford TMS ether 78 (228 mg, 0.876 mmol, 
82%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.61 – 7.55 (m, 2H), 7.49 – 7.43 (m, 1H), 7.42 – 7.36 (m, 2H), 
3.65 (t, J = 6.2 Hz, 2H), 2.76 (t, J = 7.3 Hz, 2H), 1.97 (p, J = 7.1, 6.7 Hz, 2H), 0.13 (s, 9H) ppm; 
Rf = 0.81 (n-pentane/Et2O 3/1). 
 
Ketal 326 
 
To a solution of ynone 8173 (235 mg, 1.28 mmol, 1.0 eq) in dry benzene (15 mL) was added 
ethylene glycol (0.711 mL, 12.8 mmol, 10.0 eq) and pTSA (12.1 mg, 63.8 μmol, 5.0 mol%). The 
reaction mixture was refluxed using a Dean-Stark water separator. After 3 h, the reaction mixture 
was allowed to cool to 23 °C and quenched by addition of sat. aqueous sodium bicarbonate 
(8 mL). The aqueous phase was extracted with EtOAc (3 x 10 mL), the combined organic layers 
were washed with brine (10 mL), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 
50/1) to afford ketal 326 (277 mg, 1.21 mmol, 95%) as a yellow oil. 
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1H NMR (400 MHz, CDCl3) δ 7.49 – 7.44 (m, 2H), 7.37 – 7.29 (m, 3H), 5.91 (ddt, J = 16.8, 
10.2, 6.5 Hz, 1H), 5.09 (dq, J = 17.1, 1.6 Hz, 1H), 5.00 (dq, J = 10.2, 1.4 Hz, 1H), 4.22 – 4.13 
(m, 2H), 4.10 – 4.00 (m, 2H), 2.44 – 2.36 (m, 2H), 2.13 – 2.07 (m, 2H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 137.8, 131.8 (2C), 128.6, 128.2 (2C), 121.9, 114.6, 103.4, 86.6, 83.9, 64.8 
(2C), 38.6, 28.3 ppm; Rf = 0.34 (n-pentane/EtOAc 50/1). 
 
1,5-Ynal 82 
 
A solution of ketal 326 (31.4 mg, 138 μmol, 1.0 eq) in CH2Cl2 (3.0 mL) was cooled to 78 °C 
and purged with O2 for 1 min. The solution was then saturated with ozone until a blue color 
persisted (2 min). Excess ozone was then removed with a stream of N2 and PPh3 (54.1 mg, 
206 μmol, 1.5 eq) was added at 78 °C. The reaction mixture was stirred at 78 °C for 30 min 
and then allowed to warm to 23 °C within additional 30 min. After removal of the solvent under 
reduced pressure, the crude product was purified by flash chromatography (n-pentane/EtOAc 
6/1) to afford unstable 1,5-ynal 82 (21.6 mg, 93.8 μmol, 68%) as a yellow liquid. 
1H NMR (400 MHz, CDCl3) δ 9.80 (t, J = 1.5 Hz, 1H), 7.47 – 7.42 (m, 2H), 7.37 – 7.29 (m, 
3H), 4.19 – 4.13 (m, 2H), 4.07 – 3.99 (m, 2H), 2.70 (td, J = 7.2, 1.6 Hz, 2H), 2.42 (t, J = 7.2 Hz, 
2H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 201.5, 131.8 (2C), 128.9, 128.3 (2C), 121.6, 
102.6, 86.1, 84.2, 64.9 (2C), 38.4, 32.1 ppm; Rf = 0.23 (n-pentane/EtOAc 4/1). 
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10.2.2 Studies Involving Pd0 Catalyzed Cascade Cyclization via Carbopalladation / Susuki 
Coupling / Direct Arylation 
Tetrabromodiol 92 
 
Step 1: To a suspension of silica gel immobilized NaIO476 (19.1 g, 15 wt.%, 13.0 mmol, 1.3 eq) 
in CH2Cl2 (50 mL) was added a solution of diol 9075 (1.14 g, 10.0 mmol, 1.0 eq) in dry CH2Cl2 
(50 mL) and the resulting suspension was stirred at 23 °C for 20 min. The suspension was then 
filtered, the filtrate was dried over MgSO4, filtered again, and the solvent was removed under 
reduced pressure. Crude bis-aldehyde 327 was obtained as a pale yellow oil and was used in the 
next step without further purification. 
Rf = 0.62 (EtOAc). 
Step 2: To an ice-cooled solution of PPh3 (15.7 g, 60.0 mmol, 6.0 eq) in dry CH2Cl2 (85 mL) 
was added CBr4 (9.95 g, 30.0 mmol, 3.0 eq) in four portions over a period of 5 min. The resulting 
mixture was stirred at 0 °C for additional 5 min before a soliton of crude bis-aldehyde 327 in dry 
CH2Cl2 (10 mL) was added dropwise at 0 °C. The resulting solution was stirred at 0 °C for 
20 min before it was quenched by addition of sat. aqueous sodium bicarbonate (100 mL). The 
aqueous phase was extracted with CH2Cl2 (3 x 50 mL), the combined organic layers were dried 
over MgSO4, filtered, and the solvent was removed under reduced pressure to afford a black oil. 
Pentane was then added, the resulting precipitate (triphenylphosphine oxide) was filtered off, 
and the solvent was removed under reduced pressure. The crude product was flashed through a 
short pad of silica (pentane) to afford tetrabromotriene 91 (2.06 g, 4.86 mmol, 49%) as a pale 
yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.37 (t, J = 7.2 Hz, 1H), 5.46 (t, J = 4.7 Hz, 1H), 2.94 – 2.84 (m, 
4H) ppm; Rf = 0.56 (n-pentane). 
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Step 3: To a solution of tetrabromotriene 91 (1.91 g, 4.52 mmol, 1.0 eq) in acetone/H2O (44 mL, 
v/v = 10/1) was subsequently added a solution of NMO (50 wt.% in H2O, 1.39 mL, 6.77 mmol, 
1.5 eq) and a solution of OsO4 (2.5 wt.% in tBuOH, 1.13 mL, 0.090 mmol, 2.0 mol%). The 
resulting solution was stirred at 23 °C for 3.5 h before additional NMO (50 wt.% in H2O, 
0.37 mL, 1.81 mmol, 0.4 eq) was added. Stirring was continued at 23 °C for 1 h and the reaction 
was then quenched by addition of sat. aqueous sodium thiosulfate (30 mL). The aqueous phase 
was extracted with EtOAc (3 x 40 mL), the combined organic layers were washed with sat. 
aqueous CuSO4 (2 x 10 mL), dried over Na2SO4, filtered, and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 
4/1 to 2/1) to afford tetrabromodiol 92 (1.51 g, 3.30 mmol, 73%) as a pale brown solid. 
1H NMR (400 MHz, CDCl3) δ 6.56 (t, J = 7.2 Hz, 2H), 3.81 – 3.72 (m, 2H), 2.40 – 2.35 (m, 
4H), 1.98 (d, J = 4.2 Hz, 2H) ppm; Rf = 0.14 (n-pentane/EtOAc 4/1). 
 
Propargylic alcohol (±)-93 
 
Step 1: To a suspension of silica gel immobilized NaIO476 (6.08 g, 14.6 w%, 4.15 mmol, 1.3 eq) 
in CH2Cl2 (16 mL) was added a solution of tetrabromodiol 92 (1.46 g, 3.19 mmol, 1.0 eq) in dry 
CH2Cl2 (21 mL) and the resulting suspension was stirred at 23 °C for 2 h. The suspension was 
then filtered, the filtrate was dried over MgSO4, filtered again, and the solvent was removed 
under reduced pressure. Crude dibromoaldehyde 89 was obtained as a yellow oil and was used 
in the next step without further purification. 
1H NMR (400 MHz, CDCl3) δ 9.69 (t, J = 0.9 Hz, 1H), 6.72 (t, J = 6.8 Hz, 1H), 3.31 (dd, J = 6.8, 
1.0 Hz, 2H). 
Step 2: To an ice-cooled solution of trimethylsilylacetylene (1.06 mL, 7.66 mmol, 1.2 eq) in dry 
THF (30 mL) was added a solution of nBuLi (2.5 M in n-hexane, 3.06 mL, 7.66 mmol, 1.2 eq) 
dropwise. The reaction mixture was stirred at 0 °C for 10 min before a solution of crude 
dibromoaldehyde 89 (1.46 g, 6.38 mmol, 1.0 eq) in dry THF (5.0 mL) was added. The resulting 
yellow reaction mixture was stirred at 0 °C for 1 h before it was quenched by addition of sat. 
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aqueous ammonium chloride (20 mL). The aqueous phase was extracted with EtOAc (3 x 
20 mL), the combined organic layers were washed with brine (20 mL), dried over MgSO4, 
filtered, and the solvent solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/EtOAc 25/1 to 15/1) to afford propargylic alcohol 
(±)-93 (874 mg, 2.68 mmol, 42% over 2 steps) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.55 (t, J = 7.2 Hz, 1H), 4.48 (q, J = 5.9 Hz, 1H), 2.53 (t, 
J = 6.9 Hz, 3H), 1.96 (d, J = 4.9 Hz, 1H), 0.19 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
δ 133.5, 104.9, 91.5, 90.9, 60.8, 41.0, -0.2 (3C) ppm; Rf = 0.70 (n-pentane/EtOAc 4/1). 
 
Propargylic alcohol (±)-88 
 
To an ice-cooled solution of propargylic alcohol (±)-93 (853 mg, 2.62 mmol, 1.0 eq) in dry THF 
(5.0 mL) was added a solution of TBAF (1.0 M in THF, 2.88 mL, 2.88 mmol, 1.1 eq) and the 
resulting solution mixture was stirred at 0 °C for 20 min. The reaction mixture was then diluted 
with EtOAc (20 mL), washed with water (2 x 5 mL) and brine (10 mL), dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/EtOAc 6/1) to afford propargylic alcohol (±)-88 (570 mg, 
2.24 mmol, 86%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.58 (t, J = 7.1 Hz, 1H), 4.51 (qd, J = 6.1, 2.1 Hz, 1H), 2.59 – 
2.53 (m, 3H), 1.91 (d, J = 5.5 Hz, 1H) ppm; Rf = 0.41 (n-pentane/EtOAc 4/1). 
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Bis-MOM ether 105 
 
Step 1: To a solution of trimethylsilylacetylene (2.54 mL, 18.4 mmol, 2.4 eq) in dry THF 
(40 mL) was added a solution of nBuLi (1.6 M in n-hexane, 11.5 mL, 18.4 mmol, 2.4 eq) 
dropwise at 78 °C. The reaction mixture was stirred at 78 °C for 15 min before a solution of 
crude bis-aldehyde 327 (858 mg, 7.65 mmol, 1.0 eq) in dry THF (10 mL) was added dropwise 
(vide supra). The mixture was allowed to warm to 0 °C over a period of 1.5 h before it was 
quenched by addition of sat. aqueous ammonium chloride (30 mL). The aqueous phase was 
extracted with EtOAc (3 x 30 mL), the combined organic layers were washed with brine 
(30 mL), dried over MgSO4, filtered, and the solvent solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 6/1) to 
afford bis-propargylic alcohol 328 (1.38 g, 4.46 mmol, 58% from diol 90) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 5.81 – 5.68 (m, 2H), 4.44 (q, J = 5.9 Hz, 2H), 2.61 – 2.46 (m, 
4H), 1.82 (br. s, 2H), 0.18 (s, 18H) ppm; Rf = 0.45 (n-pentane/EtOAc 3/1). 
Step 2: To a solution of bis-propargylic alcohol 328 (1.31 g, 4.23 mmol, 1.0 eq) in 
dimethoxymethane (10 mL) was subsequently added LiBr (147 mg, 1.70 mmol, 0.4 eq) and 
pTSA (161 mg, 0.85 mmol, 0.2 eq). The resulting mixture was stirred at 23 °C for 12 h before 
additional portions of LiBr (147 mg, 1.70 mmol, 0.4 eq) and pTSA (161 mg, 0.85 mmol, 0.2 eq) 
were added. The reaction mixture was stirred at 23 °C for a further 24 h, quenched by addition 
of brine (6 mL) and stirred for additional 10 min at 23 °C. The aqueous phase was extracted with 
EtOAc (3 x 8 mL), the combined organic layers were washed with brine (10 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/EtOAc 40/1 to 15/1) to afford bis-MOM ether 105 
(1.36 g, 3.44 mmol, 81%) as a pale yellow oil. 
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1H NMR (400 MHz, CDCl3) δ 5.67 (m, 2H), 4.94 (d, J = 6.8 Hz, 2H), 4.60 (d, J = 6.7 Hz, 2H), 
4.33 (t, J = 6.5 Hz, 2H), 3.38 (s, 6H), 2.54 (m, 4H), 0.17 (s, 18H) ppm; 13C{1H} NMR (101 MHz, 
CDCl3) δ 127.2 (2C), 103.8 (2C), 94.1 (2C), 90.5 (2C), 65.7 (2C), 55.6 (2C), 33.9 (2C), -0.1 
(6C) ppm; IR (ATR): ῦ = 2957, 2895, 2171, 1342, 1250, 1151, 1098, 1028, 843, 761 cm-1; 
HRMS (ESI) calc’d. for [M+Na]+ = [C20H36NaO4Si2]+: 419.2044, found: 419.2044; Rf = 0.45 
(n-pentane/EtOAc 20/1). 
 
Dibromoenyne (±)-106 
 
Step 1: To an ice-cooled solution of bis-MOM ether 105 (1.02 g, 2.57 mmol, 1.0 eq) in dry 
CH2Cl2 (26 mL) was added mCPBA (70 wt.%, 1.27 g, 5.14 mmol, 2.0 eq). The reaction mixture 
was stirred at 0 °C for 1 h and then at 23 °C for 11 h before it was quenched by addition of sat. 
aqueous sodium thiosulfate (20 mL) and stirred for an additional 10 min. The organic phase was 
washed with sat. aqueous sodium bicarbonate (2 x 15 mL) and the combined aqueous layers 
were extracted with CH2Cl2 (3 x 30 mL). The combined organic layers were dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure to afford crude epoxide 329, which 
was used in the next step without further purification. 
1H NMR (400 MHz, CDCl3) δ 4.98 (t, J = 6.4 Hz, 2H), 4.67 – 4.60 (m, 2H), 4.57 – 4.50 (m, 
2H), 3.40 (s, 3H), 3.40 (s, 3H), 3.28 – 3.18 (m, 2H), 2.13 – 1.87 (m, 4H), 0.18 (s, 18H) ppm. 
Step 2: To an ice-cooled solution of crude epoxide 329 (1.37 g, 3.32 mmol, 1.0 eq) in dry CPME 
(20 mL) was added periodic acid (1.13 g, 4.98 mmol, 1.5 eq) and the reaction mixture was stirred 
at 0 °C for 2.5 h before being allowed to warm to 23 °C. After 4 h, additional periodic acid 
(0.38 g, 1.66 mmol, 0.5 eq) was added followed by addition of a third portion of periodic acid 
(0.76 g, 3.32 mmol, 1.0 eq) after 5 h. After a total reaction time of 7.5 h, the reaction was 
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quenched by addition of sat. aqueous sodium thiosulfate (20 mL). The organic phase was washed 
with sat. aqueous sodium bicarbonate (2 x 10 mL) and the combined aqueous layers were 
extracted with Et2O (3 x 30 mL). The combined organic layers were washed with sat. aqueous 
sodium bicarbonate (20 mL) and brine (20 mL), dried over MgSO4, filtered, and the solvent was 
removed under reduced pressure to afford crude aldehyde 330, which was used in the next step 
without further purification. 
1H NMR (400 MHz, CDCl3) δ 9.84 (t, J = 1.9 Hz, 1H), 4.98 (d, J = 6.9 Hz, 1H), 4.85 (dd, 
J = 7.5, 4.7 Hz, 1H), 4.63 (d, J = 6.9 Hz, 1H), 3.40 (s, 3H), 2.88 (dd, J = 16.8, 7.4 Hz, 1H), 2.77 
(dd, J = 16.8, 4.0 Hz, 1H), 0.20 (s, 9H) ppm. 
Step 3: To an ice-cooled solution of PPh3 (6.97 g, 26.6 mmol, 4.0 eq) in dry CH2Cl2 (45 mL) 
was added CBr4 (4.56 g, 13.3 mmol, 2.0 eq) in 4 portions over a period of 5 min. The resulting 
orange solution was stirred at 0 °C for additional 5 min before a solution of crude aldehyde 330 
in dry CH2Cl2 (5.0 mL) was added. The reaction mixture was stirred at 0 °C for 15 min and was 
then quenched by addition of sat. aqueous sodium bicarbonate (50 mL). The aqueous phase was 
extracted with CH2Cl2 (3 x 50 mL), the combined organic layers were dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/EtOAc 50/1) to afford dibromoenyne (±)-106 (1.65 g, 
4.47 mmol, 67% over 2 steps) as a yellow oil.  
1H NMR (400 MHz, CDCl3) δ 6.55 (t, J = 7.0 Hz, 1H), 4.93 (d, J = 6.8 Hz, 1H), 4.60 (d, 
J = 6.8 Hz, 1H), 4.41 (t, J = 6.2 Hz, 1H), 3.39 (s, 3H), 2.55 (t, J = 6.6 Hz, 2H), 0.19 (s, 9H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 133.8, 102.6, 94.1, 91.6, 91.1, 63.9, 55.8, 39.1, -0.2 (3C) 
ppm; IR (ATR): ῦ = 2958, 2897, 2171, 1744, 1250, 1151, 1098, 1020, 891, 841, 761 cm-1; 
HRMS (ESI) calc’d. for [M+H]+ = [C11H1979Br2O2Si]+: 370.9496, found: 370.9494; Rf = 0.50 
(n-pentane/EtOAc 20/1). 
 
 
 
 
 
 
 
10. Experimental Section  172 
 
Dibromoenyne (±)-107 
 
To a solution of dibromoenyne (±)-106 (500 mg, 1.35 mmol, 1.0 eq) in MeOH (14 mL) was 
added K2CO3 (18.7 mg, 0.135 mmol, 0.1 eq) and the resulting mixture was stirred at 23 °C for 
1.5 h. The reaction mixture was then diluted with Et2O (20 mL) and quenched by addition of sat. 
aqueous ammonium chloride (20 mL). The aqueous phase extracted with Et2O (3 x 10 mL), the 
combined organic layers were washed with brine (20 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/Et2O 20/1) to afford dibromoenyne (±)-107 (382 mg, 1.28 mmol, 
95%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.58 (t, J = 6.9 Hz, 1H), 4.93 (d, J = 6.9 Hz, 1H), 4.62 (d, 
J = 6.9 Hz, 1H), 4.44 (td, J = 6.2, 1.6 Hz, 1H), 3.40 (s, 3H), 2.57 (t, J = 6.6 Hz, 2H), 2.48 (d, 
J = 2.0 Hz, 1H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 133.5, 94.1, 91.4, 81.1, 74.5, 63.2, 
55.8, 39.0 ppm; IR (ATR): ῦ = 3297, 2949, 2844, 1627, 1217, 1150, 1095, 1020, 919, 846, 809, 
780, 668, 640 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C8H1179Br2O2]+: 298.9100, found: 
298.9094; Rf = 0.42 (n-pentane/EtOAc 20/1). 
 
(Z)-Vinyl bromide 111 
 
To an ice-cooled solution of ZnBr2203 (270 mg, 1.2 mmol, 1.2 eq) in dry THF (5.0 mL) was 
added a solution of phenyl lithium (2.0 M in nBu2O, 0.60 mL, 1.20 mmol, 1.2 eq) and the 
resulting mixture was stirred at 23 °C for 30 min. Concurrently, a second flask was charged with 
dibromoenyne (±)-106 (370 mg, 1.00 mmol, 1.0 eq) and (DpePhos)PdCl2204 (34.0 mg, 
                                                 
203 Previously dried by heating to 150 °C under high vacuum overnight.  
204 Prepared according to a literature procedure: M. Kranenburg, P. C. J. Kamer, P. W. N. M. van Leeuwen, Eur. J. 
Inorg. Chem. 1998, 1998, 155-157. 
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0.047 mmol, 5.0 mol%) before the prepared solution of phenylzinc bromide was added. The 
resulting mixture was stirred at 23 °C for 2 h before it was quenched by addition of sat. aqueous 
ammonium chloride (5 mL). The aqueous phase was extracted with EtOAc (3 x 5 mL), the 
combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/Et2O 80/1) to afford (Z)-vinyl bromide 111 (308 mg, 0.838 mmol, 
84%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.58 – 7.51 (m, 2H), 7.38 – 7.29 (m, 3H), 6.37 (t, J = 6.7 Hz, 
1H), 4.97 (d, J = 6.8 Hz, 1H), 4.64 (d, J = 6.8 Hz, 1H), 4.52 (t, J = 6.4 Hz, 1H), 3.40 (s, 3H), 
2.83 (td, J = 6.6, 1.5 Hz, 2H), 0.19 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 139.8, 
128.5, 128.2 (2C), 127.5 (2C), 127.5, 126.5, 103.3, 94.1, 91.2, 64.6, 55.7, 38.7, -0.2 (3C) ppm; 
IR (ATR): ῦ = 2956, 2892, 2172, 1444, 1250, 1151, 1097, 1026, 843, 758, 694 cm-1; HRMS 
(ESI) calc’d. for [M+H]+ = [C17H2479BrO2Si]+: 367.0723, found: 367.0717; Rf = 0.52 
(n-pentane/Et2O 10/1). 
 
(Z)-Vinyl bromide 109 
 
To a solution of (Z)-vinyl bromide 111 (200 mg, 0.544 mmol, 1.0 eq) in MeOH (5.4 mL) was 
added K2CO3 (22.6 mg, 0.163 mmol, 0.3 eq) and the resulting mixture was stirred at 23 °C for 
1.5 h. The reaction mixture was then diluted with Et2O (20 mL) and quenched by addition of sat. 
aqueous ammonium chloride (20 mL). The aqueous phase extracted with Et2O (3 x 10 mL), the 
combined organic layers were washed with brine (20 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/Et2O 30/1) to afford (Z)-vinyl bromide 109 (157 mg, 0.532 mmol, 
98%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.58 – 7.53 (m, 2H), 7.38 – 7.28 (m, 3H), 6.39 (t, J = 6.6 Hz, 
1H), 4.97 (d, J = 6.8 Hz, 1H), 4.66 (d, J = 6.8 Hz, 1H), 4.55 (td, J = 6.4, 1.5 Hz, 1H), 3.41 (s, 
3H), 2.85 (t, J = 6.3 Hz, 2H), 2.49 (d, J = 2.0 Hz, 1H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
δ 139.7, 128.6, 128.2 (2C), 127.8, 127.6 (2C), 126.2, 94.1, 81.7, 74.2, 64.0, 55.8, 38.6 ppm; IR 
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(ATR): ῦ = 3293, 2928, 2890, 1444, 1150, 1096, 1021, 919, 875, 757, 693, 647, 635 cm-1; 
HRMS (ESI) calc’d. for [M-Br]+ = [C14H15O2]+: 215.1067, found: 215.1063; Rf = 0.39 (n-
pentane/Et2O 10/1). 
 
Monocycle 119 
 
A vial was charged with (Z)-vinyl bromide 111 (11.0 mg, 30.0 μmol, 1.0 eq), Pd(OAc)2 
(0.34 mg, 1.5 μmol, 5.0 mol%) and PPh3 (0.79 mg, 3.0 μmol. 10 mol%). The vial was sealed, 
placed under vacuum and backfilled with N2 (3 x). Dry DMF (300 μL), Et3N (12.7 μL, 
90.0 μmol, 3.0 eq) and formic acid (2.26 μL, 60.0 μmol, 2.0 eq) were then added. The yellow 
solution was degassed by freeze-pump-thaw cycles (3 x) before it was stirred at 60 °C for 2 h. 
The red/brown reaction mixture was then allowed to cool to ambient temperature, filtered 
through a short pad of silica gel (n-pentane/EOAc 10/1), and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/Et2O 
60/1) to afford monocycle 119 (6.70 mg, 23.2 μmol, 77%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.41 – 7.30 (m, 5H), 6.14 (t, J = 2.8 Hz, 1H), 5.73 (dd, J = 1.8, 
0.8 Hz, 1H), 4.86 – 4.81 (m, 3H), 3.45 (s, 3H), 2.87 (ddd, J = 18.3, 6.6, 2.7 Hz, 1H), 2.70 (dt, 
J = 18.3, 2.6 Hz, 1H), 0.15 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 159.7, 146.3, 135.9, 
134.0, 128.5 (2C), 128.2 (2C), 127.4, 122.7, 96.7, 79.7, 56.3, 38.7, 0.1 (3C) ppm; HRMS (ESI) 
calc’d. for [M+H]+ = [C17H25O2Si]+: 289.1618, found: 289.1616; Rf = 0.52 (n-pentane/Et2O 
10/1). 
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10.2.3 Studies Involving RuII Catalyzed [2+2+2] Cycloaddition / AuI Catalyzed Bis-Alkyne 
Isomerization 
Bromopropargylic alcohol 331 
 
A round-bottom flask was charged with (PPh3)2PdCl2 (82.0 mg, 0.117 mmol, 1.0 mol%) and CuI 
(44.0 mg, 0.234 mol, 2.0 mol%). The flask was sealed, placed under vacuum and backfilled with 
N2 (3 x). Freshly distilled Et3N (33 mL) was added followed by 2-bromoiodobenzene (1.50 mL, 
11.7 mmol, 1.0 eq) and but-3-yn-2-ol (1.12 mL, 14.0 mmol, 1.2 eq). The dark reaction mixture 
was degassed by passing gaseous N2 through the solution before it was stirred at 50 °C. Since 
the reaction progress had stopped after 3.5 h (TLC in n-pentane), the reaction mixture was then 
allowed to cool to ambient temperature, filtered through a short pad of Celite (Et2O), and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 4/1) to afford bromopropargylic alcohol 331 (1.42 g, 
6.33 mmol, 54%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.58 (dd, J = 8.0, 1.1 Hz, 1H), 7.46 (dd, J = 7.7, 1.7 Hz, 1H), 
7.26 (td, J = 7.6, 1.2 Hz, 1H), 7.17 (td, J = 7.8, 1.7 Hz, 1H), 4.81 (q, J = 6.6 Hz, 1H), 1.94 (br. s, 
1H), 1.60 (d, J = 6.6 Hz, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 133.4, 132.4, 129.5, 
127.0, 125.5, 124.7, 95.6, 82.6, 58.9, 24.2 ppm; IR (ATR): ῦ = 3322, 2981, 2930, 1469, 1434, 
1103, 1026, 935, 854, 751, 654 cm-1; HRMS (ESI) calc’d. for [M-OH]+ = [C10H879Br]+: 
206.9804, found: 206.9800; Rf = 0.36 (n-pentane/EtOAc 4/1).  
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Propargylic alcohol 137 
 
Step 1: A round-bottom flask was charged with (PhCN)2PdCl2 (68.5 mg, 0.179 mmol, 
3.0 mol%), CuI (34.1 mg, 0.179 mmol, 3.0 mol%), (tBu)3P•HBF4 (104 mg, 0.357 mmol, 
6.0 mol%) and bromopropargylic alcohol 331 (1.34 g, 5.95 mmol, 1.0 eq). The flask was sealed, 
placed under vacuum and backfilled with N2 (3 x). Dry dioxane (12 mL) was added followed by 
HN(iPr)2 (1.09 mL, 7.74 mmol, 1.3 eq) and trimethylsilylacetylene (1.07 mL, 7.74 mmol, 
1.3 eq). The resulting brown suspension was degassed by passing gaseous N2 through the 
solution before it was stirred at 30 °C for 1.5 h. The reaction mixture was then filtered through 
a short pad of Celite (Et2O), and the solvent was removed under reduced pressure. Crude bis-
alkyne 332 was obtained as a black residue und used in the next step without further purification.  
Rf = 0.52 (n-pentane/EtOAc 3/1). 
Step 2: To an ice-cooled solution of crude bis-alkyne 332 (1.44 g, 5.95 mmol, 1.0 eq) in dry 
THF (60 mL) was added a solution of TBAF (1.0 M in THF, 7.14 mL, 7.14 mmol, 1.2 eq) 
dropwise and the resulting black solution was stirred at 0 °C for 20 min. The reaction was then 
quenched by addition of sat. aqueous ammonium chloride (30 mL). The aqueous phase was 
extracted with Et2O (3 x 30 mL), the combined organic layers were washed brine (30 mL), dried 
over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography (n-pentane/EtOAc 4/1) to afford propargylic alcohol 137 
(626 mg, 3.68 mmol, 62% over 2 steps) as a brown oil. 
1H NMR (400 MHz, CDCl3) δ 7.52 – 7.46 (m, 1H), 7.45 – 7.40 (m, 1H), 7.31 – 7.23 (m, 2H), 
4.80 (q, J = 6.6 Hz, 1H), 3.32 (s, 1H), 2.29 (br. s, 1H), 1.57 (d, J = 6.6 Hz, 3H) ppm; 13C{1H} 
NMR (101 MHz, CDCl3) δ 132.5, 131.9, 128.5, 128.0, 125.5, 124.6, 95.2, 82.3, 82.0, 81.1, 58.8, 
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24.3 ppm; IR (ATR): ῦ = 3282, 2981, 1477, 1440, 1327, 1107, 1092, 1075, 1028, 934, 857, 755, 
621 cm-1; HRMS (ESI) calc’d. for [M-OH]+ = [C12H9]+: 153.0699, found: 153.0686; Rf = 0.41 
(n-pentane/EtOAc 3/1). 
 
TES protected bis-alkyne 135a 
 
To a solution of propargylic alcohol 137 (50.0 mg, 0.294 mmol, 1.0 eq) in dry DMF (2.9 mL) 
were added 1H-imidazole (80.0 mg, 1.18 mmol, 4.0 eq) and chlorotriethylsilane (197 μL, 
1.18 mmol, 4.0 eq). The resulting mixture was stirred at 23 °C for 13 h and was then quenched 
by addition of half-sat. aqueous sodium bicarbonate (4 mL). The aqueous phase was extracted 
with Et2O (3 x 5 mL), the combined organic layers were dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/Et2O 60/1) to afford bis-alkyne 135a (72.2 mg, 0.254 mmol, 86%) 
as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.51 – 7.47 (m, 1H), 7.45 – 7.41 (m, 1H), 7.32 – 7.22 (m, 2H), 
4.81 (q, J = 6.5 Hz, 1H), 3.27 (s, 1H), 1.56 (d, J = 6.5 Hz, 3H), 1.01 (t, J = 7.9 Hz, 9H), 0.71 (qd, 
J = 8.4, 7.9, 2.3 Hz, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 132.5, 132.0, 128.4, 127.8, 
126.1, 124.5, 95.9, 82.1, 81.5, 80.8, 59.1, 25.5, 6.8 (3C), 4.8 (3C) ppm; IR (ATR): ῦ = 2954, 
2876, 1478, 1337, 1239, 1097, 1054, 1005, 978, 892, 756, 743, 645 cm-1; HRMS (ESI) calc’d. 
for [M-OSiEt3]+ = [C12H9]+: 153.0699, found: 153.0696; Rf = 0.30 (n-pentane/Et2O 60/1). 
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Benzyl protected bis-alkyne 135b 
 
To an ice-cooled solution of propargylic alcohol 137 (50.0 mg, 0.294 mmol, 1.0 eq) in dry THF 
(2.9 mL) was added sodium hydride (10.6 mg, 0.441 mmol, 1.5 eq) in one portion. The resulting 
suspension was stirred at 0 °C for 30 min before tetrabutylammonium iodide (32.6 mg, 
88.3 μmol, 0.3 eq) and benzyl bromide (45.4 μL, 0.382 mmol, 1.3 eq) was added subsequently. 
The resulting reaction mixture was allowed to warm to 23 °C and stirred for 2.5 h before it was 
quenched by addition of sat. ammonium chloride (4 mL). The aqueous phase was extracted with 
EtOAc (3 x 5 mL), the combined organic layers were washed with brine (5 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/Et2O 50/1) to afford bis-alkyne 135b (66.8 mg, 
0.257 mmol, 87%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.55 – 7.42 (m, 4H), 7.40 – 7.26 (m, 5H), 4.94 (d, J = 11.6 Hz, 
1H), 4.66 (d, J = 11.6 Hz, 1H), 4.51 (q, J = 6.6 Hz, 1H), 3.29 (s, 1H), 1.60 (d, J = 6.6 Hz, 3H) 
ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 138.0, 132.5, 131.9, 128.5, 128.4 (2C), 128.2 (2C), 
128.0, 127.7, 125.8, 124.7, 93.3, 83.6, 82.2, 81.0, 70.5, 64.8, 22.1 ppm; IR (ATR): ῦ = 3285, 
2985, 2862, 1478, 1441, 1328, 1095, 1059, 758, 698, 619 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C19H17O]+: 261.1274, found: 261.1267; Rf = 0.21 (n-pentane/Et2O 50/1). 
 
Bromopropargylic alcohol 333 
 
A round-bottom flask was charged with (PPh3)2PdCl2 (45.6 mg, 65.0 μmol, 2.0 mol%) and CuI 
(24.8 mg, 130 μmol, 4.0 mol%). The flask was sealed, placed under vacuum and backfilled with 
N2 (3 x). Freshly distilled Et3N (9.2 mL) was added followed by 2-bromoiodobenzene 
(0.501 mL, 3.90 mmol, 1.2 eq) and hex-1-yn-3-ol89 (319 mg, 3.25 mmol, 1.0 eq). The dark 
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reaction mixture was degassed by passing gaseous N2 through the solution before it was stirred 
at 50 °C for 1 h. The reaction mixture was then allowed to cool to ambient temperature, filtered 
through a short pad of Celite (Et2O), and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (n-pentane/EtOAc 12/1 to 5/1) to afford 
bromopropargylic alcohol 333 (589 mg, 2.33 mmol, 72%) as a brown oil. 
1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.0 Hz, 1H), 7.46 (dd, J = 7.7, 1.7 Hz, 1H), 7.25 (tt, 
J = 7.7, 1.2 Hz, 1H), 7.19 – 7.13 (m, 1H), 4.66 (t, J = 6.6 Hz, 1H), 2.18 (br. d, J = 22.0 Hz, 1H), 
1.86 – 1.79 (m, 2H), 1.60 (dq, J = 14.7, 7.4 Hz, 2H), 0.99 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 133.4, 132.3, 129.5, 126.9, 125.5, 124.8, 94.9, 83.3, 62.8, 39.8, 18.4, 13.8 
ppm; IR (ATR): ῦ = 3327, 2958, 2932, 2872, 1468, 1433, 1120, 1025, 927, 750, 655 cm-1; 
HRMS (ESI) calc’d. for [M-OH]+ = [C12H12Br]+: 235.0117, found: 235.0102; Rf = 0.40 
(n-pentane/Et2O 2/1). 
 
Propargylic alcohol 335 
 
Step 1: A round-bottom flask was charged with (PhCN)2PdCl2 (26.8 mg, 69.9 μmol, 3.0 mol%), 
CuI (13.3 mg, 69.9 μmol, 3.0 mol%), (tBu)3P•HBF4 (40.5 mg, 0.140 mmol, 6.0 mol%) and 
bromopropargylic alcohol 333 (589 mg, 2.33 mmol, 1.0 eq). The flask was sealed, placed under 
vacuum and backfilled with N2 (3 x). Dry dioxane (5.0 mL) was added followed by HN(iPr)2 
(0.426 mL, 3.02 mmol, 1.3 eq) and trimethylsilylacetylene (0.419 mL, 3.02 mmol, 1.3 eq). The 
resulting brown suspension was degassed by passing gaseous N2 through the solution before it 
was stirred at 30 °C for 1.5 h. The reaction mixture was then filtered through a short pad of Celite 
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(Et2O), and the solvent was removed under reduced pressure. The crude product was purified by 
flash chromatography (n-pentane/EtOAc 20/1) to afford bis-alkyne 334 (607 mg, 2.24 mmol, 
96%) as a brown oil, which was directly used for the subsequent TMS cleavage step. 
1H NMR (400 MHz, CDCl3) δ 7.51 – 7.46 (m, 1H), 7.45 – 7.40 (m, 1H), 7.29 – 7.23 (m, 2H), 
4.66 (q, J = 6.4 Hz, 1H), 1.87 – 1.79 (m, 3H), 1.65 – 1.56 (m, 2H), 1.00 (t, J = 7.4 Hz, 3H), 0.28 
(s, 9H) ppm; Rf = 0.49 (n-pentane/Et2O 1/1). 
Step 2: To an ice-cooled solution of bis-alkyne 334 (607 mg, 2.24 mmol, 1.0 eq) in dry THF 
(22 mL) was added a solution of TBAF (1.0 M in THF, 2.69 mL, 2.69 mmol, 1.2 eq) dropwise 
and the resulting black solution was stirred at 0 °C for 20 min. The reaction was then quenched 
by addition of sat. aqueous ammonium chloride (20 mL). The aqueous phase was extracted with 
EtOAc (3 x 20 mL), the combined organic layers were washed brine (20 mL), dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/EtOAc 20/1 to 10/1 to 5/1) to afford propargylic alcohol 
335 (356 mg, 1.80 mmol, 80%) as a brown oil.  
1H NMR (400 MHz, CDCl3) δ 7.50 – 7.45 (m, 1H), 7.45 – 7.39 (m, 1H), 7.29 – 7.23 (m, 2H), 
4.66 (q, J = 6.4 Hz, 1H), 1.87 – 1.78 (m, 2H), 1.66 – 1.53 (m, 2H), 1.49 (d, J = 13.1 Hz, 1H), 
1.02 (s, 3H), 0.28 (s, 9H) ppm; Rf = 0.35 (n-pentane/EtOAc 5/1). 
 
TBS Protected bis-alkyne 138b 
 
To a solution of propargylic alcohol 335 (50.0 mg, 0.252 mmol, 1.0 eq) in dry DMF (3.0 mL) 
were added 1H-imidazole (68.7 mg, 1.01 mmol, 4.0 eq) and TBSCl (152 mg, 1.01 mmol, 
4.0 eq). The resulting mixture was stirred at 23 °C for 16 h and was then quenched by addition 
of half-sat. aqueous sodium bicarbonate (4 mL). The aqueous phase was extracted with Et2O (3 
x 5 mL), the combined organic layers were dried over MgSO4, filtered, and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane/Et2O 60/1) to afford bis-alkyne 138b (64.9 mg, 0.208 mmol, 82%) as a yellow oil. 
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1H NMR (400 MHz, CDCl3) δ 7.51 – 7.47 (m, 1H), 7.45 – 7.41 (m, 1H), 7.32 – 7.23 (m, 2H), 
4.64 (t, J = 6.6 Hz, 1H), 3.25 (s, 1H), 1.84 – 1.74 (m, 2H), 1.55 (ddd, J = 12.3, 8.4, 5.7 Hz, 2H), 
0.97 (t, J = 7.4 Hz, 3H), 0.94 (s, 9H), 0.20 (s, 3H), 0.17 (s, 3H) ppm; 13C{1H} NMR (101 MHz, 
CDCl3) δ 132.5, 132.0, 128.4, 127.7, 126.2, 124.4, 95.4, 82.2, 82.2, 80.8, 63.3, 40.8, 25.9 (3C), 
18.6, 18.3, 13.8, -4.3, -4.9 ppm; IR (ATR): ῦ = 2957, 2929, 2857, 1477, 1251, 1112, 1076, 1038, 
835, 776, 756, 645, 614 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C20H29OSi]+: 313.1982, 
found: 313.1976; Rf = 0.58 (n-pentane/Et2O 30/1). 
 
Benzyl protected bis-alkyne 138c 
 
To an ice-cooled solution of propargylic alcohol 335 (58.3 mg, 0.294 mmol, 1.0 eq) in dry THF 
(2.9 mL) was added sodium hydride (14.1 mg, 0.588 mmol, 2.0 eq) in one portion. The resulting 
suspension was stirred at 0 °C for 30 min before tetrabutylammonium iodide (32.6 mg, 
88.3 μmol, 0.3 eq) and benzyl bromide (45.4 μL, 0.382 mmol, 1.3 eq) was added subsequently. 
The resulting reaction mixture was allowed to warm to 23 °C and stirred for 20 h before it was 
quenched by addition of sat. ammonium chloride (4 mL). The aqueous phase was extracted with 
EtOAc (3 x 5 mL), the combined organic layers were washed with brine (5 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/EtOAc 120/1) to afford benzyl protected bis-
alkyne 138c (69.4 mg, 0.241 mmol, 82%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.54 – 7.40 (m, 4H), 7.39 – 7.24 (m, 5H), 4.94 (d, J = 11.7 Hz, 
1H), 4.65 (d, J = 11.7 Hz, 1H), 4.38 (t, J = 6.6 Hz, 1H), 3.27 (s, 1H), 1.94 – 1.77 (m, J = 6.5 Hz, 
2H), 1.65-1.56 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 138.2, 
132.5, 132.0, 128.4, 128.3 (2C), 128.1 (2C), 127.9, 127.6, 126.0, 124.7, 92.7, 84.3, 82.3, 80.9, 
70.5, 69.0, 37.8, 18.7, 13.8 ppm; IR (ATR): ῦ = 2958, 2931, 2870, 1477, 1454, 1333, 1112, 
1070, 756, 735, 697, 648, 618 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C21H21O]+: 289.1587, 
found: 289.1582; Rf = 0.44 (n-pentane/Et2O 30/1). 
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Silylated bis-alkyne 141 
 
Step 1: A round-bottom flask was charged with (PPh3)2PdCl2 (20.1 mg, 28.6 μmol, 3.0 mol%) 
and CuI (10.9 mg, 57.2 μmol, 6.0 mol%). The flask was sealed, placed under vacuum and 
backfilled with N2 (3 x). Dry THF (1.9 mL) was added followed by freshly distilled Et3N 
(672 μL, 4.78 mmol, 5.0 eq), 2-bromoiodobenzene (147 μL, 1.15 mmol, 1.2 eq) and alkyne 
14092 (180 mg, 0.956 mmol, 1.0 eq). The dark reaction mixture was degassed by passing gaseous 
N2 through the solution before it was stirred at 23 °C for 2 h. The reaction mixture was then 
filtered through a short pad of Celite (Et2O), and the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane) to afford 
bromoalkyne 336 (117 mg, 0.341 mmol, 36%) as a brown oil, which was directly used in the 
subsequent Sonogashira cross-coupling step. 
1H NMR (400 MHz, CDCl3) δ 7.66 – 7.61 (m, 2H), 7.58 – 7.53 (m, 1H), 7.41 – 7.35 (m, 4H), 
7.21 (td, J = 7.6, 1.2 Hz, 1H), 7.09 (td, J = 7.8, 1.7 Hz, 1H), 2.20 (q, J = 7.2 Hz, 1H), 1.27 (d, 
J = 7.2 Hz, 3H), 0.48 (s, 3H), 0.47 (s, 3H) ppm. 
Steps 2: A vial was charged with (PhCN)2PdCl2 (6.54 mg, 17.1 μmol, 5.0 mol%), CuI (3.25 mg, 
17.1 μmol, 5.0 mol%) and (tBu)3P•HBF4 (9.89 mg, 34.2 mmol, 10 mol%). The vial was sealed, 
placed under vacuum and backfilled with N2 (3 x). A solution of bromoalkyne 336 (117 mg, 
341 μmol, 1.0 eq) in dry dioxane (680 μL) was added followed by HN(iPr)2 (67.2 μL, 477 μmol, 
1.4 eq) and trimethylsilylacetylene (61.4 μl, 443 μmol, 1.3 eq). The resulting brown suspension 
was degassed by freeze-pump-thaw cycles (3 x) before it was stirred at 23 °C for 3 h. The 
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reaction mixture was then filtered through a short pad of Celite (Et2O), and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane) to afford bis-alkyne 337 (61.3 mg, 170 μmol, 50%) as a pale brown oil, which was 
directly used for the subsequent TMS cleavage step. 
1H NMR (400 MHz, CDCl3) δ 7.65 – 7.60 (m, 2H), 7.45 (dd, J = 7.1, 1.6 Hz, 1H), 7.41 – 7.35 
(m, 3H), 7.33 (dd, J = 7.6, 1.2 Hz, 1H), 7.21 (td, J = 7.6, 1.8 Hz, 1H), 7.17 (td, J = 7.5, 1.7 Hz, 
1H), 2.19 (q, J = 7.2 Hz, 1H), 1.26 (d, J = 7.2 Hz, 3H), 0.47 (s, 6H), 0.25 (s, 9H) ppm. 
Step 3: To an ice-cooled solution of bis-alkyne 337 (54.0 mg, 150 μmol, 1.0 eq) in EtOH 
(2.4 mL) was added a solution of AgNO3 (35.0 mg, 206 μmol, 1.4 eq) in EtOH/H2O (2.8 mL, 
v/v = 3/1) in four equal portions over a period of 1 h, resulting in formation of a brown 
suspension. Stirring was continued at 0 °C for 30 min before a solution of KCN (67.0 mg, 
1.03 mmol, 6.9 eq) in H2O (1.0 mL) was added, resulting in precipitation of a white solid. The 
reaction mixture was then stirred at 23 °C for 2 h before it was diluted with H2O (5 mL) and 
pentane (5 mL). The aqueous phase was extracted with pentane (3 x 5 mL), the combined organic 
layers were washed with water (3 x 5 mL) and brine (5 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane) to afford silylated bis-alkyne 141 (26.4 mg, 91.4 μmol, 61%) as a 
colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.66 – 7.61 (m, 2H), 7.47 (dd, J = 7.6, 1.2 Hz, 1H), 7.41 – 7.34 
(m, 4H), 7.26 (td, J = 7.6, 1.5 Hz, 1H), 7.20 (td, J = 7.6, 1.4 Hz, 1H), 3.21 (s, 1H), 2.20 (q, 
J = 7.2 Hz, 1H), 1.26 (d, J = 7.2 Hz, 3H), 0.47 (s, 3H), 0.47 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 136.7, 134.1 (2C), 132.9, 132.4, 131.9, 129.3 (2C), 128.3, 127.7 (2C), 
126.7, 98.4, 82.7, 80.3, 79.2, 15.0, 13.9, -4.4, -5.4 ppm. 
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Silylated bis-alkyne 145 
 
Step 1: To a solution of dibromoalkene 14395 (901 mg, 3.15 mmol, 1.0 eq) in dry THF (40 mL) 
was added a solution of nBuLi (1.6 M in Et2O, 4.54 mL, 7.27 mmol, 2.1 eq) dropwise at 78 °C. 
The resulting mixture was stirred at 78 °C for 1 h and then allowed to warm to 23 °C. Stirring 
was continued at 23 °C for an additional 1.5 h before the reaction was quenched by addition of 
sat. aqueous ammonium chloride (20 mL). The aqueous phase was extracted with Et2O (3 x 
20 mL), the combined organic layers were washed with brine (20 mL), dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure (25 °C). The crude product was 
purified by flash chromatography (n-pentane) to afford highly volatile alkyne 338 (150 mg, 
1.19 mmol, 38%) as a pale yellow oil. The product was immediately subjected to the subsequent 
Sonogashira cross coupling. 
Step 2: A round-bottom flask was charged with (PPh3)2PdCl2 (25.0 mg, 35.6 μmol, 3.0 mol%) 
and CuI (13.6 mg, 71.3 μmol, 6.0 mol%). The flask was sealed, placed under vacuum and 
backfilled with N2 (3 x). Dry THF (2.4 mL) was added followed by freshly distilled Et3N 
(835 μL, 5.94 mmol, 5.0 eq), 2-bromoiodobenzene (168 μL, 1.31 mmol, 1.1 eq) and alkyne 338 
(150 mg, 1.19 mmol, 1.0 eq). The dark reaction mixture was degassed by passing gaseous N2 
through the solution before it was stirred at 23 °C for 2 h. The reaction mixture was then filtered 
through a short pad of Celite (Et2O), and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (n-pentane) to afford bromoalkyne 144 
(28.5 mg, 101 μmol, 9%) as a brown oil, which was directly used in the subsequent Sonogashira 
cross-coupling step. 
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Steps 3: A vial was charged with (PhCN)2PdCl2 (2.3 mg, 6.08 μmol, 6.0 mol%), CuI (1.2 mg, 
6.08 μmol, 6.0 mol%) and (tBu)3P•HBF4 (3.5 mg, 12.2 μmol, 12 mol%). The vial was sealed, 
placed under vacuum and backfilled with N2 (3 x). A solution of bromoalkyne 144 (28.5 mg, 
301 μmol, 1.0 eq) in dry dioxane (200 μL) was added followed by HN(iPr)2 (20.0 μL, 142 μmol, 
1.4 eq) and trimethylsilylacetylene (21.1 μl, 152 μmol, 1.5 eq). The resulting brown suspension 
was degassed by freeze-pump-thaw cycles (3 x) before it was stirred at 30 °C for 3 h. The 
reaction mixture was then filtered through a short pad of Celite (Et2O), and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane) to afford bis-alkyne 339 (23.8 mg, 79.7 μmol, 79%) as a yellow oil, which was 
directly used for the subsequent TMS cleavage step. 
Step 4: To an ice-cooled solution of bis-alkyne 339 (23.8 mg, 79.7 μmol, 1.0 eq) in EtOH 
(1.3 mL) was added a solution of AgNO3 (18.6 mg, 110 μmol, 1.4 eq) in EtOH/H2O (1.5 mL, 
v/v = 3/1) in four equal portions over a period of 1 h. Stirring was continued at 0 °C for 30 min 
before a solution of KCN (35.7 mg, 548 μmol, 6.9 eq) in H2O (0.5 mL) was added, resulting in 
precipitation of a white solid. The reaction mixture was then stirred at 23 °C for 2 h before it was 
diluted with H2O (5 mL) and pentane (5 mL). The aqueous phase was extracted with pentane (3 
x 5 mL), the combined organic layers were washed with water (3 x 5 mL) and brine (5 mL), 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane) to afford silylated bis-alkyne 145 
(16.7 mg, 73.8 μmol, 93%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 7.6, 1.3 Hz, 1H), 7.40 (dd, J = 7.7, 1.1 Hz, 1H), 
7.30 – 7.24 (m, 1H), 7.22 (td, J = 7.5, 1.5 Hz, 1H), 3.28 (s, 1H), 2.52 (t, J = 8.0 Hz, 2H), 0.93 (t, 
J = 8.0 Hz, 2H), 0.07 (s, 9H) ppm. 
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Cyclopenta[a]indene 146 
 
To a solution of bis-alkyne 145 (3.5 mg, 15.5 μmol, 1.0 eq) in CDCl3 (300 μl) was added N-
oxide N2 (1.0 mg, 7.73 µmol, 0.5 eq), BrettPhosAuNTf2 (0.8 mg, 0.773 µmol, 5.0 mol%) and 
water (2.79 μL, 155 μmol, 10 eq). The resulting yellow reaction mixture was stirred at 23 °C for 
19 h before a solution of 1,3,5-TMB (0.01 M, 400 μL, 4.00 μmol) was added as internal standard. 
After determination of the crude 1H NMR yield (54%), the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane/Et2O 100/1) to 
afford a yellow oily product that was tentatively assigned to be cyclopenta[a]indene 146 (yield 
n.d.). 
1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 7.4 Hz, 1H), 7.23 (dd, J = 15.1, 7.8 Hz, 2H), 7.08 (t, 
J = 7.3 Hz, 1H), 6.89 (s, 1H), 6.29 (s, 1H), 2.92 – 2.83 (m, 2H), 2.73 – 2.64 (m, 1H), 0.04 (s, 
9H) ppm. 
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10.2.4 Studies involving RuII Catalyzed [2+2+2] Cycloaddition / Allenic Pauson-Khand 
Reaction 
Diynylboronate 125 
 
Step 1: To an ice-cooled solution of TMS acetylene dimer 170205 (18.3 g, 93.9 mmol) in dry 
Et2O (105 mL) was slowly added a solution of MeLi•LiBr complex (2.2 M in Et2O, 46.9 mL, 
103 mmol) over a period of 20 min. The mixture was allowed to warm to 23 °C and stirred for 
14 h under a N2 atmosphere. The dark green solution was then cooled to 78 °C and slowly 
added to a 78 °C cold solution of triisopropyl borate (32.4 mL, 141 mmol) in dry Et2O (90 mL) 
over a period of 50 min via cannula. The first flask was rinsed with additional Et2O (10 mL), and 
the resulting yellow suspension was stirred at 78 °C for 2 h before being allowed to warm to 
23 °C over 1.5 h. After stirring for one additional hour at 23 °C the suspension was filtered, and 
the filter cake was thoroughly washed with dry Et2O (400 mL) under air and dried under high 
vacuum to afford lithium borate 171 (23.4 g, 74.0 mmol, 79%). 
Step 2: To a suspension of lithium borate 171 (6.00 g, 19.0 mmol) in dry Et2O (60 mL) at 78 °C 
was slowly added an anhydrous solution of HCl (2.0 M in Et2O, 12.5 mL, 25 mmol) under a N2 
atmosphere, and the resulting yellow solution was stirred at 78 °C for 15 min before being 
allowed to warm to 23 °C over 30 min. Stirring was then stopped and the resulting white 
precipitate (LiCl) was allowed to settle. The supernatant liquid was filtered through a POR4 frit 
under N2, and the solvent was removed under high vacuum. The obtained neat liquid was filtered 
through KIMTECH paper in a glovebox to afford diynylboronate 125 (3.36 g, 13.4 mmol, 71%) 
as an amber colored liquid. 
1H NMR (400 MHz, CDCl3)  = 4.56 (sept, J = 6.3 Hz, 2H), 1.20 (d, J = 6.3 Hz, 12H), 0.21 (s, 
9H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 99.2, 88.2, 87.6, 85.2, 68.2 (2C), 24.4 (4C), -0.6 
(3C) ppm; IR (ATR): ῦ = 3228, 2093, 1371, 1341, 846 cm-1.  
                                                 
205 Prepared according to a literature procedure: A. B. Smith III, S. Dong, R. J. Fox, J. B. Brenneman, J. A. Vanecko, 
T. Maegawa, Tetrahedron 2011, 67, 9809-9828. 
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General Procedure for the [2+2+2] Cycloaddition of Three Different Alkynes:  
 
To a degassed solution of the alkynylboronate (0.100 mmol, 1.0 eq), the third alkyne component 
(0.400 mmol, 4.0 eq) and Cp*Ru(cod)Cl (1.9 mg, 5.00 μmol, 5.0 mol%) in dry DCE (0.3 mL) 
was added a degassed solution of the propargyl alcohol206 (0.110 mmol, 1.1 eq) in dry DCE 
(0.7 mL) over a period of 20 min. The dark brown reaction mixture was stirred at 23 °C for 
12 - 20 h under a N2 atmosphere. The solvent was then removed under reduced pressure, the 
residue was taken up in Et2O (10 mL) and washed with aqueous 1 M HCl (4 mL). The aqueous 
phase was extracted with Et2O (3 x 5 mL), the combined organic layers were washed with brine 
(5 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (n-pentane/EtOAc) and the obtained 
boraphthalides (brown oils) were analyzed by 1H NMR spectroscopy. 
 
  
Isolated in 62%; 1H NMR (400 MHz, CDCl3) δ 7.36 (s, 1H), 7.19 
(s, 1H), 6.96 (s, 1H), 5.21 (t, J = 5.6 Hz, 1H), 4.73 (s, 2H), 3.94 
(dd, J = 10.3, 5.4 Hz, 1H), 3.75 (dd, J = 10.3, 5.8 Hz, 1H), 3.48 
(s, 3H), 2.67 – 2.61 (m, 2H), 1.65 – 1.57 (m, 2H), 1.36 (dt, 
J = 14.6, 7.4 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H), 0.87 (s, 9H), 0.05 
(s, 3H), 0.05 (s, 3H) ppm. 
                                                 
206 In case of TMS (or bromine) substituted propargyl alcohols, an increased catalyst loading of Cp*Ru(cod)Cl              
(3.8 mg, 10.00 μmol, 10 mol%) was employed. 
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Isolated in 72% yield; 1H NMR (400 MHz, CDCl3) δ 7.27 (s, 
1H), 7.14 (s, 1H), 5.22 (s, 1H), 5.04 (s, 2H), 2.68 – 2.62 (m, 2H), 
1.65 – 1.56 (m, 2H), 1.35 (dq, J = 14.6, 7.3 Hz, 2H), 0.93 (t, 
J = 7.3 Hz, 3H), 0.30 (s, 9H) ppm. 
 
 
Isolated in 70% yield; 1H NMR (400 MHz, CDCl3) δ 7.27 (s, 
1H), 7.25 (s, 1H), 5.20 (s, 1H), 5.16 (t, J = 5.8 Hz, 1H), 3.93 (dd, 
J = 10.3, 5.5 Hz, 1H), 3.70 (dd, J = 10.3, 6.0 Hz, 1H), 2.64 (t, 
J = 7.7 Hz, 2H), 1.61 (p, J = 7.6 Hz, 2H), 1.36 (dt, J = 14.9, 
7.4 Hz, 2H), 0.93 (t, J = 7.3 Hz, 3H), 0.88 (s, 9H), 0.30 (s, 9H), 
0.05 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 155.2, 
146.5, 146.1, 130.8, 123.8, 122.9, 104.5, 96.8, 81.0, 66.4, 35.8, 
33.4, 25.8 (3C), 22.3, 18.3, 13.9, -0.1 (3C), -5.4 (2C) ppm; 
Rf = 0.66 (n-pentane/EtOAc 6/1). 
 
 
 
 
Isolated in 23% yield; 1H NMR (400 MHz, CDCl3) δ 7.41 (s, 
1H), 5.48 (s, 1H), 5.33 (dd, J = 5.8, 1.8 Hz, 1H), 4.13 (dd, 
J = 11.2, 1.9 Hz, 1H), 3.56 (dd, J = 11.2, 5.8 Hz, 1H), 2.81 – 2.75 
(m, 2H), 1.65 – 1.58 (m, 2H), 1.39 (dq, J = 14.6, 7.3 Hz, 2H), 
0.96 (t, J = 7.3 Hz, 3H), 0.80 (s, 9H), 0.34 (s, 9H), 0.30 (s, 9H), 
0.03 (s, 3H), 0.00 (s, 3H) ppm. 
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Boraphthalide 182a 
 
In a glovebox, diynylboronate 125 (50.4 mg, 201 μmol. 1.1 eq) and propargylic alcohol (±)-174 
(53.1 mg, 181 μmol, 1.0 eq) were loaded into a vial. Dry Et2O (1.0 mL) was added and the 
solution was stirred at 23 °C under a N2 atmosphere. After 4 h, the solvent was removed under 
high vacuum to afford a pale brown oil, which was stirred under reduced pressure (1 mbar) for 
an additional 4 h. To this oil was added added Cp*Ru(cod)Cl (5.1 mg, 13.6 μmol, 7.5 mol%) 
(glovebox) and a degassed solution of diyne 183 (62.5 μL, 362 μmol, 2.0 eq) in dry DCE 
(1.8 mL). The mixture was stirred for 13 h at 23 °C under a N2 atmosphere before an additional 
portion of Cp*Ru(cod)Cl (5.1 mg, 13.6 μmol, 7.5 mol%) in dry DCE (200 μL) and diyne 183 
(62.5 μL, 362 μmol, 2.0 eq) was added. After stirring at 23 °C for additional 9 h, the solvent was 
removed under reduced pressure (25 °C), the black residue was taken up in Et2O (10 mL) and 
washed with 1 N aq. HCl (6 mL). The aqueous phase was extracted with Et2O (3 x 10 mL), the 
combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified using a Biotage 
Isolera™ Four chromatographic isolation system under gradient elution (2% EtOAc to 10% 
EtOAc/n-pentane) to afford boraphthalide 182a (55.3 mg, 99.3 μmol, 55%) as a brown oil.  
1H NMR (400 MHz, CDCl3) δ 7.91 (s, 1H), 5.39 (br. s, 1H), 5.35 (dd, J = 5.6, 1.7 Hz, 1H), 4.14 
(dd, J = 11.3, 1.9 Hz, 1H), 3.87 (d, J = 19.8 Hz, 1H), 3.79 (d, J = 19.8 Hz, 1H), 3.59 (dd, 
J = 11.2, 5.7 Hz, 1H), 0.81 (s, 9H), 0.37 (s, 9H), 0.30 (s, 9H), 0.22 (s, 9H), 0.03 (s, 3H), 0.01 (s, 
3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 157.2, 137.2 (2C), 136.1, 134.8, 123.3, 103.6, 
102.9, 102.1, 87.8, 83.0, 67.1, 25.8 (3C), 24.2, 18.2, 0.2 (3C), 0.1 (3C), -0.1 (3C), -5.3, -5.4 ppm; 
IR (ATR): ῦ = 3596, 2956, 2929, 2898, 2857, 2178, 2144, 1437, 1343, 1250, 1126, 835, 
759 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C28H50BO3Si4]+: 557.2925, found: 557.2911; 
Rf = 0.56 (n-pentane/EtOAc 6/1). 
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Chlorobenzene 185 
 
To a solution of boraphthalide 182a (98.7 mg, 177 μmol, 1.0 eq) in MeCN (3.5 mL) was added 
copper(I) chloride (17.5 mg, 177 μmol, 1.0 eq), NCS (23.7 mg, 177 μmol, 1.0 eq) and H2O 
(16.0 μL, 886 μmol, 5.0 eq). The resulting yellow solution was stirred at 80 °C for 21 h and was 
then allowed to cool to 23 °C. The brown reaction mixture was diluted with Et2O (20 mL) and 
washed with 1 M HCl (6 mL), 1 M NaOH (6 mL) and brine (4 mL). The organic layer was then 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/Et2O 20/1 to 3/1 to 1/1) to afford 
chloroarene 185 (22.5 mg, 39.8 μmol, 22%) as a yellow oil, along with unreacted starting 
material 182a (32.2 mg, 57.8 μmol, 33%). 
1H NMR (400 MHz, CDCl3) δ 7.91 (s, 1H), 5.28 (d, J = 9.7 Hz, 1H), 3.89 (dd, J = 10.1, 3.6 Hz, 
1H), 3.87 – 3.74 (m, 2H), 3.61 (t, J = 10.0 Hz, 1H), 3.11 (s, 1H), 0.94 (s, 9H), 0.37 (s, 9H), 0.28 
(s, 9H), 0.22 (s, 9H), 0.11 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 148.4, 141.3, 140.6, 
138.0, 133.4, 123.4, 106.7, 102.9, 99.3, 88.3, 74.2, 65.3, 25.9 (3C), 25.5, 18.3, 2.5 (3C), 0.1 (3C), 
-0.1 (3C), -5.2, -5.3 ppm; Rf = 0.64 (n-pentane/Et2O 5/1). 
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Indenylcyclopentenone 189 
 
Step 1: To cooled chloroarene 185 (25.4 mg, 44.9 μmol, 1.0 eq) was added a cooled solution of 
KOH (5 wt.% in MeOH, 1.8 mL) and the resulting solution was stirred at 18 °C for 4.5 h. The 
reaction mixture was then warmed to 0 °C and stirred for an additional 3 h before it was 
quenched by addition of sat. aqueous ammonium chloride (4 mL). The aqueous phase was 
extracted with Et2O (3 x 5 mL), the combined organic layers were washed with brine (5 mL), 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/EtOAc 20/1) to afford allene-yne 188 
(16.4 mg, 38.9 μmol, 87%) as an orange oil. Due to the observed instability, allene-yne 188 was 
directly subjected to the subsequent Pauson-Khand reaction. 
1H NMR (400 MHz, CDCl3) δ 7.73 (s, 1H), 6.71 (t, J = 6.8 Hz, 1H), 5.27 (dd, J = 9.6, 3.8 Hz, 
1H), 5.22 (d, J = 6.8 Hz, 2H), 3.90 (dd, J = 10.1, 3.9 Hz, 1H), 3.68 – 3.59 (m, 2H), 3.12 (s, 1H), 
0.94 (s, 9H), 0.35 (s, 9H), 0.11 (s, 6H) ppm. 
Step 2: To Mo(CO)3(MeCN)3115 (4.0 mg, 13.1 μmol, 1.1 eq) was added a solution of allene-yne 
188 (5.0 mg, 11.9 μmol, 1.0 eq) in dry and degassed CH2Cl2 (240 µl) and the dark orange 
solution was stirred at 23 °C under a N2 atmosphere. After 2 h, the reaction mixture was filtered 
through a short pad of silica gel (n-pentane/Et2O 1/1) and the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane/Et2O 10/1) to 
afford indenylcyclopentenone 189 (1.4 mg, 3.12 μmol, 26%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.39 (s, 1H), 6.86 (s, 1H), 6.45 (s, 1H), 5.32 – 5.26 (m, 1H), 3.89 
(dd, J = 10.2, 4.3 Hz, 1H), 3.82 (t, J = 10.2 Hz, 1H), 3.22 (s, 2H), 0.94 (s, 9H), 0.39 (s, 9H), 0.12 
(s, 6H) ppm (the proton of the alcohol was not detected in CDCl3); Rf = 0.28 (n-pentane/Et2O 
10/1). 
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Ynone 194 
 
To a solution of trimethylsilylacetylene (7.08 mL, 51.1 mmol, 1.6 eq) in dry THF (80 mL) was 
added a solution of nBuLi (1.6 M in n-hexane, 28.9 mL, 46.2 mmol, 1.4 eq) at 78 °C over 
15 minutes, and the reaction was then stirred for a further 30 min at 78 °C. In a second flask, 
Weinreb amide 193124,125 (11.8 g, 33.0 mmol, 1.0 eq) was dissolved in dry THF (120 mL) and 
cooled to 78 °C. The solution of lithium trimethylsilylacetylide was slowly added over 30 min 
via cannula. The reaction mixture was allowed to warm to 15 °C over 1.5 h, cooled to 78 °C, 
and quenched by addition of glacial acetic acid (2.80 mL). The cooling bath was removed and 
the mixture was allowed to warm to 10 °C before being poured onto a mixture of brine 
(100 mL) and Et2O (100 mL). The aqueous phase was extracted with Et2O (3 x 70 mL), the 
combined organic layers were washed with brine (100 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure to afford ynone 194 (12.6 g, 31.9 mmol, 97%) as 
a pale yellow oil. The crude product was used in the next step without further purification. 
1H NMR (400 MHz, CDCl3)  = 7.71 - 7.69 (m, 4H), 7.46 - 7.41 (m, 6H), 4.30 (s, 2H), 1.12 (s, 
9H), 0.24 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 186.0, 135.5 (4C), 132.6 (2C), 
129.9 (2C), 127.8 (4C), 101.3, 100.2, 70.3, 26.7 (3C), 19.3, -0.8 (3C) ppm; IR (ATR): ῦ = 3072, 
3050, 2959, 2931, 2858, 2152, 1679, 1428, 1253, 1112, 1085, 845, 701, 504 cm-1; HRMS (ESI) 
calc’d. for [M-C6H5]+ = [C17H25O2Si2]+: 317.1388, found: 317.1393; Rf = 0.50 
(n-pentane/EtOAc 4/1). 
 
Propargylic alcohol 191 
 
To a degassed solution of ynone 194 (6.71 g, 17.0 mmol, 1.0 eq) in dry iPrOH (113 mL) was 
added (S,S)-Ts-DpenRu(cymene) (0.366 g, 0.595 mmol, 3.5 mol%) (glovebox), and the 
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resulting brown reaction mixture was stirred at 24 °C under a N2 atmosphere. After 4 h, the 
solvent was removed under reduced pressure (24 °C). The crude product was directly purified 
by flash chromatography (n-pentane/Et2O 20/1 to 10/1) to afford enantioenriched propargylic 
alcohol 191 (6.30 g, 15.9 mmol, 93%, 96% ee) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3)  = 7.76 - 7.68 (m, 4H), 7.50 - 7.39 (m, 6H), 4.54 - 4.45 (m, 1H), 
3.83 (dd, J = 10.0, 4.0 Hz, 1H), 3.76 (dd, J = 10.0, 6.5 Hz, 1H), 2.69 (br. s, 1H), 1.10 (s, 9H), 
0.19 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 135.6 (2C), 135.5 (2C), 132.9, 132.7, 
129.9 (2C), 127.8 (2C), 127.8 (2C), 103.5, 90.2, 67.3, 63.6, 26.7 (3C), 19.3, -0.2 (3C) ppm; IR 
(ATR): ῦ = 3437, 3072, 3051, 2958, 2931, 2858, 1429, 1113, 843, 702, 613, 505 cm-1; HRMS 
(ESI) calc’d. for [M+Na]+ = [C23H32NaO2Si2]+: 419.1833, found: 419.1833; [α]D20 = +15.0 
(c = 1.0, CHCl3); Rf = 0.45 (n-pentane/EtOAc 12/1); HPLC separation (Chiralpak IB, 
4.6 x 250 mm; 1% iPrOH/n-hexane, 1.0 mL/min, 222 nm; tR(major) = 7.0 min, 
tR(minor) = 11.5 min), 96% ee.  
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Boraphthalide 195 
 
In a glovebox, diynylboronate 125 (1.54 g, 6.17 mmol, 1.1 eq) and propargylic alcohol 191 
(2.33 g, 5.87 mmol, 1.0 eq) were loaded into a two-neck round-bottom flask. Dry Et2O (20 mL) 
was added and the solution was stirred at 23 °C under a N2 atmosphere. After 4.5 h the solvent 
was removed under high vacuum to afford a pale brown oil, which was stirred under reduced 
pressure (1 mbar) for an additional 4.5 h. To this oil was added added Cp*Ru(cod)Cl (100 mg, 
0.263 mmol, 4.5 mol%) (glovebox) and a degassed solution of diyne 183 (1.40 mL, 8.11 mmol, 
1.3 eq) in dry DCE (59 mL). The mixture was stirred for 12 h at 23 °C under a N2 atmosphere 
before an additional portion of Cp*Ru(cod)Cl (100 mg, 0.263 mmol, 4.5 mol%) and diyne 183 
(1.40 mL, 8.11 mmol, 1.3 eq) in degassed DCE (2.0 mL each) were added. After 12 h of stirring 
at 23 °C, further Cp*Ru(cod)Cl (95 mg, 0.250 mmol, 4.3 mol%) and diyne 183 (1.40 mL, 
8.11 mmol, 1.3 eq) in degassed DCE (2.0 mL each) was added, and stirring was continued at 
23 °C. After a total reaction time of 36 h, the solvent was removed under reduced pressure 
(25 °C), the black residue was taken up in Et2O (50 mL) and washed with 1 N aq. HCl (50 mL). 
The aqueous phase was extracted with Et2O (3 x 50 mL), the combined organic layers were 
washed with brine (50 mL), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 
60/1 to 10/1) in order to remove major impurities (predominately the trimerization product of 
183 and ruthenium residues). Unreacted starting material was then separated from the target 
using a Biotage Isolera™ Four chromatographic isolation system under gradient elution (1% 
EtOAc to 10% EtOAc/n-pentane) to afford pure boraphthalide 195 (2.35 g, 3.46 mmol, 59%, 
67% brsm) as a yellow foam along with unreacted propargylic alcohol 191 (283 mg, 0.71 mmol, 
12%). 
1H NMR (400 MHz, CDCl3)  = 7.90 (s, 1H), 7.65 (dd, J = 7.9, 1.6 Hz, 2H), 7.53 (dd, J = 8.0, 
1.5 Hz, 2H), 7.44 - 7.32 (m, 6H), 5.46 (dd, J = 5.0, 2.0 Hz, 1H), 5.39 (s, 1H), 4.16 (dd, J = 11.0, 
2.1 Hz, 1H), 3.91 - 3.79 (m, 2H), 3.63 (dd, J = 11.0, 5.0 Hz, 1H), 0.98 (s, 9H), 0.32 (s, 9H), 0.22 
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(s, 18H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 157.2, 137.2 (2C), 136.1, 135.7 (2C), 
135.7 (2C), 134.8, 133.4, 133.1, 129.6, 129.5, 127.6 (2C), 127.6 (2C), 123.2, 103.6, 102.9, 102.2, 
87.8, 82.6, 67.3, 26.6 (3C), 24.3, 19.2, 0.1 (3C), 0.1 (3C), -0.1 (3C) ppm; IR (ATR): ῦ = 3595, 
2957, 2931, 2857, 2179, 2145, 1546, 1435, 1343, 1250, 1113, 836, 760, 701 cm-1; HRMS (ESI) 
calc’d. for [M+H]+ = [C38H54BO3Si4]+: 681.3238, found: 681.3240; [α]D20 = +6.0 (c = 1.0, 
CHCl3); Rf = 0.55 (n-pentane/EtOAc 12/1). 
 
Chlorobenzene 196 
 
A two-neck round-bottom flask was charged with boraphthalide 195 (5.33 g, 7.83 mmol, 1.0 eq), 
NCS (1.05 g, 7.83 mmol, 1.0 eq) and copper(I) chloride (0.775 g, 7.83 mmol, 1.0 eq). The flask 
was placed under vacuum and backfilled with N2 (3 x). A degassed mixture of water (0.71 mL, 
39.1 mmol, 5.0 eq) and acetonitrile (150 mL) was added and the resulting solution was stirred at 
80 °C for 22 h. The reaction was cooled to ambient temperature, diluted with Et2O (150 mL) and 
washed with 1 N aq. HCl (60 mL), 1 N aq. NaOH (60 mL) and brine (60 mL). The organic phase 
was dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/EtOAc 100/1 to 60/1) to afford 
chlorobenzene 196 (1.59 g, 2.31 mmol, 30%) as a yellow foam, along with unreacted 
boraphthalide 195 (3.30 g, 4.85 mmol, 62%). The re-isolated starting material was again 
subjected to the reaction conditions to afford chlorobenzene 196 (3.77 g, 5.47 mmol, 70% overall 
yield) after 5 consecutive chlorodeboronation steps. 
1H NMR (400 MHz, CDCl3)  = 7.86 (s, 1H), 7.68 (dd, J = 7.8, 1.5 Hz, 4H), 7.47 - 7.35 (m, 
6H), 5.38 (dt, J = 9.7, 3.0 Hz, 1H), 3.90 (dd, J = 10.3, 3.8 Hz, 1H), 3.76 (s, 2H), 3.72 (t, 
J = 10.0 Hz, 1H), 3.17 (d, J = 2.5 Hz, 1H), 1.10 (s, 9H), 0.36 (s, 9H), 0.25 (s, 9H), 0.21, (s, 9H) 
ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 141.3, 140.4, 138.1, 135.5 (2C), 135.5 (2C), 133.9, 
133.3, 132.9, 132.9, 129.9, 129.9, 127.8 (2C), 127.8 (2C), 123.4, 106.6, 102.9, 99.2, 88.3, 74.2, 
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66.0, 26.9 (3C), 25.4, 19.3, 2.4 (3C), 0.1 (3C), -0.1 (3C) ppm; IR (ATR): ῦ = 3564, 2957, 2897, 
2858, 2179, 1249, 1113, 842, 760, 701, 505 cm-1; HRMS (ESI) calc’d. for 
[M+Na]+ = [C38H5335ClNaO2Si4]+: 711.2703, found: 711.2704; [α]D20 = +9.0 (c = 0.5, CHCl3); 
Rf = 0.30 (n-pentane/EtOAc 60/1). 
 
Indenylcyclopentenone 198 
 
Step 1: To a solution of chlorobenzene 196 (425 mg, 0.616 mmol, 1.0 eq) in MeOH (6.2 mL) 
was added a solution of KOH (20 wt.% in MeOH, 6.2 mL, 17.5 mmol, 28 eq) at 18 °C and the 
resulting mixture was stirred for 1.5 h and at 18 °C and was then allowed to warm to 7 °C 
over 3 h before the reaction was quenched by addition of sat. aqueous ammonium chloride 
(50 mL). The aqueous phase was extracted with Et2O (3 x 30 mL), the combined organic layers 
were washed with brine (20 mL), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 
120/1 to 80/1) to afford allene-yne 197 (306 mg, 0.561 mmol, 91%) as an orange oil, which was 
directly subjected to the subsequent reaction conditions. 
1H NMR (400 MHz, CDCl3) δ 7.64 – 7.58 (m, 5H), 7.38 – 7.27 (m, 6H), 6.59 (t, J = 6.8 Hz, 
1H), 5.29 (dd, J = 9.6, 3.4 Hz, 1H), 5.11 (d, J = 6.8 Hz, 2H), 3.82 (dd, J = 10.4, 3.8 Hz, 1H), 
3.63 (t, J = 10.3 Hz, 1H), 3.53 (s, 1H), 3.09 (s, 1H), 1.03 (s, 9H), 0.25 (s, 9H) ppm; Rf = 0.45 
(n-pentane/Et2O 5/1). 
Step 2: A two-neck round-bottom flask equipped with a reflux condenser was charged with 
Mo(CO)6 (222 mg, 0.839 mmol, 1.5 eq). A degassed solution of allene-yne 197 and DMSO (397 
µl, 4.59 mmol, 10 eq) in dry toluene (10 mL) was added. The resulting yellow suspension was 
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placed in a pre-heated oil bath and stirred at 90 °C under a N2 atmosphere. After 13 min the 
reaction mixture was cooled to 0 °C in an ice bath and was then directly purified by flash 
chromatography (n-pentane/Et2O 1/0 to 8/1 to 5/1) to afford indenylcyclopentenone 198 
(161 mg, 0.281 mmol, 50% over 2 steps) as an orange foam. 
1H NMR (400 MHz, CDCl3) δ 7.70 (ddd, J = 8.0, 3.9, 1.5 Hz, 4H), 7.48 – 7.37 (m, 6H), 7.34 (s, 
1H), 6.79 (d, J = 1.7 Hz, 1H), 6.41 (d, J = 1.5 Hz, 1H), 5.39 (dd, J = 9.0, 4.8 Hz, 1H), 3.99 – 
3.82 (m, 2H), 3.19 (d, J = 1.2 Hz, 2H), 3.15 (br. s, 1H), 1.11 (s, 9H), 0.37 (s, 9H) ppm; 13C{1H} 
 NMR (101 MHz, CDCl3) δ 207.0, 169.1, 147.5, 147.0, 143.1, 139.2, 135.6 (2C), 135.5 (2C), 
132.8 (2C), 132.0, 129.9, 129.9, 129.6, 129.1, 127.8 (2C), 127.8 (2C), 126.7, 122.2, 74.0, 66.1, 
35.4, 26.9 (3C), 19.3, 2.2 (3C) ppm; IR (ATR): ῦ = 3517, 2952, 2893, 2857, 1712, 1605, 1428, 
1248, 1112, 841, 738, 701, 505 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C33H3835ClO3Si2]+: 
573.2043, found: 573.2044; [α]D20 =  50.9 (c = 0.9, CHCl3); Rf = 0.57 (n-pentane/EtOAc 5/1). 
 
Indene epoxide 199  
 
To a solution of indenylcyclopentenone 198 (20.0 mg, 34.9 μmol, 1.0 eq) in dry toluene (350 μL) 
was added mCPBA (95 wt.%, 63.4 mg, 349 μmol, 10 eq) and the resulting bright orange 
suspension was stirred at 33 °C. After 3 h, the almost colorless reaction mixture was diluted with 
CH2Cl2 (10 mL) and washed sat. aqueous sodium thiosulfate/sodium bicarbonate (8 mL, 1/1). 
The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), the combined organic layers were 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/EtOAc 10/1) to afford a 1.1:1 
diastereomeric mixture of indene epoxide 199 (10.4 mg, 17.5 μmol, 51%) as a white solid.  
1H NMR (400 MHz, CDCl3) δ 7.73 (s, 1H), 7.71 – 7.66 (m, 4H), 7.47 – 7.37 (m, 6H), 6.75 (s, 
1H), 5.41 (ddd, J = 9.5, 4.1, 1.9 Hz, 1H), 4.72 (s, 1H), 3.88 – 3.78 (m, 2H), 3.20 (d, J = 2.1 Hz, 
1H), 3.02 (d, J = 19.0 Hz, 1H), 2.86 (d, J = 19.0 Hz, 1H), 1.11 (s, 9H), 0.38 (s, 9H) ppm;  
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HRMS (ESI) calc’d. for [M+H]+ = [C33H3835ClO4Si2]+: 589.1992, found: 589.1995; Rf = 0.39 
(n-pentane/Et2O 3/1). 
 
 
 
10.3 Synthesis of the β-Amino Acid Fragment  
Benzoic acid 203 
 
Step 1: To a solution of benzoic acid 202 (4.58 g, 22.6 mmol, 1.0 eq) and benzyl bromide 
(7.52 mL, 63.3 mmol, 2.8 eq) in dry DMF (68 mL) was added potassium carbonate (8.74 g, 
63.3 mmol, 2.8 eq) and the resulting brown suspension was stirred at 27 °C for 15 h. The reaction 
mixture was then diluted with EtOAc (120 mL), washed with H2O (1 x 120 mL, 2 x 60 mL) and 
brine (60 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
Crude benzyl ester 340 was obtained as a brown solid and used in the next step without further 
purification. 
Rf = 0.36 (n-pentane/Et2O 5/1). 
Step 2: To a solution of crude benzyl ester 340 (synthesized from 22.6 mmol benzoic acid 202) 
in EtOH (35 mL) was added aqueous sodium hydroxide (2 M, 35 mL, 70.0 mmol, 3.1 eq) and 
the resulting brown suspension was stirred at 80 °C. After 1 h, the homogenous reaction mixture 
was cooled to 0 °C, followed by addition of conc. HCl (37%, 4 mL) and H2O (40 mL). The 
aqueous phase was extracted with EtOAc (2 x 50 mL), the combined organic layers were washed 
with brine (50 mL), dried over MgSO4, filtered, and the solvent was removed under reduced 
pressure. The crude product (yellow solid) was thoroughly washed with pentane to afford known 
benzoic acid 203 (5.44 g, 18.6 mmol, 82% over 2 steps) as an off-white solid.207 
                                                 
207 L. C. Raiford, W. S. Port, R. P. Perry, J. Am. Chem. Soc. 1949, 71, 3851-3851. 
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1H NMR (400 MHz, CDCl3) δ 9.97 (s, 1H), 7.80 (d, J = 1.9 Hz, 1H), 7.56 (d, J = 1.9 Hz, 1H), 
7.55 – 7.49 (m, 2H), 7.42 – 7.32 (m, 3H), 5.17 (s, 2H), 3.95 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 170.3, 153.7, 148.9, 136.6, 128.8, 128.5 (2C), 128.4 (2C), 128.3, 125.0, 
124.6, 112.3, 75.0, 56.3 ppm; Rf = 0.33 (CH2Cl2/MeOH 20/1). 
 
β-Keto ester 201 
 
Freshly dried MgCl2 (1.65 g, 17.4 mmol, 1.1 eq) and potassium 3-methoxy-3-oxopropanoate 
(3.87 g, 24.8 mmol, 1.5 eq) were suspended in dry THF (25 mL) and stirred at 50 °C for 4 h. In 
a separate flask, a solution of benzoic acid 203 (4.84 g, 16.5 mmol, 1.0 eq) in dry THF (40 mL) 
was cooled to 0 °C and CDI (3.22 g, 19.8 mmol, 1.2 eq) was added portionwise over 15 min. 
The suspension was allowed to warm to ambient temperature and stirred at 23 °C for 1.5 h before 
the resulting solution of the activated benzoic acid 203 was slowly added to the first suspension 
at 23 °C and stirring was continued for 17 h. The reaction was quenched by slow addition of 
aqueous HCl (1 M, 40 mL). The aqueous phase was extracted with EtOAc (3 x 30 mL), the 
combined organic layers were washed with brine (30 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 10/1 to 6/1) to afford β-keto ester 201 (5.02 g, 14.4 mmol, 
87%) as a colorless oil and as a mixture of tautomers (5:1 in favor of the keto tautomer). 
1H NMR (400 MHz, CDCl3) δ (keto tautomer) = 7.58 – 7.45 (m, 4H), 7.44 – 7.31 (m, 3H), 5.16 
(s, 2H), 3.96 (s, 2H), 3.93 (s, 3H), 3.77 (s, 3H) ppm; δ (enol tautomer) = 12.53 (s, 1H), 7.58 – 
7.45 (m, 4H), 7.43 – 7.31 (m, 3H), 5.62 (s, 1H), 5.11 (s, 2H), 3.92 (s, 3H), 3.82 (s, 3H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ (keto tautomer) 190.4, 167.6, 154.0, 149.0, 136.5, 131.9, 
128.4 (2C), 128.4 (2C), 128.3 (2C), 123.4, 110.3, 75.1, 56.3, 52.6, 45.4 ppm; δ (enol 
tautomer) = 173.4, 169.8, 153.9, 146.6, 136.7, 129.6, 128.9, 128.5 (2C), 128.3 (2C), 128.2, 
120.1, 108.6, 87.2, 75.0, 56.2, 51.6 ppm; Rf = 0.44 (n-pentane/EtOAc 3/1). 
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β-Amino ester 200 
 
Step 1: A 100 mL round-bottom flask was charged with β-keto ester 201 5.44 g, 15.6 mmol, 
1.0 eq) and ammonium acetate (6.01 g, 78.0 mmol, 5.0 eq). Dry MeOH (31 mL) was added and 
the resulting solution was stirred at reflux. After 9 h, heating was stopped and the mixture was 
stirred at 23 °C for 20 h. The reaction mixture was diluted with CH2Cl2 (50 mL) and washed 
with saturated aqueous sodium bicarbonate (50 mL) and brine (50 mL). The organic phase was 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure to afford 
enamine 204 (5.28 mg, 15.2 mmol, 97%) as a colorless oil, which was used in next step without 
further purification. 
Step 2: A 20 mL microwave vial was charged with crude enamine 204 (1.12 g, 3.22 mmol, 
1.0 eq) and ((R)-DM-Segphos)Ru(OAc)2 (30.0 mg, 32.2 μmol, 1.0 mol%). The vial was sealed 
with a rubber septum, placed under vacuum and backfilled with argon (3 x). Dry MeOH (3.2 mL) 
and acetic acid (368 µl, 6.43 mmol, 2.0 eq) were added resulting in a deep green/black solution. 
The vial was placed in an autoclave and the rubber septum was pierced by two short cannula. 
The autoclave was closed and purged with H2 (3 x 10 atm.). Finally, H2 (30 atm.) was applied 
and the autoclave was heated to 80 °C under vigorous stirring. After 5 h, the autoclave was 
placed in an ice-bath and remaining H2 was released. The reaction mixture was diluted with 
EtOAc and washed with saturated aqueous sodium bicarbonate (30 mL). The aqueous phase was 
extracted with EtOAc (3 x 30 mL), the combined organic layers were washed with brine 
(30 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (EtOAc/aq. NH3 (25%) 100/1) to afford 
β-amino ester 200 (736 mg, 2.10 mmol, 65%, 97% ee) as a pale brown oil. 
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1H NMR (400 MHz, CDCl3) δ 7.55 – 7.50 (m, 2H), 7.41 – 7.32 (m, 3H), 7.00 (d, J = 1.9 Hz, 
1H), 6.90 (d, J = 1.9 Hz, 1H), 5.03 (s, 2H), 4.39 (t, J = 6.8 Hz, 1H), 3.87 (s, 3H), 3.71 (s, 3H), 
2.68 (d, J = 6.6 Hz, 2H), 1.83 (br. s, 2H) ppm; Rf = 0.15 (EtOAc); HPLC separation (Chiralpak 
IC, 4.6 x 250 mm; 60% (iPrOH + 0.25% HNBu2)/n-hexane, 0.5 mL/min, 210 nm; 
tR(minor) = 18.3 min, tR(major) = 20.6 min), 97% ee. 
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β-Acetamido ester 205  
 
To an ice-cooled solution of β-amino ester 200 (836 mg, 2.39 mmol, 1.0 eq) in dry CH2Cl2 
(19 mL) was added freshly distilled Et3N (433 µL, 3.11 mmol, 1.3 mL) and acetyl chloride 
(195 µL, 2.75 mmol. 1.2 eq). The reaction mixture was stirred at 0 °C for 10 min before the 
cooling bath was removed and the mixture was allowed to warm to 23 °C. After 1 h, the reaction 
was quenched by addition of saturated aqueous sodium bicarbonate (20 mL). The aqueous phase 
was extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed with brine 
(15 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (EtOAc) to afford β-acetamido ester 205 
(873 mg, 2.23 mmol, 93%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.55 – 7.50 (m, 2H), 7.41 – 7.31 (m, 3H), 6.90 (d, J = 2.0 Hz, 
1H), 6.78 (d, J = 2.0 Hz, 1H), 6.58 (d, J = 8.4 Hz, 1H), 5.35 (dt, J = 8.3, 5.8 Hz, 1H), 5.01 (s, 
2H), 3.86 (s, 3H), 3.66 (s, 3H), 2.89 (dd, J = 15.8, 5.8 Hz, 1H), 2.82 (dd, J = 15.9, 5.8 Hz, 1H), 
2.06 (s, 3H) ppm; HRMS (ESI) calc’d. for [M+H]+ = [C20H2335ClNO5]+: 392.1259, found: 
392.1253; Rf = 0.33 (EtOAc). 
 
β-tyrosine methyl ester 206 
 
A flask was charged with β-acetamido ester 205 (3.61 g, 9.21 mmol, 1.0 eq) and 10% Pd/C 
(245 mg, 230 μmol, 2.5 mol%). The flask was sealed, placed under vacuum and backfilled with 
N2 (3 x). EtOAc (60 mL) was added and the resulting black reaction mixture was stirred at 23 °C 
while getting saturated with dihydrogen by passing gaseous H2 (from a balloon) through the 
suspension for 10 min. The reaction mixture was stirred at 23 °C for an additional 15 min under 
a H2 atmosphere before the H2 balloon was removed and the reaction mixture was purged with 
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N2 for 5 min in order to remove remaining H2. The suspension was then filtered through a short 
pad of Celite and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/EtOAc 1.5/1 to 0/1) to afford β-tyrosine methyl 
ester 206 (2.78 g, 9.21 mmol, >99%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ 6.87 (d, J = 2.0 Hz, 1H), 6.74 (d, J = 1.8 Hz, 1H), 6.62 (d, 
J = 7.2 Hz, 1H), 5.86 (s, 1H), 5.32 (dt, J = 8.0, 5.9 Hz, 1H), 3.89 (s, 3H), 3.65 (s, 3H), 2.89 (dd, 
J = 15.8, 5.8 Hz, 1H), 2.81 (dd, J = 15.8, 6.0 Hz, 1H), 2.04 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 171.6, 169.4, 147.5, 141.5, 132.8, 119.5, 119.2, 108.2, 56.4, 51.9, 49.2, 
39.6, 23.4 ppm; IR (ATR): ῦ = 3274, 3069, 2953, 2845, 1730, 1650, 1504, 1428, 1285, 1174, 
1050, 852, 730 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C13H1735ClNO5]+: 302.0790, found: 
302.0794; [α]D20 = 70.3 (c = 1.0, CHCl3); m.p.: 97 - 99 °C; Rf = 0.43 (EtOAc).  
 
β-Amino acid 64 
 
To a solution of β-tyrosine methyl ester 206 (500 mg, 1.66 mmol, 1.0 eq) in THF/MeOH 
(7.5 mL, v/v = 2/1) was added aqueous sodium hydroxide (2 M, 3.31 mL, 6.63 mmol, 4.0 eq) 
and the resulting mixture was stirred 25 °C for 90 min. The reaction mixture was then acidified 
with aqueous HCl (2 M, 5 mL) and stirred at 23 °C for an additional 20 min. The aqueous phase 
was then extracted with EtOAc (3 x 15 mL), the combined organic layers were washed with 
brine (15 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (CH2Cl2/MeOH 12/1 + 1% AcOH) to 
afford β-amino acid 64 (473 mg, 1.64 mmol, 99%) as a white solid. 
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1H NMR (400 MHz, Methanol-d4) δ 6.89 (d, J = 1.9 Hz, 1H), 6.87 (d, J = 2.0 Hz, 1H), 5.23 (t, 
J = 7.4 Hz, 1H), 3.88 (s, 3H), 2.78 (dd, J = 15.6, 8.1 Hz, 1H), 2.72 (dd, J = 15.6, 6.8 Hz, 1H), 
1.95 (s, 3H) ppm (the exchangeable phenol, amide and carboxylic acid protons were not detected 
in MeOH-d4); 13C{1H} NMR (101 MHz, Methanol-d4) δ 174.2, 172.5, 150.1, 143.6, 134.6, 
121.3, 120.8, 110.0, 56.9, 51.3, 41.8, 22.8 ppm; IR (ATR): ῦ = 3335, 3083, 2940, 1713, 1610, 
1546, 1505, 1427, 1286, 1188, 1050, 852 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C12H1535ClNO5]+: 288.0623, found: 288.0629; [α]D20 = 80.3 (c = 1.0, MeOH); 
m.p.: 198 – 200 °C; Rf = 0.30 (CH2Cl2/MeOH/AcOH 10/1/0.1). 
 
 
 
 
10.4 Studies towards the Fijiolide A Aglycone 
10.4.1 Intermolecular Etherification/ Macrolactonization Approach 
Model epoxide (±)-215 
 
To a solution of indenylcyclopentenone 14897 (30.3 mg, 180 μmol, 1.0 eq) in dry toluene 
(1.8 mL) was added mCPBA (95%, 327 mg, 1.80 mmol, 10 eq) and the resulting suspension 
was stirred at 25 °C for 2.5 h. The reaction mixture was then diluted with CH2Cl2 (10 mL) and 
poured into a mixture of saturated aqueous sodium thiosulfate/sodium bicarbonate (4 mL, 1/1). 
The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), the combined organic layers were 
washed with brine (5 mL), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/Et2O 2/1) 
to afford model epoxide (±)-215 (23.6 mg, 128 μmol, 71%) as an off-white solid. 
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1H NMR (400 MHz, CDCl3) δ 7.75 – 7.71 (m, 1H), 7.64 – 7.60 (m, 1H), 7.51 – 7.43 (m, 2H), 
6.51 (s, 1H), 4.77 (s, 1H), 3.08 (d, J = 18.9 Hz, 1H), 2.91 (d, J = 18.9 Hz, 1H) ppm; 13C{1H} 
NMR (101 MHz, CDCl3) δ 205.9, 170.9, 145.8, 133.2, 131.9, 129.6, 127.1, 126.1, 125.8, 69.3, 
60.2, 36.5 ppm, IR (ATR): ῦ = 2924, 2852, 1709, 1632, 1457, 1389, 1331, 1194, 1116, 964, 
856, 768, 732 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C12H9O2]+: 185.0597, found: 185.0592; 
m.p.: 103 - 106 °C; Rf = 0.30 (n-pentane/Et2O 2/1). 
 
Phenol ether (±)-216 
 
To an ice-cooled solution of epoxide (±)-215 (1.8 mg, 10.0 μmol, 1.0 eq) and phenol (9.4 mg, 
100 μmol, 10 eq) in dry CH2Cl2 (200 μL) was added BF3•OEt2 (7.92 μL, 30.0 μL, 3.0 eq) and 
the resulting solution was stirred at 0 °C for 45 min before being quenched by addition of 
saturated aqueous sodium bicarbonate (2 mL). The aqueous phase was extracted with CH2Cl2 
(3 x 5 mL), the combined organic layers were washed with brine (5 mL), dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/Et2O 1.5/1 to 1/1) to afford phenol ether (±)-216 (1.8 mg, 
6.47 μmol, 65%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.79 (dd, J = 5.9, 2.8 Hz, 1H), 7.61 – 7.54 (m, 3H), 7.34 (dd, 
J = 8.7, 7.4 Hz, 2H), 7.04 (t, J = 7.4 Hz, 1H), 7.01 – 6.97 (m, 2H), 6.31 (s, 1H), 5.55 (s, 1H), 
2.84 (d, J = 17.3 Hz, 1H), 2.59 (d, J = 17.3 Hz, 1H) ppm (the tertiary alcohol was not detected 
in CDCl3); HRMS (ESI) calc’d. for [M+H]+ = [C18H15O3]+: 279.1016, found: 279.1026; 
Rf = 0.34 (n-pentane/Et2O 1/1). 
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Indenylcyclopentenone 222 
 
Step 1: To a stirred solution of chlorobenzene 196 (1.80 g, 2.61 mmol, 1.0 eq) in dry THF 
(26 mL) was slowly added a solution of TBAF (1 M in THF, 13.1 mL, 13.1 mmol, 5.0 eq). The 
reaction mixture instantaneously turned black and was stirred at 23 °C for 45 min before it was 
quenched by addition of sat. aqueous ammonium chloride (10 mL). The aqueous phase was 
extracted with Et2O (3 x 10 mL), the combined organic layers were washed with brine (10 mL), 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure (25 °C). Crude 
allene-yne 220 was obtained as a brown oil and was used in the next step without further 
purification. 
Rf = 0.40 (n-pentane/EtOAc 1/1). 
Step 2: To a solution of crude allene-yne 220 (synthesized from 2.61 mmol 196) in dry acetone 
(25 mL) was subsequently added FeCl3 (85.0 mg, 0.522 mmol, 0.2 eq) and 4Å-MS. The 
resulting orange suspension was stirred at 23 °C for 40 min before the solvent was removed 
under reduced pressure (25 °C). The crude product was purified by flash chromatography 
(n-pentane/Et2O 100/1 to 50/1 to 30/1) to afford allene-yne 221 (568 mg, 2.07 mmol, 79%) as a 
pale yellow oil, which was directly subjected to the subsequent reaction conditions. 
Rf = 0.72 (n-pentane/EtOAc 1/1). 
Step 3: A two-neck round-bottom flask equipped with a reflux condenser was charged with 
Mo(CO)6 (807 mg, 3.06 mmol, 1.5 eq). A degassed and over 4Å-MS dried solution of allene-
yne 221 (560 mg, 2.04 mmol, 1.0 eq) and DMSO (1.45 mL, 20.4 mmol, 10 eq) in dry toluene 
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(14 mL) was added. The resulting yellow suspension was placed in a pre-heated oil bath and 
stirred at 90 °C under a N2 atmosphere. After 15 min, the reaction mixture was cooled to 0 °C 
in an ice bath and was directly purified by flash chromatography (n-pentane/Et2O 8/1 to 4/1) to 
afford indenylcyclopentenone 222 (347 mg, 1.15 mmol, 56%) as an orange oil. 
1H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.4 Hz, 1H), 7.16 (d, J = 7.7 Hz, 1H), 6.85 (d, 
J = 1.7 Hz, 1H), 6.46 (d, J = 1.6 Hz, 1H), 5.45 (t, J = 6.9 Hz, 1H), 4.55 (dd, J = 8.3, 6.5 Hz, 1H), 
3.67 (dd, J = 8.2, 7.3 Hz, 1H), 3.22 (d, J = 1.3 Hz, 2H), 1.59 (s, 3H), 1.53 (s, 3H) ppm; 13C{1H} 
NMR (101 MHz, CDCl3) δ 206.8, 168.5, 148.9, 143.2, 135.4, 130.7, 130.3, 128.8, 128.4, 121.9, 
120.2, 109.8, 74.4, 70.5, 35.3, 26.4, 25.6 ppm; IR (ATR): ῦ = 2986, 2935, 2877, 1711, 1608, 
1381, 1372, 1226, 1157, 1104, 1066, 937, 851 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C17H1635ClO3]+: 303.0782, found: 303.0784; [α]D20 = .5 (c = 1.0, CHCl3); m.p.: 
78 - 81 °C; Rf = 0.52 (n-pentane/EtOAc 5/1). 
 
Keto epoxide 223 
 
To a solution of indenylcyclopentenone 222 (31.8 mg, 105 μmol, 1.0 eq) in dry toluene (1.5 mL) 
was added mCPBA (95%, 191 mg, 1.05 mmol, 10 eq) and the resulting suspension was stirred 
at 30 °C for 4 h. The reaction mixture was then diluted with CH2Cl2 (10 mL) and poured into a 
mixture of saturated aqueous sodium thiosulfate/sodium bicarbonate (4 mL, 1/1). The aqueous 
phase was extracted with CH2Cl2 (3 x 5 mL), the combined organic layers were washed with 
brine (5 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure.  
Crude keto epoxide 223 (90% by NMR, dr = 1:1) was obtained as a pale yellow oil and was 
used in the next step without further purification. 
Characterization data for inseparable 1:1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) 
δ 7.76 (d, J = 7.8 Hz, 1H), 7.55 (d, J = 7.8 Hz, 1H), 6.83 (d, J = 3.3 Hz, 1H), 5.45 (q, J = 6.8 Hz, 
1H), 4.79 (d, J = 2.6 Hz, 1H), 4.58 (ddd, J = 8.2, 6.7, 1.5 Hz, 1H), 3.65 (ddd, J = 14.4, 8.3, 
7.1 Hz, 1H), 3.07 (dd, J = 18.9, 2.1 Hz, 1H), 2.90 (dd, J = 18.9, 1.5 Hz, 1H), 1.58 (s, 3H), 1.53 
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(s, 3H) ppm; HRMS (ESI) calc’d. for [M+H]+ = [C17H1635ClO4]+: 319.0732, found: 319.0727; 
Rf = 0.64 (n-pentane/EtOAc 3/1). 
 
Diol (±)-225 
 
To a solution of indenylcyclopentenone 148 (200 mg, 1.19 mmol, 1.0 eq) and citric acid 
(274 mg, 1.43 mmol, 1.2 eq) in tBuOH/H2O (12 mL, v/v = 1:1) was added a solution of OsO4 
(2.5 wt% in tBuOH, 0.746 mL, 59.4 μmol, 5.0 mol%) and NMO (167 mg, 1.43 mmol, 1.2 eq). 
The resulting brown solution was stirred at 23 °C for 17 h before being quenched by addition of 
sat. aqueous sodium thiosulfate (10 mL). The aqueous phase was extracted with EtOAc (3 x 
10 mL), the combined organic layers were washed with brine (10 mL), dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/EtOAc 1/1 to 1/2) to afford diol (±)-225 as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 7.6 Hz, 1H), 7.63 (d, J = 7.4 Hz, 1H), 7.58 (t, 
J = 7.4 Hz, 1H), 7.47 (t, J = 7.4 Hz, 1H), 6.26 (s, 1H), 5.11 (d, J = 9.3 Hz, 1H), 2.94 (d, 
J = 9.3 Hz, 1H), 2.80 (d, J = 17.5 Hz, 1H), 2.73 (d, J = 17.5 Hz, 1H), 2.61 (s, 1H) ppm; 13C{1H} 
NMR (101 MHz, CDCl3) δ 207.3, 175.2, 148.3, 132.9, 132.4, 129.5, 125.8, 125.4, 122.3, 86.3, 
77.5, 47.4 ppm; HRMS (ESI) calc’d. for [M+H]+ = [C12H11O3]+: 203.0703, found: 203.0700; 
Rf = 0.31 (n-pentane/EtOAc 1/2).  
 
Tosylate (±)-228 
 
To a solution of diol (±)-225 (90.0 mg, 0.445 mmol, 1.0 eq) in freshly distilled pyridine 
(5.5 mL) was added TsCl (170 mg, 0.890 mmol, 2.0 eq) and the resulting mixture was stirred at 
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23 °C. After 61 h, the reaction was quenched by addition of aqueous HCl (2 M, 20 mL) and the 
aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
washed with sat. aqueous CuSO4 (15 mL) and sat. aqueous sodium bicarbonate (10 mL), dried 
over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography (n-pentane/EtOAc 2/1 to 1/1) to afford model tosylate 
(±)-228 (149 mg, 0.418 mmol, 94%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ 7.97 – 7.92 (m, 2H), 7.67 (d, J = 6.9 Hz, 1H), 7.56 – 7.46 (m, 
2H), 7.46 – 7.42 (m, 3H), 6.25 (s, 1H), 5.72 (s, 1H), 2.95 (s, 1H), 2.59 – 2.46 (m, 5H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 206.2, 173.0, 146.0, 142.1, 132.8, 132.7, 132.5, 130.4, 
130.3 (2C), 128.2 (2C), 126.0, 125.5, 123.1, 86.2, 83.3, 48.0, 21.8 ppm; HRMS (ESI) calc’d. 
for [M+H]+ = [C19H17O5S]+: 357.0791, found: 357.0801. 
 
Aryl ether 8,9-trans-217 
 
A microwave vial, equipped with a stir bar, was charged with tosylate (±)-228 (5.0 mg, 
14.0 μmol, 1.0 eq), β-tyrosine 206 (5.1 mg, 16.8 μmol, 1.2 eq) and Cs2CO3 (11.0 mg, 
32.6 μmol, 2.4 eq). The vial was sealed, placed under vacuum and backfilled with N2 (3 x). Dry 
THF (250 μL) was added and the suspension was heated to 100 °C for 8 h under microwave 
irradiation. The resulting deep purple suspension was taken up in EtOAc (5 mL) and a solution 
of 1,3,5-TMB (0.01 M in EtOAc, 200 μL, 2.00 μmol) was added as internal standard. Aqueous 
pH 7 phosphate buffer (3 mL) was then added and the aqueous phase extracted with EtOAc (3 
x 5 mL). The combined organic layers were washed with brine (5 mL), dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. After determination of the crude 
1H NMR yield (42%) the product was commonly purified with other batches of crude 8,9-trans-
217 by flash chromatography (n-pentane/EtOAc 1/2 to 1/4 to 0/1) to afford a 1:1 diastereomeric 
mixture of 8,9-trans-217 as a colorless foam. 
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Characterization data for inseparable 1:1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) 
δ 8.00 (d, J = 7.6 Hz, 1H), 7.70 (d, J = 7.5 Hz, 1H), 7.60 (t, J = 7.5 Hz, 1H), 7.50 (t, J = 7.5 Hz, 
1H), 7.04 – 7.01 (m, 1H), 6.90 – 6.87 (m, 1H), 6.74 (d, J = 8.2 Hz, 1H), 6.26 (s, 1H), 5.43 – 
5.36 (m, 1H), 5.33 (s, 1H), 4.89 (s, 1H), 3.95 (s, 3H), 3.70 – 3.66 (m, 3H), 2.92 – 2.84 (m, 2H), 
2.55 – 2.38 (m, 2H), 2.08 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 207.4, 207.4, 174.6, 
174.5, 171.5, 171.5, 169.4 (2C), 152.9 (2C), 145.3 (2C), 142.9, 142.8, 139.0, 138.9, 133.1 (2C), 
132.4 (2C), 129.6 (2C), 128.5 (2C), 126.5 (2C), 125.2 (2C), 122.7 (2C), 120.3, 120.2, 109 
(2C).4, 88.1 (2C), 86.0 (2C), 56.3, 56.3, 52.1 (2C), 49.0, 48.9, 47.8 (2C), 39.4, 39.4, 23.4 (2C) 
ppm; HRMS (ESI) calc’d. for [M+H]+ = [C25H2535ClNO7]+: 486.1314, found: 486.1316; 
Rf = 0.45 (EtOAc). 
 
Diol 8,9-cis-341 
 
To a solution of indenylcyclopentenone 222 (300 mg, 0.991 mmol, 1.0 eq) in THF/H2O (10 mL, 
v/v = 9/1) was added a solution of OsO4 (4 wt.% in H2O, 315 μL, 49.6 μmol, 5.0 mol%) and 
NMO (232 mg, 1.98 mmol, 2.0 eq). The resulting brown solution was stirred at 23 °C for 4 h, 
and then directly subjected to flash chromatography (n-pentane/EtOAc 1/1 to 1/1.5). Mixed 
fraction were re-subjected to flash chromatography (n-pentane/EtOAc 1/1 to 1/1.5) to afford an 
inseparable 1.2:1 diastereomeric mixture of 8,9-cis-341 (255 mg, 0.757 mmol, 76%) as an off-
white amorphous solid. 
Characterization data for inseparable 1.2:1 mixture diastereomers: 1H NMR (400 MHz, CDCl3) 
δ 7.85 (d, J = 7.9 Hz, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.57 – 7.52 (m, 2H), 6.56 (s, 1H), 6.55 (s, 
1H), 5.49 – 5.43 (m, 2H), 5.10 (s, 1H), 5.08 (s, 1H), 4.62 – 4.54 (m, 2H), 3.67 (ddd, J = 8.4, 7.2, 
2.0 Hz, 2H), 3.01 (br. s, 2H), 2.86 – 2.67 (m, 6H), 1.59 (s, 6H), 1.53 (s, 3H), 1.52 (s, 3H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 208.6, 208.6, 173.1, 173.0, 149.9, 149.9, 139.4, 139.4, 
131.3, 131.3, 131.0, 131.0, 130.1, 130.0, 124.2, 124.1, 124.1, 124.1, 110.1, 110.0, 86.4, 86.2, 
77.2, 77.1, 74.3 (2C), 70.1, 70.0, 47.1, 47.1, 26.2, 26.2, 25.4, 25.4 ppm; IR (ATR): ῦ = 3395, 
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2986, 2935, 2880, 1707, 1626, 1376, 1241, 1202, 1156, 1062, 856, 692 cm-1; HRMS (ESI) 
calc’d. for [M+H]+ = [C17H1835ClO5]+: 337.0837, found: 337.0840; Rf = 0.25 (n-pentane/EtOAc 
1/2). 
 
Tosylate 8,9-cis-229 
 
To an ice-cooled solution of 8,9-cis-341 (212 mg, 0.630 mmol, dr = 1.2:1, 1.0 eq) and DMAP 
(8.5 mg, 69.6 μmol, 0.15 eq) in freshly distilled pyridine (5.0 mL) was added TsCl (480 mg, 
2.52 mmol, 4.0 eq). The resulting yellow solution was allowed to warm to 23 °C and stirred for 
13 h. The brown reaction mixture was cooled to 0 °C and quenched by addition of water (10 mL) 
and EtOAc (10 mL). The aqueous phase was extracted with EtOAc (3 x 15 mL). The combined 
organic layers were washed with 2 M aq. HCl (2 x 10 mL) and brine (10 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/EtOAc 2/1) to afford an inseparable 1.2:1 
diastereomeric mixture of tosylate 8,9-cis-229 (297 mg, 0.605 mmol, 96 %) as an off-white 
solid. 
Characterization data for inseparable 1.2:1 mixture diastereomers: 1H NMR (400 MHz, CDCl3) 
δ 7.94 (d, J = 8.3 Hz, 4H), 7.79 (d, J = 8.0 Hz, 2H), 7.44 (d, J = 8.1 Hz, 4H), 7.34 (t, J = 8.1 Hz, 
2H), 6.56 (s, 1H), 6.56 (s, 1H), 5.71 (s, 1H), 5.68 (s, 1H), 5.43 (td, J = 6.8, 2.2 Hz, 2H), 4.57 
(td, J = 8.6, 6.8 Hz, 2H), 3.67 – 3.58 (m, 2H), 2.93 (br. s, 2H), 2.60 – 2.43 (m, 10H), 1.57 (s, 
3H), 1.56 (s, 3H), 1.51 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 206.0, 206.0, 169.7, 
169.6, 146.2, 146.2, 143.3, 143.2, 141.3, 141.0, 132.3, 132.3, 131.6, 131.0, 130.9, 130.4, 130.3 
(2C), 130.3 (4C), 128.2 (4C), 125.7, 125.5, 124.3, 124.2, 110.2 (2C), 86.4, 86.1, 82.9, 82.8, 
74.4, 74.4, 70.1, 70.0, 47.8, 47.6, 26.3, 26.2, 25.5, 25.4, 21.8 (2C) ppm; Rf = 0.34 
(n-pentane/EtOAc 2/1). 
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Triol 8,9-trans-231 
 
Step 1: A 20 mL microwave vial was charged with tosylate 8,9-cis-229 (315 mg, 0.642 mmol, 
dr = 1.2:1, 1.0 eq), β-tyrosine 206 (232 mg, 0.770 mmol, 1.2 eq) and Cs2CO3 (251 mg, 
0.770 mmol, 1.2 eq). The vial was sealed, placed under vacuum and backfilled with N2 (3 x). 
Dry dioxane (6.4 mL) was added, the vial placed in a pre-heated oil bath and the heterogeneous 
reaction mixture was stirred at 90 °C for 7.5 h. The resulting mixture was then allowed to cool 
to ambient temperature, taken up in EtOAc (20 mL) and quenched by addition of aqueous pH 7 
phosphate buffer (15 mL). The aqueous phase was extracted with EtOAc (3 x 15 mL), the 
combined organic layers were washed with brine (15 mL), dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 2/1 to 1/1 to EtOAc/MeOH 40/1 to 30/1) to afford an 
inseparable 1.2:1 diastereomeric mixture of arylether 8,9-trans-230 (348 mg, 46.6 wt.%, 
0.261 mmol, 41%) as a gray solid, contaminated with inseparable unreacted β-tyrosine 206.  
Steps 2: To ice-cooled aryl ether 8,9-trans-230 (348 mg, 46.6 wt.%, 0.261 mmol, dr = 1.2:1, 
1.0 eq) was added TFA (3.00 mL, 38.9 mmol, 149 eq) and the resulting brown reaction mixture 
was stirred at 0 °C for 60 min before being diluted with CH2Cl2 (20 mL) and quenched by 
addition of sat. aqueous sodium bicarbonate (30 mL). The aqueous phase was extracted with 
CH2Cl2 (3 x 20 mL) and the combined organic layers were washed with sodium bicarbonate 
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(15 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (EtOAc/MeOH 1/0 to 20/1) to afford an 
inseparable 1.2:1 diastereomeric mixture of triol 8,9-trans-231 (137 mg, 0.236 mmol, 90%) as 
a pale yellow foam. 
Characterization data for inseparable 1.2:1 mixture of diastereomers: 1H NMR (400 MHz, 
CDCl3) δ 7.93 (dd, J = 8.0, 2.7 Hz, 2H), 7.84 (dd, J = 7.9, 2.9 Hz, 2H), 7.02 (dd, J = 4.8, 1.7 Hz, 
2H), 6.91 – 6.85 (m, 2H), 6.76 (d, J = 8.4 Hz, 2H), 6.57 (s, 1H), 6.56 (s, 1H), 5.42 – 5.35 (m, 
2H), 5.35 – 5.30 (m, 2H), 5.30 (s, 1H), 5.27 (s, 1H), 4.85 (br. s, 1H), 4.83 (br. s, 1H), 3.94 (s, 
9H), 3.69 (s, 6H), 3.66 – 3.37 (m, 3H), 2.91 – 2.82 (m, 5H), 2.50 (dd, J = 17.3, 5.1 Hz, 2H), 
2.43 – 2.34 (m, 3H), 2.08 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 207.5, 207.4, 171.4, 
171.4 (2C), 171.3, 169.8, 169.8, 152.7, 152.7, 146.5 (2C), 142.6, 142.5, 140.4, 140.2, 139.2, 
139.1, 131.8, 131.8, 131.8, 131.7, 130.3, 130.2, 128.3, 128.3, 125.1, 125.0, 124.8, 124.8, 120.3, 
120.2, 109.5, 109.5, 87.7, 87.7, 86.2, 86.0, 70.8, 70.8, 66.0, 66.0, 56.3, 56.3, 52.1 (2C), 49.2, 
49.1, 47.4, 47.4, 39.5, 39.5, 23.3 (2C) ppm; IR (ATR): ῦ = 3313, 2952, 2874, 1712, 1630, 1487, 
1422, 1267, 1229, 1176, 1049, 860, 731 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C27H2835Cl2NO9]+: 580.1136, found: 580.1139; Rf = 0.46 (EtOAc/MeOH 10/1). 
 
Seco-acid 8,9-trans-208 
 
To a solution of triol 8,9-trans-231 (137 mg, 0.236 mmol, dr = 1.2:1, 1.0 eq) in MeCN (2 mL) 
was added a solution of LiOH (8.5 mg, 0.354 mmol, 1.5 eq) in H2O (2 mL) and the resulting 
mixture was stirred at 23 °C. After 4 h, the reaction was quenched by addition of 2 M HCl 
(6 mL). The aqueous phase was extracted with EtOAc (8 x 10 mL), the combined organic layers 
were dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. The 
10. Experimental Section  215 
 
crude product was purified by flash chromatography (CH2Cl2/MeOH/AcOH 10/1/0 to 50/5/1) 
to afford an inseparable 1.1:1 diastereomeric mixture of seco-acid 8,9-trans-208 (125 mg, 
0.221 mmol, 94 %) as an off-white solid. 
Characterization data for inseparable 1.1:1 mixture of diastereomers: 1H NMR (400 MHz, 
Methanol-d4) δ 7.91 (d, J = 8.0 Hz, 2H), 7.86 (dd, J = 8.0, 2.4 Hz, 2H), 7.11 (s, 4H), 6.50 (s, 
1H), 6.49 (s, 1H), 5.51 (s, 1H), 5.48 (s, 1H), 5.29 (t, J = 6.8 Hz, 2H), 5.26 – 5.21 (m, 2H), 3.97 
(s, 6H), 3.79 – 3.76 (m, 1H), 3.76 – 3.73 (m, 1H), 3.60 – 3.57 (m, 1H), 3.55 (dd, J = 7.3, 1.1 Hz, 
1H), 2.71 (d, J = 7.2 Hz, 4H), 2.63 (dd, J = 17.3, 4.9 Hz, 2H), 2.46 (d, J = 17.3 Hz, 2H), 1.98 
(s, 3H), 1.98 (s, 3H) ppm (the exchangeable protons (OH, NH) were not detected in 
Methanol-d4); 13C{1H} NMR (101 MHz, Methanol-d4) δ 210.4 (2C), 174.3, 174.2, 172.6 (2C), 
154.3 (2C), 149.1, 149.0, 144.1, 144.1, 142.7, 142.7, 142.2, 142.1, 133.4 (2C), 133.3 (2C), 
133.0, 133.0, 131.5 (2C), 129.0 (2C), 126.2, 126.1, 125.3, 125.2, 121.5, 121.4, 111.4 (2C), 88.9, 
88.9, 88.2, 88.0, 72.1 (2C), 67.2 (2C), 56.9 (2C), 52.0 (2C), 50.0 (2C), 43.6 (2C), 22.8, 22.8 
ppm; IR (ATR): ῦ = 3300, 2926, 1707, 1627, 1487, 1418, 1269, 1219, 1045, 1017, 757, 731, 
694 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C26H2635Cl2NO9]+: 566.0979, found: 566.0974; 
Rf = 0.43 (EtOAc/MeOH 1/1). 
 
Thioester 8,9-trans-233 
 
To an ice-cooled solution of seco-acid 8,9-trans-208 (3.0 mg, 5.30 µmol, dr = 1.1:1, 1.0 eq) and 
HATU (6.0 mg, 15.9 mmol, 3.0 eq) in dry DMF (100 μl) was added a solution of tert-butyl 
mercaptan (3.58 μL, 31.8 μmol, 6.0 eq) in dry DMF (50 μL), followed by freshly distilled 
Hünig’s base (9.25 μL, 53.0 μmol, 10 eq). The resulting reaction mixture was stirred and 
allowed to slowly warm to 23 °C. After 13 h, the reaction mixture was diluted with EtOAc 
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(5 mL) and quenched by addition of 0.5 M HCl (3 mL). The aqueous phase was extracted with 
EtOAc (3 x 5 mL), the combined organics layers were washed with brine (5 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (CH2Cl2/MeOH 30/1 to 15/1) to afford an inseparable 1.1:1 
diastereomeric mixture of thioester 8,9-trans-233 (2.5 mg, 3.92 μmol, 74%) as a pale yellow 
oil. 
Characterization data for inseparable 1.1:1 mixture of diastereomers: 1H NMR (400 MHz, 
CDCl3) δ 8.44 (d, J = 8.4 Hz, 1H), 7.93 (d, J = 7.6 Hz, 2H), 7.85 (dd, J = 7.9, 3.5 Hz, 2H), 7.46 
– 7.40 (m, 1H), 7.01 – 6.98 (m, 2H), 6.92 – 6.83 (m, 4H), 6.57 (s, 1H), 6.56 (s, 1H), 5.35 – 5.32 
(m, 2H), 5.29 (s, 1H), 5.28 (s, 1H), 3.95 (s, 8H), 3.69 – 3.55 (m, 4H), 3.45 (s, 1H), 3.16 – 3.04 
(m, 2H), 3.00 – 2.85 (m, 5H), 2.50 (dd, J = 17.3, 6.5 Hz, 2H), 2.37 (dd, J = 17.3, 2.1 Hz, 2H), 
2.09 (s, 3H), 2.08 (s, 3H), 1.43 (s, 9H), 1.42 (s, 9H) ppm; HRMS (ESI) calc’d. for 
[M+H]+ = [C30H3435Cl2NO8]+: 638.1377, found: 638.1382; Rf = 0.37 (CH2Cl2/MeOH 15/1).  
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10.4.2 Intermolecular Esterification / Macroetherification Approach 
Triol 8,9-cis-238 
 
To a solution of acetonide 8,9-cis-229 (50.0 mg, 102 μmol, dr = 1.4:1 1.0 eq) in MeCN (3.0 mL) 
was added aqueous HCl (2 M, 1.5 mL, 3.00 mmol, 30 eq) and the resulting colorless solution 
was stirred at 23 °C for 1 h. The reaction mixture was then diluted with EtOAc (10 mL) and 
quenched by addition of sat. aqueous sodium bicarbonate (8 mL). The aqueous phase was 
extracted with EtOAc (3 x 10 mL), the combined organic layers were dried over MgSO4, filtered, 
and the solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 3/1 to 2/1) to afford an inseparable 1.4:1 diastereomeric 
mixture of triol 8,9-cis-238 (45.8 mg, 95 wt.%, 96.5 μmol, 95%) as a white foam. 
Characterization data for an inseparable 1:1 mixture of diastereomers: 1H NMR (400 MHz, 
Methanol-d4) δ 7.98 (d, J = 8.3 Hz, 4H), 7.80 (d, J = 8.0 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.51 
(d, J = 8.2 Hz, 4H), 7.30 (d, J = 8.0 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H), 6.46 (s, 1H), 6.45 (s, 1H), 
5.85 (s, 1H), 5.83 (s, 1H), 5.22 – 5.15 (m, 2H), 3.72 (dt, J = 11.4, 3.3 Hz, 2H), 3.52 (ddd, 
J = 11.5, 7.2, 2.0 Hz, 2H), 2.56 – 2.43 (m, 8H), 2.17 (dd, J = 17.5, 4.9 Hz, 2H) ppm 
(exchangeable alcohol protons were not detected in MeOH-d4); 13C{1H} NMR (101 MHz, 
MeOD) δ 209.7 (2C), 173.9, 173.8, 147.4 (2C), 146.3, 146.3, 143.4, 143.3, 134.6 (2C), 133.6, 
133.6, 132.9, 132.9, 131.8 (2C), 131.4 (4C), 129.7 (2C), 129.7 (2C), 125.1, 125.1, 125.0, 125.0, 
87.7, 87.5, 84.2 (2C), 72.0, 72.0, 67.1, 67.1, 48.5 (2C), 21.8 (2C) ppm; HRMS (ESI) calc’d. for 
[M-OH]+ = [C21H1835ClO6S]+: 433.0507, found: 433.0514; Rf = 0.35 (n-pentane/EtOAc 1/4). 
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Ester 8,9-cis-239 
 
A vial was charged with triol 8,9-cis-238 (35.0 mg, 77.6 μmol, dr = 1.4:1, 1.0 eq), β-amino acid 
237 (43.7 mg, 109 μmol, 1.4 eq) and DMAP (0.9 mg, 7.76 µmol, 0.1 eq). The vial was sealed, 
placed under vacuum, and backfilled with N2 (3 x). Dry CH2Cl2/DMF (800 µl, v/v = 7/1) was 
added and the resulting colorless solution was cooled with an ice bath. EDCI (20.8 mg, 
109 μmol, 1.4 eq) was then added and the homogenous solution was stirred at 0 °C for 20 h 
before being quenched by addition of sat. aqueous sodium bicarbonate (6 mL). The aqueous 
phase was extracted with EtOAc (3 x 10 mL), the combined organic layers were washed with 
brine (10 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (n-pentane/EtOAc 1/5 to 0/1) followed 
by preparative HPLC (Chromolith column, n-hexane/EtOAc 1/3 to 0/1, 25 mL/min, 254 nm) to 
afford ester 8,9-cis-239 (19.3 mg, 23.1 μmol, 30%) as a white foam, along with ester 8-epi-9-
epi-239 (8.5 mg, 10.2 μmol, 13%) as a colorless foam, ester 8,9-cis-240 (6.1 mg, 7.31 μmol, 9%) 
as a colorless oil, diester 8,9-cis-241 (13.4 mg, 11.0 μmol, 14%) as a colorless foam, and diester 
8-epi-9-epi-241 (21.7 mg, 17.8 μmol, 23%) as a pale yellow foam. 
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Ester 8,9-cis-239: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 2H), 7.84 (d, J = 8.0 Hz, 
1H), 7.43 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 7.9 Hz, 1H), 6.85 (d, J = 2.0 Hz, 1H), 6.67 (d, 
J = 2.0 Hz, 1H), 6.54 (s, 1H), 6.14 (d, J = 8.4 Hz, 1H), 5.69 (s, 1H), 5.40 (td, J = 8.9, 4.7 Hz, 
1H), 5.34 (dd, J = 7.2, 3.5 Hz, 1H), 4.54 – 4.43 (m, 1H), 4.06 (br. s, 1H), 4.01 (dd, J = 11.3, 
7.4 Hz, 1H), 3.80 (s, 3H), 3.75 (br. s, 1H), 2.87 – 2.72 (m, 2H), 2.57 – 2.43 (m, 5H), 1.98 (s, 
3H), 1.02 (s, 9H), 0.18 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 206.4, 170.3, 170.3, 
170.2, 151.6, 146.1, 143.8, 141.5, 140.4, 133.1, 132.4, 132.2, 131.7, 130.7, 130.3 (2C), 128.2 
(2C), 126.0, 125.4, 124.3, 119.1, 108.8, 86.3, 82.9, 67.9, 67.8, 55.5, 49.7, 47.8, 41.2, 25.8 (3C), 
23.3, 21.8, 18.8, -4.1 (2C) ppm; IR (ATR): ῦ = 3375, 2953, 2930, 2857, 1715, 1630, 1497, 1252, 
1176, 1054, 1006, 909, 837, 734, 669 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C39H4635Cl2NO11SSi]+: 834.1932, found: 834.19.1939; [α]D20 = .3 (c = 0.5, 
CHCl3); Rf = 0.62 (EtOAc). 
Ester 8-epi-9-epi-239: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.3 Hz, 2H), 7.83 (d, 
J = 8.0 Hz, 1H), 7.44 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 7.9 Hz, 1H), 6.87 (d, J = 2.0 Hz, 1H), 6.70 
(d, J = 2.0 Hz, 1H), 6.56 (s, 1H), 6.21 (d, J = 8.8 Hz, 1H), 5.68 (s, 1H), 5.52 – 5.43 (m, 1H), 5.27 
(dd, J = 8.0, 2.4 Hz, 1H), 4.50 (dd, J = 11.4, 2.7 Hz, 1H), 4.16 (br. s, 1H), 3.93 (dd, J = 11.4, 
8.1 Hz, 1H), 3.81 (s, 3H), 3.31 (br. s, 1H), 2.88 – 2.79 (m, 2H), 2.50 (s, 3H), 2.49 (s, 2H), 2.05 
(s, 3H), 1.03 (s, 9H), 0.19 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 206.2, 170.4, 170.2, 
170.0, 151.7, 146.2, 143.7, 141.5, 140.2, 133.1, 132.3, 132.3, 131.6, 130.6, 130.3 (2C), 128.2 
(2C), 126.0, 125.5, 124.3, 119.1, 108.9, 86.1, 82.9, 68.1, 67.8, 55.5, 49.6, 47.6, 41.1, 25.8 (3C), 
23.4, 21.8, 18.8, -4.1 (2C) ppm; IR (ATR): ῦ = 3352, 2929, 2857, 1716, 1630, 1497, 1252, 1177, 
1054, 1006, 901, 839, 570 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C39H4635Cl2NO11SSi]+: 
834.1932, found: 834.1935; Rf = 0.51 (EtOAc). 
Ester 8,9-cis-240: 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.3 Hz, 2H), 7.46 (d, J = 8.0 Hz, 
1H), 7.43 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 7.9 Hz, 1H), 6.89 (d, J = 2.0 Hz, 1H), 6.71 (d, 
J = 2.0 Hz, 1H), 6.56 (s, 1H), 6.35 (d, J = 8.3 Hz, 1H), 6.25 (dd, J = 6.5, 3.2 Hz, 1H), 5.64 (s, 
1H), 5.38 – 5.30 (m, 1H), 3.90 (dd, J = 12.4, 3.2 Hz, 1H), 3.80 (s, 4H), 3.24 (br. s, 1H), 2.98 (dd, 
J = 15.5, 7.3 Hz, 1H), 2.85 (dd, J = 15.5, 5.2 Hz, 1H), 2.50 (s, 3H), 2.48 (s, 2H), 1.97 (s, 3H), 
1.64 (br. s, 1H), 1.03 (s, 9H), 0.19 (s, 3H), 0.19 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
δ 206.1, 169.9, 169.9, 169.7, 151.6, 146.2, 144.0, 141.4, 137.2, 133.5, 132.3, 132.0, 131.9, 131.2, 
130.3 (2C), 128.2 (2C), 126.0, 125.7, 124.3, 119.1, 108.8, 86.1, 82.9, 73.5, 63.7, 55.5, 49.5, 47.6, 
40.4, 25.8 (3C), 23.4, 21.8, 18.8, -4.1, -4.1 ppm; IR (ATR): ῦ = 3342, 2930, 2857, 1715, 1632, 
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1497, 1252, 1176, 1054, 839, 734, 668, 569 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C39H4635Cl2NO11SSi]+: 834.1932, found: 834.1930; Rf = 0.37 (EtOAc). 
Diester 8,9-cis-241: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 2H), 7.47 – 7.37 (m, 
4H), 6.86 (d, J = 1.9 Hz, 1H), 6.80 (d, J = 1.9 Hz, 1H), 6.71 (d, J = 1.9 Hz, 1H), 6.65 (d, 
J = 1.9 Hz, 1H), 6.55 (s, 1H), 6.45 (d, J = 8.2 Hz, 1H), 6.32 (t, J = 6.0 Hz, 1H), 6.11 (d, 
J = 8.3 Hz, 1H), 5.65 (s, 1H), 5.30 (q, J = 7.2 Hz, 1H), 5.16 (q, J = 7.7 Hz, 1H), 4.55 (br. s, 1H), 
4.37 (dd, J = 11.5, 5.4 Hz, 1H), 4.27 (dd, J = 11.5, 6.7 Hz, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 2.98 
(dd, J = 15.8, 7.2 Hz, 1H), 2.82 (dd, J = 16.0, 5.9 Hz, 1H), 2.77 – 2.67 (m, 2H), 2.49 (s, 3H), 
2.39 (s, 2H), 1.95 (s, 3H), 1.90 (s, 3H), 1.02 (s, 9H), 1.02 (s, 9H), 0.20 – 0.16 (m, 12H) ppm; IR 
(ATR): ῦ = 3283, 2954, 2929, 2857, 1717, 1651, 1496, 1251, 1176, 1053, 908, 840, 733 cm-1; 
HRMS (ESI) calc’d. for [M+H]+ = [C57H72Cl3N2O15SSi2]+: 1217.3252, found: 1217.3251; 
Rf = 0.38 (EtOAc). 
Diester 8-epi-9-epi-241: 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.2 Hz, 2H), 7.48 – 7.40 (m, 
3H), 7.35 (d, J = 7.9 Hz, 1H), 6.88 (d, J = 1.5 Hz, 1H), 6.83 (d, J = 1.6 Hz, 1H), 6.73 – 6.71 (m, 
1H), 6.70 – 6.68 (m, 1H), 6.64 (d, J = 7.4 Hz, 1H), 6.54 (s, 1H), 6.43 (d, J = 8.2 Hz, 1H), 6.32 
(dd, J = 7.5, 3.2 Hz, 1H), 5.66 (s, 1H), 5.34 – 5.21 (m, 2H), 4.37 (dd, J = 11.9, 3.2 Hz, 1H), 4.19 
(dd, J = 12.0, 7.7 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.55 (br. s, 1H), 2.97 (dd, J = 15.9, 7.6 Hz, 
1H), 2.86 – 2.71 (m, 3H), 2.49 (s, 3H), 2.46 (s, 2H), 2.01 (s, 3H), 1.94 (s, 3H), 1.02 (s, 9H), 1.02 
(s, 9H), 0.18 (s, 6H), 0.17 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 206.1, 170.3, 169.7, 
169.6, 169.6, 169.5, 151.5, 151.5, 146.2, 144.6, 141.2, 141.2, 136.1, 133.7, 133.5, 132.3, 132.2, 
131.9 (2C), 131.3, 130.3 (2C), 128.2 (2C), 125.8, 125.8 (2C), 124.5, 119.1, 119.1, 108.9 (2C), 
86.2, 82.8, 70.0, 64.1, 55.4 (2C), 49.2, 49.1, 47.6, 39.8, 39.7, 25.8 (6C), 23.3, 23.3, 21.8, 18.8, -
4.0 (2C), -4.1 (2C) ppm; IR (ATR): ῦ = 3293, 2930, 2857, 1651, 1492, 1251, 1176, 1148, 1053, 
908, 840, 733 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C57H72Cl3N2O15SSi2]+: 1217.3252, 
found: 1217.3250; Rf = 0.33 (EtOAc). 
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Cyclization precursor 8,9-cis-236 
 
To an ice-cooled solution of ester 8,9-cis-239 (19.3 mg, 23.1 μmol, 1.0 eq) and glacial acetic 
acid (35.0 µl, 0.612 mmol, 26 eq) in dry THF (1.0 mL) was added a solution of TBAF (1.0 M in 
THF, 34.7 µl, 34.7 µmol, 1.5 eq) and the resulting colorless reaction mixture was stirred at 0 °C 
for 3 h before being quenched by addition of aqueous pH 7 phosphate buffer (3 mL). The 
aqueous phase was extracted with EtOAc (3 x 5 mL), the combined organic layers were washed 
with brine (5 mL), dried over MgSO4, filtered, and the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 1/3 to 0/1) 
to afford cyclization precursor 8,9-cis-236 (13.7 mg, 19.0 μmol, 82%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.3 Hz, 2H), 7.80 (d, J = 8.0 Hz, 1H), 7.44 (d, 
J = 8.0 Hz, 2H), 7.35 (d, J = 8.4 Hz, 1H), 6.84 (d, J = 1.8 Hz, 1H), 6.69 (d, J = 1.9 Hz, 1H), 6.54 
(s, 1H), 6.15 (d, J = 8.7 Hz, 1H), 5.93 (s, 1H), 5.68 (s, 1H), 5.41 – 5.31 (m, 2H), 4.47 (dd, 
J = 11.4, 3.7 Hz, 1H), 4.05 (dd, J = 11.4, 7.0 Hz, 1H), 3.89 (s, 3H), 3.87 – 3.81 (m, 1H), 3.73 (s, 
1H), 2.87 – 2.73 (m, 2H), 2.54 – 2.43 (m, 5H), 1.99 (s, 3H) ppm; 13C{1H} NMR (101 MHz, 
CDCl3) δ 206.3, 170.3, 170.2, 170.1, 147.6, 146.2, 143.8, 141.8, 140.3, 132.3, 132.3, 132.1, 
131.7, 130.8, 130.3, 128.2, 125.5, 124.3, 119.7, 119.1, 108.2, 86.3, 82.9, 67.8 (2C), 56.5, 49.6, 
47.8, 41.0, 23.3, 21.8 ppm; HRMS (ESI) calc’d. for [M+Na]+ = [C33H3135Cl2NNaO11S]+: 
742.0887, found: 742.0868; [α]D20 = .0 (c = 0.3, CHCl3); Rf = 0.29 (EtOAc). 
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Cyclization precursor 8,9-cis-242 
 
To a suspension of keto ester 8,9-cis-236 (5.5 mg, 7,63 µmol, 1.0 eq) and CeCl3•7H2O (4.3 mg, 
11.5 μmol, 1.5 eq) in dry THF/MeOH (0.4 mL, v/v = 1/1) was added NaBH4 (0.4 mg, 11.5 μmol, 
1.5 eq) at 78 °C and the resulting mixture was stirred for 2 h, maintaining a cooling-bath 
temperature of 78 °C to 65 °C. An additional portion of CeCl3•7H2O (4.3 mg, 11.5 μmol, 
1.5 eq) and NaBH4 (0.4 mg, 11.5 μmol, 1.5 eq) was then added and stirring was continued for 
1 h while the cooling-bath was allowed to warm to 50 °C. The reaction was then quenched by 
addition of acetone (0.2 mL), followed by addition of aqueous pH 7 phosphate buffer (3.0 mL). 
The aqueous phase was extracted with EtOAc (3 x 5 mL), the combined organic layers were 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (CH2Cl2/MeOH 15/1) to afford diastereomerically 
pure cyclization precursor 8,9-cis-242 (5.3 mg, 7.33 μmol, 96%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 8.0 Hz, 1H), 7.44 (d, 
J = 8.0 Hz, 2H), 7.16 (d, J = 8.4 Hz, 1H), 6.85 (d, J = 1.8 Hz, 1H), 6.69 (d, J = 1.9 Hz, 1H), 6.38 
(d, J = 1.5 Hz, 1H), 6.18 (d, J = 8.7 Hz, 1H), 5.92 (s, 1H), 5.59 (s, 1H), 5.58 (br. s, 1H), 5.41 (td, 
J = 8.1, 5.4 Hz, 1H), 5.30 – 5.24 (m, 1H), 4.45 (dd, J = 11.4, 3.2 Hz, 1H), 3.99 (dd, J = 11.5, 
7.3 Hz, 1H), 3.90 (s, 3H), 3.79 – 3.71 (m, 1H), 3.50 (s, 1H), 2.92 (s, 1H), 2.88 – 2.77 (m, 2H), 
2.50 (s, 4H), 2.03 (s, 3H), 1.73 (dd, J = 13.2, 6.6 Hz, 1H) ppm; HRMS (ESI) calc’d. for 
[M+Na]+ = [C33H3335Cl2NNaO11S]+: 744.1044, found: 744.1039; Rf = 0.15 (CH2Cl2/MeOH 
15/1). 
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Tris-silyl ether 9,11-trans-249 
 
Steps 1: To a solution of acetonide 8,9-cis-229 (75.0 mg, 153 μmol, dr = 1.2:1, 1.0 eq) in MeCN 
(4.0 mL) was added aqueous HCl (2 M, 2.0 mL, 4.00 mmol, 26 eq) and the resulting colorless 
solution was stirred at 23 °C for 1 h. The reaction mixture was then diluted with EtOAc (10 mL) 
and quenched by addition of sat. aqueous sodium bicarbonate (10 mL). The aqueous phase was 
extracted with EtOAc (3 x 10 mL), the combined organic layers were washed with brine 
(10 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
Crude keto triol 8,9-cis-238 was obtained as an off-white solid and was used in the next step 
without further purification. 
Rf = 0.35 (n-pentane/EtOAc 1/4). 
Steps 2: To a solution of crude keto triol 8,9-cis-238 (synthesized from 153 μmol 8,9-cis-229) 
and CeCl3•7H2O (85.5 mg, 230 μmol, 1.5 eq) in dry THF/MeOH (5.0 mL, v/v = 1/1) was added 
NaBH4 (8.7 mg, 230 μmol, 1.5 eq) at  °C and the resulting mixture was stirred for 40 min 
before being quenched by addition of acetone (0.2 mL). The reaction mixture was allowed to 
warm to ambient temperature over 15 min before aqueous pH 7 phosphate buffer (10 mL) was 
added. The aqueous phase was extracted with EtOAc (3 x 10 mL), the combined organic layers 
were washed with brine (10 mL), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. Crude tetrol 8,9-cis-245 was obtained as an off-white solid and used in the 
next step without further purification. 
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Rf = 0.36 (EtOAc). 
Step 3: To an ice-cooled solution of crude tetrol 8,9-cis-245 (synthesized from 153 μmol 8,9-
cis-229) in dry CH2Cl2/THF (5.5 mL, v/v = 10/1) was subsequently added freshly distilled 2,6-
lutidine (300 μL, 2.58 mmol, 17 eq) and TBSOTf (176 μL, 0.765 mmol, 5.0 eq). The resulting 
solution was stirred at 0 °C for 1 h before being quenched by addition of sat. aqueous sodium 
bicarbonate (10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL), the combined 
organic layers were dried over MgSO4, filtered, and the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane/Et2O 5/1) to afford 
an inseparable 1.1:1 diastereomeric mixture of tris-silyl ether 9,11-trans-249 (105 mg, 
132 μmol, 86%) as a white foam.  
Characterization data for inseparable 1.1:1 diastereomeric mixture of tris-silyl ether 9,11-trans-
249: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, 2H), 7.90 (d, J = 8.0 Hz, 2H), 7.52 (d, J = 7.9 Hz, 
1H), 7.51 (d, J = 7.9 Hz, 1H), 7.43 (d, J = 8.0 Hz, 4H), 7.18 (d, J = 7.9 Hz, 1H), 7.15 (d, 
J = 7.9 Hz, 1H), 6.30 (d, J = 1.5 Hz, 1H), 6.28 (d, J = 1.5 Hz, 1H), 5.65 (s, 1H), 5.63 (s, 1H), 
5.53 (t, J = 5.9 Hz, 2H), 5.17 (dt, J = 8.0, 3.3 Hz, 2H), 3.62 (ddd, J = 9.9, 6.4, 3.3 Hz, 2H), 3.48 
(dt, J = 10.5, 7.8 Hz, 2H), 2.55 (d, J = 10.0 Hz, 2H), 2.49 (s, 6H), 2.35 – 2.24 (m, 2H), 1.69 (ddd, 
J = 13.1, 8.5, 6.6 Hz, 2H), 0.92 (s, 18H), 0.87 (s, 18H), 0.87 (s, 18H), 0.13 (s, 6H), 0.11 (s, 6H), 
0.08 (s, 6H), 0.02 (s, 9H), 0.01 (s, 3H), -0.05 (s, 3H), -0.05 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 145.7 (2C), 144.3, 144.2, 142.9, 142.8, 141.8 (2C), 132.7, 132.7, 132.1, 
132.0, 132.0 (2C), 130.1 (4C), 129.5, 129.3, 128.4, 128.3, 128.3 (4C), 123.5, 123.5, 91.3, 90.9, 
84.6, 84.5, 81.3, 81.2, 72.5, 72.4, 68.3, 68.3, 48.3, 48.3, 26.0 (6C), 25.8 (6C), 25.8 (6C), 21.7 
(2C), 18.4 (2C), 18.3, 18.2, 18.1 (2C), -4.7 (3C), -4.7, -4.8, -4.8, -5.0, -5.0, -5.3, -5.3, -5.4, -5.4 
ppm; HRMS (ESI) calc’d. for [M+Na]+ = [C39H6335ClNaO7SSi3]+: 817.3183, found: 817.3184; 
Rf = 0.27 (n-pentane/Et2O 5/1). 
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Mono-silyl ether 9,11-trans-252 
 
To an ice-cooled solution of tris-silyl ether 9,11-trans-249 (16.5 mg, 20.7 μmol, dr = 1.1:1, 
1.0 eq) in dry CH2Cl2/MeOH (0.5 mL, v/v = 1/1) was added CSA (1.0 mg, 4.15 μmol, 0.2 eq), 
and the resulting colorless solution was stirred at 0 °C for 5 h. The reaction was then quenched 
by addition of sat. aqueous sodium bicarbonate (4 mL) followed by a solution of 1,3,5-TMB 
(1 M in EtOAc, 0.40 mL, 40.0 μmol) as internal standard. The aqueous phase was extracted with 
CH2Cl2 (3 x 5 mL), the combined organic layers were dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. After determination of the crude 1H NMR yield 
(74%) the crude product was purified by flash chromatography (n-pentane/EtOAc 1/1 to 1/2) to 
afford a 1.4:1 diastereomeric mixture of mono-silyl ether 9,11-trans-252 (7.6 mg, 13.6 μmol, 
65%) as a colorless oil. 
Characterization data for a 1.4:1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) δ 7.96 
– 7.91 (m, 4H), 7.61 (d, J = 2.6 Hz, 1H), 7.48 (d, J = 3.6 Hz, 1H), 7.43 (d, J = 8.2 Hz, 4H), 7.23 
(d, J = 8.0 Hz, 1H), 7.18 (d, J = 7.8 Hz, 1H), 6.40 (d, J = 1.2 Hz, 1H), 6.39 (d, J = 1.2 Hz, 1H), 
5.60 – 5.50 (m, 4H), 5.23 (dt, J = 6.3, 3.3 Hz, 2H), 3.75 – 3.64 (m, 2H), 3.51 – 3.43 (m, 2H), 
2.50 (s, 9H), 1.80 (s, 4H), 1.71 (dd, J = 13.1, 6.6 Hz, 3H), 0.92 (s, 18H), 0.10 (s, 3H), 0.09 (s, 
3H), -0.07 (s, 6H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 145.8, 145.8, 145.1, 145.0, 143.5, 
143.4, 140.8, 138.6, 132.6, 132.5, 132.1, 132.1, 131.3, 131.3, 130.2 (2C), 130.2 (2C), 130.1, 
129.4, 129.2, 128.6, 128.2 (2C), 128.2 (2C), 123.8, 123.7, 91.5, 91.1, 84.4, 84.3, 81.2, 81.1, 71.8, 
71.7, 66.9, 66.9, 48.1, 48.0, 25.8 (6C), 21.8 (2C), 18.2, 18.1, -4.7 (2C), -5.0, -5.0 ppm; 
Rf (diastereomer 1) = 0.53 (n-pentane/EtOAc 1/2); Rf (diastereomer 2) = 0.45 
(n-pentane/EtOAc 1/2). 
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MOM ether 9,11-trans-253 
 
Step 1: To a solution of acetonide 8,9-cis-229 (75.0 mg, 153 μmol, dr = 1.2:1, 1.0 eq) and 
CeCl3•7H2O (85.0 mg, 229 μmol, 1.5 eq) in dry THF/MeOH (3.1 mL, v/v = 1/1) was added 
NaBH4 (8.7 mg, 229 μmol, 1.5 eq) at  °C and the resulting mixture was stirred for 45 min 
before being quenched by addition of acetone (0.5 mL). The reaction mixture was allowed to 
warm to ambient temperature over 15 min before aqueous pH 7 phosphate buffer (10 mL) was 
added. The aqueous phase was extracted with EtOAc (3 x 10 mL), the combined organic layers 
were dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/EtOAc 2/3) to afford a 1.2:1 
diastereomeric mixture of diol 9,11-trans-342 (72.0 mg, 146 μmol, 96%) as an off-white solid, 
which was directly subjected to the subsequent reaction conditions. 
HRMS (ESI) calc’d. for [M-OH]+ = [C324H2435ClO6S]+: 475.0977, found: 475.0971; Rf = 0.36 
(n-pentane/EtOAc 2/3) 
Step 2: To an ice-cooled solution of diol 9,11-trans-342 (70 mg, 142 μmol, dr = 1.2:1, 1.0 eq) 
in dry CH2Cl2 (1.4 mL) was added EtN(iPr)2 (37.2 µl, 213 μmol, 1.5 eq) and a solution of 
MOMCl164 (~3.6 M in CH2Cl2, 59.2 µl, 213 μmol, 1.5 eq). The resulting mixture was stirred at 
0 °C for 5 min and was then allowed to warm to 23 °C. After 3 h, additional EtN(iPr)2 (37.2 µl, 
213 μmol, 1.5 eq) and a solution of MOMCl (~3.6 M in CH2Cl2, 59.2 µl, 213 μmol, 1.5 eq) was 
added and stirring was continued at 23 °C for 13 h. The reaction was then quenched by addition 
of sat. aqueous bicarbonate (5 mL) and stirred at 23 °C for 15 min in order to decompose residual 
MOMCl. The aqueous phase was then extracted with CH2Cl2 (3 x 5 mL), the combined organic 
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layers were dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (n-pentane/EtOAc 3/1 to 2/1 to 1/1) to 
afford an inseparable 1.2:1 diastereomeric mixture of MOM ether 9,11-trans-253 (42.6 mg, 
79.3 μmol, 56%) as an colorless oil, along with unreacted diol 9,11-trans-342 (16.9 mg, 
34.3 μmol, 24%) as an off-white solid. 
Characterization data for inseparable 1.2:1 diastereomeric mixture of MOM ether 9,11-trans-
253: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 4H), 7.56 (d, J = 7.9 Hz, 2H), 7.43 (d, 
J = 8.0 Hz, 4H), 7.18 (t, J = 8.3 Hz, 2H), 6.45 – 6.41 (m, 2H), 5.65 (s, 1H), 5.62 (s, 1H), 5.45 – 
5.35 (m, 4H), 4.73 (s, 2H), 4.73 (s, 2H), 4.54 (ddd, J = 14.4, 8.3, 6.6 Hz, 2H), 3.63 – 3.53 (m, 
2H), 3.40 (s, 3H), 3.40 (s, 3H), 2.61 (br. s, 1H), 2.57 (br. s, 1H), 2.53 – 2.41 (m, 8H), 1.84 (ddd, 
J = 16.2, 13.1, 6.7 Hz, 2H), 1.55 (s, 3H), 1.53 (s, 3H), 1.50 (s, 3H), 1.50 (s, 3H) ppm; 13C{1H} 
NMR (101 MHz, CDCl3) δ 145.8, 145.7, 145.0, 145.0, 143.6, 143.5, 140.2, 140.0, 132.6, 132.6, 
132.3 (2C), 130.2 (4C), 129.9, 129.7, 128.3, 128.2 (5C), 127.6, 127.5, 123.9, 123.9, 109.9 (2C), 
96.4 (2C), 91.0, 90.7, 86.8 (2C), 84.4, 84.3, 74.6 (2C), 70.2, 70.1, 55.5, 55.5, 45.7, 45.6, 26.3, 
26.2, 25.6, 25.5, 21.7 (2C) ppm; HRMS (ESI) calc’d. for [M+Na]+ = [C26H2935ClNaO8S]+: 
559.1164, found: 559.1169; Rf = 0.36 (n-pentane/EtOAc 2/1). 
 
Bis-silyl ether 9,11-trans-254 
 
Step 1: To a solution of acetonide 9,11-trans-253 (75.4 mg, 140 μmol, dr = 1.2:1, 1.0 eq) in 
MeCN (3.7 mL) was added aqueous HCl (1 M, 1.82 mL, 1.82 mmol, 13 eq) and the resulting 
colorless solution was stirred at 23 °C for 3 h. The reaction mixture was then diluted with EtOAc 
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(10 mL) and quenched by addition of sat. aqueous sodium bicarbonate (8 mL). The aqueous 
phase was extracted with EtOAc (3 x 10 mL), the combined organic layers were washed with 
brine (10 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
Crude triol 9,11-trans-343 was obtained as an off-white solid and was used in the next step 
without further purification. 
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 4H), 7.55 (d, J = 8.1 Hz, 1H), 7.54 (d, 
J = 7.8 Hz, 1H), 7.43 (d, J = 8.2 Hz, 4H), 7.19 (d, J = 7.6 Hz, 1H), 7.17 (d, J = 7.8 Hz, 1H), 6.45 
(d, J = 1.4 Hz, 1H), 6.44 (d, J = 1.5 Hz, 1H), 5.64 (s, 1H), 5.61 (s, 1H), 5.43 – 5.34 (m, 2H), 5.25 
(dd, J = 7.7, 2.9 Hz, 2H), 4.77 – 4.71 (m, 4H), 3.88 (ddd, J = 9.7, 6.5, 3.0 Hz, 2H), 3.57 – 3.45 
(m, 2H), 3.43 – 3.39 (m, 6H), 2.49 (s, 8H), 1.84 (ddd, J = 17.4, 13.2, 6.7 Hz, 4H), 1.65 (br. s, 
4H) ppm; Rf = 0.28 (n-pentane/EtOAc 1/2). 
Step 2: To an ice-cooled solution of crude triol 9,11-trans-343 (synthesized from 140 μmol 9,11-
trans-253) in dry CH2Cl2 (1.5 mL) was subsequently added freshly distilled 2,6-lutidine (107 μL, 
0.918 mmol, 6.0 eq) and TBSOTf (105 μL, 0.459 mmol, 3.0 eq). The resulting solution was 
stirred at 0 °C for 1 h before being quenched by addition of sat. aqueous sodium bicarbonate 
(8 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL), the combined organic layers 
were dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/Et2O 2/1 to 1.5/1) to afford an 
inseparable 1.1:1 diastereomeric mixture of bis-silyl ether 9,11-trans-254 (70.0 mg, 96.5 μmol, 
69% over 2 steps) as a yellow oil. 
Characterization data for inseparable 1.1:1 diastereomeric mixture of bis-silyl ether 9,11-trans-
254: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.4 Hz, 2H), 7.93 (d, J = 8.4 Hz, 2H), 7.54 (d, 
J = 7.8 Hz, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 8.2 Hz, 4H), 7.19 (d, J = 8.0 Hz, 1H), 7.16 
(d, J = 7.9 Hz, 1H), 6.44 (d, J = 1.5 Hz, 1H), 6.42 (d, J = 1.5 Hz, 1H), 5.65 (s, 1H), 5.63 (s, 1H), 
5.40 – 5.35 (m, 2H), 5.20 – 5.15 (m, 2H), 4.76 – 4.70 (m, 4H), 3.62 (ddd, J = 10.5, 4.7, 3.4 Hz, 
2H), 3.54 – 3.41 (m, 2H), 3.40 (s, 6H), 2.61 (br. s, 1H), 2.58 (br. s, 1H), 2.49 (s, 6H), 2.47 – 2.41 
(m, 2H), 1.86 – 1.77 (m, 2H), 0.87 (s, 27H), 0.86 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H), 0.02 (s, 3H), 
0.01 (s, 3H), 0.01 (s, 3H), -0.00 (s, 3H), -0.04 (s, 3H), -0.05 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 145.7 (2C), 145.4, 145.4, 143.2, 143.0, 142.0, 141.8, 132.6, 132.6, 131.9, 
131.8, 130.1 (2C), 130.1 (2C), 129.6, 129.5, 129.4, 129.3, 128.4, 128.4, 128.2 (4C), 123.6, 123.5, 
96.4, 96.3, 90.9, 90.6, 86.8, 86.7, 84.5, 84.4, 72.5, 72.3, 68.4 (2C), 55.5 (2C), 45.7 (2C), 25.9 
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(3C), 25.9 (3C), 25.8 (6C), 21.7 (2C), 18.4, 18.4, 18.3, 18.2, -4.7, -4.7, -5.0, -5.0, -5.3, -5.3, -5.4 
(2C) ppm; HRMS (ESI) calc’d. for [M+Na]+ = [C35H5335ClNaO8SSi2]+: 747.2580, found: 
747.2581; Rf = 0.24 (n-pentane/Et2O 2/1).  
 
Primary alcohols 255a and 255b 
 
To an ice-cooled solution of bis-silyl ether 9,11-trans-254 (70.0 mg, 96.5 μmol, dr = 1.1:1, 
1.0 eq) in dry CH2Cl2/MeOH (2.3 mL, v/v = 1/1) was added CSA (4.5 mg, 19.3 μmol, 0.2 eq), 
and the resulting colorless solution was stirred at 0 °C. After 6 h, the reaction was quenched by 
addition of sat. aqueous sodium bicarbonate (6 mL). The aqueous phase was extracted with 
CH2Cl2 (3 x 10 mL), the combined organic layers were dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/Et2O 1/1 to 1/2) to afford diastereomerically pure alcohol 255a 
(25.5 mg, 41.7 μmol, 43%) as white solid, along with its 8-epi-9-epi-11-epi diastereomer 255b 
(22.0 mg, 36.0 μmol, 37%) as a colorless oil. 
Undesired diastereomer 255a: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 2H), 7.47 (d, 
J = 7.9 Hz, 1H), 7.42 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 8.0 Hz, 1H), 6.45 (d, J = 1.5 Hz, 1H), 5.58 
(s, 1H), 5.41 – 5.35 (m, 1H), 5.22 (dd, J = 6.6, 3.2 Hz, 1H), 4.73 (s, 2H), 3.71 (dd, J = 11.3, 
3.3 Hz, 1H), 3.47 (dd, J = 11.3, 6.7 Hz, 1H), 3.40 (s, 3H), 2.64 (br. s, 1H), 2.51 – 2.44 (m, 4H), 
2.04 (br. s, 1H), 1.82 (dd, J = 13.1, 6.8 Hz, 1H), 0.91 (s, 9H), 0.09 (s, 3H), -0.07 (s, 3H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 145.7, 145.2, 143.4, 140.7, 132.5, 132.2, 130.2 (2C), 129.7, 
129.1, 128.2 (2C), 128.1, 123.6, 96.3, 90.5, 86.6, 84.4, 71.7, 66.8, 55.5, 45.7, 25.8 (3C), 21.7, 
18.1, -4.7, -5.0 ppm; IR (ATR): ῦ = 3426, 2952, 2929, 286, 1634, 1253, 1177, 1100, 1045, 1031, 
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836, 669 cm-1; HRMS (ESI) calc’d. for [M+Na]+ = [C29H3935ClNaO8SSi]+: 633.1716, found: 
633.1719; [α]D20 = .7 (c = 0.5, CHCl3); Rf = 0.48 (n-pentane/Et2O 1/2). 
Desired diastereomer 255b: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 2H), 7.49 (d, 
J = 7.9 Hz, 1H), 7.42 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 7.9 Hz, 1H), 6.43 (d, J = 1.5 Hz, 1H), 5.66 
(s, 1H), 5.37 (t, J = 6.7 Hz, 1H), 5.22 (dd, J = 7.3, 3.1 Hz, 1H), 4.75 – 4.70 (m, 2H), 3.66 (dd, 
J = 11.3, 3.1 Hz, 1H), 3.45 – 3.41 (m, 1H), 3.39 (s, 3H), 2.65 (br. s, 1H), 2.49 (s, 3H), 2.43 (dd, 
J = 13.1, 5.6 Hz, 1H), 2.05 (br. s, 1H), 1.80 (dd, J = 13.1, 6.7 Hz, 1H), 0.91 (s, 9H), 0.09 (s, 3H), 
-0.08 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 145.7, 145.3, 143.6, 140.7, 132.6, 132.2, 
130.1 (2C), 129.7, 129.3, 128.2 (2C), 128.1, 123.8, 96.4, 90.9, 86.8, 84.3, 71.8, 66.9, 55.5, 45.6, 
25.8 (3C), 21.7, 18.2, -4.7, -5.0 ppm; IR (ATR): ῦ = 3431, 2952, 2929, 2856, 1363, 1254, 1177, 
1101, 1046, 1030, 836, 669 cm-1; HRMS (ESI) calc’d. for [M+Na]+ = [C29H3935ClNaO8SSi]+: 
633.1716, found: 633.1713; [α]D20 = .0 (c = 0.5, CHCl3); Rf = 0.26 (n-pentane/Et2O 1/2). 
 
TES Protected β-amino acid 256 
 
To a suspension of β-amino acid 64 (250 mg, 0.869 mmol, 1.0 eq) and DMAP (10.6 mg, 
86.9 μmol) in dry THF (5.0 mL) was added triethylamine (363 μl, 2.61 mmol, 2.4 eq). The 
suspension was stirred at 23 °C for 10 min resulting in a partial dissolution of the starting 
material. The suspension was then cooled to 0 °C and a solution of TESCl (350 μl, 2.09 mmol, 
2.4 eq) in dry THF (3.0 mL) was added dropwise. The resulting suspension was then allowed to 
warm to 23 °C and stirred for 2 h before the reaction was quenched by addition of sat. aqueous 
ammonium chloride (10 mL). The aqueous phase was extracted with EtOAc (3 x 10 mL), the 
combined organic layers were dried over MgSO4, filtered, and the solvent removed under 
reduced pressure. The crude product was purified by flash chromatography 
(CH2Cl2/MeOH/AcOH 30/1/0 to 30/1/0.3) to afford TES protected β-amino acid 256 (314 mg, 
0.717 mmol, 83 %) as a pale yellow foam. 
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1H NMR (400 MHz, CDCl3) δ 6.89 – 6.87 (m, 1H), 6.71 (s, 1H), 6.44 (d, J = 7.9 Hz, 1H), 5.40 
– 5.32 (m, 1H), 3.80 (s, 3H), 2.99 – 2.80 (m, 2H), 2.04 (s, 3H), 0.98 (t, J = 7.9 Hz, 9H), 0.75 (q, 
J = 8.6, 8.0 Hz, 6H) ppm (the exchangeable carboxylic acid proton was not detected in CDCl3); 
13C{1H} NMR (101 MHz, Acetone-d6) δ (mixture of rotamers) 172.3 (2C), 170.0, 170.0, 152.4, 
149.2, 143.0, 141.5, 136.9, 134.8, 125.7 (2C), 120.5, 120.2, 110.2, 110.0, 56.7, 56.1, 50.5, 50.5, 
41.4 (2C), 23.0 (2C), 7.1 (3C), 7.1 (3C), 6.6 (3C), 6.2 (3C) ppm; IR (ATR): ῦ = 3283, 2955, 
2915, 2877, 1720, 1617, 1573, 1498, 1285, 1237, 1053, 1006, 897, 739 cm-1; HRMS (ESI) 
calc’d. for [M+H]+ = [C18H2935ClNO5Si]+: 402.1498, found: 402.1490; [α]D20 = 127.7 (c = 1.0, 
CHCl3); Rf = 0.40 (CH2Cl2/MeOH/AcOH 10/1/0.1). 
 
TES Protected ester 258 
 
A vial was charged with alcohol 255b (22.0 mg, 36.0 μmol, 1.0 eq), β-amino acid 256 (20.3 mg, 
50.4 μmol, 1.4 eq) and DMAP (1.1 mg, 9.00 µmol, 25 mol%). The vial was sealed, placed under 
vacuum, and backfilled with N2 (3 x). Dry CH2Cl2 (360 µl) was added and the resulting colorless 
solution was cooled with an ice bath. EDCI (9.0 mg, 46.8 μmol, 1.3 eq) was then added and the 
homogenous solution was stirred at 0 °C for 4 h before being quenched by addition of sat. 
aqueous sodium bicarbonate (6 mL). The aqueous phase was extracted with EtOAc (4 x 10 mL), 
the combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered, and 
the solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 1/1 to 0/1) to afford TES protected ester 257 (17.9 mg, 
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18.0 μmol, 50%) as a colorless oil, along with free phenol 258 (7.9 mg, 9.01 μmol, 25%) as a 
colorless oil. 
TES protected ester 257: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.3 Hz, 2H), 7.51 (d, 
J = 8.0 Hz, 1H), 7.41 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 7.4 Hz, 1H), 6.80 (d, J = 2.0 Hz, 1H), 6.65 
(d, J = 2.0 Hz, 1H), 6.42 (d, J = 1.5 Hz, 1H), 6.22 (d, J = 8.3 Hz, 1H), 5.66 (s, 1H), 5.41 – 5.31 
(m, 2H), 5.22 – 5.14 (m, 1H), 4.75 – 4.70 (m, 2H), 4.12 (dd, J = 10.9, 5.5 Hz, 1H), 4.04 (dd, 
J = 10.9, 6.7 Hz, 1H), 3.78 (s, 3H), 3.40 (s, 3H), 2.82 – 2.71 (m, 2H), 2.49 (s, 3H), 2.37 (dd, 
J = 13.0, 5.5 Hz, 1H), 1.91 (s, 3H), 1.75 (dd, J = 13.0, 6.7 Hz, 1H), 0.98 (t, J = 7.9 Hz, 9H), 0.86 
(s, 9H), 0.74 (q, J = 7.9 Hz, 6H), 0.05 (s, 3H), -0.07 (s, 3H) ppm; 13C{1H} NMR (101 MHz, 
CDCl3) δ 170.4, 169.4, 151.5, 145.8, 145.5, 144.1, 141.3, 140.6, 133.7, 132.9, 132.4, 130.0 (2C), 
129.4, 129.2, 128.5, 128.2 (2C), 125.8, 124.0, 119.0, 108.8, 96.4, 90.7, 86.9, 84.3, 68.3, 68.2, 
55.5, 55.5, 49.1, 45.7, 39.9, 25.6 (3C), 23.1, 21.7, 18.1, 6.7 (3C), 5.5 (3C), -5.0, -5.1 ppm; IR 
(ATR): ῦ = 3302, 2953, 2932, 2879, 1741, 1656, 1497, 1253, 1177, 1051, 836, 669 cm-1; HRMS 
(ESI) calc’d. for [M+Na]+ = [C47H6535Cl2NNaO12SSi2]+: 1016.3035, found: 1016.3032; 
[α]D20 = .0 (c = 0.5, CHCl3); Rf = 0.16 (n-pentane/EtOAc 1/1). 
 
Cyclization precursor 258 
 
To a solution of TES aryl ether 257 (15 mg, 15.1 μmmol, 1.0 eq) in MeCN/H2O (1.5 mL, 
v/v = 95/5) was added DBU (2.25 µl, 15.1 μmol, 1.0 eq) and the reaction mixture was stirred at 
23 °C for 30 min before being quenched by addition of sat. aqueous ammonium chloride (5 mL). 
The aqueous phase was extracted with EtOAc (3 x 5 mL), the combined organic layers were 
washed with brine (5 mL), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography (n-pentane/EtOAc 
1/3) to afford cyclization precursor 258 (11.2 mg, 12.7 μmol, 84%) as a colorless oil. 
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Cyclization precursor 258: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.3 Hz, 2H), 7.49 (d, 
J = 8.0 Hz, 1H), 7.42 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 8.0 Hz, 1H), 6.80 (d, J = 1.8 Hz, 1H), 
6.67 (d, J = 2.0 Hz, 1H), 6.42 (d, J = 1.5 Hz, 1H), 6.36 (br. d, J = 8.3 Hz, 1H), 5.90 (s, 1H), 5.64 
(s, 1H), 5.40 - 5.31 (m, 2H), 5.20 - 5.12 (m, 1H), 4.75 - 4.70 (m, 2H), 4.12 (dd, J = 10.8, 5.3 Hz, 
1H), 4.05 (dd, J = 11.0, 6.3 Hz, 1H), 3.86 (s, 3H), 3.52 (br. s, 1H), 3.40 (s, 3H), 2.76 (dd, J = 6.0, 
3.8 Hz, 2H), 2.49 (s, 3H), 2.37 (dd, J = 13.1, 5.5 Hz, 1H), 1.93 (s, 3H), 1.75 (dd, J = 13.1, 
6.8 Hz, 1H), 0.85 (s, 9H), 0.03 (s, 3H), -0.08 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
 = 170.6, 169.5, 147.4, 145.7, 145.6, 144.0, 141.4, 140.5, 132.8, 132.7, 132.4, 130.1 (2C), 
129.5, 129.3, 128.4, 128.2 (2C), 123.9, 119.5, 119.0, 108.1, 96.4, 90.7, 86.9, 84.3, 68.3, 68.1, 
56.3, 55.5, 49.2, 45.7, 40.0, 25.6 (3C), 23.1, 21.7, 18.1, -5.0, -5.1 ppm; IR (ATR): ῦ = 3307, 
2952, 2930, 1738, 1657, 1504, 1364, 1287, 1176, 1099, 1049, 836, 669 cm-1; HRMS (ESI) 
calc’d. for [M+Na]+ = [C41H5135Cl2NNaO12SSi]+: 902.2170, found: 902.2171; [α]D20 = 30.0 
(c = 0.5, CHCl3); Rf = 0.28 (n-pentane/EtOAc 1/3). 
 
[2.6]Paracyclophanes 259 and 260 
 
Cyclization precursor 258 (15.2 mg, 17.3 μmol,1.0 eq) was loaded into a 20 mL microwave vial 
and azeotroped with toluene (3 x 3 mL). Activated powdered 4Å-MS (40 mg) were then added, 
followed by cesium carbonate (11.2 mg, 34.6.2 μmol, 2.0 eq). The vial was sealed, freshly 
distilled DMF (8.6 mL) was added, and the resulting mixture was stirred at 23 °C for 10 min 
under a N2 atmosphere before being heated to 100 °C. After 13 h the pale brown reaction mixture 
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was allowed to cool to 23 °C, filtered through a short pad of Celite, and the solvent was removed 
under reduced pressure (45 °C). Remaining amounts of DMF were removed by azeotropic 
evaporation with toluene (3 x 5 mL). The obtained brown solid was entirely dissolved in 
MeOH-d4 and subjected to 1H NMR analysis for determination of product ratios 
(259:260 = 1.5:1). The crude product was purified by flash chromatography (n-pentane/EtOAc 
1/3 to EtOAc/MeOH 20/1) to afford [2.6]paracyclophane 259 (5.6 mg, 7.9 μmol, 46%) as a 
colorless foam along with its atropisomer 260 (3.8 mg, 5.4 μmol, 31%) as a white solid. 
[2.6]paracyclophane 259: 1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 7.7 Hz, 1H), 6.62 (d, 
J = 7.7 Hz, 1H), 6.57 (d, J = 2.0 Hz, 1H), 6.53 (d, J = 1.2 Hz, 1H), 6.25 (d, J = 1.9 Hz, 1H), 5.79 
(d, J = 6.7 Hz, 1H), 5.60 – 5.52 (m, 1H), 5.42 (s, 1H), 5.05 (ddd, J = 10.6, 6.8, 3.4 Hz, 1H), 4.86 
– 4.82 (m, 2H), 4.76 – 4.65 (m, 2H), 3.71 (dd, J = 9.1, 3.1 Hz, 1H), 3.47 (s, 3H), 3.46 (s, 3H), 
2.98 (dd, J = 10.7, 3.2 Hz, 1H), 2.96 – 2.92 (m, 1H), 2.55 (dd, J = 12.6, 5.5 Hz, 1H), 2.23 – 2.16 
(m, 1H), 2.02 (s, 3H), 1.88 (br. s, 1H), 0.87 (s, 9H), 0.04 (s, 3H), -0.08 (s, 3H) ppm; 13C{1H} 
NMR (101 MHz, CDCl3)  = 169.3, 168.8, 154.3, 150.0, 145.1, 141.6, 139.2, 137.7, 135.7, 
131.1, 130.5, 129.8, 128.7, 126.3, 115.0, 110.1, 96.3, 92.6, 87.5, 84.6, 74.3, 65.8, 55.5, 54.5, 
51.1, 42.9, 39.9, 25.6 (3C), 23.4, 18.1, -5.0, -5.3 ppm; IR (ATR): ῦ = 3302, 2952, 2929, 1738, 
1656, 1563, 1148, 1109, 1050, 856, 839, 779 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C34H4435Cl2NO9Si]+: 708.2157, found: 708.2155; [α]D20 = 225.8 (c = 0.2, CHCl3); 
Rf = 0.29 (n-pentane/EtOAc 1/3). 
Atropisomer 260: 1H NMR (400 MHz, CDCl3) δ 6.95 (d, J = 7.6 Hz, 1H), 6.59 (d, J = 7.7 Hz, 
1H), 6.56 (d, J = 1.9 Hz, 1H), 6.55 – 6.52 (m, 1H), 6.40 (d, J = 1.9 Hz, 1H), 5.81 (d, J = 6.1 Hz, 
1H), 5.53 (t, J = 6.3 Hz, 1H), 5.38 (s, 1H), 4.95 (ddd, J = 10.9, 6.2, 3.5 Hz, 1H), 4.85 - 4.79 (m, 
2H), 4.73 (dd, J = 10.8, 4.1 Hz, 1H), 4.47 (t, J = 10.5 Hz, 1H), 3.94 (s, 3H), 3.74 (dd, J = 10.2, 
4.1 Hz, 1H), 3.45 (s, 3H), 3.06 (dd, J = 12.9, 7.1 Hz, 1H), 3.00 (dd, J = 13.7, 3.6 Hz, 1H), 2.54 
(dd, J = 12.9, 5.7 Hz, 1H), 2.29 (dd, J = 13.6, 11.5 Hz, 1H), 2.02 (s, 3H), 1.89 (br. s, 1H), 0.88 
(s, 9H), 0.04 (s, 3H), -0.06 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 169.5, 168.6, 
154.8, 149.0, 145.8, 141.9, 139.3, 136.3, 135.8, 131.3, 130.5, 130.4, 130.2, 125.9, 122.5, 105.9, 
96.5, 92.8, 88.1, 84.5, 74.4, 66.4, 56.1, 55.4, 51.5, 42.4, 39.3, 25.6 (3C), 23.5, 
18.1, -5.0, -5.2 ppm; IR (ATR): ῦ = 3299, 2073, 2953, 2893, 1737, 1656, 1146, 1110, 1051, 
857, 839, 880 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C34H4435Cl2NO9Si]+: 708.2157, found: 
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708.2156; [α]D20 = 376.7 (c = 0.1, CHCl3); m.p.: 177-182 °C (decomp.); Rf = 0.31 
(EtOAc/MeOH 10/1). 
 
Cyclization precursors 262a and 262b 
 
Steps 1: A vial was charged with keto alcohol 8,9-cis-261 (66.0 mg, 114 μmol, dr = 1:1, 1.0 eq), 
β-amino acid 256 (61.8 mg, 154 μmol, 1.4 eq) and DMAP (3.2 mg, 26.2 µmol, 23 mol%). The 
vial was sealed, placed under vacuum, and backfilled with N2 (3 x). Dry CH2Cl2 (1.1 mL) was 
added and the resulting colorless solution was cooled with an ice bath. EDCI (27.3 mg, 
142 μmol, 1.3 eq) was then added and the homogenous solution was stirred at 0 °C for 19 h 
before being quenched by addition of sat. aqueous ammonium chloride (8 mL). The aqueous 
phase was extracted with EtOAc (4 x 10 mL), the combined organic layers were washed with 
brine (10 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (n-pentane/EtOAc 1/1 to 1/2) to afford 
a 1:1 diastereomeric mixture of keto ester 8,9-cis-344 (85.7 mg, 90.2 μmol, 79%) as a colorless 
oil, which was directly subjected to the subsequent reaction conditions. 
Rf (diastereomer 1) = 0.36 (n-pentane/EtOAc 1/1); Rf (diastereomer 2) = 0.20 (n-pentane/EtOAc 
1/1). 
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Step 2: To a solution of keto ester 8,9-cis-344 (85.0 mg, 89.6 μmol, dr = 1:1, 1.0 eq) 
(synthesized from 114 μmol keto alcohol 8,9-cis-261) and CeCl3•7H2O (50.1 mg, 134 μmol, 
1.5 eq) in dry THF/MeOH (5.0 mL, v/v = 1/1) was added NaBH4 (5.1 mg, 134 μmol, 1.5 eq) at 
 °C and the resulting mixture was stirred for 40 min before being quenched by addition of 
acetone (0.3 mL). The reaction mixture was allowed to warm to ambient temperature over 15 
min before aqueous pH 7 phosphate buffer (10 mL) was added. The aqueous phase was extracted 
with EtOAc (3 x 10 mL), the combined organic layers were dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 1/2 to 1/3 to 0/1) followed by preparative HPLC (Chromolith 
column, n-hexane/EtOAc 1/1.3, 25 mL/min, 254 nm, tR(262a) = 11.8 min, tR(262b) = 16.6 min), 
to afford the desired cyclization precursor 262a (34.7 mg, 36.5 μmol, 41%) as a colorless oil, 
along with the diastereomeric cyclization precursor 262b (35.4 mg, 37.2 μmol, 42%) as a white 
foam. 
Desired cyclization precursor 262a: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 2H), 
7.52 (d, J = 7.8 Hz, 1H), 7.41 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 7.8 Hz, 1H), 6.80 (d, J = 2.0 Hz, 
1H), 6.65 (d, J = 2.0 Hz, 1H), 6.37 (d, J = 1.5 Hz, 1H), 6.26 (br. d, J = 8.3 Hz, 1H), 5.65 (s, 1H), 
5.54 (t, J = 5.6 Hz, 1H), 5.35 (t, J = 6.0 Hz, 1H), 5.21 - 5.13 (m, 1H), 4.12 (dd, J = 10.8, 5.5 Hz, 
1H), 4.04 (dd, J = 10.9, 6.7 Hz, 1H), 3.77 (s, 3H), 2.82 - 2.70 (m, 2H), 2.48 (s, 3H), 2.40 (dd, 
J = 13.1, 5.5 Hz, 1H), 1.91 (s, 3H), 1.63 (dd, J = 13.1, 6.8 Hz, 1H), 0.97 (t, J = 7.9 Hz, 9H), 
0.86 (s, 9H), 0.77 - 0.70 (m, 6H), 0.05 (s, 3H), -0.07 (s, 3H) ppm (both allylic alcohols were not 
detected in CDCl3); 13C{1H} NMR (101 MHz, CDCl3)  = 170.4, 169.5, 151.5, 145.6, 145.6, 
144.0, 141.3, 140.6, 133.7, 132.8, 132.4, 131.1, 130.1 (2C), 129.2, 128.5, 128.2 (2C), 125.8, 
124.0, 119.0, 108.8, 91.3, 84.4, 81.3, 68.3, 68.2, 55.5, 49.1, 48.0, 39.9, 25.6 (3C), 23.1, 21.7, 
18.1, 6.7 (3C), 5.5 (3C), -5.0, -5.1 ppm; IR (ATR): ῦ = 3315, 2954, 2932, 2878, 1740, 1652, 
1497, 1254, 1177, 837, 669 cm-1; HRMS (ESI) calc’d. for 
[M+Na]+ = [C45H6135Cl2NNaO11SSi2]+: 972.2773, found: 972.2776; [α]D20 = 44.0 (c = 0.5, 
CHCl3); Rf = 0.15 (n-hexane/EtOAc 1/2). 
Diastereomeric cyclization precursor 262b: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 
2H), 7.50 (d, J = 7.9 Hz, 1H), 7.42 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.0 Hz, 1H), 6.81 (d, 
J = 1.9 Hz, 1H), 6.67 (d, J = 2.0 Hz, 1H), 6.48 (d, J = 8.4 Hz, 1H), 6.38 (d, J = 1.4 Hz, 1H), 5.62 
(s, 1H), 5.54 (t, J = 5.6 Hz, 1H), 5.33 – 5.23 (m, 2H), 4.12 (dd, J = 11.1, 4.1 Hz, 1H), 3.99 (dd, 
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J = 11.1, 7.2 Hz, 1H), 3.78 (s, 3H), 2.89 – 2.75 (m, 2H), 2.69 (s, 1H), 2.49 (s, 4H), 2.09 (br. s, 
1H), 2.01 (s, 3H), 1.72 (dd, J = 13.2, 6.6 Hz, 1H), 0.98 (t, J = 7.9 Hz, 9H), 0.86 (s, 9H), 0.74 (q, 
J = 8.6, 7.9 Hz, 6H), 0.04 (s, 3H), -0.07 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 170.8, 
169.2, 151.6, 145.8, 144.9, 143.7, 141.3, 140.4, 133.6, 132.5, 132.1, 131.5, 130.2 (3C), 129.2, 
128.3, 128.2 (2C), 125.8, 123.9, 119.0, 108.8, 91.1, 84.3, 81.1, 68.8, 68.2, 55.5, 48.9, 48.1, 39.6, 
25.6 (3C), 23.4, 21.8, 18.1, 6.7 (3C), 5.5 (3C), -4.9, -5.0 ppm; IR (ATR): ῦ = 3304, 2954, 2931, 
2878, 1739, 1655, 1496, 1252, 1176, 1097, 836, 731, 669 cm-1; HRMS (ESI) calc’d. for 
[M+Na]+ = [C45H6135Cl2NNaO11SSi2]+: 972.2773, found: 972.2774; [α]D20 =  (c = 0.5, 
CHCl3); Rf = 0.15 (n-hexane/EtOAc 1/2). 
 
[2.6]Paracyclophanes 263 and 264 
 
Cyclization precursor 262a (30.0 mg, 31.5 μmol) was loaded into a 20 mL microwave vial and 
azeotroped with toluene (3 x 3 mL). Activated powdered 4Å-MS (85 mg) was then added, 
followed by freshly ground cesium fluoride (9.6 mg, 63.2 μmol) (glovebox). The vial was sealed, 
freshly distilled DMF (16 mL) was added, and the resulting mixture was stirred at 23 °C for 1 h 
under a N2 atmosphere before being heated to 100 °C. After 18 h, the slightly brownish reaction 
mixture was allowed to cool to ambient temperature, filtered through a short pad of Celite, and 
the solvent was removed under reduced pressure (45 °C). Remaining amounts of DMF were 
removed by azeotropic evaporation with toluene (3 x 5 mL). The obtained brown solid was 
entirely dissolved in MeOH-d4 and subjected to 1H NMR analysis for determination of product 
ratios (263:264 = 2.8:1). The crude product was purified by flash chromatography 
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(EtOAc/MeOH 1/0 to 20/1) to afford [2.6]paracyclophane 263 (12.8 mg, 19.3 μmol, 61%) as a 
white foam along with its atropisomer 264 (4.7 mg, 7.1 μmol, 22%) as a white solid. 
[2.6]paracyclophane 263: 1H NMR (400 MHz, CDCl3) δ = 7.17 (d, J = 7.5 Hz, 1 H), 6.62 (d, 
J = 7.8 Hz, 1H), 6.59 (d, J = 2.0 Hz, 1H), 6.52 (d, J = 1.3 Hz, 1H), 6.27 (d, J = 1.8 Hz, 1H), 
5.78 (d, J = 6.5 Hz, 1H), 5.70 (br. s, 1H), 5.41 (s, 1H), 5.06 (ddd, J = 11.2, 7.1, 3.5 Hz, 1H), 
4.74 (dd, J = 10.8, 4.2 Hz, 1H), 4.63 (t, J = 10.6 Hz, 1H), 3.72 (dd, J = 10.0, 4.0 Hz, 1H), 3.47 
(s, 3H), 2.97 (dd, J = 13.8, 3.3 Hz, 1H), 2.76 (dd, J = 13.2, 6.4 Hz, 1H), 2.62 (dd, J = 13.2, 
5.8 Hz, 1H), 2.20 (dd, J = 13.7, 11.7 Hz, 1H), 2.03 (s, 3H), 1.90 (br. s, 2H), 0.88 (s, 9H), 0.04 
(s, 3H), -0.07 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 169.3, 168.8, 154.1, 149.8, 
145.2, 141.6, 139.3, 137.7, 135.7, 131.1, 130.6, 130.3, 129.9, 126.2, 115.3, 110.2, 93.5, 84.1, 
82.4, 74.3, 66.0, 54.8, 51.0, 42.9, 42.2, 25.6 (3C), 23.4, 18.1, -5.0, -5.3 ppm; IR (ATR): 
ῦ = 3299, 2956, 2929, 1736, 1656, 1486, 1296, 1193, 1145, 1106, 853, 838, 753, 666 cm-1; 
HRMS (ESI) calc’d. for [M+H]+ = [C32H4035Cl2NO8Si]+: 664.1895, found: 664.1896; 
[α]D20 = 274.2 (c = 0.2, CHCl3); Rf = 0.36 (EtOAc). 
Atropisomer 264: 1H NMR (400 MHz, CDCl3) δ 6.94 (d, J = 7.8 Hz, 1H), 6.60 (d, J = 7.8 Hz, 
1H), 6.57 (d, J = 2.0 Hz, 1H), 6.47 (d, J = 1.3 Hz, 1H), 6.42 (d, J = 2.0 Hz, 1H), 5.79 (br. d, 
J = 6.3 Hz, 1H), 5.71 - 5.66 (m, 1H), 5.38 (s, 1H), 4.95 (ddd, J = 10.8, 6.7, 3.5 Hz, 1H), 4.74 
(dd, J = 10.7, 4.1 Hz, 1H), 4.44 (t, J = 10.5 Hz, 1H), 3.95 (s, 3H), 3.75 (dd, J = 10.3, 4.0 Hz, 
1H), 3.00 (dd, J = 13.7, 3.4 Hz, 1H), 2.87 - 2.80 (m, 1H), 2.64 (dd, J = 13.3, 5.8 Hz, 1H), 2.29 
(dd, J = 13.6, 11.5 Hz, 1H), 2.06 - 2.01 (m, 4H), 1.88 (br. s, 1H), 0.88 (s, 9H), 0.04 (s, 3H), -0.05 
(s, 3H); 13C{1H} NMR (101 MHz, CDCl3)  = 169.5, 168.6, 154.8, 149.1, 145.8, 141.8, 139.4, 
136.5, 135.7, 132.5, 130.6, 130.3, 129.9, 125.9, 122.4, 106.1, 93.6, 84.3, 82.7, 74.4, 66.5, 56.2, 
51.4, 42.4, 42.1, 25.6 (3C), 23.5, 18.1, -5.0, -5.2 ppm; IR (ATR): ῦ = 3304, 2953, 2930, 2857, 
1733, 1654, 1301, 1144, 1109, 1052, 855, 836, 732, 667 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C32H4035Cl2NO8Si]+: 664.1895, found: 664.1896; [α]D20 = 249.2 (c = 0.2, CHCl3); 
m.p.: 200 - 202 °C; Rf = 0.23 (EtOAc/MeOH 20/1). 
 
 
 
 
 
10. Experimental Section  239 
 
[2.6]Paracyclophanes 265 and 266 
 
Cyclization precursor 262b (35.0 mg, 37.8 μmol) was loaded into a 20 mL microwave vial and 
azeotroped with toluene (3 x 5 mL). Activated powdered 4Å-MS (100 mg) were then added, 
followed by freshly ground cesium fluoride (11.4 mg, 75.6 μmol) (glovebox). The vial was 
sealed, freshly distilled DMF (18 mL) was added, and the resulting mixture was stirred at 23 °C 
for 1 h under a N2 atmosphere before being heated to 100 °C. After 18 h, the slightly brownish 
reaction mixture was allowed to cool to ambient temperature, filtered through a short pad of 
Celite, and the solvent was removed under reduced pressure (45 °C). Remaining amounts of 
DMF were removed by azeotropic evaporation with toluene (3 x 5 mL). The obtained brown 
solid was entirely dissolved in MeOH-d4 and subjected to 1H NMR analysis for determination 
of product ratios (265:266 = 1.3:1). The crude product was purified by flash chromatography 
(pure EtOAc), followed by preparative HPLC (Chromolith column, n-hexane/EtOAc 1/2.5, 
25 mL/min, 254 nm, tR(minor) = 8.7 min, tR(major) = 10.4 min) to afford [2.6]paracyclophane 
265 (9.1 mg, 13.7 μmol, 37%) as a white foam along with its atropisomer 266 (6.8 mg, 
10.4 μmol, 28%) as a white foam. 
[2.6]paracyclophane 265: 1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.2 Hz, 1H), 7.19 (d, 
J = 7.9 Hz, 1H), 7.12 (d, J = 7.9 Hz, 1H), 6.73 (d, J = 1.9 Hz, 1H), 6.45 (d, J = 1.3 Hz, 1H), 6.06 
(d, J = 1.9 Hz, 1H), 5.71 - 5.64 (m, 1H), 5.40 (s, 1H), 5.38 (s, 1H), 5.11 (dt, J = 8.0, 4.0 Hz, 1H), 
4.30 (dd, J = 11.5, 1.4 Hz, 1H), 3.88 (dd, J = 11.5, 2.2 Hz, 1H), 3.34 (s, 3H), 2.78 - 2.58 (m, 3H), 
2.48 (dd, J = 14.8, 3.6 Hz, 1H), 2.01 (s, 5H), 0.87 (s, 9H), 0.04 (s, 3H), -0.05 (s, 3H) ppm; 
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13C{1H} NMR (101 MHz, CDCl3) δ 172.3, 169.2, 154.3, 149.8, 144.8, 141.8, 139.5, 138.0, 
133.6, 130.6, 129.4, 129.1, 126.7, 126.5, 119.0, 105.7, 93.5, 83.7, 82.3, 68.2, 67.7, 54.6, 49.4, 
42.5, 41.1, 25.7 (3C), 23.4, 18.1, -4.9, -5.2 ppm; IR (ATR): ῦ = 3408, 2953, 2930, 2857, 1720, 
1664, 1486, 1382, 1259, 1053, 834, 779 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C32H4035Cl2NO8Si]+: 664.1895, found: 664.1891; [α]D20 =  (c = 0.2, CHCl3); 
Rf = 0.33 (EtOAc).
Atropisomer 266: 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.3 Hz, 1H), 7.15 (d, J = 7.9 Hz, 
1H), 6.88 (d, J = 7.9 Hz, 1H), 6.51 (d, J = 2.0 Hz, 1H), 6.41 (d, J = 1.2 Hz, 1H), 6.35 (d, 
J = 2.0 Hz, 1H), 5.69 (s, 1H), 5.40 (s, 1H), 5.38 (s, 1H), 5.14 (dt, J = 8.1, 3.9 Hz, 1H), 4.10 (dd, 
J = 11.4, 1.3 Hz, 1H), 3.98 (s, 3H), 3.90 (dd, J = 11.4, 2.3 Hz, 1H), 2.78 - 2.69 (m, 2H), 2.64 
(dd, J = 13.3, 5.8 Hz, 1H), 2.51 (dd, J = 14.5, 3.7 Hz, 1H), 2.05 - 1.99 (m, 4H), 1.79 (br. s, 1H), 
0.87 (s, 9H), 0.05 (s, 3H), -0.05 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 171.8, 169.3, 
154.4, 149.4, 145.6, 141.4, 139.6, 137.2, 133.4, 131.4, 130.1, 129.1, 127.4, 126.0, 117.8, 108.6, 
93.3, 83.7, 82.6, 68.0, 67.9, 56.0, 49.3, 42.3, 41.1, 25.7 (3C), 23.4, 18.1, -4.9, -5.2 ppm; IR 
(ATR): ῦ = 3402, 2953, 2930, 2930, 2857, 1719, 1665, 1382, 1261, 1053, 946, 834, 755 cm-1; 
HRMS (ESI) calc’d. for [M+H]+ = [C32H4035Cl2NO8Si]+: 664.1895, found: 664.1894; 
[α]D20 =  (c = 0.2, CHCl3); Rf = 0.42 (EtOAc). 
 
Indenylcyclopentenone 149 
 
Step 1: To a stirred solution of chlorobenzene 196 (309 mg, 0.448 mmol, 1.0 eq) in dry THF 
(4.5 mL) was slowly added a solution of TBAF (1 M in THF, 2.24 mL, 2.24 mmol, 5.0 eq). The 
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reaction mixture instantaneously turned black and was stirred at 23 °C for 45 min before it was 
quenched by addition of sat. aqueous ammonium chloride (10 mL). The aqueous phase was 
extracted with Et2O (3 x 15 mL), the combined organic layers were washed with brine (15 mL), 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure (25 °C). Crude 
allene-yne 220 was obtained as a brown oil and was used in the next step without further 
purification. 
Rf = 0.40 (n-pentane/EtOAc 1/1). 
Step 2: To an ice-cooled solution of crude allene-yne 220 (synthesized from 0.448 mmol 196) 
in dry CH2Cl2 (4.5 mL) was subsequently added freshly distilled 2,6-lutidine (0.261 mL, 
2.24 mmol, 5.0 eq) and TBSOTf (0.257 mL, 1.12 mmol, 2.5 eq). The resulting solution was 
stirred at 0 °C for 1 h before being quenched by addition of saturated aqueous sodium 
bicarbonate (8 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL), the combined 
organic layers were dried over MgSO4, filtered, and the solvent was removed under reduced 
pressure (25 °C). Crude allene-yne 150 was obtained as an orange oil and was used in the next 
step without further purification. 
Rf = 0.43 (n-pentane/Et2O 50/1). 
Step 3: A two-neck round-bottom flask equipped with a reflux condenser was charged with 
Mo(CO)6 (177 mg, 0.672 mmol, 1.5 eq). A degassed and over 4Å-MS dried solution of allene-
yne 150 (synthesized from 0.448 mmol 196) and DMSO (318 µl, 4.48 mmol, 10 eq) in dry 
toluene (3.0 mL) was added. The resulting yellow suspension was placed in a pre-heated oil bath 
and stirred at 90 °C under a N2 atmosphere. After 20 min the reaction mixture was cooled to 0 °C 
in an ice bath and was directly purified by flash chromatography (n-pentane/Et2O 1/0 to 150/1 
to 66/1 to 15/1) to afford indenylcyclopentenone 149 (120 mg, 0.234 mmol, 52% over 3 steps) 
as an orange oil. 
1H NMR (400 MHz, CDCl3)  = 7.58 (d, J = 7.5 Hz, 1H), 7.13 (d, J = 7.5 Hz, 1H), 6.86 (d, 
J = 1.8 Hz, 1H), 6.44 (d, J = 1.5 Hz, 1H), 5.20 (dd, J = 7.0, 3.8 Hz, 1H), 3.68 (dd, J = 10.3, 
3.8 Hz, 1H), 3.58 (dd, J = 10.4, 7.2 Hz, 1H), 3.22 (d, J = 1.0 Hz, 2H), 0.89 (s, 9H), 0.87 (s, 9H) 
0.11 (s, 3H), 0.02 (s, 6H), -0.01 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 207.0, 169.1, 
148.6, 143.0, 137.7, 132.3, 131.0, 128.7, 128.0, 122.0, 120.0, 72.1, 68.6, 35.4, 25.9 (3C), 25.8 
(3C), 18.4, 18.3, -4.7, -4.9, -5.3, -5.4 ppm; IR (ATR): ῦ = 2954, 2929, 2857, 1717, 1608, 1471, 
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1255, 1131, 1099, 835, 728 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C26H40ClO3Si2]+: 
491.2199, found: 491.2201; [α]D26 = 131.7 (c = 0.5, CHCl3); Rf = 0.27 (n-pentane/Et2O 15/1). 
 
Diol 8,9-cis-281 
 
To an ice-cooled solution of indenylcyclopentenone 149 (523 mg, 1.07 mmol, 1.0 eq) in 
THF/H2O (11 mL, v/v = 10/1) was added (DHQ)2PHAL (87.0 mg, 0.106 mmol, 10 mol%), 
OsO4 (5% in H2O, 0.217 mL, 42.6 μmol, 4.0 mol%) and NMO (249 mg, 2.13 mmol, 2.0 eq). The 
resulting brown solution was stirred at 0 °C for 4 h, and was then quenched by addition of 
saturated aqueous sodium thiosulfate (20 mL). Stirring was continued for 10 min at 0 °C, and 
then for 15 min at 23 °C. The aqueous phase was extracted with EtOAc (3 x 20 mL), the 
combined organic layers were washed with brine, dried over MgSO4, filtered, and the solvent 
was removed under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane/EtOAc 3/1 to 2/1) to afford an inseparable 1:1.1 diastereomeric mixture of diol 8,9-
cis-281 (396 mg, 0.754 mmol, 71%) as a brown oil. 
Characterization data for inseparable 1:1.1 mixture of diastereomers: 1H NMR (400 MHz, 
CDCl3) = 7.81 (d, J = 7.8 Hz, 1H), 7.80 (d, J = 7.9 Hz, 1H), 7.51 (br. d, J = 7.9 Hz, 2H), 6.55 
(s, 1H), 6.54 (s, 1H), 5.27 - 5.20 (m, 2H), 5.09 (br. s, 1H), 5.06 (br. s, 1H), 3.70 - 3.64 (m, 2H), 
6.63 - 6.53 (m, 2H), 3.32 (br. s, 2H), 3.20 (br. s, 2H), 2.81 - 2.6 (m, 4H), 0.90 (s, 9H), 0.89 (s, 
9H), 0.87 (s, 9H), 0.86 (s, 9H), 0.11 (s, 6H), 0.02 (s, 6H), 0.00 (s, 6H), - 0.01 (s, 6H) ppm; 
13C{1H} NMR (101 MHz, CDCl3)  = 207.8 (2C), 173.0, 172.9, 149.5, 149.3, 141.8, 141.7, 
133.2, 133.1, 130.9, 130.8, 130.4 (2C), 124.4, 124.2, 123.8, 123.7, 86.4, 86.2, 77.4 (2C), 72.2, 
72.1, 68.3 (2C), 47.2 (2C), 25.9 (3C), 25.9 (3C), 25.8 (6C), 18.4, 18.4, 18.3, 18.2, -4.7 (2C), -4.9, 
-4.9, -5.3, -5.3, -5.4, -5.5 ppm; IR (ATR): ῦ = 3374, 2953, 2929, 2886, 1701, 1624, 1252, 1131, 
1099, 831, 776, 733 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C26H4235ClO5Si2]+: 525.2254, 
found: 525.2253; Rf = 0.33 (n-pentane/EtOAc 2/1). 
10. Experimental Section  243 
 
Tosylate 8,9-cis-275 
 
To an ice-cooled solution of diol 8,9-cis-281 (390 mg, 0.743 mmol, dr = 1:1, 1.0 eq) and DMAP 
(13.6 mg, 0.111 mmol, 0.15 eq) in freshly distilled pyridine (6.0 mL) was added TsCl (566 mg, 
2.97 mmol, 4.0 eq). The resulting yellow solution was allowed to warm to 23 °C and stirred for 
15 h. The brown reaction mixture was cooled to 0 °C and quenched by addition of water (15 mL) 
and EtOAc (15 mL). The biphasic mixture was stirred for additional 10 min at 23 °C before the 
aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic layers were 
washed with 1 M aq. HCl (2 x 40 mL), saturated aqueous sodium bicarbonate (15 mL), dried 
over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography (n-pentane/EtOAc 5/1) to afford an inseparable 1:1 
diastereomeric mixture of tosylate 8,9-cis-275 (464 mg, 0.683 mmol, 92 %) as a white solid. 
Characterization data for inseparable 1:1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) 
 = 7.95 (d, J = 8.5 Hz, 2H), 7.93 (d, J = 8.5 Hz, 2H), 7.78 (d, J = 7.8 Hz, 1H), 7.76 (d, 
J = 7.8 Hz, 1H), 7.44 (br. d, J = 8.5 Hz, 4H), 7.36 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 7.8 Hz, 1H), 
6.57 (s, 1H), 6.57 (s, 1H), 5.71 (s, 1H), 5.70 (s, 1H), 5.24 - 5.18 (m, 2H), 3.67 - 3.63 (m, 2H), 
3.60 - 3.50 (m, 2H), 2.90 (br. s, 1H), 2.87 (br. s, 1H), 2.59 - 2.46 (m, 10H), 0.88 (s, 9H), 0.88 (s, 
9H), 0.86 (s, 9H), 0.85 (s, 9H), 0.10 (s, 3H), 0.10 (s, 3H), 0.01 (s, 6H), -0.01 (s, 6H), -0.03 (s, 
3H), -0.03 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 206.1, 206.1, 170.2, 170.2, 146.2, 
146.2, 143.1, 143.0, 142.9, 142.8, 133.0, 133.0, 132.4, 132.3, 131.2, 131.2, 130.6, 130.5, 130.3 
(2C), 130.3 (2C), 128.2 (4C), 125.5, 125.2, 123.9, 123.8, 86.3, 86.1, 83.0, 82.9, 72.2, 72.0, 68.2, 
68.2, 47.7 (2C), 25.9 (3C), 25.9 (3C), 25.8 (6C), 21.8 (2C), 18.4, 18.4, 18.2, 18.2, -4.7, -4.7, -
5.0, -5.0, -5.3, -5.4, -5.5, -5.5 ppm; IR (ATR): ῦ = 2954, 2929, 2857, 1718, 1630, 1372, 1255, 
1177, 834, 779, 668, 567 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C33H4835ClO7SSi2]+: 
679.2342, found: 679.2335; Rf = 0.30 (n-pentane/EtOAc 5/1). 
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Primary alcohols 261a and 261b 
 
To an ice-cooled solution of tosylate 8,9-cis-275 (464 mg, 0.683 mmol, dr = 1:1, 1.0 eq) in dry 
CH2Cl2/MeOH (13.0 mL, v/v = 1/1) was added CSA (39.7 mg, 0.171 mmol. 0.25 eq), and the 
resulting colorless solution was stirred at 0 °C. After 7 h, the reaction was quenched by addition 
of saturated aqueous sodium bicarbonate (15 mL). The aqueous phase was extracted with CH2Cl2 
(4 x 10 mL), the combined organic layers were dried over MgSO4, filtered, and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(CH2Cl2/Et2O 10/1 to 4/1) to afford primary alcohol 261a (175 mg, 0.309 mmol, 45%) as a 
colorless foam along with its diastereomer 261a (166 mg, 0.294 mmol, 43%) as a pale yellow 
foam. 
Primary alcohol 261a: 1H NMR (400 MHz, CDCl3)  = 7.92 (d, J = 8.1 Hz, 2H), 7.74 (d, 
J = 7.9 Hz, 1H), 7.46 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 7.9 Hz, 1H), 6.51 (s, 1H), 5.67 (s, 1H), 
5.25 (dd, J = 6.1, 3.1 Hz, 1H), 3.70 (ddd, J = 11.2, 8.0, 3.2 Hz, 1H), 3.55 - 3.44 (m, 1H), 3.00 (s, 
1H), 2.54 - 2.35 (m, 5H), 2.06 (dd, J = 7.4, 6.0 Hz, 1H), 0.91 (s, 9H), 0.11 (s, 3H), -0.06 (s, 3H) 
ppm; 13C{1H} NMR (101 MHz, CD2Cl2)  = 206.4, 170.6, 147.0, 144.1, 142.4, 133.4, 132.8, 
132.1, 130.9 (2C), 130.7, 128.7 (2C), 125.9, 124.5, 86.9, 83.6, 72.3, 67.2, 48.2, 26.1 (3C), 22.1, 
18.6, -4.5, -4.7 ppm; IR (ATR): ῦ = 3402, 2953, 2929, 2857, 1710, 1629, 1365, 1191, 1177, 
834, 811, 567 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C27H3435ClO7SSi]+: 565.1478, found: 
565.1484; [α]D20 = 48.3 (c = 0.5, CH2Cl2); Rf = 0.31 (n-pentane/EtOAc 3/2). 
Diastereomer 261b: 1H NMR (400 MHz, CDCl3)  = 7.82 (d, J = 8.3 Hz, 2H), 7.60 (d, 
J = 8.0 Hz, 1H), 7.33 (d, J = 8.0 Hz, 2H), 7.21 (d, J = 8.0 Hz, 1H), 6.46 (s, 1H), 5.54 (s, 1H), 
5.14 (dd, J = 6.1, 3.3 Hz, 1H), 3.64 (dd, J = 11.4, 3.3 Hz, 1H), 3.41 (dd, J = 11.4, 6.2 Hz, 1H), 
2.46 - 2.36 (m 2H), 2.39 (s, 3H), 2.23 (br. s, 2H), 0.81 (s, 9H), 0.00 (s, 3H), -0.16 (s, 3H) ppm; 
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13C{1H} NMR (101 MHz, CDCl3)  = 206.2, 169.9, 146.2, 143.3, 141.7, 132.5, 132.2, 131.5, 
130.3, 130.1, 128.2, 125.4, 123.9, 86.0, 82.9, 71.5, 66.7, 47.7, 25.8, 21.8, 18.1, -4.8, -5.0 ppm; 
IR (ATR): ῦ = 3400, 2953, 2928, 2857, 1710, 1630, 1368, 1191, 1177, 1006, 869, 835, 668 cm-1; 
HRMS (ESI) calc’d. for [M+H]+ = [C27H3435ClO7SSi]+: 565.1478, found: 565.1476; 
α]D23 = 23.0 (c = 0.5, CHCl3); Rf = 0.39 (n-pentane/EtOAc 3/2). 
 
Keto ester 345a 
 
To an ice-cooled solution of β-amino acid 274 (242 mg, 0.481 mmol, 1.5 eq) and DMAP 
(7.84 mg, 0.064 mmol, 0.2 eq) in dry CH2Cl2 (1.5 mL) was added EDCI (123 mg, 0.642 mmol, 
2.0 eq). The resulting solution was allowed to warm to 23 °C and stirred for 30 min before being 
added to an ice-cooled suspension of alcohol 261a (200 mg, 0.321 mmol) in dry CH2Cl2 
(2.0 mL). The mixture was allowed to warm to 23 °C and was stirred for 5 h before it was 
quenched by addition of aqueous pH 7 phosphate buffer (15 mL) at 0 °C. The aqueous phase 
was extracted with CH2Cl2 (4 x 10 mL) and EtOAc (2 x 10 mL), the combined organic layers 
were dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/acetone 6/1 to 4/1) to afford keto ester 
345a (293 mg, 0.221 mmol, 69%) as a colorless oil. 
1H NMR (400 MHz, CDCl3)  = 7.94 (d, J = 8.3 Hz, 2H), 7.72 (d, J = 8.0 Hz, 1H), 7.48 (d, 
J = 8.0 Hz, 1H), 7.40 (d, J = 8.3 Hz, 2H), 6.73 (d, J = 2.3 Hz, 1H), 6.62 (d, J = 2.3 Hz, 1H), 6.53 
(s, 1H), 6.02 (d, J = 8.3 Hz, 1H), 5.70 (s, 1H), 5.46 (t, J = 6.8 Hz, 1H), 5.38 (br. s, 1H), 5.03 (td, 
J = 8.4, 5.3 Hz, 1H), 4.22 - 4.08 (m, 2H), 2.75 (dd, J = 15.6, 5.3 Hz, 1H), 2.64 (dd, J = 15.6, 
8.8 Hz, 1H), 2.48 (s, 3H), 2.36 - 2.24 (m, 2H), 1.76 (s, 3H), 0.95 (td, J = 7.9, 4.0 Hz, 18H), 0.87 
(s, 9H), 0.79 - 0.71 (m, 12H), 0.08 (s, 3H), -0.07(s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
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 = 206.9, 171.1, 169.9, 169.7, 148.1, 145.7, 144.2, 143.3, 141.7, 133.5, 132.8, 132.2 (2C), 
130.8, 130.0 (2C), 128.2 (2C), 126.6, 125.0, 124.4, 119.3, 116.7, 86.0, 83.0, 68.6, 67.4, 49.0, 
47.9, 40.2, 25.6 (3C), 22.6, 21.8, 18.0, 6.7 (3C), 6.6 (3C), 5.4 (3C), 5.0 (3C), -4.9, -5.1 ppm; IR 
(ATR): ῦ = 3289, 2955, 2936, 2878, 1719, 1490, 1490, 1177, 1004, 836, 746, 568 cm-1; HRMS 
(ESI) calc’d. for [M+H]+ = [C50H7235Cl2NO11SSi3]+: 1048.3505, found: 1048.3506; 
[α]D20 = 40.8 (c = 0.2, CHCl3); Rf = 0.27 (n-pentane/EtOAc 2/1).  
 
Cyclization precursor 276a 
 
To a solution of keto ester 345a (205 mg, 0.195 mmol, 1.0 eq) and CeCl3•7H2O (109 mg, 
0.293 mmol, 1.5 eq) in dry THF/MeOH (6.5 mL, v/v = 1/1) at 55 °C was added NaBH4 
(11.1 mg, 0.293 mmol, 1.5 eq). The reaction mixture was stirred for 45 min maintaining a 
temperature between 60 °C and 55 °C before it was quenched by addition of acetone (1.0 mL). 
The mixture was allowed to warm to 0 °C and aqueous pH 7 phosphate buffer (10 mL) was 
added. The aqueous phase was extracted with EtOAc (3 x 15 mL), the combined organic layers 
were dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/acetone 4/1 to 2/1) to afford 
diastereomerically pure cyclization precursor 276a (201 mg, 0.192 mmol, 98%) as a colorless 
oil. 
1H NMR (400 MHz, CDCl3)  = 7.92 (d, J = 8.3 Hz, 2H), 7.50 (d, J = 8.0 Hz, 1H), 7.40 (d, 
J = 8.3 Hz, 2H), 7.27 (d, J = 8.0 Hz, 1H), 6.79 (d, J = 2.3 Hz, 1H), 6.64 (d, J = 2.3 Hz, 1H), 6.36 
(d, J = 1.5 Hz, 1H), 6.34 (br. d, J = 8.3 Hz, 1H), 5.63 (s, 1H), 5.58 - 5.47 (m, 1H), 5.36 (t, 
J = 6.3 Hz, 1H), 5.20 - 5.07 (m, 1H), 4.14 (dd, J = 10.8, 5.5 Hz, 1H), 3.99 (dd, J = 10.8, 6.8 Hz, 
1H), 3.86 (s, 1H), 2.80 - 2.67 (m, 2H), 2.47 (s, 3H), 2.37 (dd, J = 12.9, 5.6 Hz, 1H), 2.21 (br. s, 
1H), 1.88 (s, 3H), 1.61 (dd, J = 13.1, 6.8 Hz, 1H), 0.99 - 0.92 (m, 18H), 0.86 (s, 9H), 0.81 - 0.70 
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(m, 12H), 0.05 (s, 3H), -0.08 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 170.4, 169.5, 
148.0, 145.5, 145.5, 144.0, 143.1, 140.5, 133.6, 132.8, 132.5, 131.2, 130.0 (2C), 129.1, 128.5, 
128.2 (2C), 126.5, 124.0, 119.7, 116.4, 91.2, 84.4, 81.2, 68.3, 68.1, 48.7, 48.0, 39.8, 25.6 (3C), 
22.9, 21.7, 18.1, 6.7 (3C), 6.6 (3C), 5.3 (3C), 5.0 (3C), -5.0, -5.1 ppm; IR (ATR): ῦ = 3308, 
2955, 2934, 2878, 1741, 1657, 1490, 1254, 1176, 837, 748, 669, 565 cm-1; HRMS (ESI) calc’d. 
for [M+Na]+ = [C50H7335Cl2NNaO11SSi3]+: 1072.3481, found: 1072.3483; [α]D20 = 43.8 
(c = 0.2, CHCl3); Rf = 0.36 (n-pentane/EtOAc 2/3). 
 
Keto Ester 345b 
 
A 5 mL microwave vial was charged with alcohol 261b (97.5 mg, 168 μmol, 1.0 eq), β-amino 
acid 274 (115 mg, 229 μmol, 1.4 eq, 1.4 eq) and DMAP (5.1 mg, 42.0 µmol, 25 mol%), and the 
content was azeotroped with toluene (2 x 2 mL). The vial was sealed, placed under vacuum, and 
backfilled with N2 (3 x). Dry CH2Cl2 (1.7 mL) was added and the resulting colorless solution 
was cooled with an ice bath. EDCI (45.0 mg, 236 μmol, 1.4 eq) was then added and the 
homogenous solution was stirred at 0 °C for 18 h before being quenched by addition of sat. 
aqueous ammonium chloride (15 mL). The aqueous phase was extracted with EtOAc (4 x 
15 mL), the combined organic layers were dried over MgSO4, filtered, and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane/EtOAc 3/1 to 3/2) to afford hydroxy ester 345b (113.0 mg, 108 μmol, 64%) as a white 
solid. 
1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.3 Hz, 2H), 7.73 (d, J = 8.0 Hz, 1H), 7.44 (d, 
J = 8.4 Hz, 2H), 7.36 (d, J = 8.0 Hz, 1H), 6.81 (d, J = 2.2 Hz, 1H), 6.66 (d, J = 2.2 Hz, 1H), 6.57 
(s, 1H), 6.45 (d, J = 8.5 Hz, 1H), 5.69 (s, 1H), 5.32 (dd, J = 7.2, 3.6 Hz, 1H), 5.29 – 5.22 (m, 
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1H), 4.18 (dd, J = 11.2, 3.7 Hz, 1H), 3.92 (dd, J = 11.2, 7.4 Hz, 1H), 3.20 (br. s, 1H), 2.85 (dd, 
J = 16.1, 5.6 Hz, 1H), 2.78 (dd, J = 16.2, 5.9 Hz, 1H), 2.53 – 2.49 (m, 5H), 2.01 (s, 3H), 0.96 (q, 
J = 7.6 Hz, 18H), 0.88 (s, 9H), 0.76 (q, J = 7.9 Hz, 12H), 0.07 (s, 3H), -0.04 (s, 3H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 206.1, 170.7, 169.8, 169.2, 148.1, 146.2, 143.7, 143.3, 
141.2, 133.4, 132.5, 132.2, 131.6, 130.3 (2C), 129.0, 128.2 (2C), 126.6, 125.5, 124.2, 119.8, 
116.4, 86.1, 82.9, 68.9, 67.9, 48.4, 47.8, 39.4, 25.6 (3C), 23.3, 21.8, 18.1, 6.7 (3C), 6.6 (3C), 5.4 
(3C), 5.0 (3C), -5.0, -5.0 ppm; IR (ATR): ῦ = 3350, 2955, 2933, 2878, 1719, 1657, 1633, 1461, 
1310, 1177, 1005, 837 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C50H7235Cl2NO11SSi3]+: 
1048.3505, found: 1048.3506; [α]D25 = 42.5 (c = 0.2, CHCl3); m.p.: 88-90 °C; Rf = 0.20 (n-
pentane/EtOAc 2/1).  
 
Cyclization precursor 276b 
 
To a solution of keto ester 345b (56.5 mg, 53.8 μmol, 1.0 eq) and CeCl3•7H2O (30.1 mg, 
80.8 μmol, 1.5 eq) in dry THF/MeOH (1.8 mL, v/v = 1/1) at 55 °C was added NaBH4 (3.1 mg, 
80.8 μmol, 1.5 eq). The reaction mixture was stirred for 1 h maintaining a temperature between 
60 °C and 55 °C before it was quenched by addition of acetone (0.5 mL). The mixture was 
allowed to warm to 0 °C and aqueous pH 7 phosphate buffer (15 mL) was added. The aqueous 
phase was extracted with EtOAc (3 x 15 mL), the combined organic layers were dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/acetone 4/1 to 2/1) to afford diastereomerically 
pure cyclization precursor 276b (4.2 mg, 43.9 μmol, 82%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 2H), 7.51 (d, J = 8.0 Hz, 1H), 7.43 (d, 
J = 8.1 Hz, 2H), 7.21 (d, J = 7.9 Hz, 1H), 6.81 (d, J = 2.1 Hz, 1H), 6.66 (d, J = 2.2 Hz, 1H), 6.47 
(d, J = 8.5 Hz, 1H), 6.40 (d, J = 1.4 Hz, 1H), 5.62 (s, 1H), 5.60 – 5.52 (m, 1H), 5.30 (dd, J = 7.3, 
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3.9 Hz, 1H), 5.24 (dt, J = 8.4, 5.6 Hz, 1H), 4.15 (dd, J = 11.1, 4.0 Hz, 1H), 3.92 (dd, J = 11.1, 
7.4 Hz, 1H), 2.87 – 2.74 (m, 2H), 2.66 (s, 1H), 2.54 - 2.46 (m, 4H), 2.01 (s, 3H), 1.98 (d, 
J = 6.2 Hz, 1H), 1.72 (dd, J = 13.2, 6.6 Hz, 1H), 0.97 (q, J = 7.8 Hz, 18H), 0.87 (s, 9H), 0.77 (q, 
J = 7.9 Hz, 12H), 0.05 (s, 3H), -0.06 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 170.8, 
169.1, 148.1, 145.8, 144.9, 143.7, 143.2, 140.4, 133.5, 132.5, 132.2, 131.5, 130.2 (2C), 129.2, 
128.3, 128.2 (2C), 126.6, 123.9, 119.9, 116.4, 91.1, 84.3, 81.1, 68.8, 68.2, 48.4, 48.1, 39.3, 25.6 
(3C), 23.4, 21.8, 18.1, 6.7 (3C), 6.6 (3C), 5.4 (3C), 5.0 (3C), -4.9, -5.0 ppm; IR (ATR): ῦ = 2956, 
2932, 2878, 1741, 1656, 1490, 1371, 1310, 1252, 1177, 1004, 838, 745 cm-1; HRMS (ESI) 
calc’d. for [M+Na]+ = [C50H7335Cl2NNaO11SSi3]+: 1072.3481, found: 1072.3482; [α]D20 = 45.8 
(c = 0.2, CHCl3); Rf = 0.29 (n-pentane/EtOAc 2/3). 
 
[2.6]Paracyclophane 268 
 
Cyclization precursor 276a (232 mg, 0.221 mmol, 1.0 eq) was loaded into a 250 mL two-neck 
round- bottom flask and azeotroped with toluene (3 x 20 mL). Activated powdered 4Å-MS 
(720 mg) were then added, followed by freshly ground cesium fluoride (101 mg, 0.663 mmol, 
3.0 eq) (glovebox). Freshly distilled DMF (120 mL) was added and the resulting mixture was 
stirred at 23 °C for 1 h under a N2 atmosphere before being heated to 100 °C. After 11 h the pale 
brown reaction mixture was allowed to cool to 23 °C, filtered through a short pad of Celite, and 
the solvent was removed under reduced pressure (45 °C). Remaining amounts of DMF were 
removed by azeotropic evaporation with toluene (3 x 10 mL). The obtained brown solid was 
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dissolved in MeOH-d4 and subjected to 1H NMR analysis for determination of product ratios 
(268:277 = 6.8:1). The crude product was purified by flash chromatography (toluene/acetone 2/1 
to 1.5/1), followed by preparative HPLC (Chromolith column, n-hexane/EtOAc 2/3, 25 mL/min, 
254 nm, tR(major) = 12.3 min, tR(minor) = 15.8 min), to afford [2.6]paracyclophane 268 
(87.4 mg, 0.134 mmol, 60%) as a white solid along with [2.6]metacyclophane 277 (10.9 mg, 
16.8 μmol, 7.6%) as an off-white solid.  
[2.6]paracyclophane 268: 1H NMR (400 MHz, Acetone-d6) δ 7.63 (d, J = 7.5 Hz, 1H), 7.22 (d, 
J = 7.5 Hz, 1H), 6.83 (d, J = 7.8 Hz, 1H), 6.76 (d, J = 2.3 Hz, 1H), 6.65 (s, 1H), 6.40 (d, 
J = 1.5 Hz, 1H), 6.22 (d, J = 2.3 Hz, 1H), 5.66-5.60 (m, 1H), 5.38 (s, 1H), 4.96 (ddd, J = 11.8, 
7.9, 3.5 Hz, 1H), 4.89 (dd, J = 11.0, 4.0 Hz, 1H), 4.64 (s, 1H), 4.49 - 4.40 (m, 2H), 3.71 (dd, 
J = 10.0, 4.0 Hz, 1H), 2.80 (dd, J = 13.6, 3.5 Hz, 1H), 2.67 (dd, J = 13.6, 5.5 Hz, 1H), 2.49 (dd, 
J = 13.6, 6.0 Hz, 1H), 2.28 (dd, J = 13.6, 12.3 Hz, 1H), 1.87 (s, 3H), 0.90 (s, 9H), 0.10 (s, 3H), 
-0.02 (s, 3H) ppm; 13C{1H} NMR (101 MHz, Acetone-d6)  = 169.7, 169.3, 152.3, 150.1, 147.5, 
140.6, 140.4, 140.1, 136.9, 133.1, 131.6, 130.5, 130.5, 126.8, 116.4, 115.3, 94.4, 85.3, 82.1, 75.4, 
66.7, 51.4, 44.0, 42.7, 26.2 (3C), 23.0, 18.8, -4.7, -5.0 ppm; IR (ATR): ῦ = 3289, 2950, 2855, 
1735, 1656, 1259, 1144, 1111, 857, 839, 757, 667 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C31H3835Cl2NO8Si]+: 650.1738, found: 650.1738; [α]D20 = 244.2 (c = 0.2, CHCl3), 
m.p.: 226 – 232 °C (decomp.); Rf = 0.47 (EtOAc), 0.20 (toluene/acetone 2/1). 
[2.6]metacyclophane 277: 1H NMR (400 MHz, Acetone-d6) δ 8.66 (s, 1H), 7.62 (br. d, 
J = 8.0 Hz, 1H), 7.08 (d, J = 2.3 Hz, 1 H), 6.71 (d, J = 7.5 Hz, 1H), 6.47 (d, J = 1.5 Hz, 1H), 
6.32 (d, J = 7.5 Hz, 1H), 5.84 (d, J = 2.0 Hz, 1H), 5.62 - 5.55 (m, 1H), 5.47 (t, J = 10.5 Hz, 1H), 
5.22 (s, 1H), 4.94 (ddd, J = 11.2, 8.0, 1.9 Hz, 1H), 4.76 (dd, J = 10.7, 5.1 Hz, 1H), 4.46 (s, 1H), 
4.31 (d, J = 8.0 Hz, 1H), 3.70 (dd, J = 10.4, 5.1 Hz, 1H), 2.73 (dd, J = 17.2, 1.9 Hz, 1H), 2.45 - 
2.31 (m, 3H), 1.82 (s, 3H), 0.89 (s, 9H), 0.10 (s, 3H), -0.07 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, Acetone-d6)  = 169.8, 168.9, 149.0, 147.9, 147.2, 144.7, 139.1, 136.9, 136.1, 133.3, 
132.4, 131.2, 126.2, 125.1, 122.5, 122.1, 93.0, 82.9, 82.2, 75.7, 64.3, 49.0, 43.7, 42.9, 26.1, 23.0, 
18.7, -4.6, -4.9 ppm; IR (ATR): ῦ = 3375, 2954, 2857, 1746, 1641, 1426, 1253, 1110, 862, 839, 
781 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C31H3835Cl2NO8Si]+: 650.1738, found 650.1738; 
[α]D20 =  (c = 0.2, CHCl3), m.p.: 172 – 176 °C (decomp.); Rf = 0.33 (toluene/acetone 
1/1). 
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[2.6]Paracyclophanes 279 and 280 
 
Cyclization precursor 276b (45.0 mg, 42.8 μmol, 1.0 eq) was loaded into a 25 mL two-necked 
flask and azeotroped with toluene (3 x 5 mL). Activated powdered 4Å-MS (140 mg) were then 
added, followed by freshly ground cesium fluoride (19.5 mg, 128 μmol, 3.0 eq) (glovebox). The 
vial was sealed, freshly distilled DMF (21 mL) was added, and the resulting mixture was stirred 
at 23 °C for 1 h under a N2 atmosphere before being heated to 100 °C. After 11 h, the slightly 
brownish reaction mixture was allowed to cool to ambient temperature, filtered through a short 
pad of Celite, and the solvent was removed under reduced pressure (45 °C). Remaining amounts 
of DMF were removed by azeotropic evaporation with toluene (3 x 5 mL). The obtained brown 
solid was entirely dissolved in Acetone-d6 and subjected to 1H NMR analysis for determination 
of product ratios (279:280 = 3.3:1). The crude product was purified by flash chromatography 
(n-pentane/acetone 4/1 to 1/1), followed by preparative HPLC (Chromolith column, 
n-hexane/EtOAc 1/1.6, 25 mL/min, 254 nm, tR(major) = 10.20 min, tR(minor) = 18.1 min) to 
afford [2.6]paracyclophane 279 (10.3 mg, 15.8 μmol, 37%) as a white foam, along with 
[2.6]metacyclophane 280 (5.6 mg, 8.61 μmol, 20%) as a colorless film. 
[2.6]paracyclophane 279: 1H NMR (400 MHz, Acetone-d6) δ 7.54 (d, J = 8.2 Hz, 1H), 7.25 (d, 
J = 7.9 Hz, 1H), 7.18 (d, J = 7.9 Hz, 1H), 6.74 (d, J = 2.1 Hz, 1H), 6.37 (d, J = 1.2 Hz, 1H), 6.30 
(s, 1H), 6.27 (d, J = 2.1 Hz, 1H), 5.64 (t, J = 5.3 Hz, 1H), 5.52 - 5.47 (m, 1H), 5.42 (s, 1H), 5.03 
(dt, J = 8.3, 4.7 Hz, 1H), 4.67 (s, 1H), 4.51 (s, 1H), 4.17 (dd, J = 11.6, 1.8 Hz, 1H), 4.03 (dd, 
J = 11.5, 2.6 Hz, 1H), 2.77 (dd, J = 14.7, 5.0 Hz, 1H), 2.61 (dd, J = 13.6, 5.8 Hz, 1H), 2.54 - 2.46 
(m, 2H), 1.90 (s, 3H), 0.88 (s, 9H), 0.10 (s, 3H), -0.01 (s, 3H) ppm; 13C{1H} NMR (101 MHz, 
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Acetone-d6) δ 172.2, 169.1, 152.7, 149.9, 146.9, 140.8, 140.5, 140.3, 134.7, 132.5, 130.0, 129.5, 
127.8, 127.1, 119.5, 112.1, 94.0, 84.9, 82.0, 69.2, 68.1, 50.2, 42.7, 41.4, 26.2 (3C), 23.1, 18.8, -
4.7, -4.8 ppm; IR (ATR): ῦ = 3401, 2953, 2930, 2857, 1719, 1659, 1517, 1383, 1126, 1011, 834, 
778 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C31H3835Cl2NO8Si]+: 650.1738, found: 650.1734; 
[α]D20 =  (c = 0.2, CHCl3); Rf = 0.56 (n-pentane/acetone 1/1). 
[2.6]metacyclophane 280: 1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 9.0 Hz, 1H), 7.10 (d, 
J = 7.8 Hz, 1H), 6.96 (d, J = 1.9 Hz, 1H), 6.56 (s, 1H), 6.35 (d, J = 7.8 Hz, 1H), 6.17 (br. s, 1H), 
5.95 (d, J = 1.9 Hz, 1H), 5.72 (t, J = 5.8 Hz, 1H), 5.38 – 5.33 (m, 1H), 5.22 (s, 1H), 5.11 (dd, 
J = 11.3, 2.0 Hz, 1H), 5.00 - 4.94 (m, 1H), 3.85 (dd, J = 11.3, 2.6 Hz, 1H), 3.80 – 3.62 (m, 1H), 
2.78 (dd, J = 18.2, 6.4 Hz, 1H), 2.57 - 2.45 (m, 2H), 2.37 (dd, J = 13.2, 6.6 Hz, 1H), 2.16 (d, 
J = 16.3 Hz, 1H), 1.93 (s, 3H), 0.89 (s, 9H), 0.08 (s, 3H), -0.03 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 170.9, 169.5, 148.3, 145.4, 145.3, 143.3, 139.9, 133.6, 133.2, 131.3, 128.8, 
127.7, 126.4, 125.0, 122.7, 120.1, 92.8, 82.2, 82.0, 69.7, 66.3, 48.2, 42.4, 38.6, 25.7 (3C), 23.5, 
18.2, -4.9, -5.1 ppm; IR (ATR): ῦ = 3313, 2954, 2929, 2857, 1742, 1653, 1493, 1430, 1255, 
1174, 1102, 837, 781 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C31H3835Cl2NO8Si]+: 650.1738, 
found: 650.1739; [α]D20 =  (c = 0.2, CHCl3); Rf = 0.45 (n-pentane/acetone 1/1). 
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10.4.3 2nd Generation Synthesis of the β-Amino Acid from 5-Chloroveratric acid 
β-Keto ester 284 
 
Freshly dried MgCl2 (231 mg, 2.42 mmol, 1.1) and potassium 3-methoxy-3-oxopropanoate 
(541 mg, 3.46 mmol, 1.5 eq) were suspended in dry THF (3.6 mL) and stirred at 50 °C for 4 h. 
In a separate flask, a solution of benzoic acid 283 (500 mg, 2.31 mmol) in dry THF (8.5 mL) 
was cooled to 0 °C and CDI (449 mg, 2.77 mmol, 1.2 eq) was added portionwise over 15 min. 
The resulting suspension was allowed to warm to 23 °C and became homogenous after 1.5 h. 
The solution of activated benzoic acid 283 was then slowly added to the first suspension at 23 °C 
and stirring was continued for 18 h. The reaction was quenched by slow addition of 1 N aq. HCl 
(10 mL). The aqueous phase was extracted with EtOAc (3 x 10 mL), the combined organic 
layers were washed with saturated aqueous sodium bicarbonate (15 mL), brine (10 mL), dried 
over Na2SO4, filtered, and the solvent was removed under reduced pressure. Crude β-keto ester 
284 (629 mg, 2.31 mmol, >99%) was obtained as a mixture of tautomers (5:1 in favor of the keto 
tautomer) and the colorless oil was used in the next step without further purification. 
1H NMR (400 MHz, CDCl3) (keto tautomer) = 7.55 (d, J = 1.8 Hz, 1H), 7.47 (d, J = 1.8 Hz, 
1H), 3.96 (s, 2H), 3.96 (s, 3H), 3.93 (s, 3H), 3.77 (s, 3H) ppm; (enol tautomer) = 12.52 (s, 1H), 
7.41 (d, J = 1.8 Hz, 1H), 7.25 (d, J = 1.8 Hz, 1H), 5.61 (s, 1H), 3.93 (s, 3H), 3.92 (s, 3H), 3.82 
(s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) (keto tautomer) = 109.3, 167.6, 153.8, 150.2, 
131.8, 128.3, 123.3, 110.4, 60.8, 56.2, 52.5, 45.4; (enol tautomer) = 173.3, 169.8, 153.6, 147.9, 
129.5, 121.9, 120.0, 108.6, 87.2, 60.8, 56.2, 51.5; IR (ATR): ῦ = 2948, 1745, 1686, 1569, 1406, 
1327, 1289, 1144, 1040, 998, 855 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C12H1435ClO5]+: 
273.0524, found: 273.0525; Rf = 0.46 (n-pentane/EtOAc 3/1). 
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Enamine 285 
 
A 10 mL round-bottom flask was charged with crude β-keto ester 284 (629 mg, 2.31 mmol, 
1.0 eq) and ammonium acetate (890 mg, 11.5 mmol, 5.0 eq). Dry MeOH (4.6 mL) was added 
and the resulting solution was stirred at reflux. After 12 h heating was stopped and the mixture 
was stirred at 23 °C for 13 h. The reaction mixture was diluted with CH2Cl2 (20 mL) and washed 
with saturated aqueous sodium bicarbonate (15 mL) and brine (10 mL). The organic phase was 
dried over Na2SO4, filtered, and the solvent was removed under reduced pressure to afford 
enamine 285 (626 mg, 2.30 mmol, >99%) as a colorless oil, which was used in next step without 
further purification. 
1H NMR (400 MHz, CDCl3)  = 7.18 (d, J = 2.3 Hz, 1H), 6.97 (d, J = 2.3 Hz, 1H), 4.93 (s, 1H), 
3.91 (s, 3H), 3.91 (s, 3H), 3.73 (s, 3H) ppm (the protons of the amino group were not detected 
in CDCl3); 13C{1H} NMR (101 MHz, CDCl3)  = 170.4, 159.1, 153.9, 146.9, 134.0, 128.7, 
119.8, 108.9, 84.5, 60.8, 56.2, 50.5 ppm; IR (ATR): ῦ = 3444, 3328, 2945, 1666, 1672, 1556, 
1489, 1263, 1163, 1050, 998, 855, 792cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C12H1535ClNO4]+: 272.0684, found: 272.0673; Rf = 0.44 (n-pentane/Et2O 1/1). 
 
β-Amino Ester 286 
 
A vial was charged with enamine 285 (432 mg, 1.59 mmol, 1.0 eq) and ((R)-DM-
Segphos)Ru(OAc)2 (15.0 mg, 0.016 mmol, 1.0 mol%). The vial was sealed with a rubber 
septum, placed under vacuum and backfilled with argon (3 x). Dry MeOH (1.6 mL) and acetic 
acid (182 µl, 3.18 mmol, 2.0 eq) were added, resulting in deep green/black solution. The vial 
was placed in an autoclave and the rubber septum was pierced by two short cannula. The 
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autoclave was closed and purged with H2 (3 x 10 atm.). Finally, H2 (30 atm.) was applied and 
the autoclave was heated to 80 °C under vigorous stirring. After 6.5 h, the autoclave was placed 
in an ice-bath and remaining H2 was released. The reaction mixture was diluted with EtOAc and 
washed with saturated aqueous sodium bicarbonate (15 mL). The aqueous phase was extracted 
with EtOAc (3 x 15 mL), the combined organic layers were washed with brine (10 mL), dried 
over Na2SO4, filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography (EtOAc/aq. NH3 (25%) 100/0 to 100/1 to 100/2) to afford 
β-amino ester 286 (245 mg, 0.895 mmol, 56%, 98% ee) as a pale brown gum. 
1H NMR (400 MHz, CDCl3)  = 6.98 (d, J = 2.0 Hz, 1H), 6.87 (d, J = 2.0 Hz, 1H), 4.37 (dd, 
J = 7.5, 6.0 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 3.70 (s, 3H), 2.70 – 2.58 (m, 2H), 1.90 (br. s, 
2H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 172.1, 153.9, 144.6, 140.6, 128.2, 119.5, 108.9, 
60.6, 56.1, 52.1, 51.8, 43.4 ppm; IR (ATR): ῦ = 3380, 2941, 2833, 1731, 1574, 1491, 1279, 
1138, 1050, 1002, 848 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C12H1735ClNO4]+: 274.0841, 
found: 274.0843; [α]D25 = 9.5 (c = 1.0, CHCl3); Rf = 0.50 (EtOAc/aq. NH3 (25%) 50/1); HPLC 
separation (Chiralpak IC, 4.6 x 250 mm; 60% (iPrOH + 0.25% HNBu2)/n-hexane, 0.5 mL/min, 
224 nm; tR(minor) = 17.9 min, tR(major) = 24.6 min), 98% ee. 
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β-Acetamido ester 287 
 
To an ice-cooled solution of β-amino ester 286 (195 mg, 0.705 mmol, 1.0 eq) in dry CH2Cl2 
(5.7 mL) was added freshly distilled Et3N (129 µL, 0.926 mmol, 1.3 eq) and acetyl chloride 
(58.3 µL, 0.819 mmol, 1.2 eq). The reaction mixture was stirred at 0 °C for 15 min before the 
cooling bath was removed and the mixture was allowed to warm to 23 °C. After 1 h, the reaction 
was quenched by addition of saturated aqueous sodium bicarbonate (10 mL). The aqueous phase 
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was extracted with CH2Cl2 (4 x 10 mL), the combined organic layers were dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/acetone 2.5/1) to afford β-acetamido ester 287 (193 mg, 
0.611 mmol, 87%) as a white solid. 
1H NMR (400 MHz, CDCl3)  = 6.89 (dd, J = 2.0, 0.6 Hz, 1H), 6.77 (d, J = 2.0 Hz, 1H), 6.60 
(br. d, J = 8.3 Hz, 1H), 5.33 (dt, J = 8.3, 5.9 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 3.66 (s, 3H), 
2.88 (dd, J = 15.9, 5.9 Hz, 1H), 2.81 (dd, J = 15.9, 5.9 Hz, 1H), 2.05 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3)  = 171.5, 169.3, 153.8, 144.7, 137.3, 128.4, 119.2, 109.6, 60.6, 56.1, 51.9, 
49.2, 39.6, 23.3 ppm; IR (ATR): ῦ = 3280, 3068, 2946, 2833, 1737, 1651, 1542, 1493, 1432, 
1371, 1283, 1237, 1144, 1050, 1001, 851 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C14H1935ClNO5]+: 316.0946, found: 316.0949; [α]D24 = 68.8 (c = 1.0, CHCl3); 
m.p.: 125 – 126 °C; Rf = 0.19 (n-pentane/acetone 2.5/1). 
 
Catechol carboxylic acid 288 
 
To an ice-cooled solution of aluminum tribromide (4.16 g, 15.6 mmol, 8.0 eq) in ethanethiol 
(10.1 mL, 136 mmol, 70 eq) was added a solution of β-acetamido ester 287 (0.615 g, 1.95 mmol, 
1.0 eq) in dry CH2Cl2 (9.4 mL). The mixture was allowed to warm to 23 °C and stirred for 21 h 
before being quenched by addition of 2 M aq. HCl (20 mL) and diluted with EtOAc. The aqueous 
phase was saturated with NaCl and extracted with EtOAc (8 x 20 mL) until the product could no 
longer be detected in the aqueous phase (TLC). The combined organic layers were dried over 
Na2SO4, filtered, and the solvent was removed under reduced pressure to afford crude catechol 
carboxylic acid 288 (653 mg, ~82% purity) as a brown foam, which was used in the next step 
without further purification. 
Rf = 0.19 (CH2Cl2/MeOH/AcOH 10/1:/0.5). 
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β-Amino acid 274 
 
To a stirred solution of crude catechol carboxylic acid 288 (300 mg, ~82% purity, 0.899 mmol, 
1.0 eq) and DMAP (16.7 mg, 0.136 mmol, 0.15 eq) in dry DMF (4.5 mL) was added 
triethylamine (1.02 mL, 7.28 mmol, 8.0 eq). The resulting suspension was cooled to 0 °C before 
TESCl (0.616 mL, 3.64 mmol, 4.0 eq) was added dropwise. The reaction mixture was then 
allowed to warm to 23 °C and stirred for 4 h before additional TESCl (0.40 mL, 2.36 mmol, 
2.6 eq) was added. The reaction was stirred for 4 h at 23 °C, and was then quenched by addition 
of saturated aqueous ammonium chloride (15 mL). The aqueous phase was extracted with Et2O 
(3 x 15 mL), the combined organic layers were washed with brine, dried over Na2SO4, filtered, 
and the solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (CH2Cl2/MeOH/AcOH 10/1/0 to 100/2/1) to afford β-amino acid 274 (293 mg, 
0.583 mmol, 65% over 2 steps) as a colorless oil. 
1H NMR (400 MHz, CDCl3)  = 6.87 (d, J = 2.3 Hz, 1H), 6.68 (d, J = 2.3 Hz, 1H), 6.47 (d, 
J = 8.5 Hz, 1H), 5.32 (dt, J = 8.4, 5.8 Hz, 1H), 2.91 (dd, J = 16.1, 5.8 Hz, 1H), 2.82 (dd, J = 16.1, 
5.8 Hz, 1H), 2.04 (s, 3H), 0.97 (td, J = 7.8, 6.0 Hz, 18H), 0.82 - 0.73 (m, 12H) ppm (the 
carboxylic acid proton of pure 274 was not detected in CDCl3, but in the crude product: 9.60 (br. 
s, 1H)); 13C{1H} NMR (101 MHz, CDCl3)  = 175.0, 170.1, 148.2, 143.4, 133.3, 126.6, 119.8, 
116.4, 48.6, 39.5, 23.2, 6.7 (3C), 6.6 (3C), 5.4 (3C), 5.0 (3C) ppm; IR (ATR): ῦ = 3271, 3075, 
2956, 2878, 1716, 1653, 1566, 1490, 1425, 1310, 1005, 911, 744 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C23H4135ClNO5Si2]+: 502.2206, found: 502.2210; [α]D20 = 54.8 (c = 1.0, CHCl3); 
Rf = 0.16 (CH2Cl2/MeOH/AcOH 100/2/1). 
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10.4.4 Studies Targeting Dehydration of the C-11 Allylic Alchol 
Bis(trifluoromethyl)benzyl ether 291 
 
A vial was charged with [2.6]paracyclophane 263 (1.8 mg, 2.71 μmol, 1.0 eq) and the content 
was azeotroped with toluene (3 x 0.2 mL). The vial was then sealed, placed under vacuum and 
backfilled with N2 (3 x). Dry CH2Cl2 (180 μl) was added and the resulting colorless solution was 
cooled with an ice bath. A solution of Martin’s sulfurane (2.2 mg, 3.25 μmol, 1.2 eq) in dry 
CH2Cl2 (20 μl) was added and the resulting yellow solution was stirred at 0 °C for 50 min before 
being quenched by addition of sat. aqueous sodium bicarbonate (3 mL). The aqueous phase was 
extracted with EtOAc (3 x 5 mL), the combined organic layers were dried over MgSO4, filtered, 
and the solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (n-pentane/EtOAc 1/2.5) to afford bis(trifluoromethyl)benzyl ether 291 
(1.0 mg, 1.12 μmol, 42%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.80 – 7.71 (m, 2H), 7.58 – 7.53 (m, 3H), 7.20 (d, J = 7.7 Hz, 
1H), 6.66 (d, J = 7.8 Hz, 1H), 6.57 (d, J = 2.0 Hz, 1H), 6.47 (d, J = 2.8 Hz, 1H), 6.15 (d, 
J = 2.0 Hz, 1H), 5.74 (d, J = 6.9 Hz, 1H), 5.56 (s, 1H), 5.10 (dd, J = 5.9, 2.9 Hz, 1H), 5.03 (ddd, 
J = 11.0, 6.9, 3.5 Hz, 1H), 4.75 (dd, J = 10.8, 4.1 Hz, 1H), 4.59 (t, J = 10.6 Hz, 1H), 3.72 (dd, 
J = 10.3, 4.1 Hz, 1H), 3.19 – 3.11 (m, 4H), 2.93 (dd, J = 13.8, 3.5 Hz, 1H), 2.51 (s, 1H), 2.36 (d, 
J = 14.3 Hz, 1H), 2.22 – 2.14 (m, 1H), 2.01 (s, 3H), 0.90 (s, 9H), 0.05 (s, 3H), -0.04 (s, 3H) ppm; 
HRMS (ESI) calc’d. for [M+Na]+ = [C41H43Cl2F6NNaO8Si]+: 912.1931, found 912.1923; 
Rf = 0.67 (EtOAc). 
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Cyclopentadienol 289 
 
A microwave vial was charged with [2.6]paracyclophane 268 (8.4 mg, 12.9 μmol, 1.0 eq) and 
the content was azeotroped with toluene (3 x 1.0 mL). The vial was then sealed, placed under 
vacuum and backfilled with N2 (3 x). A solution of MTPI (29.2 mg, 64.6 μmol, 5.0 eq) in freshly 
distilled DMPU (300 µl) was added and the yellow reaction mixture was stirred at 70 °C. After 
3.5 h, additional MTPI (9.3 mg, 20.7 μmol, 1.6 eq) in DMPU (100 µl) was added and stirring 
was continued at 70 °C for an additional 30 min. The brown reaction mixture was then allowed 
to cool to 23 °C, quenched by addition of MeOH (0.5 mL) and diluted with Et2O (10 mL). The 
organic phase was washed with sat. aqueous sodium thiosulfate (2 x 5 mL), water (3 x 5 mL) 
and brine (5 mL). The organic layer was then dried over MgSO4, filtered, and the solvent were 
removed under reduced pressure (25 °C). The crude product was purified by flash 
chromatography (toluene/acetone 1.5:1), followed by preparative HPLC (Chromolith column, 
n-hexane/EtOAc 1/1, 25 mL/min, 254 nm, tR = 15.3 min) to afford unstable cyclopentadienol 
289 (0.6 mg, 0.95 μmol, 7%) as a pale yellow amorphous solid.  
1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 7.7 Hz, 1H), 6.92 (d, J = 1.8 Hz, 1H), 6.85 (dd, 
J = 5.4, 1.9 Hz, 1H), 6.81 (d, J = 5.3 Hz, 1H), 6.69 (d, J = 7.8 Hz, 1H), 6.48 (d, J = 2.1 Hz, 1H), 
6.30 (d, J = 2.1 Hz, 1H), 6.03 (s, 1H), 5.69 (d, J = 6.5 Hz, 1H), 5.09 (s, 1H), 4.94 (ddd, J = 11.1, 
6.6, 3.4 Hz, 1H), 4.78 (dd, J = 10.8, 4.2 Hz, 1H), 4.54 (t, J = 10.6 Hz, 1H), 3.77 (dd, J = 10.3, 
4.2 Hz, 1H), 2.96 (dd, J = 13.3, 3.5 Hz, 1H), 2.63 (s, 1H), 2.17 (dd, J = 13.4, 11.7 Hz, 1H), 2.00 
(s, 3H), 0.89 (s, 9H), 0.06 (s, 3H), -0.05 (s, 3H) ppm; HRMS (ESI) calc’d. for 
[M+H]+ = [C31H3635Cl2NO7Si]+: 632.1633, found 632.1629; Rf = 0.65 (toluene/acetone 1:1). 
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Fijiolide A aglycone 62 
 
To an ice-cooled solution of cyclopentadienol 289 (0.6 mg, 0.95 μmol, 1.0 eq) in dry THF 
(300 μL) was added a solution of TBAF (1.0 M in THF, 2.85 μL, 3.0 eq) and the resulting 
reaction mixture was stirred at 0 °C. Formation of white precipitate was observed after ~30 min, 
and the reaction was quenched after 1 h by addition of aqueous pH 7 buffer (3 mL). The aqueous 
phase was extracted with EtOAc (3 x 5 mL), the combined organic layers were dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (toluene/acetone 2:1 to 1:1) to afford unstable fijiolide A 
aglycone 62 (yield n.d.) as an amorphous off-white solid.  
1H NMR (400 MHz, DMSO-d6) δ 8.40 (d, J = 8.2 Hz, 1H), 8.10 (s, 1H), 7.19 (d, J = 7.7 Hz, 
1H), 6.73 (d, J = 7.8 Hz, 1H), 6.69 (d, J = 1.9 Hz, 1H), 6.66 (dd, J = 5.4, 2.0 Hz, 1H), 6.60 – 
6.57 (m, 2H), 6.04 (d, J = 2.0 Hz, 1H), 5.81 (d, J = 4.0 Hz, 1H), 5.66 (s, 1H), 5.55 (s, 1H), 4.76 
– 4.65 (m, 2H), 4.39 – 4.32 (m, 1H), 3.70 (dd, J = 9.8, 3.9 Hz, 1H), 2.69 – 2.65 (m, 1H), 2.18 – 
2.09 (m, 1H), 1.80 (s, 3H) ppm; HRMS (ESI) calc’d. for [M+H]+ = [C25H2235Cl2NO7]+: 
518.0768, found 518.0752; Rf = 0.32 (toluene/acetone 1:1). 
 
Selenide 292 
 
To a solution of [2.6]paracyclophane 268 (28.0 mg, 43.0 μmol, 1.0 eq) and o-NO2PhSeCN 
(14.8 mg, 64.5 μmol, 1.5 eq) in dry THF (1.4 mL) at78 °C was added tributylphosphine (16.7 
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µl, 66.7 μmol, 1.1 eq) dropwise. The resulting red mixture was stirred at 78 °C for 45 min 
before additional o-NO2PhSeCN (14.8 mg, 64.5 μmol, 1.5 eq) in dry THF (0.2 mL) and 
tributylphosphine (16.7 µl, 66.7 μmol, 1.1 eq) was added. After stirring at 78 °C for an 
additional 45 min, the reaction was quenched by addition of pH 7 phosphate buffer (8 mL) and 
diluted with EtOAc. The mixture was allowed to warm to 23 °C, the aqueous phase was extracted 
with EtOAc (3 x 5 mL), the combined organic layers were dried over MgSO4, filtered, and the 
solvent was removed under reduced pressure (30 °C). The crude product was purified by flash 
chromatography (toluene/acetone 6/1 to 4/1 to 2/1) to afford selenide 292 (33.6 mg, 40.3 μmol, 
93 %) as a yellow solid.  
1H NMR (400 MHz, CDCl3)  = 8.37 (dd, J = 8.3, 1.5 Hz, 1H), 7.76 - 7.72 (m, 1H), 7.66 (td, 
J = 7.7, 1.5 Hz, 1H), 7.43 (ddd, J = 8.3, 7.2, 1.1 Hz, 1H), 7.20 (d, J = 7.5 Hz, 1H), 6.73 (d, 
J = 3.3 Hz, 1H), 6.67 (d, J = 7.8 Hz, 1H), 6.55 (d, J = 2.0 Hz, 1H), 6.30 (d, J = 2.0 Hz, 1H), 5.89 
(br. d, J = 6.8 Hz, 1H), 5.59 (s, 1H), 5.22 (s, 1H), 5.05 (dd, J = 7.0, 3.3 Hz, 1H), 5.00 (ddd, 
J = 11.1, 7.2, 3.9 Hz, 1H), 4.77 (dd, J = 10.8, 4.0 Hz, 1H), 4.41 (t, J = 10.5 Hz, 1H), 3.79 (dd, 
J = 10.3, 4.0 Hz, 1H), 3.61 (dd, J = 14.6, 7.0 Hz, 1H), 2.88 (dd, J = 13.1, 3.5 Hz, 1H), 2.60 (br. 
s, 1H), 2.50 (d, J = 14.6 Hz, 1H), 2.19 (dd, J = 13.1, 11.8 Hz, 1H), 2.03 (s, 3H), 0.89 (s, 9H), 
0.05 (s, 3H), -0.04 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 169.3, 168.6, 152.7, 
150.8, 147.5, 146.5, 139.8, 139.4, 138.4, 134.2, 134.1, 133.7, 131.2, 130.9, 129.6, 129.4, 126.7, 
126.2, 126.0, 126.0, 115.1, 114.0, 93.5, 83.3, 74.3, 66.6, 50.9, 48.2, 43.0, 37.6, 25.7 (3C), 23.4, 
18.1, -4.9, -5.3 ppm; IR (ATR): ῦ = 2955, 2928, 2856, 1737, 1658, 1517, 1331, 1303, 1260, 
1146, 1115, 855, 839 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C37H4135Cl2N2O9SeSi]+: 
835.1118, found 835.1114; [α]D20 = 295.8 (c = 0.2, CHCl3); m.p.: 174 – 179 °C (decomp.); 
Rf = 0.24 (n-pentane/EtOAc 1/2), 0.39 (toluene/acetone 2/1). 
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Doubly bridged bis-aryl ether 293 
 
A vial was charged with [2.6]paracyclophane 268 (5.0 mg, 7.68 μmol, 1.0 eq) and the content 
was azeotroped with toluene (3 x 0.3 mL). The vial was then sealed, placed under vacuum and 
backfilled with N2 (3 x). The solid was dissolved in dry CH2Cl2 (100 μL) and cooled to 0 °C. A 
solution of o-NO2PhSeCN (3.5 mg, 15.4 μmol, 2.0 eq) in dry CH2Cl2 (50 μL) was added, 
followed by tributylphosphine (4.03 μL, 16.2 μmol, 2.1 eq). The resulting red mixture was 
stirred at 0 °C for 5 min and then allowed to warm to 23 °C. After 45 min, additional 
o-NO2PhSeCN (3.5 mg, 15.4 μmol, 2.0 eq) in dry CH2Cl2 (50 μL) and tributylphosphine 
(4.03 μL, 16.2 μmol, 2.1 eq) was added. After stirring at 23 °C for an additional 30 min, the 
reaction was quenched by addition of pH 7 phosphate buffer (5 mL) and diluted with EtOAc. 
The aqueous phase was extracted with EtOAc (3 x 5 mL), the combined organic layers were 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure (30 °C). The 
crude product was purified by flash chromatography (toluene/acetone 5/1 to 3/1) to afford doubly 
bridged bis-aryl ether 293 (4.1 mg, 4.91 μmol, 64%) as a yellow solid. 
1H NMR (400 MHz, CDCl3) δ 8.37 (dd, J = 8.3, 1.4 Hz, 1H), 7.79 (d, J = 7.6 Hz, 1H), 7.67 (td, 
J = 8.2, 7.8, 1.4 Hz, 1H), 7.46 – 7.37 (m, 1H), 7.00 (d, J = 8.3 Hz, 1H), 6.77 (d, J = 7.8 Hz, 1H), 
6.65 (d, J = 1.9 Hz, 1H), 6.58 (d, J = 1.9 Hz, 1H), 6.44 (d, J = 1.5 Hz, 1H), 5.93 (s, 1H), 5.79 (d, 
J = 5.1 Hz, 1H), 5.44 (t, J = 10.5 Hz, 1H), 5.25 (t, J = 6.1 Hz, 1H), 4.92 (ddd, J = 10.7, 6.1, 
3.1 Hz, 1H), 4.66 (dd, J = 10.2, 5.0 Hz, 1H), 3.59 (dd, J = 10.8, 5.0 Hz, 1H), 3.21 (dd, J = 14.2, 
5.9 Hz, 1H), 2.96 (dd, J = 15.8, 3.2 Hz, 1H), 2.44 (dd, J = 14.2, 7.4 Hz, 1H), 2.12 (dd, J = 15.8, 
11.0 Hz, 1H), 1.99 (s, 3H), 0.84 (s, 9H), 0.02 (s, 3H), -0.13 (s, 3H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 169.5, 168.4, 148.5, 146.6, 146.5, 144.5, 142.5, 142.0, 137.7, 136.8, 135.7, 
134.2, 133.5, 132.2, 130.8, 129.7, 127.1, 126.7, 126.0, 125.0, 122.4, 118.7, 118.5, 104.6, 84.2, 
74.2, 50.7, 47.2, 42.1, 40.5, 25.6 (3C), 23.4, 18.1, -4.9, -5.2 ppm; IR (ATR): ῦ = 2953, 2924, 
2853, 1737, 1656, 1515, 1461, 1377, 1303, 1260, 1147, 1100, 856, 781, 730 cm-1; HRMS (ESI) 
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calc’d. for [M+H]+ = [C37H3935Cl2N2O8SeSi]+: 817.1012, found 817.1015; Rf = 0.42 
(toluene/acetone 3/1). 
 
Bis-TES ether 294 
 
To an ice-cooled solution of selenide 292 (3.5 mg, 4.19 µmol, 1.0 eq) in dry CH2Cl2 (500 µl) 
was added freshly distilled 2,6-lutidine (4.88 µl, 41.9 μmol, 10 eq) and TESOTf (4.74 µl, 
21.0 μmol, 5.0 eq). The resulting dark yellow reaction mixture was stirred at 0 °C for 5 min and 
then allowed to warm to 23 °C. After 60 min, additional 2,6-lutidine (4.88 µl, 41.9 μmol, 10 eq) 
and TESOTf (4.74 µl, 21.0 μmol, 5.0 eq) was added and stirring was continued at 23 °C. After 
4.5 h, additional 2,6-lutidine (19.5 μL, 168 μmol, 40 eq) and TESOTf (19.0 μL, 83.8 μmol, 
20 eq) was added. After a total reaction time of 7 h, the reaction was quenched by addition of 
aqueous pH 7 phosphate buffer (5 mL) and diluted with EtOAc. The aqueous phase was 
extracted with EtOAc (3 x 5 mL), the combined organic layers were washed with brine (5 mL), 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/acetone 4/1 to 3/1) to afford bis-TES 
ether 294 (2.0 mg, 1.88 μmol, 45%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 8.33 (dd, J = 8.3, 1.4 Hz, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.62 – 
7.58 (m, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.19 (d, J = 7.7 Hz, 1H), 6.63 – 6.55 (m, 3H), 6.23 (d, 
J = 2.0 Hz, 1H), 5.78 (d, J = 6.6 Hz, 1H), 5.54 (s, 1H), 5.01 (ddd, J = 10.9, 6.8, 3.3 Hz, 1H), 4.92 
(dd, J = 7.5, 3.3 Hz, 1H), 4.78 (dd, J = 10.7, 4.2 Hz, 1H), 4.50 (t, J = 10.5 Hz, 1H), 3.75 (dd, 
J = 10.3, 4.2 Hz, 1H), 3.61 (dd, J = 13.4, 7.5 Hz, 1H), 2.97 (dd, J = 13.9, 3.5 Hz, 1H), 2.37 – 
2.30 (m, 1H), 2.22 – 2.18 (m, 1H), 2.04 (s, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.88 (s, 9H), 0.81 (t, 
J = 7.9 Hz, 9H), 0.73 – 0.67 (m, 6H), 0.43 – 0.29 (m, 6H), 0.03 (s, 3H), -0.06 (s, 3H) ppm; 
HRMS (ESI) calc’d. for [M+H]+ = [C49H6935Cl2N2O9SeSi3]+: 1053.2848, found 1063.2850; 
Rf = 0.36 (n-pentane/acetone 3/1). 
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10.5 Synthesis and Activation of the Amino Sugar Moiety  
Ethyl L-pyroglutamate 297 
 
To an ice-cooled suspension of L-pyroglutamic acid 296 (15.0 g, 116 mmol, 1.0 eq) in dry EtOH 
(50 mL) was added thionyl chloride (10.2 mL, 139 mmol, 1.2 eq) dropwise via a dropping 
funnel. The reaction mixture was allowed to slowly warm to 23 °C and stirred for 17 h before 
all volatiles were removed under reduced pressure. The resulting greenish oil was taken up in 
EtOAc (250 mL) and stirred over K2CO3 (40.0 g, 289 mmol, 2.5 eq) for 45 min. The mixture 
was then filtered, the organic phase was dried over MgSO4, filtered again, and the solvent was 
removed under reduced pressure to afford ethyl L-pyroglutamate 297 (18.9 g, 96 wt.%, 
115 mmol, >99%) as a pale yellow solid.  
1H NMR (400 MHz, CDCl3) δ 6.71 (br. s, 1H), 4.25 – 4.17 (m, 3H), 2.52 – 2.27 (m, 3H), 2.25 
– 2.15 (m, 1H), 1.28 (t, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 178.0, 172.0, 
61.6, 55.4, 29.2, 24.7, 14.1 ppm. 
 
Tertiary TMS ether 298 
 
To a solution of (S)-ethyl 5-oxopyrrolidine-2-carboxylate (9.90 g, 63.0 mmol, 1.0 mmol) in dry 
THF (315 mL) was added a solution of MeLi (1.6 M in Et2O, 98.0 mL, 157 mmol, 2.5 eq) over 
40 min at 78 °C. The reaction mixture was stirred for further 10 min at 78 °C before the 
cooling bath was removed and the reaction mixture was allowed to warm to 23 °C within 1 h. 
After stirring at 23 °C for further 3 h, Et3N (53.6 mL, 384 mmol, 6.1 eq) and TMSCl (48.3 mL, 
378 mmol, 6.0 eq) were added to the reaction mixture. The resulting suspension was stirred at 
23 °C for further 4.5 h before being quenched by addition of sat. aqueous ammonium chloride 
(200 mL) at 0 °C. The aqueous phase was extracted with EtOAc (3 x 100 mL), the combined 
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organic layers were washed with brine (100 mL), dried over MgSO4, filtered, and the solvent 
was removed under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane/EtOAc 1/1 to 0/1) to afford tertiary TMS ether 298 (6.63 g, 30.8 mmol, 49%) as a 
colorless oil. 
1H NMR (400 MHz, CDCl3) δ 6.31 (br. s, 1H), 3.49 (dd, J = 8.2, 5.3 Hz, 1H), 2.40 – 2.24 (m, 
2H), 2.13 – 2.02 (m, 1H), 1.89 – 1.79 (m, 1H), 1.21 (s, 3H), 1.16 (s, 3H), 0.11 (s, 9H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 178.8, 75.2, 64.1, 30.4, 25.9, 24.9, 21.8, 2.3 (3C) ppm; IR 
(ATR): ῦ = 3206, 3097, 2957, 1691, 1462, 1385, 1248, 1172, 1142, 1039, 834, 750 cm-1; HRMS 
(ESI) calc’d. for [M+H]+ = [C10H22NO2Si]+: 216.1414, found 216.1417; Rf = 0.27 (n-
pentane/EtOAc 1/2). 
 
Boc protected γ-lactam 51 
 
To an ice-cooled solution of TMS ether 298 (6.18 g, 28.7 mmol, 1.0 eq) and DMAP (701 mg, 
5.74 mmol, 0.2 eq) in dry MeCN (137 mL) was added Et3N (8.00 mL, 57.4 mmol, 2.0 eq) and 
Boc2O (11.9 g, 54.5 mmol, 1.9 eq). The resulting slightly brown solution was allowed to slowly 
warm to 23 °C under stirring. After 14 h, the dark brown reaction mixture was quenched with 
sat. aqueous ammonium chloride (150 mL) at 0 °C. The aqueous phase was extracted with 
EtOAc (3 x 100 mL), the combined organic layers were washed with brine (50 mL), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (n-pentane/EtOAc 10/1 to 5/1) to afford Boc protected 
γ-lactam 51 (8.00 g, 25.4 mmol, 88%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 4.06 (dd, J = 8.7, 0.9 Hz, 1H), 2.68 (ddd, J = 17.6, 11.3, 9.3 Hz, 
1H), 2.30 (ddd, J = 17.6, 10.1, 1.3 Hz, 1H), 2.10 (dd, J = 12.8, 9.2 Hz, 1H), 2.05 – 1.92 (m, 1H), 
1.52 (s, 9H), 1.28 (s, 3H), 1.23 (s, 3H), 0.10 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 
175.7, 150.8, 82.5, 77.1, 65.6, 32.9, 27.9 (3C) , 27.9, 27.2, 20.6, 2.4 (3C) ppm; IR (ATR): 
ῦ = 2979, 1786, 1750, 1713, 1366, 1301, 1249, 1151, 1137, 1036, 876, 839 cm-1; HRMS (ESI) 
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calc’d. for [M+Na]+ = [C15H29NNaO4Si]+: 338.1758, found 338.1755; [α]D20 = 48.2 (c = 1.0, 
CHCl3);  Rf = 0.48 (n-pentane/EtOAc 5/1). 
 
Unsaturated γ-lactam 299 
 
Steps 1: To an ice-cooled solution of hexamethyldisilazane (9.73 mL, 45.8 mmol, 1.6 eq) in dry 
THF (60 mL) was added a solution of nBuLi (1.6 M in n-hexane, 26.8 mL, 43.0 mmol, 1.5 eq) 
over a period of 5 min. The resulting solution was stirred at 0 °C for 30 min before being cooled 
to 78 °C. A solution of γ-lactam 51 (9.04 g, 28.6 mmol, 1.0 eq) in dry THF (60 mL) was slowly 
added over 10 min via cannula. The yellow solution was stirred at 78 °C for 50 min before a 
solution of PhSeCl (6.86 g, 35.8 mmol, 1.3 eq) in dry THF (30 mL) was added dropwise. Stirring 
was continued at 78 °C for 1.5 h before the dark reaction mixture was quenched by addition of 
sat. aqueous ammonium chloride (150 mL) at 78 °C and allowed to warm to 23 °C. The aqueous 
phase was extracted with EtOAc (3 x 70 mL), the combined organic layers were washed with 
brine (70 mL), dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. 
The crude phenylselenide was obtained as a yellow oil and used in the next step without further 
purification. 
Steps 2: To an ice-cooled solution of crude phenylselenide (synthesized from 28.6 mmol 
γ-lactam 51) in CH2Cl2 (143 mL) was subsequently added pyridine (6.94 mL, 85.8 mmol, 3.0 eq) 
and aqueous H2O2 (30 wt.%, 9.93 mL, 97.3 mmol, 3.4 eq). The resulting yellow solution was 
stirred at 0 °C for 75 min before being diluted with CH2Cl2 (100 mL). The organic phase was 
washed with water (70 mL), sat. aqueous sodium thiosulfate (70 mL) and brine (70 mL), dried 
over MgSO4, filtered, and the solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography (n-pentane/EtOAc 15/1 to 5/1) to afford unsaturated 
γ-lactam 299 (7.83 g, 25.0 mmol, 87%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.27 – 7.24 (m, 1H), 6.10 (dd, J = 6.1, 1.2 Hz, 1H), 4.73 (t, 
J = 1.6 Hz, 1H), 1.56 (s, 9H), 1.38 (s, 3H), 1.10 (s, 3H), 0.14 (s, 9H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 170.4, 151.2, 150.3, 126.5, 83.0, 76.3, 69.9, 29.7, 28.0 (3C), 25.4, 2.4 (3C) 
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ppm; IR (ATR): ῦ = 2980, 1781, 1741, 1719, 1368, 1298, 1250, 1153, 1035, 837, 751 cm-1; 
HRMS (ESI) calc’d. for [M+Na]+ = [C15H27NNaO4Si]+: 336.1602, found 336.1609; 
[α]D24 = 197.8 (c = 1.0, CH2Cl2);  Rf = 0.44 (n-pentane/EtOAc 7/1). 
 
Diol 52 
 
To a solution of unsaturated γ-lactam 299 (7.80 g, 24.9 mmol, 1.0 eq) in acetone/tBuOH/H2O 
(42 mL, v/v = 1/3.3/1.2) was subsequently added NMO (5.83 g, 49.8 mmol, 2.0 eq) and a 
solution of OsO4 (5% wt.% in H2O, 2.53 mL, 0.498 mmol, 2.0 mol%). The brown reaction 
mixture was then stirred at 23 °C for 18 h before being quenched by addition of sat. aqueous 
sodium thiosulfate (20 mL) at 0 °C. Stirring was then continued at 0 °C for 30 min and additional 
sat. aqueous sodium thiosulfate (20 mL) was added. The aqueous phase was extracted with 
EtOAc (3 x 40 mL), the combined organic layers were washed with sat. aqueous sodium 
thiosulfate (30 mL)  and brine (30 mL), dried over MgSO4, filtered, and the solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
(n-pentane/EtOAc 2/1 to 1/1) to afford diol 52 (7.24 g, 20.8 mmol, 84%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ 4.60 (d, J = 4.8 Hz, 1H), 4.45 (d, J = 4.9 Hz, 1H), 4.01 (s, 1H), 
3.59 (br. s, 1H), 3.18 (br. s, 1H), 1.52 (s, 9H), 1.42 (s, 3H), 1.23 (s, 3H), 0.09 (s, 9H) ppm; 
13C{1H} NMR (101 MHz, CDCl3) δ 175.0, 150.7, 83.6, 75.4, 71.9, 71.5, 68.6, 28.2, 27.8 (3C), 
27.7, 2.3 (3C) ppm; IR (ATR): ῦ = 3434, 2980, 1779, 1724, 1367, 1292, 1250, 1151, 1126, 
1027, 895, 837, 730 cm-1; HRMS (ESI) calc’d. for [M+Na]+ = [C15H29NNaO6Si]+: 370.1656, 
found 370.1654; [α]D24 = 21.7 (c = 1.0, CHCl3);  Rf = 0.57 (n-pentane/EtOAc 1/2). 
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δ-Lactone 53 
 
To an ice-cooled solution of diol 52 (7.24 g, 20.8 mmol, 1.0 eq) in THF (70 mL) was added a 
solution of lithium hydroxide (1.1 M in H2O, 57.3 mL, 62.5 mmol, 3.0 eq) and the resulting 
slightly yellow biphasic mixture was stirred at 0 °C. After 2.5 h, the reaction mixture was diluted 
with water (35 mL) and acidified with 15 wt.% aqueous potassium bisulfate (80 mL). The 
aqueous phase was saturated with sodium chloride and extracted with EtOAc (4 x 70 mL). The 
combined organic layers were dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The obtained pale yellow foam was taken up in dry CH2Cl2 (70 mL) and pTSA 
(198 mg, 1.04 mmol, 5.0 mol%) was added. The resulting solution was stirred at 23 °C for 6 h 
before being poured into ice-cooled sat. aqueous sodium bicarbonate (50 mL). The aqueous 
phase was extracted with EtOAc (3 x 50 mL), the combined organic layers were washed with 
brine (50 mL), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (n-pentane/EtOAc 1/1 to 1/2) to afford 
δ-lactone 53 (5.42 g, 17.3 mmol, 83% over 2 steps) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 5.96 – 5.43 (m, 1H), 4.27 (s, 3H), 4.09 (d, J = 9.8 Hz, 1H), 3.93 
– 3.76 (m, 1H), 1.48 (s, 3H), 1.47 (s, 3H), 1.45 (s, 9H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
δ 172.6, 155.4, 87.6, 80.4, 70.8, 69.8, 53.6, 30.1, 28.3 (3C), 25.5 ppm; IR (ATR): ῦ = 3435, 
2980, 2936, 1703, 1501, 1368, 1248, 1162, 1116, 1004, 914, 878, 731 cm-1; HRMS (ESI) calc’d. 
for [M+Na]+ = [C12H21NNaO6]+: 298.1261, found 298.1260; [α]D24 =  (c = 1.0, CHCl3);  
Rf = 0.45 (n-pentane/EtOAc 1/2). 
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Dimethyl amine 54 
 
Step 1: To an ice-cooled solution of δ-lactone 53 (2.40 g, 8.72 mmol, 1.0 eq) in dry CH2Cl2 
(70 mL) was added TFA (17.5 mL, 227 mmol, 26 eq) dropwise. The resulting colorless solution 
was stirred at 0 °C for 5 min and then allowed to warm to 23 °C. After 100 min, toluene (3 x 
4 mL) was added and all volatiles were azeotropically removed under reduced pressure (30 °C). 
Step 2: The obtained yellow residue was dissolved in MeCN (43 mL) at 0 °C. Aqueous 
formaldehyde (30% wt.%, 28.8 mL, 314 mmol, 36 eq) was added, followed by formic acid 
(0.669 mL, 17.4 mmol, 2.0 eq) and NaBH3CN (1.18 g, 17.9 mmol, 2.1 eq). After stirring for 
10 min at 0 °C, the reaction mixture was allowed to warm to 23 °C and stirred for 3.5 h. The 
reaction was then quenched by addition of sat. aqueous sodium bicarbonate (50 mL) at 0 °C. The 
aqueous phase was saturated with NaCl and the pH was adjusted to pH 10 with 2 M NaOH. The 
aqueous phase was then extracted with CHCl3 (5 x 50 mL), the combined organic layers were 
dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/acetone 4/1 to 3/1) to afford 
dimethylamine 54 (1.17 g, 5.76 mmol, 66%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 4.54 – 4.48 (m, 1H), 4.08 (d, J = 2.9 Hz, 1H), 3.41 (br. s, 2H), 
2.63 (d, J = 1.5 Hz, 1H), 2.52 (s, 6H), 1.63 (s, 3H), 1.50 (s, 3H) ppm; 13C{1H} NMR (101 MHz, 
CDCl3) δ 172.7, 90.4, 71.4, 67.4, 65.7, 45.2 (2C), 30.4, 25.3 ppm. 
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TIPDS protected lactone 301 
 
To a solution of dimethylamine 54 (1.17 g, 5.76 mmol, 1.0 eq) and 1H-imidazol (1.57 g, 23.0 
mmol, 4.0 eq) in dry DMF (29 mL) was added TIPDSCl (3.80 mL, 11.5 mmol, 2.0 eq) and the 
resulting colorless solution was stirred at 23 °C. After 14 h, the reaction mixture was quenched 
by addition of sat. aqueous sodium bicarbonate (40 mL) at 0 °C. The aqueous phase was 
extracted with Et2O (3 x 50 mL), the combined organic layers were washed with water (20 mL), 
dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (n-pentane/Acetone 30/1 to 20/1) to afford TIPDS 
protected lactone 301 (2.33 g, 5.22 mmol, 91%) as colorless needles. 
1H NMR (400 MHz, CDCl3) δ 4.85 – 4.80 (m, 1H), 4.44 (d, J = 2.1 Hz, 1H), 2.73 – 2.69 (m, 
1H), 2.54 (s, 6H), 1.62 (s, 3H), 1.46 (s, 3H), 1.17 – 0.97 (m, 28H) ppm; 13C{1H} NMR 
(101 MHz, CDCl3) δ 169.3, 87.3, 76.7, 71.9, 68.7, 44.9 (2C), 31.3, 25.7, 17.9, 17.6, 17.6, 17.3, 
17.2, 17.2, 16.9, 16.8, 14.3, 14.0, 13.3, 12.8 ppm; IR (ATR): ῦ = 2945, 2895, 2867, 2826, 1742, 
1456, 1274, 1180, 1115, 1041, 1015, 948, 885, 802, 695 cm-1; [α]D24 =  (c = 1.0, CHCl3); 
m.p.: 164-166 °C; Rf = 0.23 (n-pentane/EtOAc 20/1). 
 
Amino sugar 55 
 
To a cooled solution of lactone 301 (163 mg, 0.478 mmol) in dry CH2Cl2 (4.8 mL) was added a 
solution of DIBAL-H (1 M in n-hexane, 0.956 mL, 0.956 mmol, 2.0 eq) dropwise at 78 °C.  
The resulting colorless solution was stirred at 78 °C for 80 min before being quenched by 
addition of sat. aqueous potassium sodium tartrate (10 mL). The reaction mixture was allowed 
to warm to 23 °C and stirred for 1.5 h. The aqueous phase was then extracted with CH2Cl2 (4 x 
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10 mL), the combined organic layers were washed with brine (10 mL), dried over Na2SO4, 
filtered, and the solvent was removed under reduced pressure. The crude product was purified 
by flash chromatography (n-pentane/EtOAc/Et3N 10/1/0.1 to 5/1/0.05) to afford amino sugar 55 
(219 mg, 95 wt.%, 0.465 mmol, 97%) as a coloress oil. 
1H NMR (400 MHz, CDCl3) δ 5.02 (dd, J = 7.7, 3.3 Hz, 1H), 4.75 (t, J = 2.7 Hz, 1H), 3.50 (dd, 
J = 7.9, 3.1 Hz, 1H), 2.84 (br. s, 1H), 2.56 (s, 6H), 2.47 (d, J = 2.3 Hz, 1H), 1.61 (s, 3H), 1.31 
(s, 3H), 1.16 – 1.03 (m, 28H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 90.5, 78.3, 78.1, 74.8, 
69.4, 44.5 (2C), 30.8, 23.7, 17.6, 17.5, 17.5, 17.4, 17.4, 17.4, 17.1, 17.0, 14.4, 13.6, 13.3, 13.1 
ppm; HRMS (ESI) calc’d. for [M+H]+ = [C21H46NNaO5Si2]+: 448.2909, found 448.3148. 
 
Schmidt donor 56 
 
Amino sugar 55 (451 mg, 0.957 mmol) was loaded into a 25 mL round-bottom flask and 
azeotroped with toluene (3 x 5 mL). Freshly distilled 2,2,2-trichloroacetonitrile (2.88 mL, 
28.7 mmol) was added, followed by dry CH2Cl2 (9.6 mL) and polymer-bound DBU (pDBU) 
(1.4 - 2.2 mmol/g, 2.05 g, 2.87 mmol). The reaction mixture was gently stirred at 23 °C under a 
N2 atmosphere for 4 h and then filtered through dry KIMTECH paper (glovebox). The filter cake 
was washed with CH2Cl2 and the solvent was removed under high vacuum to afford Schmidt 
donor 56 (564 mg, 0.952 mmol, >99%) as a pale brown oil. If not immediately used for 
glycosylation, 56 was stored in a benzene matrix at 30 °C under a N2 atmosphere. Thus, no 
degradation was observed, even after prolonged storage over 2-3 weeks.  
1H NMR (400 MHz, C6DC6) 8.54 (s, 1H), 6.59 (d, J = 8.3 Hz, 1H), 4.80 (t, J = 2.9 Hz, 1H), 
4.00 (dd, J = 8.3, 3.5 Hz, 1H), 2.44 - 2.40 (m, 7H), 1.87 (s, 3H), 1.35 (s, 3H), 1.25 - 1.07 (m, 
28H) ppm; 13C{1H} NMR (101 MHz, C6D6)  = 162.4, 94.7, 92.5, 79.3, 76.8, 76.0, 69.8, 44.9 
(2C), 31.4, 24.3, 18.1, 18.0 (2C), 18.0 (2C), 17.9, 17.8, 17.7, 15.2, 14.1 (2C), 13.9 ppm. 
 
 
10. Experimental Section  273 
 
10.6 Completion of the Synthesis 
Selenide (±)-306 
 
To an ice-cooled solution of trans-diol (±)-305199 (100 mg, 0.396 mmol, 1.0 eq) and 
o-NO2PhSeCN (135 mg, 0.595 mmol, 1.5 eq) in dry THF/pyridine (2.0 mL, v/v = 1/1) was 
added a solution of tributylphosphine (160 µl, 0.643 mmol, 1.6 eq) in dry THF (0.16 mL) 
dropwise. The resulting red mixture was stirred at 0 °C for 15 min and was then allowed to warm 
to 23 °C. After 75 min additional o-NO2PhSeCN (36.0 mg, 159 μmol, 0.4 eq) and 
tributylphosphine (50.0 µl, 201 μmol, 0.5 eq) in dry THF (50 μL each) was added. After stirring 
for an additional 60 min at 23 °C, the reaction was quenched by addition of sat. aqueous sodium 
bicarbonate (5 mL). The aqueous phase was extracted with EtOAc (3 x 5 mL), the combined 
organic layers were dried over MgSO4, filtered, and the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography (n-pentane/CH2Cl2 2/1 to 1/2 
to 1/3) to afford selenide (±)-306 (100 mg, 229 μmol, 58%) as a yellow solid. 
1H NMR (400 MHz, CDCl3) δ 8.34 (dd, J = 8.3, 1.3 Hz, 1H), 7.69 – 7.63 (m, 1H), 7.56 (td, 
J = 8.2, 7.7, 1.4 Hz, 1H), 7.47 – 7.42 (m, 2H), 7.42 – 7.35 (m, 3H), 7.33 – 7.28 (m, 2H), 7.25 – 
7.17 (m, 4H), 6.58 (d, J = 2.5 Hz, 1H), 4.66 (dt, J = 7.0, 2.4 Hz, 1H), 3.12 (dd, J = 14.7, 7.2 Hz, 
1H), 2.72 – 2.63 (m, 2H) ppm; 13C{1H} NMR (101 MHz, CDCl3) δ 150.4, 146.7, 145.1, 133.8, 
133.8, 133.2, 129.6, 128.8, 128.3 (2C), 128.2 (2C), 128.0, 127.3 (2C), 126.8, 126.6, 126.0, 125.0 
(2C), 86.9, 52.5, 41.8 ppm; HRMS (ESI) calc’d. for [M-OH]+ = [C23H18NO2Se]+: 420.0497, 
found: 420.0494; m.p.: 157-159 °C; Rf = 0.48 (n-pentane/CH2Cl2 1/1). 
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Selenyl glycoside 1,3-cis-307 
 
Selenide (±)-306 (3.0 mg, 6.88 μmol, 1.0 eq) was loaded into a glass vial and azeotroped with 
toluene (3 x 0.5 mL). Activated powdered 4Å-MS (14 mg) were added, the vial was sealed, 
placed under vacuum and backfilled with N2 (3 x). A solution of Schmidt donor 56 (20.4 mg, 
34.4 μmol, 5.0 eq) in dry benzene (0.4 mL) was added, followed by removal of all volatiles by 
sublimation under high vacuum at 0 °C. Dry toluene (220 μL) was added and the yellow 
suspension was stirred for 1.5 h at 23 °C. After being cooled to 20 °C, freshly distilled TBSOTf 
(0.8 µl, 3.44 μmol, 0.5 eq) was added and stirring was continued at 20 °C. Additional portions 
of TBSOTf (0.8 µl, 3.44 μmol, 0.5 eq) were added after 1 h, 2 h and 3 h. After 4 h an additional 
portion of TBSOTf (1.6 µl, 6.88 μmol, 1.0 eq) was added and stirring was continued at 20 °C. 
After a total reaction time of 4.5 h, Et3N (19.2 μL, 138 μmol, 20 eq) was added at 20 °C, 
followed by saturated aqueous sodium bicarbonate (3 mL) and a solution of 1,4-DMT (0.01 M 
in EtOAc, 100 μL, 1.00 μmol). The aqueous phase was extracted with CH2Cl2 (3 x 5 mL), the 
combined organic layers were dried over Na2SO4, filtered, and the solvent was removed under 
reduced pressure (30 °C). After determination of the crude 1H NMR yield (70%) the product was 
commonly purified with other batches of crude 1,3-cis-307 by flash chromatography 
(n-pentane/EtOAc 40/1 to 25/1). 
1.1:1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) δ 8.37 – 8.30 (m, 2H), 7.72 (d, 
J = 7.8 Hz, 1H), 7.63 – 7.47 (m, 7H), 7.40 – 7.29 (m, 10H), 7.26 – 7.20 (m, 2H), 7.19 – 7.13 (m, 
3H), 7.12 – 7.04 (m, 3H), 6.72 (d, J = 2.2 Hz, 1H), 6.71 (d, J = 2.2 Hz, 1H), 5.13 (d, J = 7.9 Hz, 
1H), 5.03 (d, J = 7.7 Hz, 1H), 4.69 – 4.60 (m, 3H), 4.58 – 4.52 (m, 1H), 3.80 (td, J = 8.6, 8.1, 
3.8 Hz, 2H), 3.62 (dd, J = 14.4, 6.5 Hz, 1H), 3.21 (dd, J = 15.0, 6.2 Hz, 1H), 3.01 (dd, J = 15.0, 
8.1 Hz, 1H), 2.93 (dd, J = 14.4, 8.6 Hz, 1H), 2.54 – 2.49 (m, 7H), 2.47 (s, 6H), 2.39 (d, 
J = 2.6 Hz, 1H), 1.51 (s, 3H), 1.41 (s, 3H), 1.38 (s, 3H), 1.17 – 0.98 (m, 44H), 0.94 (s, 3H), 0.90 
(s, 3H), 0.77 (d, J = 7.6 Hz, 3H), 0.66 (d, J = 7.4 Hz, 3H), 0.58 (s, 3H) ppm; 13C{1H} NMR 
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(101 MHz, CDCl3) δ 147.4, 146.9, 146.7, 146.3, 146.0, 145.8, 134.9, 134.7, 133.9, 133.7, 133.6, 
133.5, 132.4, 130.5, 129.8, 129.8, 128.6 (2C), 128.3 (2C), 128.1 (2C), 127.9 (2C), 127.6, 127.5 
(2C), 127.4, 126.9, 126.8 (2C), 126.7, 126.5, 126.5, 125.5 (2C), 124.7 (2C), 124.2 (2C), 93.7, 
93.2, 92.2, 92.0, 78.0, 77.0, 76.6, 76.3, 76.2, 75.5, 69.1, 69.0, 49.4, 49.2, 44.5 (4C), 41.5, 41.0, 
31.0, 29.9, 23.9, 23.3, 17.7, 17.7, 17.6, 17.6, 17.5 (3C), 17.4, 17.3, 17.3, 17.2, 17.2, 17.2, 17.0, 
16.9, 16.9, 14.3 (2C), 14.1, 13.8, 13.7, 13.5, 13.4, 13.3 ppm; HRMS (ESI) calc’d. for 
[M+H]+ = [C44H63N2O7SeSi2]+: 867.3334, found: 867.3337; Rf = 0.28 (n-pentane/EtOAc 25/1). 
 
Cyclopentadienyl glycoside 308 
 
To an ice-cooled solution of selenide 1,3-cis-307 (3.0 mg, 3.46 μmol, dr = 1.1:1, 1.0 eq) in THF 
(200 μL) was added Et3N (4.83 μL, 34.7 μmol, 10 eq), followed by aqueous H2O2 (30%, 
3.54 μL, 34.7 μmol, 10 eq). The bright yellow reaction mixture was stirred at 0 °C for 5 min and 
then allowed to warm to 23 °C. After 4 h, additional H2O2 (30%, 3.54 μL, 34.7 μmol, 10 eq) was 
added, followed by a further portion of H2O2 (30%, 7.08 μL, 69.4 μmol, 20 eq) after 8 h. Stirring 
was continued at 23 °C. After a total reaction time of 22 h, the reaction mixture was diluted with 
CH2Cl2 (6 mL) and poured into mixture of saturated aqueous sodium thiosulfate/pH 7 buffer 
(6 mL, 1/1). A solution of 1,3,5-TMB (0.01 M in EtOAc, 100 μL, 1.00 μmol) was added as 
internal standard, and the aqueous phase was extracted with CH2Cl2 (3 x 5 mL). The combined 
organic layers were dried over Na2SO4, filtered, and the solvent was removed under reduced 
pressure (30 °C). After determination of the crude 1H NMR yield (≥45%), the crude product was 
purified by flash chromatography (n-pentane/EtOAc 50/1 to 30/1) to afford a 1.9:1 
diastereomeric mixture of cyclopentadienyl glycoside 308 as a pale yellow oil.  
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1.9: 1 mixture of diastereomers: 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.39 (m, 4H), 7.25 – 7.05 
(m, 6H), 6.93 (dt, J = 7.1, 1.8 Hz, 1H), 6.50 – 6.26 (m, 1H), 6.23 – 6.15 (m, 1H), 4.77 – 4.60 (m, 
2H), 3.76 – 3.71 (m, 1H), 2.54 – 2.44 (m, 7H), 1.50 – 1.45 (m, 3H), 1.35 – 1.30 (m, 3H), 1.05 – 
0.98 (m, 10H), 0.94 – 0.73 (m, 18H) ppm; HRMS (ESI) calc’d. for [M+H]+ = [C38H58NO5Si2]+: 
66.3848, found: 664.3857; Rf = 0.80 (n-pentane/Et2O 5/1). 
 
C-9-TBS Ether 310  
 
To an ice-cooled solution of selenide 292 (2.0 mg, 2.40 μmol, 1.0 eq) in dry CH2Cl2 (100 μL) 
was added freshly distilled 2,6-lutidine (1.40 μL, 12.0 μmol, 5.0 eq) and TBSOTf (1.38 μL, 
5.99 μmol, 2.5 eq) under a N2 atmosphere. The yellow reaction mixture was stirred at 0 °C for 
2 h before additional 2,6-lutidine (2.80 μL, 24.0 μmol, 10 eq) and TBSOTf (2.75 μL, 12.0 μmol, 
5.0 eq) was added. Further portions of 2,6-lutidine (4.20 μL, 36.0 μmol, 15 eq) and TBSOTf 
(4.13 μL, 18.0 μmol, 7.5 eq) were added after 5 h and stirring was continued at 0 °C. After 22 h, 
additional 2,6-lutidine (8.40 μL, 72.0 μmol, 30 eq) and TBSOTf (8.26 μL, 36.0 μmol, 15 eq) was 
added. The reaction mixture was stirred at 0 °C for an additional 2 h, and quenched after a total 
reaction time of 24 h by addition of saturated aqueous sodium bicarbonate (3 mL). The aqueous 
phase was extracted with Et2O (3 x 5 mL), the combined organic layers were washed with 
saturated aqueous ammonium chloride (10 mL), dried over Na2SO4, filtered, and the solvent was 
removed under reduced pressure (30 °C). The crude product was purified by flash 
chromatography (toluene/acetone 4/1 to 2/1) to afford the main reaction product C-9 TBS ether 
310 as a bright yellow oil. 
1H NMR (400 MHz, Acetone-d6) δ 8.33 (dd, J = 8.3, 1.3 Hz, 1H), 8.01 (d, J = 7.8 Hz, 1H), 7.83 
– 7.74 (m, 1H), 7.56 – 7.47 (m, 1H), 7.32 (d, J = 7.7 Hz, 1H), 6.90 (d, J = 7.7 Hz, 1H), 6.74 (d, 
J = 2.1 Hz, 1H), 6.63 (d, J = 3.4 Hz, 1H), 6.26 (d, J = 2.1 Hz, 1H), 5.43 (s, 1H), 5.15 (dd, J = 7.8, 
3.4 Hz, 1H), 4.95 – 4.86 (m, 2H), 4.67 (t, J = 10.5 Hz, 1H), 4.07 (t, J = 6.6 Hz, 1H), 3.95 (dd, 
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J = 14.3, 8.0 Hz, 1H), 3.68 (dd, J = 9.9, 4.1 Hz, 1H), 2.61 (t, J = 7.1 Hz, 1H), 2.33 – 2.24 (m, 
3H), 1.86 (s, 3H), 0.88 (s, 9H), 0.77 (s, 9H), 0.09 (s, 3H), -0.03 (s, 3H), -0.04 (s, 3H), -0.35 (s, 
3H) ppm; HRMS (ESI) calc’d. for [M+H]+ = [C43H5535Cl2N2O9SeSi2]+: 949.1983, found 
949.1983; Rf = 0.43 (toluene/acetone 2/1). 
 
C-9 TMS Ether 312 
 
Selenide 292 (2.5 mg, 3.00 μmol, 1.0 eq) was loaded into a glass vial and azeotroped with 
toluene (3 x 0.2 mL). Activated powdered 4Å-MS (6.0 mg) were added, the vial was sealed, 
placed under vacuum and backfilled with N2 (3 x). A solution of previously azeotroped Schmidt 
donor 56 (17.7 mg, 30.0 μmol, 10 eq) in dry CH2Cl2 (100 μL) was added and the yellow 
suspension was stirred for 1.5 h at 23 °C. After being cooled to 40 °C, a solution of freshly 
distilled TMSOTf (1.1 µl, 6.00 μmol, 2.0 eq) in dry CH2Cl2 (5.0 μL) was added and the mixture 
was allowed to warm to 25 °C over a period of 1 h. After stirring for an additional hour at 
25 °C, the mixture was allowed to further warm to 0 °C over a period of 2.5 h before an 
additional portion of TMSOTf (1.1 µl, 6.00 μmol, 2.0 eq) in dry CH2Cl2 (5.0 μL) was added. 
Stirring was continued at 0 °C before the reaction was quenched after a total reaction time of 7 h 
by addition of Et3N (30.0 μL, 215 μmol, 72 eq) followed by sat. aqueous sodium bicarbonate 
(3 mL). The aqueous phase was extracted with Et2O (3 x 5 mL), the combined organic layers 
were dried over Na2SO4, filtered, and the solvent was removed under reduced pressure (25 °C). 
The crude product was purified by flash chromatography (toluene/acetone 10/1 to 7/1 to 3/1), 
followed by preparative HPLC (Chromolith column, n-hexane/EtOAc 1/1.8, 25 mL/min, 
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254 nm, tR(312) = 10.0 min) to afford the main reaction product C-9 TMS ether 312 as a bright 
yellow oil. 
1H NMR (400 MHz, CDCl3) δ 8.35 (dd, J = 8.3, 1.4 Hz, 1H), 7.78 (d, J = 7.9 Hz, 1H), 7.63 (td, 
J = 8.2, 7.7, 1.4 Hz, 1H), 7.39 (ddd, J = 8.3, 7.3, 1.2 Hz, 1H), 7.16 (d, J = 7.7 Hz, 1H), 6.81 (d, 
J = 3.2 Hz, 1H), 6.67 (d, J = 7.8 Hz, 1H), 6.55 (d, J = 2.1 Hz, 1H), 6.32 (d, J = 2.1 Hz, 1H), 5.74 
(d, J = 6.1 Hz, 1H), 5.56 (s, 1H), 5.08 (s, 1H), 5.04 – 4.97 (m, 2H), 4.78 (dd, J = 10.7, 4.1 Hz, 
1H), 4.45 (t, J = 10.6 Hz, 1H), 3.80 (dd, J = 10.3, 4.3 Hz, 1H), 3.54 (dd, J = 14.5, 7.8 Hz, 1H), 
2.92 (dd, J = 13.2, 3.7 Hz, 1H), 2.47 (d, J = 14.6 Hz, 1H), 2.20 (dd, J = 13.1, 11.7 Hz, 1H), 2.03 
(s, 3H), 0.87 (s, 9H), 0.04 (s, 3H), -0.07 (s, 3H), -0.07 (s, 9H) ppm; HRMS (ESI) calc’d. for 
[MH] = [C40H4735Cl2N2O9SeSi2]: 905.1368, found 905.1370; Rf = 0.34 (toluene/acetone 2/1).  
 
Glycosyl selenide 311 
 
Selenide 292 (33.5 mg, 40.1 μmol, 1.0 eq) was loaded into a glass vial and azeotroped with 
toluene (3 x 1 mL). Activated powdered 4Å-MS (140 mg) were added, the vial was sealed, 
placed under vacuum and backfilled with N2 (3 x). A solution of Schmidt donor 56 (214 mg, 
0.361 mmol, 9.0 eq) in dry benzene (3.0 mL) was added, followed by removal of all volatiles by 
sublimation under high vacuum at 0 °C. Dry toluene (1.0 mL) was added and the yellow 
suspension was stirred at 23 °C for 1.5 h. After being cooled to 20 °C, freshly distilled TBSOTf 
(9.22 µl, 40.1 μmol, 1.0 eq) was added and stirring was continued at 20 °C. Additional portions 
of TBSOTf (9.22 µl, 40.1 μmol, 1.0 eq) were added after 1.3 h, 2.5 h and 4.5 h. After a total 
reaction time of 6 h, Et3N (0.224 mL, 1.61 mmol, 40 eq) was added at 20 °C, followed by 
10. Experimental Section  279 
 
saturated aqueous sodium bicarbonate (10 mL). The aqueous phase was extracted with CH2Cl2 
(3 x 10 mL), the combined organic layers were dried over Na2SO4 and the solvent was removed 
under reduced pressure (30 °C). The crude product was purified by flash chromatography 
(toluene/acetone 3/1 to 2/1 to 1/1) to afford glycosyl selenide 311 (25.0 mg, 19.8 μmol, 49%) as 
a yellow oil. 
1H NMR (400 MHz, CDCl3)  = 8.32 (dd, J = 8.3, 1.0 Hz, 1H), 7.74 (d, J = 7.8 Hz, 1H), 7.62 - 
7.58 (m, 1H), 7.38 - 7.32 (m, 1H), 7.07 (d, J = 7.5 Hz, 1H), 6.84 (d, J = 3.3 Hz, 1H), 6.60 (d, 
J = 7.8 Hz, 1H), 6.56 (d, J = 2.0 Hz, 1H), 6.29 (d, J = 2.0 Hz, 1H), 5.99 (s, 1H), 5.78 (br. d, 
J = 6.8 Hz, 1H), 5.15 (s, 1H), 5.01 (ddd, J = 11.0, 6.8, 4.2 Hz, 1H), 4.94 (dd, J = 7.9, 3.4 Hz, 
1H), 4.80 (d, J = 7.3 Hz, 1H), 4.74 (dd, J = 10.8, 4.0 Hz, 1H), 4.63 - 4.59 (m, 1H), 4.28 (t, 
J = 10.5 Hz, 1H), 3.80 (dd, J = 10.3, 4.0 Hz, 1H), 3.64 - 3.54 (m, 2H), 2.90 (dd, J = 12.8, 3.5 Hz, 
1H), 2.76 (d, J = 14.6 Hz, 1H), 2.50 (s, 6H), 2.46 (d, J = 2.3 Hz, 1H), 2.20 (t, J = 12.2 Hz, 1H), 
2.04 (s, 3H), 1.44 (s, 3H), 1.23 (s, 3H), 1.12 – 1.02 (m, 14 H), 1.00 - 0.93 (m, 14H), 0.90 (s, 9H), 
0.07 (s, 3H), -0.01 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3)  = 169.3, 168.8, 151.1, 
148.9, 147.0, 146.6, 139.3, 138.3, 136.1, 135.4, 133.7, 130.6, 130.2, 129.5, 129.4, 129.4, 129.0, 
128.2, 126.3, 125.4, 125.3, 115.0, 113.8, 98.7, 94.1, 82.6, 75.7, 75.4, 74.3, 68.5, 67.0, 51.0, 49.5, 
44.5 (2C), 43.2, 37.0, 31.1, 25.6 (3C), 23.7, 23.4, 22.3, 18.1, 17.5, 17.5 (2C), 17.5, 17.4, 17.3, 
17.3, 14.2, 14.0, 13.4, 12.7, -5.0, -5.1 ppm; IR (ATR): ῦ = 3293, 2947, 2930, 2866, 1738, 1517, 
1146, 1115, 1006, 867, 780, 700 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C58H8435Cl2N3O13SeSi3]+: 1264.3849, found: 1264.3850; [α]D20 = 371.7 (c = 0.1, 
CH2Cl2); Rf = 0.51 (toluene/acetone 2/1). 
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TES Ether 317 
 
To an ice-cooled solution of glycosyl selenide 311 (21.9 mg, 17.3 μmol, 1.0 eq) in dry CH2Cl2 
(2.0 mL) was added freshly distilled 2,6-lutidine (40.0 μL, 347 μmol, 20 eq) and TESOTf 
(39.0 μL, 176 μmol, 10 eq) under a N2 atmosphere. The resulting solution was allowed to warm 
to 23 °C and was stirred for 2 h before additional 2,6-lutidine (20.0 μL, 174 μmol, 10 eq) and 
TESOTf (19.5 μL, 86.5 μmol, 5.0 eq) was added at 23 °C. After stirring for one additional hour, 
the reaction mixture was diluted with CH2Cl2 and quenched by addition of saturated aqueous 
sodium bicarbonate (8 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL), the 
combined organic layers were dried over Na2SO4 and the solvent was removed under reduced 
pressure (30 °C). The crude product was purified by flash chromatography (n-pentane/acetone 
10/1 to 5/1 to 4/1) to afford TES ether 317 (17.0 mg, 12.3 μmol, 71%) as a yellow oil. 
1H NMR (400 MHz, CDCl3)  = 8.30 (d, J = 8.3 Hz, 1H), 7.74 (d, J = 8.0 Hz, 1H), 7.56 (t, 
J = 8.2 Hz, 1H), 7.33 (t, J = 7.8 Hz, 1H), 7.10 (d, J = 7.8 Hz, 1H), 6.64 (d, J = 3.5 Hz, 1H), 6.61 
(d, J = 2.0 Hz, 1H), 6.53 (d, J = 7.8 Hz, 1H), 6.21 (d, J = 2.0 Hz, 1H), 5.92 (s, 1H), 5.82 (br. d, 
J = 6.5 Hz, 1H), 5.01 (ddd, J = 11.0, 7.0, 3.4 Hz, 1H), 4.86 (dd, J = 7.5, 3.5 Hz, 1H), 4.77 (dd, 
J = 10.8, 4.0 Hz, 1H), 4.66 (d, J = 7.3 Hz, 1H), 4.61 - 4.55 (m, 1H), 4.34 (t, J = 10.5 Hz, 1H), 
3.75 (dd, J = 10.2, 4.1 Hz, 1H), 3.68 – 3.57 (m, 2H), 2.96 (dd, J = 13.8, 3.5 Hz, 1H), 2.63 (br. 
d, J = 13.3 Hz, 1H), 2.48 (s, 6H), 2.44 (d, J = 2.0 Hz, 1H), 2.22 (dd, J = 13.8, 11.3 Hz, 1H), 
2.04 (s, 3H), 1.29 (s, 3H), 1.19 (s, 3H), 1.12 – 1.01 (m, 19H), 0.99 0.91 (m, 18H), 0.90 (s, 9H), 
0.72 - 0.63 (m, 6H), 0.06 (s, 3H), -0.01 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3) 
 = 169.3, 168.7, 150.6, 148.8, 147.0, 146.9, 143.6, 138.5, 137.3, 136.7, 136.6, 133.4, 131.1, 
129.8, 129.6, 129.1, 128.3, 126.2, 125.5, 125.1, 118.2, 116.1, 98.3, 93.6, 82.5, 77.1, 75.8 (2C), 
74.4, 68.6, 66.8, 51.2, 50.7, 44.6 (2C), 42.7, 37.7, 31.1, 25.7 (3C), 23.6, 23.4, 18.1, 17.7, 17.6, 
17.6, 17.5, 17.5 (2C), 17.4, 17.3, 14.2, 13.5, 13.4, 13.0, 6.6 (3C), 4.9 (3C), -5.0, -5.1 ppm; IR 
10. Experimental Section  281 
 
(ATR): ῦ = 2951, 2895, 2867, 1742, 1657, 1518, 1473, 1302, 1146, 1115, 1004, 856, 778, 
730 cm-1; HRMS (ESI) calc’d. for [M+H]+ = [C64H9835Cl2N3O13SeSi4]+: 1378.4714, found: 
1378.4721; [α]D20 = 228.3 (c = 0.1, CH2Cl2); Rf = 0.24 (n-pentane/acetone 4/1). 
 
 
Protected fijiolide A 318 
 
A solution of selenide 317 (9.0 mg, 6.53 μmol, 1.0 eq) in toluene (9.0 mL) was distributed into 
five 15-mL Falcon® tubes (4 x 2 mL, 1 x 1 mL). Et3N (2.02 μL, 14.5 μmol, 10 eq and 1.01 μL, 
0.73 μmol, 10 eq) in toluene (100 μL and 50 μL, respectively) was added, followed by aqueous 
H2O2 (30%, 148 μL and 74.1 μL, 1000 eq, respectively) with a micropipette. The reaction tubes 
were sealed and continuously sonicated keeping the water bath temperature at 25 °C. After 2.5 h, 
additional portions of aqueous H2O2 (30%, 74.1 μL and 37.1 μL, 500 eq, respectively) were 
added and the mixtures were sonicated for additional 2.5 h at 25 °C. After a total reaction time 
of 5 h, the contents of all reaction tubes were combined, cooled to 0 °C and poured into an ice-
cold mixture of saturated aqueous sodium thiosulfate/sodium bicarbonate (20 mL, 1/1). The 
aqueous phase was extracted with Et2O (4 x 10 mL), the combined organic layers were dried 
over Na2SO4 and the solvent was removed under reduced pressure (30 °C). The crude product 
was purified by flash chromatography (n-pentane/acetone 8/1 to 6/1 to 4/1) to afford protected 
fijiolide A 318 (5.1 mg, 4.37 μmol, 67%) as a yellow oil, which was used in the next step without 
further purification. 
1H NMR (400 MHz, CDCl3)  = 7.17 (d, J = 7.5 Hz, 1H), 6.89 (s, 1H), 6.76 (d, J = 5.2 Hz, 1H), 
6.62 (d, J = 4.6 Hz, 1H), 6.56 (s, 1H), 6.47 (d, J = 7.6 Hz, 1H), 6.23 (s, 1H), 6.11 (d, J = 1.8 Hz, 
1H), 5.74 (d, J = 6.7 Hz, 1H), 4.95 (ddd, J = 10.7, 6.7, 3.4 Hz, 1H), 4.76 (dd, J = 10.7, 3.5 Hz, 
1H), 4.68 (d, J = 7.9 Hz, 1H), 4.61 (s, 1H), 4.20 (t, J = 10.5 Hz, 1H), 3.79 (dd, J = 10.2, 3.8 Hz, 
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1H), 3.45 (dd, J = 7.5, 2.7 Hz, 1H), 2.97 (dd, J = 13.3, 3.5 Hz, 1H), 2.52 (s, 6H), 2.40 (br. s, 1H), 
2.20 – 2.16 (m, 1H), 2.02 (s, 3H), 1.31 (s, 3H), 1.27 (s, 3H), 1.11 - 0.95 (m, 19H), 0.93 (s, 9H), 
0.88 (t, J = 8.0 Hz, 12H), 0.79 – 0.56 (m, 12H), 0.11 (s, 3H), 0.04 (s, 3H) ppm; HRMS (ESI) 
calc’d. for [M+H]+ = [C58H9335Cl2N2O11Si4]+: 1175.5228, found: 1175.5228; Rf = 0.38 
(n-pentane/acetone 4/1). 
 
Fijiolide A (1) 
 
In a 15-mL Falcon® tube, protected fijiolide A 318 (5.1 mg, 4.37 µmol, 1.0 eq) was dissolved 
in dry THF (1.1 mL). Freshly distilled pyridine (200 µL, 2.47 mmol, 566 eq) and HF•py (70% 
HF, 200 µL, 1.55 mmol, 356 eq) were added and the solution was stirred at 23 °C until complete 
desilylation was suggested by HRMS analysis (7.5 h). The reaction mixture was then diluted 
with CH2Cl2 and poured into ice-cold saturated aqueous sodium bicarbonate (12 mL). The 
aqueous phase (pH 8-9) was extracted with CH2Cl2 (4 x 10 mL), the combined organic layers 
were dried over Na2SO4 and the solvent was removed under reduced pressure (30 °C). The oily 
residue was azeotroped with toluene in order to remove residual pyridine. The crude product was 
purified by flash chromatography (CH2Cl2/MeOH 20/1 to 10/1 to 5/1) to afford fijiolide A (1) 
(2.6 mg, 3.68 μmol, 84%) as an off-white foam. 
Free base fijiolide A (1): 1H NMR (600 MHz, CDCl3)  = 7.43 (d, J = 7.6 Hz, 1H), 7.03 (d, 
J = 1.8 Hz, 1H), 6.94 (d, J = 5.6 Hz, 1H), 6.85 (dd, J = 5.4, 1.9 Hz, 1H), 6.75 (d, J = 7.9 Hz, 
1H), 6.48 (d, J = 1.8 Hz, 1H), 6.31 (d, J = 2.1 Hz, 1H), 6.17 (s, 1H), 5.73 (br. d, J = 6.7 Hz, 1H), 
5.08 (br. s, 1H), 4.96 (ddd, J = 10.6, 6.5, 3.5 Hz, 1H), 4.83 (dd, J = 10.9, 4.1 Hz, 1H), 4.52 (t, 
J = 10.6 Hz, 1H), 4.45 (d, J = 7.9 Hz, 1H), 4.28 (t, J = 2.6 Hz, 1H), 3.96 (dd, J = 10.3, 3.8 Hz, 
1H), 3.07 (dd, J = 7.8, 3.1 Hz, 1H), 2.96 (dd, J = 13.5, 3.5 Hz, 1H), 2.45 (s, 6H), 2.22 - 2.15 (m, 
2H), 2.10 (s, 1H), 2.01 (s, 3H), 1.78 (br. s, 2H) 1.46 (s, 3H), 1.35 (s, 3H) ppm;  
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13C{1H} NMR (150 MHz, CDCl3)  169.3, 168.5, 150.9, 149.5, 148.7, 138.5, 138.5, 138.3, 
138.1, 137.4, 134.5, 130.3, 128.9, 128.8, 127.4, 126.7, 115.1, 113.9, 100.7, 92.8, 84.1, 79.2, 74.2, 
71.7, 69.8, 67.7, 65.6, 51.0, 45.1 (2C), 42.7, 30.9, 23.4, 21.8; IR (ATR): ῦ = 3493, 3371, 2928, 
1680, 1437, 1207, 1138, 801, 724 cm-1; HRMS (ESI) calc’d. for 
[M+H]+ = [C34H3935Cl2N2O10]+: 705.1976, found: 705.1979; [α]D24 = 418.2 (c = 0.055, 
MeOH) (Lit. [α]D21 = 440 (c = 0.5, MeOH); Rf = 0.16 (CH2Cl2/MeOH 5/1).  
 
Synthetic fijiolide A was finally purified by preparative HPLC (Agilent 1260 Infinity Series) on 
reversed-phase C18 column (Phenomenex Kinetex EVO, 150mm x 21.2 mm, 100 Å, 5 μm). 
Elution was performed using a linear gradient of 5% B to 40% B over 30 min at a flow rate of 
25 mL/min with UV detection at 220 nm (Solvent A: H2O + 0.05% TFA; Solvent B: 95/5 
MeCN/H2O + 0.05% TFA; tR (fijiolide A) = 15.0 min) to afford fijiolide A • TFA as a white 
foam. 1H and 13C{1H} NMR spectroscopic data (DMSO-d6, 600 MHz) of synthetic 
fijiolide A • TFA, thus obtained, are provided below. By way of comparison, corresponding data 
of natural fijiolide A • TFA are also provided. 
 
Synthetic Fijiolide A • TFA (referenced to H8 = 5.870 ppm) 
1H NMR (600 MHz, DMSO-d6) δ 8.88 (br. s, 1H), 8.32 (d, J = 7.7 Hz, 1H), 8.32 (s, 1H), 7.08 
(d, J = 8.0 Hz, 1H), 6.76 (s, 1H), 6.65 (dd, J = 5.5, 1.9 Hz, 1H), 6.64 (d, J = 8.1 Hz, 1H), 6.62 
(d, J = 5.5 Hz, 1H), 6.52 (d, J = 1.9 Hz, 1H), 5.98 (d, J = 1.9 Hz, 1H), 5.87 (s, 1H), 5.74 (d, 
J = 4.4 Hz, 1H), 5.64 (s, 1H), 4.96 (d, J = 5.5 Hz, 1H), 4.66 (dt, J = 11.2, 4.3 Hz, 1H),), 4.61 
(ddd, J = 11.9, 8.2, 3.4 Hz, 1H), 4.46 (d, J = 7.9 Hz, 1H), 4.24 (t, J = 10.5 Hz, 1H), 4.06 - 4.01 
(m, 1 H), 3.64 (dd, J = 9.8, 3.7 Hz, 1H), 3.12 - 3.06 (m, 1H), 2.95 - 2.89 (m, 1 H), 2.80 (d, 
J = 3.3 Hz, 3H), 2.79 (d, J = 3.3 Hz, 3H), 2.58 (dd, J = 13.3, 3.9 Hz, 1H), 2.06 (t, J = 13.0 Hz, 
1H), 1.73 (s, 3H), 1.41 (s, 3H), 1.38 (s, 3H) ppm. 
 
Natural Fijiolide A • TFA (referenced to H8 = 5.870 ppm) 
1H NMR (600 MHz, DMSO-d6) δ 9.12 (br. s, 1H), 8.41 (d, J = 8.2 Hz, 1H), 8.36 (s, 1H), 7.09 
(d, J = 7.7 Hz, 1H), 6.76 (d, J = 2.0 Hz, 1H), 6.65 (dd, J = 5.5, 2.2 Hz, 1H), 6.64 (d, J = 8.0 Hz, 
1H), 6.62 (d, J = 5.5 Hz, 1H), 6.53 (d, J = 2.0 Hz, 1H), 5.98 (d, J = 2.1 Hz, 1H), 5.87 (s, 1H), 
5.84 (br. s, 1H), 5.70 (br. s, 1H), 4.95 (br. s, 1H), 4.66 (dd, J = 11.1, 4.1 Hz, 1H), 4.62 (ddd, 
J = 12.1, 8.1, 3.6 Hz, 1H), 4.46 (d, J = 8.0 Hz, 1H), 4.24 (t, J = 10.5 Hz, 1H), 4.08 - 4.03 (m, 
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1H), 3.65 (dd, J = 9.8, 3.9 Hz, 1H), 3.12 - 3.06 (m, 1H), 2.92 (dd, J = 8.5, 3.7 Hz, 1H), 2.80 (br. 
s, 6H), 2.58 (dd, J = 13.5, 3.6 Hz, 1H), 2.07 (t, J = 13.2 Hz, 1H), 1.74 (s, 3H), 1.42 (s, 3H), 1.37 
(s, 3H) ppm. 
 
Synthetic Fijiolide A • TFA (referenced to C9 = 99.80 ppm) 
13C{1H} NMR (150 MHz, DMSO-d6) 169.0, 168.4, 151.8, 148.8, 147.8, 139.3, 138.9, 138.4, 
138.1, 135.8, 135.5, 129.5, 129.3, 129.1, 126.8, 125.4, 114.3, 114.0, 99.8, 93.2, 83.4, 74.9, 72.5, 
69.6 (2C), 67.5, 65.6, 49.7, 44.6, 43.0, 43.0, 31.8, 22.7, 20.9 ppm. 
 
Natural Fijiolide A • TFA (referenced to C9 = 99.80 ppm) 
13C{1H}MR (150 MHz, DMSO-d6)169.0, 168.4, 151.8, 148.8, 147.8, 139.3, 138.9, 138.4, 
138.1, 135.8, 135.5, 129.5, 129.3, 129.2, 126.8, 125.4, 114.3, 114.0, 99.8, 93.2, 83.4, 74.9, 72.5, 
69.7, 69.5, 67.5, 65.6, 49.7, 44.6, 42.9, 42.8, 31.6, 22.6, 21.0 ppm. 
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